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INTRODUCTION
The papers submitted in this thesis represent
various aspects of research in which I have been engaged
since 1953> as Head of the Department of Pharmacology and
Chemotherapy of Beecham Research Laboratories, Ltd., the
Pharmaceutical division of Beecham Group Ltd.
During this time I have had the opportunity to
conduct investigative work in two main fields, as
indicated by the grouping of the papers. The first deals
with the pharmacology of drugs which possess chemotherapeutic
activity (Section A); the second, with drugs which act on
the autonomic nervous system or modify the inflammatory
*
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reaction or act in other ways (Section Bj.
From the beginning, my object has been to develop
methods both in vitro and vivo for the selection of
compounds which might be useful in therapeutics. These
were then studied extensively in animals so as to establish
patterns for their absorption, distribution and excretion,
and for their metabolic transformation into active or
inactive metabolites. Such information makes it possible
to interpret the pharmacological action of a drug and hence
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to consider whether or not tests of its activity should be
extended to man.
*
The subject matter of the thesis is of necessity
diverse; . nevertheless there is an underlying theme, namely
the relationship between the chemotherapeutic or pharmacol¬
ogical action of drugs and the manner of their disposal in
the body. In the following sections, factors concerned in
this disposal are reviewed briefly and references are given
to the appropriate texts in the thesis.
ABSORPTION
Absorption of drugs from the intestine is believed
to occur by passive diffusion of the unionised molecules
and it is frequently as.sumed that there is little difference
in this respect between species, but this is not so. Even
in such a series as the semi-synthetic penicillins where
differences in physical characteristics such as pB:& and
solubility are small, there are distinct variations between
species. Furthermore, after parenteral administration of
antibiotics in different species the percentage excreted in
the urine differs widely. (cf. p. 5X and Knudsen and
Rolinson, B.M.J, ii, I960, pp. 700 - 703)• This type of
study is only of limited help in extrapolating from animal
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to man. Additional factors influencing absorption and
blood concentration patterns are the effect of anaesthesia
which prolongs the time of absorption (pp.172-175) > or
the presence of inflammation which increases both the peak
and the duration of blood concentration. Studies in rats
have confirmed that, in response to an appropriate inflamm¬
atory stimulus, total antibiotic concentrations appearing
in the inflammatory fluid are high and may in fact exceed
the corresponding concentrations in the blood (pp.157 - 162).
Since the assay of tissue concentrations may be unreliable
because of residual blood, it is more appropriate to examine
concentrations appearing in the peripheral and thoracic lymph.
An extensive comparative study in dogs has shown that penicil¬
lins penetrate readily into the extravascular fluids whereas
sulphadiaaine, a typical sulphonamide, does not.
The free concentrations of antibiotics in the lymph correspond
to the free concentrations in the blood; hence it is possible
to conclude that the activity of the penicillins is not less
in the tissues than in the blood.
PROTEIN BINDING
The extent to which a drug is bound by protein
largely governs its activity; an estimate of the free
concentration is therefore essential in predicting therapeutic
value. Initially this was studied by a new method using
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Sephadex to separate the free and bound antibiotic and the
values agreed closely with those obtained by equilibrium
dialysis, (pp.145 - 148). However, the method based on
the use of Sephadex turned out to be more difficult than
that based on equilibrium dialysis, and it was therefore
abandoned in our studies on protein binding. Nevertheless,
Sephadex has since been employed in the separation of
covalent complexes of penicillin with protein which are
partially responsible for the induction of penicillin
allergy. (Batchelor, Dewdney, Feinberg & Weston, Lancet.
1967, 1175-1177)- Parallel estimations in mice of the degree
of protein binding and therapeutic efficacy have shown that
these two properties are strongly correlated, i.e. the group
of compounds having low binding being more active than
compounds with high binding (p. 81). These findings con¬
firmed the in vitro observations that binding leads to a
reduction in activity.
REMOVAL FROM THE BODY
Many drugs disappear from the body by excretion in
the urine; they may also be removed by the bile and possibly
in the breath; minor quantities are excreted in the sweat or
in tears. Penicillins are largely excreted in the urine but
in addition to glomerular filtration, they are actively
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secreted by the renal tubules. This has been demonstrated
in the hen by adapting Sperber's technique (Zool. Bidrag Upsalla
✓
1949, 27, 429-488). A compound that is removed from the body
by renal tubular secretion is injected into one leg of the
hen; the concentration of the compound appearing in the
urine is then found to be much greater from the kidney on
the side of the injection than from that on the other side.
In the hen there is a renal portal system; hence the con¬
centration of antibiotic in blood entering the kidney via
the renal portal system on the side of the injection is
much greater than in the blood on the contralateral side.
After blocking the renal tubular secretion with probenecid
the urinary concentrations become equal. These experiments
have demonstrated that penicillins are excreted not only by
glomerular filtration but also by renal tubular filtration.
Studies in the rat have confirmed that high
concentrations of penicillin are also excreted in the bile
(p. 110, p.135, P- 180).
METABOLISM
In a study of antitubercular drugs in mice, it
was demonstrated that 2,3-dimercaptopropanol had some slight
activity in that it prolongs the survival time. On the
basis of this finding a range of thiols, dithiolans, thiol
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esters, dimercaptopropyl esters and episulphides was
examined. The results led to the conclusion that the
active moiety was an episulphide and that only compounds
that could form episulphides in vitro or in vivo were
active (pp.21 - 33)• Miles and Owen J. Chem. Soc. 817,
1952 and Hardy and Owen J. Chem. Soc. 1528, 1954,
demonstrated that acetylated thiols with a vicinal
hydroxy group in the presence of mild alkali are
deacetylated with ring closure to form episulphides.
The following thiol esters which fulfil these conditions
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Both in vitro and in vivo there is rapid deacetylation
with the elimination of the elements of water to form
an episulphide .
chg.sh chg.sh
krl 403 ^ ch.sh -ho0 '
I I >
ch2.0h oh^
Compounds with higher acyl groups do not hydrolyse
so readily and hence are less active, and where the
potential hydroxy group is separated from the thiol
group by one or more carbon atoms the activity is lost.
Most esters of dimercaptopropanol were active in vivo.
This was due to the hydrolysis of the hydroxy ester, and
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Further support for the metabolic conversion of
acetylated thiols to active antitubercular episulphides
lies in the observation that 1,3-dimercapto-2-benzoyl
propyl ester is highly active both in vivo and in vitro
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whereas the parent compound, 1,3-dimercapto-2-propanol
(BRL 531), is inactive in vivo and highly toxic.
It was possible that the thiols were converted in
vivo to ethanethiol since this compound is a very active
antitubercular agent. A sample of BRL 587 (Benzyl ester
of aimercaptopropanol) labelled with S was administered
subcutaneously to animals and the expired air examined
for the presence of radioactivity, but no radioactivitjr was
found. Since ethanethiol is mostly excreted in the breath
it could be concluded that no BRL 587 was converted to
ethanethiol. However, over 80fo of the radioactivity
appeared in the urine following the administration of
BRL 587, which indicated that the bulk of the compound
had been metabolised giving inorganic sulphate.
Another example of conversion to an active compound
is that of hetacillin (pp.149-156). Hetacillin, which has
the following structure
\j
has a spectrum of activity similar to ampicillin. It is





takes place in the blood. By using high voltage electro¬
phoresis technique it can be demonstrated that hetacillin
is converted to ampicillin in the serum,
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Hetacillin migrates to the positive pole whereas ampicillin
migrates in the opposite direction. Blood determinations
in man showed that within ten minutes nearly all of the
absorbed hetacillin is converted to ampicillin in the serum.
In a study of basic esters having antiacetylcholine
properties, it has been shown in a given series that the
central "antiacetylcholin'e" activity may remain constant
whereas the peripheral activity is reduced. Compounds of
the following structure were investigated:
- 14. -
Maximal central "antiacetylcholine" activity, measured
by its prevention of oxotremorine induced tremors in
i
mice, occurred when = Et and R£= Pr (BRL 1288),
whereas the peripheral antiacetylcholine activity was
very low in relation to that of atropine. Metabolic
studies (pp.222-244) with the aid of autoradiographic
techniques, have shown that this compound is absorbed
rapidly from the intestine and is distributed throughout
the whole body. Differential assays based on the use
131 35 14-
of I, S and C-urea indicate that the drug
penetrates readily into the brain cells, and thin layer
chromatography has confirmed that it is present unchanged.
However, in the peripheral circulation within ten to
fifteen minutes there is no trace of the parent compound,
and eight metabolites have been identified. The metabol¬
ism in man is essentially similar to that in rats (p. 24-1).
The rapid disappearance from the blood accounts for the
low activity in preventing salivation and for its failure
to cause mydriasis. This compound has been tested in
Parkinson's disease and has been shown to possess marked
central activity with little or no antiacetylcholine
action, (pp. 218 - 221),
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CONVERSION IN THE INTESTINE
An active drug may be destroyed in the intestine,
either by the physical conditions within the intestine
or by bacteria; alternatively it may be converted to
another active compound. An example of this conversion
is cloxacillin, an active oral penicillin which is
effective against Penicillin G-resistant forms of staph¬
ylococci. In the intestine it was converted to a
penicillin which no longer displayed activity against
these forms of staphylococci (pp.111-112). The conversion
is due to an enzyme which is either secreted by the
intestine or by bacteria. The compound has still to be
identified, but it is probable that the isoxazole ring
has been split to produce a compound which can be attacked
by penicillinase. (p.l6).
CONVERSION TO AN ACTIVE COMPONENT IN THE BODY
Ampicillin when administered to rats gives rise to
an active metabolite which appears in the urine. There
would appear to be no trace of this compound in the blood
and the conversion could take place in the kidneys.
Experimental work suggests that this compound has lost its
broad spectrum activity, but insufficient work has been
done to characterise the particular metabolite.
- 16 -
DRUGS AFFECTED BY ENZYMES
Following the isolation and. characterisation of
6-amino-penicillanic acid in our laboratories, the
principal objective v/as to develop a penicillin effective
against staphylococci which were resistant to Penicillin
G; these had become a serious problem in hospitals.
The resistant staphylococci produce a penicillinase
which hydrolyses Penicillin G with the production of
penicilloic acid. The phenyl group was therefore
modified with sterically hindered groups which prevented
the access of penicillinase to the molecule. An early
penicillin which acted in this way was 2,6-dimethoxybenzyl-
penicillin. Before this compound could be given to man it
was necessary to show that it was active in vivo. Activity
was confirmed by modifying an intitubercular test origin¬
ally designed by Selby and 0'Grady (Brit. J. Exp. Path.
556, 1954). Staphylococci sensitive to Penicillin G
are injected under the muscle sheath in one hind limb of a
mouse and staphylococci resistant to Penicillin G are
injected into the other hind limb. The animal is treated
with the antibiotic under test and the effectiveness of
the therapy is assessed by the reduction of the size of
the local lesion produced by the staphylococcus. This
- 17 -
technique therefore provides an excellent model for
determining the effect of an antibiotic against two
strains of bacteria in the same animal and for demon¬
strating that penicillinase produced by the resistant
staphylococcus is ineffective in destroying the new
penicillin (pp. 39 -44).
The action of drugs can also be modified by enzymatic
action within the body. In a series of esters of 1-alkyl-
2-hydroxypyrrolidine (pp. 184 - 189)the diamethylaminoetnyl
ester proved to be the most active antiacetylcholine compound
tested in vitro, v/hereas in vivo its activity relative to
others within the series was much less. A method of
estimating antiacetylcholine activity was developed in
rabbits whereby the flow of saliva was stimulated by carbachol
and the effect of the compound was measured by recording the
reduction in flow. (pp. 191 - 195). However, the results in
different strains of rabbits differed markedly. The reason
for this difference was traced to the variability in atropine
esterase activity in the serum which hydrolysed the compounds,
rendering them inactive. Two factors arose out of this
study which previously had not been fully appreciated; firstly
atropine esterase activity could vary markedly between rabbit
strains - it being absent in one strain: secondly, in a
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closely related series of esters the compounds could vary in
their stability to atropine esterase. These experiments
therefore emphasised the importance of strain variation
within a species and the importance of metabolism and factors
affecting metabolism in interpreting the action of drugs.
STRAIN DIFFERENCES
The importance of strain difference in pharmacological
response was subsequently emphasised in the paper dealing
with the variability of mouse strains in the writhing response
to phenylquinone (pp.253-259) Inhibition of this response by
drugs is taken to indicate mild analgesic activity; a
reliable estimate of this activity could not have been obtained
if a suitable strain of mouse had not been selected. The
difference in response to phenylquinone between the mouse
strains has still to be clarified.
TOXICITY
Phenacetin has been widely reported to cause renal
papillary necrosis in man, yet studies in animals have
yielded little information on how the lesion is produced.
An investigation of early kidney damage caused by mild analgesic
drugs in animals showed first, that amidopyrine and antipyrene
both had a toxic action on the renal tubule; secondly, that
amidopyrene also caused renal papillary necrosis; and thirdly
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that phenacetin had no effect on either the renal tubule
or the papilla. Most of the reports on
phenacetin ignore the fact that it is usually compounded
with other drugs and this experiment suggested that phen¬
acetin was not the principal agent in causing renal papillary
necrosis. Kincaid Smith (B.M.J. 1970, 3, 539) has
subsequently confirmed from animal studies that phenacetin
is not the only analgesic likely to cause renal papillary
necrosis, but that the toxic effects which are usually
attributed to phenacetin may be due to other drugs assoc¬
iated with phenacetin in analgesic preparations. In
assessing the toxic effects of a drug an animal model may
therefore provide useful information in the analysis of
the toxicity, and can assist in predicting the adverse
reactions when it is given to man.
MISCELLANEOUS PAPERS
Anti-inflammatory test (pp. 278 - 279)
This test was developed as an entirely novel method
of measuring the potency of anti-inflammatory drugs; in
practice it has proved to be a reliable screening method.
It has not been possible to incorporate this paper into the
general theme of the thesis.
- 20 -
Ganglionic blocking activity (pp. 270 - 277)
A series of quaternary ammonium sulphate compounds
was investigated. The results confirmed that the maximum
ganglionic blocking activity occurred with an optimum
distance between the respective "onium" centres.
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THE ANTITUBERCULAR PROPERTIES OF A SERIES
OF THIOLS AND SULPHIDES
BY
P. ACRED and D. M. BROWN
From the Beccham Research Laboratories Brockham Park, Betchworth, Surrey
(RECEIVED FEBRUARY 3, 1960)
The antitubercular activity of a series of thiols, dithiolans, thiol esters, dimercaptopropyl
esters, and episulphides has been examined in vitro and in vivo in mice infected with the
H37Rv strain of Mycobacterium tuberculosis. Most of the thiol compounds were inactive,
although dimercaprol (2,3-dimercaptopropanol; B.A.L.) and a few closely related compounds
showed slight activity in vivo, the only exception being 2,3-dimercaptopropyl chloride which
was very active. The dithiolans were inactive, but some of the thiol esters were moderately
active, in particular 2,3-di(acetylthio)propyl acetate and 1,2,3-tri(acetylthio)propane. The
majority of the dimercaptopropyl esters had significant activity, the most active compounds
being 2, 3 - dimercaptopropyl benzoate, 1,3- dimercapto - 2 - propyl benzoate, 2, 3 - dimercapto¬
propyl o-chlorobcnzoate, and 2,3-dimercaptopropyl p-chlorobenzoate. All the S-acyl derivatives
of 3-mercaptopropylene sulphide had good antitubercular activity, some being more active than
streptomycin. The most active compound of the series was 3-(2-furoylthio)propylene sulphide.
The activity of the compounds is believed to be due to their conversion in vivo to 3-mercapto-
propylene sulphide and not due to the formation of ethanethiol. Slight deviation from the
basic structure abolishes antitubercular activity.
Anderson and Chin (1947) first drew attention
to the role of thiol compounds in experimental
tuberculosis. These workers found that 2,3-
dimercaptopropanol (dimercaprol; B.A.L.) 100
/ig./ml. inhibited the growth of Mycobacterium
tuberculosis grown in Dubos medium. Del Pianto
(1950) reported the activity of 2-mercaptobenzo-
thiazole in combination with salts of the ^-esters
of thiosulphonic acid. He suggested that the anti¬
tubercular activity of sodium ethyl thiosulphate
was due to the formation of ethylmercaptan
(ethanethiol). Solotorovsky and his colleagues
[Brown, Matzuk, Becker, Conbere, Constatin,
Solotorovsky, Winsten, Ironson and Quastel
(1954) ; Solotorovsky, Winsten, Ironson, Brown
and Becker (1954); and Solotorovsky, Winsten,
Ironson and Brown (1956)] examined a series of
ethylthio compounds, in particular S'-ethyl t-
cysteine, which was reported to be more active
than p-aminosalicylic acid when administered in
the diet. Other workers were unable to confirm
these findings and further investigation revealed
that the activity of S-ethyl-l-cysteine and other
members of the series depended upon the forma¬
tion of the volatile compound ethanethiol [Solo¬
torovsky (1955) (1956); Solotorovsky, Ironson,
Winsten (1956); Oginsky, Solotorovsky and
Brown (1955) (1956)]. Kushner, Dalalian, Bach,
Centola, Sanjurjo and Williams (1955) and Davies,
Driver. Hoggarth, Martin, Paige, Rose and Wilson
(1956) have investigated more recently the anti¬
tubercular activity of series of compounds related
to ethanethiol. The latter authors considered that
only compounds which were converted to
ethanethiol were active.
We have investigated the antitubercular activity
of dimercaprol and a number of related com
pounds and have found some active derivatives.
The activity of the compounds does not appear to
depend uport the formation of ethanethiol.
Methods
The organism employed was the human strain
of Mycobacterium tuberculosis, h37rv, reference
National Collection of Type Cultures 7416.
Compounds to be tested for in vitro activity were
treated according to their solubility. Aqueous solutions
were used when possible, but compounds which were
only sparingly soluble in water were dissolved in 1 ml.
ethoxyethanol and diluted 1:20 with distilled water.
This ether possesses some growth-inhibitory activity
against Mycobacterium tuberculosis at a concentration
of 1:20, but the amount of ethoxyethanol in the final
test concentration was never allowed to exceed I : 200.
Serial concentrations of the dissolved compounds
were made in Dubos medium. The tubes were inocu¬
lated with two drops of 1:10 concentration of a
T
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suspension, standardized to Wellcome opacity tube 2,
of a 10-day-old culture of Mycobacterium tuberculosis
grown in Dubos, and incubated at 37°. Readings of
growth were made at 7 days.
The activity is recorded as the lowest concentration
of the compound (/<g./ml.) inhibiting growth of the
organism, that is, the minimal inhibitory concentration
(M.I.C.).
In vivo Tests.—Male albino mice weighing 18 to
22 g. were infected by injecting intravenously 0.2 ml./
20 g. of a suspension in saline of a 15-day-oId culture
of H37Rv strain of Mycobacterium tuberculosis grown
in Proskauer and Beck medium. The suspension
opacity was adjusted to a density equivalent to 4 mg.
wet weight of organism/ml.
Compounds were administered daily in arachis oil
(uniess otherwise stated—see Tables) at doses of 1 /2,
1/5, 1/10. and 1/20th of their approximate sub¬
cutaneous LD50 values to groups of mice, 10 to a
group. The arachis oil solution acted as a depot from
which the compounds were slowly absorbed. In each
















218 CH2(SH).CH2.CH2.CH2.SH 559 CH3.CH(SH).CHO.S.[CH2]3.SH
231 CH2(SH).CH(OH).CH2.SH 560 CH2(OH).CH2.CH,.S.CH2.CH(SH).CH3
243 CH2(OH).CH2.SH 570 CH2(SH).CH2(OH).CH2.S.CH2.CH(SH).CH3
244 CH2(SH).CH(SH).CH3 573 CH2(SH).CH2.S.CH2.CH2SH
248 CH2(SH).CH(SH).CHo.SH 576 CH2(SH).CH(OH).CH2.CH2SFI
259 CH2(OH).CH2.CH2.SH 581 CH3.CH(SH).CH(SH).CH2OH
264 CH2(SH).CH(OH).CH3 584 CH2(SH).CH(SH).CH2.S.CH2.CH(SH).CH3
271 CH2(OH).CH(OH).CH2.SH 614 CH2(SH).CH(O.CO.CH3).CH2SH
449 CH2(SH).CH(SH).CH2.OC2H5 622 CH2(SH).CH,.CH(SH).CH2O.CO.CH3
458 CH2(SH).CH(SH).CO.OCH3 633 C(CH2.SH)2(0H)(C02H)
476 CH2(SH).CH(SH).CH(OCH3).CH,.OCH3 639 CH2(OH).CH(SH).CH(SH).CH2OH
484 CH2(SH).CH(SH).C02H 713 CH2(SH).CH(SH).CH,.O.C6H5
493 CH2(SH).CH(OH).CH(SH).CH3 735 CH2 [SH] •CH [SH] •CH2-0
496 CH2(SH).C(CH3)(OH).CH2.SH 756 CHj»[SH]-CH[SH] -CHz-S ^-CHj .















Extension in TD50 over Control.
Dose Fraction of LD50
1/2 1/5 1/10 1/20
— Dimercaprol
CH2(SH).CH(SH).CH,OH 500 100 9-5 7-0 — —







25-50 >500 — 140 8-0 3-5





— 250 7-5 4-0 2-0 —
567 CH2(SH).CH2(SH).CH(C1).CH3 50-0 500 11-0 7-0 3-5 —
578 CH2(SH).C(CH3)(C1).CH2SH >500 400 — 80 6-0 —
609 CH3.CH(SH).CH(SH).CH2C1 >500 300 — 40 6-0 —
784 CH2(SH).[CH2]8.CH(SH).CH2OH >500 500 j — 4-0 0-5 —
as an infected control. Some compounds were tested for
oral activity, either by administration by stomach tube
or in the diet. The doses administered were again 1/2,
1/5, 1/10, and 1 /20th of their approximate acute oral
LD50. The water-soluble compounds were given in
aqueous solution in a volume of 0.2 ml./20 g. and the
insoluble solids as acacia suspension, 0.2 ml./20 g.
When the compounds were given in the diet the solu¬
tion or suspension was added to 250 g., so that the
appropriate dose was contained in 5 g., that is, the
average daily intake for one mouse. Daily dosing
commenced in all cases 24 hr. after infection and
con'mued until the twentieth day of the experiment.
The TD50 values (median survival time) were deter¬
mined by plotting the accumulative percentage mor¬
tality against time in days on log probit paper, and in
cases where there was an increase in TD50 value over
that of the control the results were analysed by the
method of Litchfield (1949).
Toxicities.—Only approximate estimates of the acute
LD50 values were obtained. The compounds were
prepared as oil and water emulsions using acacia as
the dispersing agent, and injected subcutaneousiy into
groups of 5 mice per dose level.
Results
Thiols
The inactive thiols are shown in Table I and the
active thiols in Table II. The parent compound
of the series, dimercaprol (2,3-dimercapto-
propanol), and all the active thiols, apart from
2,3-dimercaptopropyl chloride (B.R.L. 479), were
only slightly active in vivo. In vitro their activity
was negligible. The compounds which were active
possessed free thiol groups and a hydroxyl group,
but not necessarily all compounds of this type were
active. Acylation of the hydroxyl group or
replacement of the hydroxyl group with a thiol,
carboxyl or substituted carboxyl group abolished
activity. Compounds having only one thiol group
were inactive. If the hydroxyl group in the com¬
pounds having two vicinal thiol groups was
replaced by a chlorine atom, activity was retained
and might in fact be enhanced, for example, 2,3-
dimercaptopropyl chloride (B.R.L. 479) was
appreciably active in vivo, giving a considerable
extension of the survival time. In vitro it had an
25
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activity of 6.25 ^g./ml., being the only member of
this group which had a significant in vitro activity.
The chloro compounds B.R.L. 479, B.R.L. 567
and B.R.L. 609, which were prepared from the
hydroxyl analogues and hydrochloric acid, may
be contaminated with isomeric structures (Doyle,
Holland, Mansford, Nayler, and Queen, 1960).
Dithiolans
Ring closure to form dithiolans resulted in
complete loss of activity—Table 111.
Thiol Esters
The inactive thiol esters are listed in Table IV and
the active thiol esters in Table V. Some of the active
compounds showed considerable in vitro activity.
2,3-Di(acetylthio)propyl acetate (B.R.L. 403) and
2,3-di(acetylthio)propanol (B.R.L. 464) are active
at a concentration of 0.8 /xg./ml. 1,2,3-Tri(acetyl-
thiopropane (B.R.L. 411) was also very active in
vitro. These three compounds also showed good
activity in vivo. Increasing the size of the acyl
group to a butyryl group, however, led to a
considerable decrease both of in vivo and in vitro
activity. The substitution of other radicals also
led to a diminished activity.
Table III
DITHIOLANS




























































































6-25 500 2-5 -1-0 -1-5
655
ch2- ch ch2
s-co-ch3 o-so2(]}ch3 s-co-ch3 6-25-12-5
>500 '— 14-0 11-5
150 (a) — 2-0 3-0 (a)
758
CH2 CH [CH,1, CH,
















Compounds were administered subcutaneously in arachis oil except where indicated as follows: (a) orally













Extension in TD50 over Control.
Dose Fraction of LD50
1/2 ; 1/5 1/10 1/20
463 R-CO.CH, 3-125-6-25 78 15-0 8-0 4.4 —
504 r-co.c2h5 12-5 150 13-0 I 4-0 — —
510 R-CO.C3H- 25-0 400 13-0 8-5 1-5 —
587 R-CO.CsH5 12-5
>500 28-4 18-6 16-4 9-0
600 (a) 5-2 2-5 1-25 (a) —
— -3-5 11-5 0(b) —
636 R-Co{~\ 25-0
>500 20-0 29-0 22-8 10-7
500 (a) 6-5 2-0 2-5 (a) —
637 R'CO^~\ci 12-5 500 54-0 29-0 16-0 11 -25
638 R-CO.CH2.C6H5 25-0
500 — 14-5 8-5 1-0
>500 (a) — 3-0 3-5 (a) —
651 R-CO-^ ^-PO-fa 25-0 200 22-5 11-5 5-5 —
668
R-CO
50-0 >500 — 9-5 2-5 —
670 R-CO-^ ^NH-SO;-^ ^-CH3 >50-0 >500 — 8-0 0-5 —
671 r-co.ch2.s.c2h3 25-0 300 . 8-0 3-5 —
673 R-CO.CH2.S.CH2.CsH5 50-0
>500 14-0 10-5 5-0 --





1-56 500 34-0 19-0 10-25 3-5
693 R-CO.[CH2]2.S.CH3 25-0 500 — 8-5 6-0 —
707
CI
R-CQ-^ ^-Cl 25-50 150 — 3-0 0-75 —
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Dimercaptopropyl Esters
The inactive compounds are given in Table VI
and the active compounds in Table VII. When the
hydroxyl group is esterified there is usually a
considerable increase in antitubercular activity,
particularly in compounds with vicinal thiol
groups, and where the hydroxyl group is adjacent
to these. 2,3-Dimercaptopropyl benzoate (B.R.L.
587), 2,3-dimercaptopropyl o-chlorobenzoate
(B.R.L. 636) and 2,3-dimercaptopropyl p-chloro-
benzoate (B.R.L. 637) are the most active of this
particular type. The precise nature of the ester
radical, however, does not seem to be of great
importance in determining the degree of activity.
All of the O-esters of dimercaprol were, however,
comparatively inactive in vitro.
A notable exception to the general pattern
is 2-mcrcapto-l-mercaptomethylethyl benzoate
(B.R.L. 680), which has the two thiol groups
separated by the ester group. This compound is
active both in vitro and in vivo. The isomer
2,3-dimercaptopropyl benzoate (B.R.L. 587) is
relatively inactive in vitro.
Episulphides
By eliminating the elements of water from thiol




















Compounds were administered subcutaneously in arachis oil except where indicated as follows: (a) orally in













Extension in TD50 over Control.
Dose Fraction of LD50




-1-5 -3-0 -3-0 (c) —
17-2 17-0 14-5 4-0
3-0 1-25 1-0 (a) —




100 200 2-5 1-5




500 400 — 4-5 6-75
599 r.ch(sh).ch3 12-5-25-0 100 2-5 1-5 -1-0 —
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Table X
EPISULPHIDES WITH S-ACYL GROUPS
Compounds were administered subcutaneously in arachis oil except where indicated as follows: (a) orally
















Extension in TD50 over Control.
Dose Fraction of LD50
1/2 I 1/5 1/10 1/20
459 r.co.ch3 0-4-0-8
45 17-25 14-0 12-0 4-5
110 (a) 9-25 6-25 0-5 (a) —
3-5 2-0 (b) — —
-2-5 -1-5 -2-5 (c) -




300 14-5 5-25 0-5 —
561 r.co.qh, 6-25-12-5 100 14-5 13-5 7-0 | _







200 (a) 1-5 1-5 (a) —
590 r.co.chocl 25-0
60 16-0 17-5 16-3 6-0
150 (a) 3-5 2-5 2-5 (a)
595 ch2 ch.ch(s.co.ch3).ch3 25-50 300 5-5 3-5 1-5 —
600 r.co.[ch2].,.co.och3 1-56-3-125 100 .7-5 6-5 12-0 —
601 ch2 ch.[ch2l3.s.co.ch3 3-125 >500 17-5 10-0 1-5 —
602 r.co.o.c2h5 1-56 150 16-5 18-0 15-0 4-5
605 r.co.qhs 1-56
300 30-5 16-5 20-5 0
400 (a) 4-0 2-5 2-0 (a) j —
615 r.co.ch2.co.o.c2h5 3-125 75 22-5 11-0 8-0 —










Extension in TD50 over Control.
Dose Fraction of LD50
1/2 1/5 1/10 1/20
625 r.co.ch,.ch2cl 6-25 300 — 19-5 17-5 —
629 r.co.ch2.c6h5 12-5
500 22-5 27-5 17-0 11-0
>500 (a) 13-0 9-0 6-0 (a) —
— — 4-0 0-5 (b) —
635 R.co.cc1, 25-0 500 — — 22-5 21-5
643 R.CO.CO.O.C2Hs 12-5 100 17-5 13-5 10-5 —
649 R-CO-^ ^ci 50-0
200 29-5 12-5 2-5 —
> 1000(d) 10-0 1-5 0-5 (d) —
656 R.CO^NO2 6-25
>500 29-5 15-0 110 —
>500 (d) 16-25 5-2 2-75(d) —
658
1 JR-CO^o^ 0-39
300 — 28-5 26-3 8-5
500 (a) — 7-0 0-5 (a)
664
/CV^R-CO-CH2-N >500
300 15-0 j 16-0 15 0 —
1000(d) | 4-0 2-0 3-0 (d) —
669 R-C0-CH,0^}ci >500 200 — 5-5 2-5 —
672 R.CO.CH(C6H5)2 >500 >500 6-0 1-0 1-0 —
677 r.co.ch2.s.c2h5 6-25 100 18-5 9-0 4-0
681 R.CO.[CH2]u.CH2 >500 >500 4-0 0-5 -1-0 —
690 r.co.ch2.nh.co.o.ch2.c6h5 25-0 j 150 12-5 8-5 1-5 —
710 R.CO.CH.[CHo],.CH2 6-25-12-5 >500 34-5 23-5 1-5
711 R.CO.[CH2]2.CO.CH3 25-0
100 23-5 — —
200 (a) - 7-0 2-5 (a) —
— — 2-5 2-0 (b) —
721 R-CO-^ ^CO-R 3-125 >500 25-0 17-0 17-0 (e)
31









Extension in TD50 over Control.
Dose Traction of LD50
1 2 1/5 1 10 1/20
727 R.CO.CH.,.NH.CO.CSH5 >500 400 17-0 16-0 1-5 (e)
728 r-cch^- ^-n-n'cfrhs 3-125 >500 — 8-0 11-0 2-0 (e)
733 r-co<q nh-co-ch3 3-125-6-25 >500 — ■ 21-0 13-0 5-5 (e)
746 r.co.o.ch. 6-25-12-5 50 — 8-5 4-5 —
747 r ■ coch;-<^ ^cl 25-0 12-5 9-0 (e) —
748 R.CO.CH(Cl).C6H5 25-0 >500 — 2-5 0-5 (e) —







to form episulphides the compounds produced
have enhanced antitubercular activity. The inactive
compounds are shown in Table Vlil and the active
compounds in Tables IX and X. Since the synthetic
method (Doyle, Holland, Mansford, Nayler, and
Queen, J. chem. Soc., in the press) was not struc¬
turally definite either or both of the preparations,
B.R.L. 528 and B.R.L. 599, may be mixtures of
the two isomeric structures. Of the compounds in
Table IX only 3-mercaptopropylene sulphide
(B.R.L. 482) and di(2.3-epithiopropyl) disulphide
(B.R.L. 553) show good activity. On the other
hand, the majority of episulphides with S-acyl
groups (Table X) were highly effective chemo-
therapeutic agents. The compounds with an
episulphide ring must, however, be comparatively
simple in order to be active ; compounds with high
activity being confined to 5-acyl derivatives of
3-mercaptopropylene sulphide (B.R.L. 482). Sub¬
stitution of methyl groups on any of the carbon
atoms almost abolishes activity. The addition of
groups other than simple acyl radicals also
abolishes activity. The nature of the acyl radical,
on the condition that it is a simple group, would
not appear to be the main determining factor for
antitubercular activity, but the acetyl (B.R.L. 459)
and furoyl (B.R.L. 658) derivatives both have high
in vivo and in vitro activities.
Discussion
A large number of thiol compounds and related
derivatives have been investigated for antituber¬
cular activity, and many have proved to be active
in vivo. There are, however, a number of
discrepancies between the in vitro activity and the
in vivo activity, and an explanation for this must
be sought.
Since the majority of the episulphides are very
active in vivo, it would appear that the episulphide
structure is the necessary moiety for antitubercular
activity. This view is supported by the investiga¬
tions of Miles and Owen (1952) and Harding and
Owen (1954), who have shown that acetylated
thiols with a vicinal hydroxyl group in the presence
of mild alkali are deacetylated with accompanying
ring closure to form episulphides. The activity of
the thiols and thiol O-esters can therefore be
accounted for by such a mechanism. Further
confirmation that an active derivative is formed
has been obtained by the findings of Mansford and
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Langley (to be published), who have shown that the
addition of 3-acetylthiopropylene sulphide (B.R.L.
459) to serum leads to the formation of 3-mer-
captopropylene sulphide (B.R.L. 482). If B.R.L.
482 is the active derivative, the absence of activity
in vitro may be explained by the fact that it is an
unstable compound and under the mild alkaline
conditions of the in vitro test it forms inactive
polymers.
The activity of the compounds tested is not due
to their conversion to ethanethiol which has been
shown to be the active agent produced by other
thiol antitubercular agents (Oginsky, Solotorovsky,
and Brown, 1955, 1956). We have been unable to
detect ethanethiol in the expired air of animals
injected with any of the compounds tested, nor has
it been possible by using B.R.L. 587 containing
radioactive 35S to detect 3SS in the breath. Over
80% of the injected 35S was recovered in the
urine of rats in 24 hr. as sulphate.
The activity of the compounds which are active
in vitro can possibly be explained by the assump¬
tion that the compound is absorbed on the surface
of the organisms and the active metabolite (i.e.,
B.R.L. 482) is formed in close proximity to it and
is therefore able to exert an antibacterial action
before it is destroyed chemically. While there is
little evidence for this theory, it does provide a
likely explanation.
This explanation could also account for the
apparent discrepancy between activities of 2,3-
dimercaptopropyl benzoate (B.R.L. 587) and
l,3-dimercapto-2-propyl benzoate (B.R.L. 680) in
vitro and in vivo. It is possible that B.R.L. 680
can be readily converted in vitro to the parent
episulphide whereas B.R.L. 587 cannot. In vivo,
however, the reaction may readily take place, with
the result that both compounds are equally active.
It is unlikely that the compounds are simply
dealkylated to the hydroxyl compound without
ring closure taking place, since the parent hydroxyl
compound (B.R.L. 231) of B.R.L. 680 is highly
toxic and completely inactive in vivo.
We wish to thank Mr. F. P. Doyle and his colleagues
for preparing the compounds ; Dr. L. N. Owen for the
supply of 3,4-dimethoxybutane-l : 2-dithiol (B.R.L.
476), l,4-dihydroxybutane-2:3-dithiol (B.R.L. 639)
and l,4--diacetoxy-2,3-(diacetylthio)butane (B.R.L.
640); Dr. J. H. C. Nayler for guidance on chemical
nomenclature ; and Mr. D. Wright for technical
assistance.
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THE ANTITUBERCULAR ACTIVITY OF 3-ACETYLTHIO-
PROPYLENE SULPHIDE AND 3-(2-FUROYLTHIO)PROPYLENE
SULPHIDE
BY
P. ACRED, D. M. BROWN, and D. WRIGHT
From the Beecham Research Laboratories, Brockham Park, Betchworth, Surrey
(received february 3, 1960)
Two derivatives of 3-mercaptopropylene sulphide (B.R.L. 482), 3-acetylthiopropylene sulphide
(B.R.L. 459) and 3-(2-furoyIthio)propylene sulphide (B.R.L. 658), have been tested in mice for
antitubercular activity. The compounds were administered daily in arachis oil by the sub¬
cutaneous route. When tested by a prolongation in survival time B.R.L. 459 was less active
than streptomycin, while B.R.L. 658 was of the same order of activity. When assessed by the
lesions present in the lungs after 14 days' treatment B.R.L. 658 was as active as isoniazid and
B.R.L. 459 was of the same order of activity as streptomycin. Neither compound, however,
cured an established infection and resistance developed rapidly to both compounds, both in
vitro and in vivo. It is concluded that, in view of their adverse physical and pharmacological
properties, the compounds are unsuitable for clinical use.
Acred and Brown (1960) have tested a series
of new antitubercular compounds related to
dimercaprol (2,3-dimcrcaptopropanol) and have
produced evidence that the activity of the com¬
pounds depends on the formation of 3-mercapto-
propylene sulphide. S-acyl derivatives of this
compound possess considerable antitubercular
activity. Two of the most active compounds,
3-acetylthiopropylene sulphide (B.R.L. 459) and
3-(2-furoylthio)propylenc sulphide (B.R.L. 658),
have been examined in greater detail.
Methods
The methods and techniques for assessing anti¬
tubercular activity in vitro and in vivo were the same
as those used by Acred and Brown in the previous
paper. The organism employed in all tests was the
human strain (HstRv) of Mycobacterium tuberculosis.
In all tests the propylene sulphides were administered
in arachis oil solution ; streptomycin and isoniazid
were given in aqueous solution.
Determination of the Extension of the Median
Survival Time (TD50).—The antibacterial activity of
the compounds was tested in mice (18 to 22 g.) infected
with Mycobacterium tuberculosis and compared with
that of streptomycin and isoniazid. Doses of one-
fifth, one-tenth, one-twentieth and one-fortieth of the
acute subcutaneous LD50 values were administered
daily by the subcutaneous route for 20 days following
the infection ; the activity being expressed as the
extension in days of the median survival time, over
that of the infected control.
Lung Lesion Test.—As a further check on activity
the procedure described by Solotorovsky, Winsten,
Ironson, Brown, and Becker (1954) was employed.
Ten mice (18 to 22 g.) were allocated to each group.
The mice were infected intravenously with 0.8 mg.
wet weight of Mycobacterium tuberculosis. The com¬
pounds were administered at one-fifth, one-tenth, one-
twentieth and one-fortieth of the acute subcutaneous
LD50 values. Treatment was stopped when 50% of
the infected control animals died. On that day all
surviving animals were killed and the lungs removed
and kept in 10% formol saline for 4S hr. The degree
of lung tuberculous involvement was scored in percen¬
tage for each group, the final result being expressed
as the mean percentage tuberculous involvement.
Activity Against ait Established Infection.—Groups
of 10 mice were infected intravenously with 0.8 mg.
wet weight Mycobacterium tuberculosis. Treatment
was commenced after seven days, and continued until
the twentieth day. Doses of the propylene sulphides
equal to one-fifth and of streptomycin equal to one-
tenth the acute subcutaneous LD50 were given by the
subcutaneous route. The TD50 values were estimated
and compared with an infected control group.
In vivo Resistance.—The propylene sulphides and
streptomycin were administered daily by the sub¬
cutaneous route at one-twentieth of their acute
subcutaneous LD50 values. Groups of 10 mice (18
to 22 g.) infected intravenously with 0.8 mg. wet
weight Mycobacterium tuberculosis were used. When
two or three mice remained in each group they were
killed, and the lungs and spleens removed and homo¬
genized. The tubercle bacilli were cultured from the
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homogenates on Lowenstein-Jcnsen slopes and in
Proskauer and Beck medium. For the next passage
a further group of mice were infected with an
inoculum prepared from the isolated organism grown
on Proskauer and Beck medium. The in vitro sensitivity
and virulence of the bacilli isolated at the first, third,
and fifth passages were determined and compared with
the results obtained for bacilli isolated at each passage
taken from an infected, untreated control group of
mice. The in vitro sensitivity was determined in
Dubos medium. The virulence to mice was checked
by infecting intravenously a group of 10 mice with
0.8 mg. wet weight of the organism isolated, and
determining the TD50 in the absence of drug
treatment.
Development of Resistance in vitro.—A suspension
of a 10-day culture of Mycobacterium tuberculosis,
standardized to Wellcome opacity tube 2, was diluted
1 : 10 with Dubos medium. Two drops of this suspen¬
sion were added to tubes, each containing 2.5 mi. of
serial dilutions of B.R.L. 459 and B.R.L. 658, strepto¬
mycin, and isoniazid in Dubos medium. Incubation
was carried out at 37° for 7 days. The concentration
of drug in /tg./ml. which just inhibited growth (mini¬
mal inhibitory concentration) was noted. The inoculum
for the subsequent passage was taken after a further
7 days' incubation from the tube containing the highest
concentration of drug in which growth occurred.
Passaging was continued until a high degree of
resistance to the compounds had developed.
Results
Extension of Median Survival Time.-—The
results obtained are given in Table I. B.R.L. 459
is less active than streptomycin at all dose levels.
B.R.L. 658 also appeared to be less active, but in
1 experiment with streptomycin a rather unusually
long extension of the TD50 was recorded. If this
test is not taken into account the activity of B.R.L.
658 and streptomycin would be of the same order.
Isoniazid is considerably more active than both
the compounds under test.
Lung Lesion Test.—The results obtained are
given in Table II. When tested in this way B.R.L.
459 was of the same order of activity as strepto¬
mycin. At the dose levels employed all the lungs
showed advanced tuberculous involvement. B.R.L.
658, on the other hand, was more active than
streptomycin. At one-tenth of the subcutaneous
LD50 dose the tuberculous involvement was
slightly greater than minimal, while at one-
twentieth of the LD50 there was only an average
of 25% involvement. However, at one-fortieth of
Table I
THE ANT1TUBERCULAR ACTIVITY OF 3-ACETYLTHIOPROPYLENE SULPHIDE (B.R.L. 459)
AND 3-(2-FUROYLTHIO)PROPYLENE SULPHIDE (B.R.L. 658), STREPTOMYCIN AND
ISONIAZID IN MICE
The extension of the TD50 value is the increase in survival time of the treated mice over the untreated mice,
measured from the regression of percentage mortality against time on log-probit paper at the 50% mortality











Extension in TD50 over Control—-Days.
Dose Fraction of Subcutaneous LD50
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Table ii
LUNG LESION TEST
The mice were killed and the lungs examined on the
day 50% of the control mice died.
Compound Expt.
No.
% Lung Tuberculous Involvement.


















































the LD50 there was advanced involvement, but
this was not a great deal worse than that seen in
mice treated with one-tenth the subcutaneous LD50
of streptomycin. From the limited data with













Action Against Established Infection.—Neither
B.R.L. 658 nor B.R.L. 459 gave any protection to
mice which had been infected 7 days previously.
On the other hand, streptomycin had a pronounced
antitubercular action ; all the mice still survived 30
days after the infection (see Table 111).
In vivo Resistance.—The in vitro sensitivities of
the bacilli isolated from mice at the end of the first,
third and fifth passages are given in Table IV.
Table IV
VIRULENCE AND IN VITRO SENSITIVITIES OF
MYCOBACTERIUM TUBERCULOSIS PASSAGED
IN MICE
Mice infected with Mycobacterium tuberculosis were
treated daily with one-twentieth the subcutaneous
LD50 of B.R.L. 459, B.R.L. 658, and streptomycin for
twenty days. At the end of each passage the organism
was isolated on Lowenstein and Jensen slopes from the
mice and the in vitro sensitivity (minimum inhibitory
concentration—/tg./ml.) determined in Dubos medium.
The virulence was determined by infecting groups of
ten mice and estimating the TD50 in the usual manner.











































































Resistance of the bacilli to B.R.L. 459 and B.R.L.
658 had developed markedly by ^he end of the
fifth passage, while no change in the sensitivity to
streptomycin was detectable. In every instance the
virulence of all the isolated bacilli was fully
maintained.
In vitro Resistance.—Resistance induced by
in vitro transfer to B.R.L. 658 and B.R.L. 459
developed with exceptional rapidity (see Fig. 1).
The minimal inhibitory concentration at the com¬
mencement of the test for B.R.L. 658 and B.R.L.










4 8 12 16
No. of passages
Fig. 1.—Development of resistance of Mycobacterium
tuberculosis (H37Rv) in Dubos medium to B.R.L.
459, B.R.L. 658, streptomycin, and isoniazid.
A B.R.L. 459.
O Isoniazid.
A B.R.L. 658. O "Streptomycin.
rose to 50 to 100 /tg./ml. for B.R.L. 459, and 25
to 50 /xg./ml. for B.R.L. 658. In the control series
resistance to streptomycin began to develop within
twelve passages, the minimal inhibitory concentra¬
tion rising from 0.39 to 6.25 /Ag./ml. With
isoniazid resistance began to develop at the fourth
passage, but did not increase to the degree shown
by the propylene sulphides.
Discussion
B.R.L. 459 and B.R.L. 658 are highly active
antitubercular compounds when tested in mice
infected with the H37Rv strain of Mycobacterium
tuberculosis. B.R.L. 658 is the more active of the
two compounds, comparing favourably with
streptomycin by the TD50 test, and is of the same
order of activity as isoniazid by the lung lesion
test. B.R.L. 459 shows a corresponding difference
in relative activity to streptomycin and isoniazid by
the two methods. The difference in relative
activity observed using the two methods is prob¬
ably due to the compounds having a bacteriostatic
and not bactericidal action in vivo. In the TD50
test administration of the compounds is stopped
after 20 days when a generalized lethal infection
develops. On the other hand, in the lung lesion
test the mice are still under treatment when they
are killed. The growth of the organism is well
suppressed at this stage and the lungs are prac¬
tically devoid of lesions. The lung lesion test
therefore gives a more favourable impression of
relative activity.
Resistance to the compounds develops excep¬
tionally rapidly in vitro and also in vivo. They
are also incapable of curing an established infec¬
tion and are ineffective orally. When administered
daily over a period of six months to guinea-pigs
infected with Mycobacterium tuberculosis they
give rise to ulcers of such severity that they render
an assessment of antitubercular activity in guinea-
pigs impracticable. In addition, the compounds
are odorous, oily, water-insoluble liquids which
are unstable in the presence of water and in mild
alkaline conditions. In spite, therefore, of their
initial highly promising activity in mice, their
adverse physical and pharmacological properties
would seem to rule out their possible clinical use.
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Brockhatn Park, Betchworth, Surrey
The discovery and isolation of 6-aminopenicillanic acid
(Batchelor et al. 1959) has made it possible to synthesise a
wide range of penicillins with modified properties. One
of these;, brl.1241,* has proved highly effective against
penicillin-resistant staphylococci.
Methods and Results
In the following experiments brl.1241 and penicillin G
were administered as their sodium salts.
General Pharmacology
In mice and cats no toxic symptoms were observed with
single doses of 2.5 g. per kg. intravenously, and in mice
and rats with doses of 4 g. per kg. subcutaneously. When
erl.1241 was administered daily to rats for twelve weeks at
doses of 100 and 500 mg. per kg. subcutaneously, and to
dogs for four weeks at 250 mg. per kg. twice daily sub¬
cutaneously, no biochemical, hnimatological, or histo¬
logical abnormalities were noted. Apart from the dis¬
comfort of the injection, the compound was well tolerated.
1% and 10% solutions were injected intramuscularly and
intradermally into rats, guineapigs, and rabbits without
any local irritation. Similarly, a 1% solution applied daily
to the eyes of rabbits was without effect. Administration
to anaesthetised cats at a dose of 500 mg. per kg. had no
effect on blood-pressure and respiration.
Blood-levels in rabbits and dogs after intramuscular
injection resembled those following injection of penicillin
G. The mechanism of excretion in chicks was also similar
to that of penicillin G. Like penicillin G, brl.1241
penetrates the blood-brain barrier only with difficulty. It
is protein-bound to a lesser degree than penicillin G.
* ' Celbcnin' is the registered trade name of Beecham Research
Laboratories Ltd. for brl.1241.
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c.d.50 values for brl.1241 and penicillin g determined in mice
(10 per dose level)
Organism
c.d.bo (mg. per kg.)
brl.1241 Penicillin G
Klebsiella pneumonia: Inactive Inactive
Salmonella typhimurium Inactive Inactive
Diplococcus pneumonice 100 10
Staphylococcus pyogenes Smith 1-3 0-2
Staph, pyogenes 52-75 (penicillin-resistant) . . 1000 Inactive
Protection Tests
The protective effect of brl.1241 was determined in
mice infected with Klebsiella pneumonia, Salmonella
typhimurium, Diplococcus pneumonia, Staphylococcus pyo¬
genes Smith and Staph, pyogenes 52-75, the last organism
being highly resistant to penicillin G (minimal inhibitory
concentration 125 pg. per ml.).
Of the first four organisms, serial dilutions of 18-24-hour
cultures were prepared in 5% hog gastric mucin to enhance
the virulence, and 0-5 ml. volumes were injected intra-
peritoneally. Deaths were recorded over four days and the
number of organisms killing 50% of the mice was estimated
(l.d.50). The mice under test were injected with a hundred
times this number of organisms.
Penicillin G and brl.1241 were administered subcutaneously
to groups of 10 mice in graded doses to the log base 4, in
0-2 ml. saline immediately following the infection. The mice
were observed for four days and the deaths were recorded
daily. The percentage deaths were plotted against log dose,
and the dose of compound (mg. per kg.) giving protection to
50% of the mice (c.d.50) was read off from the graph. The
estimate of the C.d.50 against Staph, pyogenes 52-75 was
carried out in exactly the same way, except that 0-5 ml. of a
1/2 dilution in 5% hog gastric mucin of an overnight culture
was used to infect the animals.
The results obtained are given in the table.
A further estimate of the in-vivo effect against penicillin-
resistant organisms was carried out using the method
described by Selbie and O'Grady (1954). Groups of 10
mice (18-22 g.) were infected by injecting into the muscle
sheath of the thigh 0.2 ml. of a 1/2 dilution of an overnight
growth of Staph, pyogenes Russell (type 80). brl.1241 in
doses of 50, 100, and 200 mg. per kg. and penicillin G
200 mg. per kg. were administered subcutaneously daily
for three days, the first injection being given immediately
following the infection. An infected control group
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received no treatment. The maximum thigh diameter of
each mouse was measured with callipers on the first,
third, and eighth day after the infection. The results
(fig. 1) clearly demonstrate a graded response to dose.
The activity against other resistant staphylococci has been
confirmed.
The activity of brl.1241 was further confirmed by a
subsequent series of experiments, using the technique of
Selbie and O'Grady (1954), in which groups of 10 mice
were infected with two strains of staphylococci. Staph,
pyogenes Russell (resistant to penicillin G) was injected
into the muscle sheath of the right hind leg, and Staph,
pyogenes 2187 (sensitive to penicillin G) was injected into
the left hind leg. Because untreated mice usually died
from this double infection, two control groups were used,
one receiving the sensitive strain in the left leg, and the
other receiving the resistant strain in the right leg. The
thigh diameters were measured as described above.
Penicillin G and bri.,1241 were administered subcu-
taneously at a dose of 100 mg. per kg. daily for three days.
day i day 3 day 8
Fig. 1—Mean thigh diameters of mice (10 per group) infected
intramuscularly with Staph, pyogenes Russell (penicillin-
resistant). The following doses were administered subcutanfiously
daily for three days:
Group A:—brl.1241. 50 mg. per kg.
yy B* yy 100 ,5 yy yy
yy Cr yy 200 yy yy yy
yy D:—Penicillin G. 200 „ „ „
E:—Untreated infected control.
v_>
Fig. 2—Mean thigh diameters of mice (10 per group) infected
intramuscularly with Staph, pyogenes Russell (penicillin-resistant)
in the right hind limb and Staph, pyogenes 2187 (penicillin-
sensitive) in the left hind limb.
brl. 1241 and penicillin G, 100 mg. per kg., were administered
subcutaneously daily for three days.
Blocks A, B, and C are the mean thigh diameters of the limb
infected with the resistant staphylococcus, and D, E, and F are the
mean diameters of the limb infected with the sensitive staphylococcus.
Group 1 (A and D) received brl. 1241, group 2 (B and E) received
penicillin G, and group 3 (C and F) was the untreated infected control.
The results (fig. 2) show the effectiveness of brl. 1241 in
mice infected simultaneously ■ with both resistant and
sensitive staphylococci. Penicillin G is completely
inactive against the resistant strain, but more effective
than brl. 1241 against the sensitive strain.
Conclusion
brl.1241 is remarkably free from toxic actions. It can
be given in high doses intramuscularly or intravenously.
The blood-levels obtained after an intramuscular injection
in rabbits and dogs follow a pattern very similar to that
obtained after penicillin G. Like penicillin G, it requires
large doses before it will penetrate into the cerebrospinal
fluid.
brl. 1241 does not combine with serum protein to the
same degree as penicillin G. This, however, does not
seem to have influenced the cross-allergenic response in
patients already sensitive to penicillin (Stewart et al.
1960).
It is highly effective against staphylococci resistant to
penicillin G, and the results obtained clearly demonstrate
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the activity in vivo. Though brl.1241 is not as effective as
penicillin G against sensitive strains of staphylococci, its
activity is still considerable. In mice infected with both
penicillin-sensitive and penicillin-resistant strains of
staphylococci, it was equally active against the two
organisms, whereas penicillin G was active only against the
sensitive strain. This is in agreement with the in-vitro
findings of Knox (1960), Rolinson et al. (1960), Stewart
et al. (1960) and Thompson et al. (1960).
We wish to thank Prof. C. A. Keele for his general interest and
helpful discussions; Dr. A. A. G. Lewis, physician to the Connaught
Hospital, Walthamstow, under whose skilled guidance the dog studies
were conducted; and Mr. F. P. Doyle and his colleagues for the
preparation of the compound. In addition, we wish to acknowledge
the excellent technical assistance of Mr. D. Wright and Mr. M. J.
Wilson.
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The pharmacology of a new antibiotic methicillin, 6(2:6-dimethoxybenzamido)-
penicillanic acid, which is effective against staphylococci resistant to penicillin G, has
been investigated. It is free from acute and chronic toxic effects, except that some pain
may be caused following intramuscular injection. It is poorly absorbed orally, but after
intramuscular injection the concentrations in the serum and in tissues are very similar
to those found with penicillin G. It is excreted by the kidneys both by renal tubular
secretion and glomerular filtration. It is also excreted in the bile in very high concen¬
trations, the ratio of concentration in the bile to the blood being approximately 2.5
times that of penicillin G. From a study of the metabolism of the drug it is
calculated that 75% is eliminated unchanged in the urine and that the remainder is
probably destroyed after the excretion into the intestine via the bile.
With the isolation of 6-aminopenicillanic acid (Batchelor, Doyle, Nayler & Rolin-
son, 1959), it is now possible to synthesize a wide range of new penicillins having
modified antibacterial properties. One of these new derivatives, 6-(2:6-dimethoxy-
benzamido)penicillanic acid, has been shown to possess remarkable stability to
staphylococcal penicillinase, and recent clinical reports have confirmed its effective¬
ness in the treatment of infections caused by staphylococci resistant to penicillin G
(Douthwaite & Trafford, 1960 ; Knox, 1960 ; Stewart, Harrison & Holt, 1960 ; and
Stewart, Nixon, Coles, Kesson, Lawson, Thomas, Mishra, Mitchell, Semtnens &
Wade, 1960). Preliminary pharmacological and chemotherapeutic findings have
been reported by Brown & Acred (1960). Full details of the pharmacological
evaluation are now presented.
METHODS
In all experiments peniciilin G and methicillin were administered as their pure sodium
salts. The antibiotics were assayed by the cup-plate technique using Sarciua lutea as the
test organism. The zone diameters obtained for the control dilutions of the antibiotics were
plotted against the log of the concentration, and from the regression line obtained the
concentrations of the antibiotics in the specimens were estimated by interpolation. The
appropriate dilutions of the controls and samples were made in phosphate buffer pH 7.0
(m/20) except in the experiments where serum concentrations were determined, in which case
the controls were prepared in serum.
Acute toxicities
The acute toxicity was determined in male albino mice (18 to 22 g) after intravenous,
subcutaneous and oral administration, and subcutaneously in rats (150 to 200 g). The effect
on respiration and the electrocardiogram was studied in guinea-pigs and cats during the slow
intravenous infusion of the antibiotic.
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Prolonged administration
The effects of prolonged administration were investigated in rats and dogs.
(i) Rats. Two groups of 12 male rats, each animal weighing 80 to 100 g, were injected
subcutaneously 5 days per week with methicillin at doses of 100 and 500 mg/kg in a volume
of 0.1 m!./100 g body weight for a period of 12 weeks. A group receiving 0.1 ml./100 g
body weight normal saline subcutaneously acted as controls. Daily food intake and the
weight of each rat was recorded. Weekly records of the red and white blood cell counts
and qualitative tests for sugar and protein in the urine were performed. Haemoglobin
determinations and spectroscopic examinations of the blood were made on the first, sixth
and twelfth week of the test.
At the end of 6 weeks, 6 rats from each group were killed and the remaining rats killed
at 12 weeks. The weights of the livers, spleens, kidneys, testes and adrenals were recorded,
and specimens of liver, spleen, kidney, lung, thyroid, heart, duodenum, stomach, pancreas,
adrenal, testis and bone marrow were removed for histological examination.
(ii) Dogs. Methicillin (250 mg/kg) was administered subcutaneously twice daily for a
period of 4 weeks to two dogs. The following biochemical and haematological estimations
were made at weekly intervals: haemoglobin (g%), packed cell volume, total white cell
count, blood urea, serum alkaline phosphatase, zinc sulphate turbidity and serum globulin
and albumin. A differential blood cell count was carried out at the end of the first and
final week of the test.
Local irritant action
Ten per cent, and 1 % solutions were injected intramuscularly and intradermally into
rats and guinea-pigs (3 per group). The solutions were administered in a volume of 0.1 ml.
intramuscularly into the hind legs, and 0.05 ml. intradermally on a shaved area on the backs.
After 24 hr the area of the injection was examined and the skin and subcutaneous tissues
removed for histological examination.
The effect of methicillin on the eye was examined in a group of 3 rabbits. A 1% solution
in normal saline was dropped into a pocket formed by pulling out the lower left eyelid. The
solution was held over the eye for 1 min. Saline was similarly applied to the right eye. The
eyes were examined at 1, 2, 4, 8 and 24 hr afterwards for signs of irritation.
Blood pressure and respiratory effects
The carotid blood pressure of 5 cats anaesthetized with a 4% urethane/1% chloralose
mixture (5 ml./kg intravenously) was recorded manomctrically on a smoked drum. Respira¬
tion was recorded by a lever connected by means of a thread which was sewn to the skin
over the xiphisternum. Methicillin in physiological saline was administered intravenously
through the femoral vein at intervals of 5 min.
A bsorption
(a) Oral
(i) Rabbits. 100 and 500 mg/kg doses of methicillin were administered orally to groups
of 5 rabbits. Blood samples for assay were removed from the lateral ear vein at 1, 2, 4 and 6 hr.
(ii) A bsorption from small intestine of rats. The bile ducts of rats, 5 to a group, were
cannulated as described by Harrison et al. (1960). The rats were restrained in close-fitting
wire cages and the total bile and urine collected at 2, 4, 6 and 24 hr after the administration
of 100 mg/kg methicillin directly into the duodenum. Blood specimens were taken from the
tail vein at 1, 3, 5 and 24 hr after injection.
(b) Intramuscular—serum and urine concentrations in dogs
Methicillin and penicillin G were injected intramuscularly at a dose of 5 mg/kg, and blood
and urine specimens were taken at intervals up to 6 hr after administration.
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The blood specimens were removed by means of a sterile syringe from the radial vein,
allowed to clot at room temperature and the serum transferred to sterile tubes and frozen.
The urine was removed from the bladder, by means of a polythene cannula, at the same time
as the blood samples were taken.
Distribution and elimination
(a) Serum and cerebrospinal fluid concentrations in rabbits
(i) Serum concentrations. Two groups of 5 rabbits were given intramuscular injections, in
the hind leg, of 100 mg/kg methicillin and 100 mg/kg penicillin G ; 0.5 ml. samples of blood
were removed from the lateral ear veins at 1, 2, 4 and 6 hr after administration. The samples
were allowed to clot at room temperature and the serum was removed and kept at 4° C
until assayed (at the end of 6 hr).
(ii) Cerebrospinal fluid concentrations. The cerebrospinal fluid .concentrations were
determined in anaesthetized rabbits after administration of 100 and 500 mg/kg methicillin
intramuscularly. The rabbits were anaesthetized with urcthane (1 g/kg intraperitoneally).
The cerebrospinal fluid samples were withdrawn from the cisternum magnum by means of a
sterile syringe and needle. Blood samples were taken from the lateral ear vein at the time
of taking the cerebrospinal fluid samples. The concentrations of methicillin in the serum
and the cerebrospinal fluid were assayed as before.
(b) Blood levels and bile excretion in the anaesthetized rat
Two groups of 5 rats (230 to 265 g) were anaesthetized with 1.0 ml./kg pentobarbitone
intraperitoneally. After laparotomy the bile duct was cannulated with polythene tubing (0.4
mm internal diameter). 100 mg/kg mcthicillin and penicillin G was administered intra¬
muscularly to each of the groups. The bile was collected over 30 min periods in sterile tubes
which were cooled in iced water. 0.1 ml. samples of arterial blood were obtained at hourly
intervals up to 5 hr from the right carotid artery and diluted with 0.4 ml. normal saline contain¬
ing 100 units heparin.
(c) Hen
The technique described by Sperber (1949) was employed. The cloacal mucosae of 6-
month-old laying Sussex hens were anaesthetized with a few drops of 2% cinchocaine hydro¬
chloride in normal saline. A polythene funnel was held in position over each ureteral
opening by stitching the mucosa to the free edge of a rubber washer which surrounded the
head of the funnel. Short polythene tubes were inserted into the stems of the funnels and
the urine from each kidney collected in sterile tubes which were cooled in iced water.
The antibiotics were dissolved in 2.0 ml. of 0.9% saline and injected into the muscles of
the left leg. Probenecid, which blocks renal tubular secretion, was administered intravenously
at a dose of 100 mg. The probenecid solution was prepared from 0.5 g tablets (Merck
Sharpe & Dohme). Five tablets were powdered and triturated with 10 ml. 0.5 n sodium
hydroxide and the pH adjusted to 7.4 with 1.0 n hydrochloric acid (2 to 3 ml.). The volume
was made up to 100 ml. with 0.9% saline, giving a solution containing 25 mg probenecid
per ml. Four ml. of this solution was injected into a wing vein 10 min prior to the administra¬
tion of the antibiotic.
In order to increase urine flow, 100 ml. of warm tap water'was given by crop tube at the
commencement of the experiment. Samples of urine were taken for assay at 10 min intervals
for the first hour after dosing and thereafter at hourly intervals up to 6 hr.
In the experiments 4 hens were employed, each of which received the following treatments
on four separate occasions: (i) 100 mg methicillin ; (ii) 100 mg penicillin G ; (iii) 100 mg
methicillin + 100 mg probenecid ; (iv) 100 mg penicillin G + 100 mg probenecid.
(d) Distribution in tissues
100 mg/kg methicillin was administered intramuscularly to groups of 10 rats, 1 group
being killed at 0, 1, 2, 4, 12 and 24 hr after the injection. The rats were exsanguinated
by cutting the throat and the blood collected. The urine and faeces from each group were
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collected and the amounts recorded. The following organs and tissues were removed and
weighed: liver, spleen, kidney, lung, small intestine, largo intestine and muscle at site of
injection. The carcass was then weighed. All specimens were homogenized in a Waring
blender. Appropriate dilutions of the homogenate were made with phosphate buffer pH
7.0 and specimens of the homogenate assayed. The total amount of antibiotic in each
specimen was calculated. The specimens which were known to be contaminated were not
specially treated, as we found that in general the assay figures obtained were not unduly
influenced.
Serum binding—dialysis
Five ml. of bovine, horse or human serum containing 5 mg of either methicillin or
penicillin G was placed in cellophane bags (Visking tubing i in.) and suspended in 20 ml.
sterile saline at 10° C for 48 hr. At the end of the period of dialysis the amounts of the
antibiotic outside and inside the tubing were assayed. Five tubes were prepared of each




Methicillin when given intravenously to mice at doses up to 2.5 g/kg produces
no signs of toxicity. When larger doses are given, 3 to 5 g/kg, occasional mild
clonic convulsions are produced within 5 min of administration. These give way
to a phase which may persist up to 4 hr in which the mice exhibit a loss of muscle
tone. If disturbed during this phase, a mild muscular spasm is induced causing
extension of the limbs. In the range 4 to 5 g/kg some deaths may occur due to
cardiac and respiratory failure. With some animals respiration may cease for
periods up to 10 sec, but this is followed by complete recovery. No toxic symptoms
were noted in mice and rats given 4 g/kg of the antibiotic orally or subcutaneously.
(ii) Prolonged administration
(a) Rats. No untoward toxic symptoms were noted in the rats treated with
methicillin. Post-mortem examination did not reveal any abnormalities and the
Weeks
Fig. 1. Mean growth curves of rats—12 to a group—following daily intramuscular administration
of {a) 500 mg/kg methicillin ( ); (b) 100 mg/kg methicillin ( ); (c) 1.0 ml./kg normal
saline ( ).
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histology of the organs examined was normal. The growth curves are shown in
Fig. 1. The animals which received the antibiotic gained more weight than the
controls.
(b) Dogs. No abnormal signs were observed in any of the tests carried out.
The histology of the essential organs was normal.
Local irritant action
Macroscopically there was no evidence of tissue damage, except following the 10%
intradermal injection, when there was a slight induration and erythema of the skin
lasting 24 to 48 hr. Histologically there is a marked inflammatory reaction in the
rat skin with necrosis of epidermis and hair follicles, following intradermal injection
of 10% methicillin. A comparable inflammatory reaction is seen in the muscle.
The changes in both skin and muscle of rats are much less marked with the 1%
solution. The changes in the guinea-pig skin and muscle are similar ; as severe
in the skin at 10% but less marked in the muscle at that strength. The skin and
muscle of guinea-pigs injected with the 1% solution showed no appreciable
abnormality.
Cardiovascular and respiratory effects
When administered by slow intravenous injection to 5 guinea-pigs, 5 g/kg
methicillin in saline given over a period of 25 min had no observable effect on the
respiration or the electrocardiogram. When similarly administered to cats, 2.5 g/kg
given over a 10 min period had no effect on the heart or respiration. In individual
doses ranging from 10 to 500 mg/kg, methicillin was again without effect. The
blood pressure response of cats to intravenous doses of adrenaline, noradrenaline,
acetylcholine and histamine was unaffected by doses of 500 mg/kg methicillin. The
pressor response to carotid occlusion was also unaffected by methicillin.
A bsorption
(a) Oral
(i) Rabbits. No blood levels were detectable after 100 mg/kg, but significant
blood levels were attained following administration of 500 mg/kg, viz., 3.0, 1.6, 1.6
and 1.45 /xg/ml. at 1, 2, 4 and 6 hr respectively after administration.
(ii) Absorption from small intestine of rats. The concentration of methicillin
found in the bile, urine and the blood after the intraduodenal administration of
100 mg/kg to rats is given in Table 1. Practically no blood levels were detectable,
and only a total of 6.5% of the antibiotic was recovered—1.8% from the bile,
3.7% from the urine and 0.97% from the intestine.
(b) Intramuscular—serum and urine concentrations in dogs
The mean serum concentrations of penicillin G and methicillin obtained in three
dogs after intramuscular injection of 5 mg/kg are shown in Fig. 2. Methicillin
gives a slightly lower maximum blood concentration (2.9 /xg/ml.) than penicillin G
(4.05 pg/ml.). The peak also occurs slightly more in advance of penicillin G, but
the fall-off in serum concentration of both antibiotics occurs at much the same rate.
The excretion in the urine of both antibiotics is also very similar, 29% of penicillin
G and 33% of methicillin being recovered in the urine in 6 hr.
Table1












































































































inintestine after 24hr 3-40 0-74 0 0-71 0 0-97
Total % recov¬ ered 8-55 8-26 4-00 6-43 5-38 6-52
Table2
DISTRIBUTIONOFMETHICILLINNHERAT
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Fig. 2.
Distribution and elimination
(a) Serum and cerebrospinal fluid concentrations in rabbits
(i) Serum concentrations. The serum concentrations of penicillin G and methicillin
after intramuscular injection to each of 5 rabbits are given in Table 3. The serum
concentration picture of each antibiotic is similar.
Table 3
SERUM CONCENTRATIONS IN RABBITS RECEIVING
100 MG/KG METHICII.L1N AND PENICILLIN G
INTRAMUSCULARLY
Serum concentration ;ig/ml. at
hr after dosing
Compound 1 ' 2 4 6
Methicillin 12-5 3-65 0-51 0
18-0 3-65 0-3 0
14-0 4-2 0-74 0
18-0 5-0 0-34 0
14-0 6-2 1-3 0
Mean 15-3 4-48 0-64 0
Penicillin G 110 5-1 2-65 1-13
9-0 5-0 1-17 0-5
16-0 10-5 . 10 0-1
10-5 4-7 0-48 0
9-8 6-1 1-15 0-23
Mean 11-26 6-28 1-29 0-39
(ii) Cerebrospinal fluid concentration. The concentration of methicillin obtained
in the serum and cerebrospinal fluid after the intramuscular administration of 100
and 500 mg/kg is shown in Table 4. The concentration of antibiotic in the cerebro¬
spinal fluid is approximately 100 times less that the concentration appearing in the
Serum concentration and urinary excretion in dogs following intramuscular administration
of 5 mg/kg methicillin ( ) and penicillin G ( ).
o




MEAN CONCENTRATIONS IN SERUM AND CEREBROSPINAL
FLUID OF RABBITS (3 PER DOSE LEVEL) AFTER INTRA¬
MUSCULAR ADMINISTRATION OF METHICILLIN
Concentration g/ml. at hr after dosing
Dose ,
mg/kg Tissue 0-5 1 2 3 6
100 C.s.f. 0-4 0-35 — — 0
Serum 34-0 24-0 — — 0
500 C.s.f. 1-17 2-3 3-6 4-4 0
Serum 130 136 288 130 1-0
serum. The time of maximum concentration of methicillin in the serum does not
coincide, however, with the time of maximum concentration in the cerebrospinal
fluid, the latter occurring somewhat later.
(b) Blood levels and bile excretion in the anaesthetized rat
The blood picture of the anaesthetized rat after the administration of penicillin G
and methicillin is shown in Fig. 3. The blood levels of both antibiotics are similar
and both are markedly concentrated in the bile, though at the end of 6 hours both
the blood and bile levels of methicillin were a little higher than those of penicillin G.
Time in minutes
Fig. 3. Mean concentration in blood and bile of methicillin ( ) and penicillin G ( ) after
intramuscular administration of 100 mg/kg of each antibiotic to groups of 5 anaesthetized rats.
(c) Hen
The excretion in urine of penicillin G and methicillin from the right and left
kidneys following intramuscular administration into the left limb of 100 mg/kg of
each antibiotic is illustrated in Fig. 4. The concentration of both antibiotics in the
urine from the left kidney is considerably greater than the concentration in the urine
from the right kidney. However, after the administration of 100 mg probenecid
intravenously the concentration of both antibiotics in the urine from the right and
left kidneys becomes identical.
(d) Distribution in tissues
The tissue concentrations of methicillin expressed as /ng/g of wet weight of tissue
are given in Table 2 (column a). In order to show the degree of concentration in the
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various tissues and organs, the results have also been expressed as a ratio of the
serum concentration (column b). Thirty min after the dose was given, the concentra¬
tion occurring in the kidneys was approximately four times, that in the small intestine
about double, and that in the liver about the same as that found in the serum.
Lower concentrations occurred in the lungs, spleen and large intestine. The con¬
centration of antibiotic in the serum falls oh rapidly, but the concentration level in
the other tissues apart from the spleen falls oh more slowly, with the result that at
the end of 4 hr the concentrations in the tissues are higher than those found in the
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Fig. 4. Excretion of methicillin and penicillin G in the hen. The rrcan urinary excretion from
the left and right kidneys of 4 hens each of which received, on four separate occasions:
(i) 100 mg penicillin G; (ii) 100 mg methicillin; (iii) 100 mg penicillin G + 100 mg probenecid;
(iv) 100 mg methicillin+100 mg probenecid. The antibiotics were given intramuscularly and
the probenecid intravenously.
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none being detectable in the serum and liver. After 24 hr no antibiotic was detect¬
able in any of the tissues. The urinary excretion is expressed as a percentage of
the dose administered, a total of 74.6% being recovered in the first 12 hr. A total of
73.7%, 73.5%, 66.6%, 55.3%, 54.3%, 75.1% and 68.4% of methicillin was recovered
from all tissues and body fluids at 0, 0.5, 1, 2, 4, 12 and 24 hr after administration.
Serum binding
Methicillin is considerably less bound to horse, bovine and human serum than
penicillin G, the figures being respectively for each of the sera 10.2%, 4.5% and
17.7% for methicillin, and 21.0%, 27.3% and 43.4% for penicillin G.
DISCUSSION
An antibiotic should preferably be free from toxic effects. In this respect
methicillin has remarkably few unwanted reactions. No toxic effects were noted in
animals after large single intravenous doses. In one experiment a dose of 18 g
was administered by slow intravenous infusion to a guinea-pig before serious toxic
effects became apparent. When administered over a prolonged period both rats
and dogs tolerated large doses, the only observable reaction being some discomfort
at the time of injection. This is in agreement with clinical reports (Douthwaite &
Trafford, I960 ; Knudsen & Rolinson, I960).
Mcthicillin is poorly absorbed from the gastro-intestinal tract, but it is well
absorbed following parenteral administration, only small quantities remaining at
the site of injection 12 hr afterwards. Good blood levels are obtained, and the
antibiotic is distributed throughout the tissues of the body. There is a high concen¬
tration of antibiotic in the kidney, while the concentration in the liver is of the
same order as that found in the serum for the first hour, but higher concentrations
than those in the serum are subsequently found. The high concentrations appearing
in the small intestine are probably accounted for by the presence of bile.
The total quantity of methicillin recovered from the intact animal falls steadily
over the first 4 hr to 55%, but fully 75% is eventually recovered in the urine after
12 hr. It would seem that the antibiotic is taken up by some of the tissues in a
non-assayable form and is then slowly released and then excreted in the urine.
That methicillin does combine with protein is shown by the dialysis experiments.
There is considerable binding with serum protein, but it is less than that found
with penicillin G. The degree of binding varies according to species, and it is
possible that some of the antibiotic is more firmly bound to one type of protein
than another and therefore it is more difficult to assay in this state. The antibiotic
may be slowly released from this combination. Otherwise, it is difficult to postulate
why there is a " loss " which is subsequently recovered in the urine.
The blood level picture and urinary excretion found for methicillin and penicillin
G are practically identical, the pattern being similar in rabbits, dogs and conscious
rats. In the anaesthetized rat the excretion is delayed, 50 to 55% of the antibiotics
appearing in the urine of conscious rats during a 4 hr period, while only 25 to 35%
is recovered in 6 hr from an anaesthetized animal, and as a consequence the blood
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level is more prolonged. In view of this difference it would seem preferable to
use non-anaesthetized animals for metabolism studies.
A marked difference is seen between the bile concentrations of methicillin and
penicillin G. Comparison of the bile/blood ratio for the two antibiotics obtained in
rats shows that methicillin is concentrated in the bile fully 2 to 2.5 times more than
penicillin G. A total of 15 to 20% of the injected dose of methicillin is excreted
in the bile—this we confirmed in both the anaesthetized and conscious rat—while
15% of penicillin G is similarly excreted. In view of the greater concentration ratio
of methicillin from the blood to the bile, it might be expected that the difference
between the amounts excreted would be more, but the initial blood levels of penicillin
G are higher and thus proportionately a larger quantity appears in the bile.
In the normal animal one would expect that a considerable proportion of the
antibiotic would be reabsorbed from the intestine after being excreted in the bile.
However, the experiments where 100 mg/kg was injected into the duodenum of
rats indicate that absorption even in the small intestine is poor—only 3.7%
is recovered from the urine and 1.8% from the bile in 24 hr. The bulk of the
dose appears to be destroyed, as only 0.97% can be accounted for in the intestine
after 24 hr. From the observations on the distribution of the antibiotic in the intact
animal one can therefore account for practically the whole of the dose administered,
75% being excreted in the urine and 15% lost in the intestine. We have found no
evidence that 6-aminopenicillanic acid is formed in the body from mcthicillin ;
neither have we found that methicillin is excreted in a conjugated form in the bile
as reported by Harrison et al. (1960).
The mode of elimination by the kidneys is well demonstrated in the hen experi¬
ment. Birds possess a renal portal system, and the venous return from the hind limbs
is shunted through the parenchyma of the renal tubules. Therefore, when a substance
is injected into a hind limb and both renal tubular secretion and glomerular filtration
take place, the concentration of the substance excreted is greater in the urine from
the ipsilaieral kidney than in the urine from the contralateral kidney. If only
glomerular filtration takes place, then the concentration in the urine excreted from
both kidneys is identical. In our experiments the ipsilateral kidneys excreted more
of the antibiotics than the contralateral kidneys, and blockage of renal tubular
secretion resulted in equal concentrations of the antibiotics appearing in the urine
from both kidneys. Therefore methicillin and penicillin G are excreted by the same
mechanism, both glomerular filtration and renal tubular secretion taking place.
We wish to thank Dr A. C. Thackray, of the Bland Sutton Institute of Pathology, for
expert histological comment; Dr A. A. G. Lewis, physician to the Connaught Hospital,
Walthamstow, under whose skilled guidance the dog studies were conducted ; and Mr F. P.
Doyle and his colleagues for the preparation of the compound.
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D. M. BROWN, B.Sc., F.P.S.
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P. ACRED, B.Sc.
Front the Beecham Research Laboratories Limited,
Brockham Park, Betchworth, Surrey
None of the present family of synthetic or natural
penicillins possess appreciable activity against Gram-
negative bacilli. Those penicillins which are absorbed
orally are inactive in this respect. Since the isolation
of 6-aminopenicillanic acid (Batchelor et ai. 1959), one
of the principal objectives has been the development of
a new penicillin which is absorbed orally and is effective
against Gram-negative bacilli. Doyle and his colleagues
have now synthesized a new penicillin, " penbritin "
(6[D(—) - a - aminophenylacetamidojpenicillanic acid),
which, from the biological studies carried out. has been
found to possess these properties.
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Penbritin (B.R.L. 1341) is non-toxic to mice, rats,
dogs, and cats. Single doses up to 5 g./kg. have been
administered orally and subcutaneously to mice and rats




amount given has been limited by solubility, but as
much as 2 g./kg. has been administered to mice without
lethal effects, although muscle tremor, slow respiration,
and mild clonic convulsions have been noted. Similarly,
in cats no adverse effects on the blood-pressure and
respiration were seen with doses up to 100 mg./kg.
intravenously. A total of 3 g./kg. was administered in
divided doses over a period of one hour without toxic
effects.
When administered orally to groups of 12 rats over a
period of 12 weeks at doses of 500 and 100 mg./kg. no
effect on the growth was observed ; neither were any
biochemical, haematological, or histological abnormali¬
ties seen. Penbrilin, when administered orally to three
dogs, 250 mg./kg. twice daily over a period of four
weeks, likewise produced no toxic symptoms, apart from
slight loosening of the stools. It gives good blood-levels
after oral administration. In dogs, maximum blood-
levels of 7.2 jug./ml. have been obtained after 20
mg./kg., the peak occurring one hour after dosing. On
the other hand, after 20 mg. phenethicillin and penicillin
V per kg. the peak levels which occurred in 30 minutes
were 4 and 2.6 jug./ml. respectively (see Chart). In
addition, the blood-levels were more persistent with
penbritin, this effect having also been noted in humans
(Knudscn el ah, 1961). After absorption the antibiotic
is evenly distributed throughout the body tissues apart
from kidney and liver, where higher concentrations than
Mean serum concentrations in groups of five dogs after oral




in the serum are found. The antibiotic which is excreted
in urine and bile is concentrated considerably in these
fluids. The concentration in the bile is 300 times and in
the urine 800 times that found in the blood. Penbritin
is eliminated by the kidney by renal tubular secretion
and glomerular filtration in a similar manner to
penicillin G and methicillin (Acred et al., 1961).
Chemotherapy
Penbritin has been tested in mice infected with
Staphylococcus aureus (Smith), Streptococcus pyogenes
(group A), Salmonella typhi-murium, and Klebsiella
pneumoniae, and compared with penicillin V, phen-
ethicillin, tetracycline, and chloramphenicol. The activity-
was assessed by determining the dose which cured 50%
of a group of 10 mice infected with one of the above
organisms. Penbritin, penicillin V, and phenethicillin all
had the same order of activity against Staph, aureus by
the oral route, the CD50 values in each case being 0.3
mg./kg., but tetracycline was fully 10 times less effec¬
tive, having a CD50 of 5.2 mg./kg. ; chloramphenicol
was ineffective orally and subcutaneously. Penbritin,
penicillin V, and phenethicillin were highly active
against Str. pyogenes, giving an oral CD50 of 0.1
mg./kg. ; tetracycline gave a CD50 of 0.5 mg/kg.,
while in this instance chloramphenicol was active with
a CD50 of 3.2 mg./kg.
Against the Gram-negative infections penbritin was
surprisingly effective when compared with tetracycline
and chloramphenicol. The CD50 values against Salm.
typhi-murium were, respectively, 19, 125, and 310 mg./
kg., and against Kleb. pneumoniae 12, >400, and 165
mg./kg. Penicillin V and phenethicillin were completely
inactive.
Conclusions
Penbritin is an effective non-toxic oral penicillin
possessing a wide spectrum of activity. Animal studies
indicate that it is better absorbed and gives more pro¬
longed blood levels than penicillin V and phenethicillin.
lis effectiveness against infections due to staphylococci
and streptococci is equal to that of the existing oral peni-
penicillins. In this respect there is agreement with the in
vitro activities (Rolinson and Stevens, 1961). On the other
hand, the activity of penbritin in vivo against infections
produced by Gram-negative organisms is considered to
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be greater than that found with tetracycline and chlor¬
amphenicol. This is in marked contrast to the in vitro
titres, where only small differences are found.
We thank Mr. F. P. Doyle and his colleagues for the
preparation of penbritin.
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PHARMACOLOGY AND CHEMOTHERAPY OF AMPICILLIN—
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BY
P. ACRED, D. M. BROWN, D. H. TURNER and M. J. WILSON
From the Department of Pharmacology and Chemotherapy, Beecham Research
laboratories, Brockham Park, Betchworth, Surrey
(Received January 5, 1962)
The pharmacology and chemotherapy of a new penicillin, 6[d( — )-n-aminophenyl-
acetamido] penicillanic acid, are described. It is non-toxic, is absorbed orally and
is distributed throughout the body in a manner similar to other penicillins. It is
eliminated unchanged from the body in high concentrations in the bile and urine.
Almost all of the antibiotic can be accounted for in the urine and intestinal contents
2 hr after intramuscular administration but not after oral administration. It is.
concluded that the antibiotic is not metabolized within the body. Studies with
infected animals show that it is as effective as the existing oral penicillins against
Staphylococcus pyogenes Smith (penicillin sensitive), Streptococcus pyogenes Group A
and Diplococcus pneumoniae. It is ineffective against penicillin-resistant Staphylo¬
cocci. When tested in mice infected with the gram-negative organisms, Salmonella
typhimurium and Klebsiella pneumoniae, it was considerably more active than
tetracycline and chloramphenicol.
There is a need for a penicillin which is effective orally and having activity against
both gram-negative and gram-positive organisms. Benzylpenicillin, although
lacking in toxicity, is unfortunately not absorbed after oral administration and its
activity against gram-negative organisms is limited. Doyle, Nayler & Smith (1961)
have synthesized a new penicillin, ampicillin (6[d( - )-a-aminophenylacetamido]
penicillanic acid), which largely overcomes these disadvantages. The preliminary
pharmacology and chemotherapy has been reported by Brown & Acred (1961). Full
details of the pharmacological and chemotherapeutic evaluation are now presented.
methods
In all experiments benzylpenicillin was administered as its sodium salt. Ampicillin, which
was 84% pure, was also administered as its sodium salt, all doses being given in terms of
the pure compound. The antibiotics were assayed by the cup-plate technique using Sarcina
lutea as the test organism. The zone diameters obtained for-the control dilutions of the
antibiotics were plotted against the log of the concentration, and from the regression line
obtained the concentrations of the antibiotics in the specimens were estimated by interpolation.
The appropriate dilutions of the controls and samples were made in phosphate buffer pH 7.0
(m/20) except in the experiments where serum concentrations were determined, in which case
the controls were prepared in serum.
Chromatographic studies were carried out using 1 cm wide strips of Whatman no. 1 filter
papers. 53 cm long with the origin at 11 cm. The solvent used was ethyl acetate-isopropanol-
water in the proportions 4:2:1. 100 ml. of solvent was used in the trough of each tank.
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All tanks were lined with Whatman no. 3 mm filter paper. The chronratograms were run
from 16 to 20 hr at 20° C after equilibrating for at least 1 hr.
Detection of the penicillin on the chromatograms was carried out by placing the strips on
agar plates seeded with Sarcina lutea and incubating overnight at 30° C. The location of
the penicillin was seen as clear zones of growth inhibition on the plates. Control strips were
set up lising an aqueous ampicillin solution.
Acute toxicities
The acute toxicity was determined in male albino mice (Edwards strain—18 to 22 g) after
intravenous, subcutaneous and oral administration, and in Sprague-Dawley rats (150 to 200 g)
after subcutaneous and oral administration.
Prolonged administration
The effects of prolonged administration were investigated in rats and dogs.
(i) Rats. Doses of 500 and 100 mg/kg were administered orally by stomach tube to groups
of 12 male rats, 5 days per week for a period of 12 weeks. The dose was administered as
a freshly prepared aqueous solution in a volume equivalent to 0.5 ml./100 g body weight.
The control group received an equivalent volume of tap water. Daily food intake and the
weight of each rat was recorded. Weekly records of the red and white blood cell counts
and qualitative tests for sugar and protein in the urine were performed. Haemoglobin
determinations and spectroscopic examination of the blood were made on the first, sixth and
twelfth week of the test. At the end of 12 weeks all the rats were killed and the weights
of the livers, spleens, kidneys, testes and adrenals were recorded. Specimens of liver, spleen,
kidney, lung, thyroid, heart, duodenum, stomach, pancreas, adrenal, testis and bone marrow
were removed from 6 animals in each group for histological examination.
(ii) Dogs. Ampicillin (250 mg/kg) was administered orally twice daily for a period of
4 weeks to 2 dogs. The following biochemical and haematological estimations were made
at weekly intervals: haemoglobin (%), packed cell volume, total white cell count, blood
urea, serum alkaline phosphatase, zinc sulphate turbidity and serum globulin and albumin.
A differential blood cell count was carried out at the end of the first and final week of the test.
Local irritant action
5% and 1% solutions were injected intramuscularly and intradermally into guinea-pigs
(3 per group). The solutions were administered in a volume of 0.1 ml. intramuscularly into
the hind legs, and 0.05 ml. intradermally in a shaved area on the back. After 24 hr the
area of the injection was examined and the skin and subcutaneous tissues were removed
for histological examination.
The effect of ampicillin on the eye was examined in a group of 3 rabbits. A 25% solution
in normal saline was dropped into a pocket formed by pulling out the lower left eyelid. The
solution was held over the eye for 1 min. Saline was similarly applied to the right eye. The
eyes were examined at 1, 2, 4, 8 and 24 hr afterwards for signs of irritation.
Blood pressure and respiratory effects
The carotid blood pressures of 5 cats anaesthetized with a 4% urethane/1% chloralose
mixture (5 ml./kg intravenously) were recorded manometrically on a smoked drum. Respira¬
tion was recorded by a lever connected to a thread which was sewn to the skin over the
xiphisternum. Ampicillin in physiological saline was administered intravenously through' the
femoral vein at intervals of 5 min.
Absorption, distribution and elimination
(a) Absorption—oral and intramuscular
(i) Rabbits. 100 mg/kg doses of ampicillin and phenoxymethyl penicillin were administered
orally and intramuscularly to groups of 5 rabbits. Blood samples for assay were removed
from the lateral ear vein at 1, 2, 4 and 6 hr.
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(ii) Dogs. Ampicillin was administered orally and intramuscularly to groups of 5 dogs.
A dose of 5 mg/kg was given intramuscularly and a dose of 20 mg/kg orally. Blood specimens
were taken up to 5 hr after administration. Following the intramuscular administration, a
comparison was made with benzylpenicillin, and following the oral administration a com¬
parison was made with phenoxymethyl penicillin. The blood specimens were removed by
means of a sterile syringe from the radial vein and were allowed to clot at room temperature
and the serum was transferred to sterile tubes and frozen.
(iii) Rats—intestinal administration. Male rats (290 to 430 g) were starved overnight. After
anaesthetizing with ether, laparotomy was performed and the bile duct was cannulated with
polythene tubing (0.40 mm bore). The latter was passed through a small aperture in the
abdominal wall and the skin and muscle incisions were sutured. The animals were then
dosed and placed in close-fitting restraining cages of wire mesh. Blood, bile and urine
specimens were obtained at intervals throughout the 24 hr following injection of ampicillin
direct into the duodenum (100 mg/kg, 1.0 ml./100 g body weight). At the termination of
the experiment, homogenized samples of the following were assayed: (a) small intestine from
pylorus to ileo-caecal valve, (b) caecum, colon, rectum and faeces.
(b) Distribution and elimination
The methods and doses used in investigating the concentrations in the cerebrospinal fluid
of rabbits, the mode of urinary excretion in the hen and the tissue distribution in rats were
the same as those used by Acred, Brown, Turner & Wright (1961). In all experiments the
antibiotic was administered intramuscularly, but in the distribution experiments it was also
given orally. The bile, blood and urine concentrations in conscious rats were determined
using the method described above for intestinal administration, the antibiotic being given
orally by stomach tube.
5 ml. of bovine, horse or human serum containing 5 mg of either ampicillin or phenoxy¬
methyl penicillin was placed in cellophane bags (Visking Tubing -} in. diameter) and suspended
in 20 ml. sterile saline at 10° C for 48 hr. At the end of the period of dialysis the amounts
of the antibiotic outside and inside the tubing were assayed. Five tubes of each antibiotic
were prepared in each experiment.
The protective effect of ampicillin was determined in mice infected with Klebsiella
pneumoniae, Salmonella typhimurium, Diplococcus pneumoniae, Streptococcus pyogenes
Group A, Staphylococcus aureus Smith (benzylpenicillin sensitive), and Staphylococcus aureus
52-75 (benzylpenicillin resistant, minimal inhibitory concentration 125 jug/ml.). The experi¬
mental infections were produced in groups of 10 mice by injections of the bacteria using from
100 to 500 median lethal doses of the bacterial culture, prepared in 5% hog gastric mucin
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preparing seven 10-fold dilutions of 18 to 25 hr cultures of the pathogens in 5% hog gastric
mucin. 0.5 ml. of the dilutions was injected intraperitoneally into male albino mice (18 to
22 g), one dilution being administered to a group of 10. The animals were observed for
4 days and deaths were recorded each day. The median lethal dose was determined graphically
by plotting the dilution factor of the culture against the percentage deaths, using log probit
paper.
The median curative dose (CD50). Ampicillin, tetracycline, chloramphenicol, phenoxy-
methyl penicillin, benzylpenicillin and phenethicillin were administered subcutaneously and
orally to the groups of mice. A 4:1 dose ratio was used, the doses being administered in
0.2 ml. normal saline immediately following the infection. The mice were observed for 4 days
and the deaths were recorded daily. The percentage deaths were plotted against log dose
on log probit paper, and the dose of compound (mg/kg) giving protection to 50% of the
mice (CD50) was read off from the graph.
RESULTS
Toxicity
(i) Acute. . Ampicillin is non-toxic to mice and rats when administered either
orally or subcutaneously in doses of 5 g/kg.
As regards intravenous dosage for mice, 2 g/kg has been administered without
lethal effects, although muscle tremors, slowed respiration and mild clonic con¬
vulsions have sometimes occurred. The amount which can be administered intra¬
venously has been limited by solubility, and the maximum dose we have been
able to give has been 2.5 g/kg. At this dose level 3 out of a group of 10 mice
have died.
(ii) Prolonged administration. No toxic symptoms were noted in rats treated
with ampicillin. Similarly there were no observable toxic symptoms in dogs apart
from a slight loosening of the stools during the early days of the test. Post-mortem
examination did not reveal any abnormalities in either species, and the histology
of the organs examined was normal.
Local irritant and pharmacological action
No macroscopical signs of damage were observed apart from a slight area of
erythema at the site of injection. Microscopical changes in the skin and muscle
were minimal and difficult to find. They consisted only of very sparse inflammatory
cell infiltration and slight accompanying interstitial fluid accumulation.
Doses up to 80 mg/kg, administered intravenously to cats, had no effect on blood
pressure or respiration. Neither had they any effect on the blood pressure response
to an injection of adrenaline, acetylcholine or histamine.
A bsorption
(i) Rabbits. The blood levels obtained after oral and intramuscular administra¬
tion of phenoxymethyl penicillin and ampicillin are given in Table 2. After intra¬
muscular dosing the peak level of phenoxymethyl penicillin at 1 hr is higher than
ampicillin, but at subsequent periods the concentrations of both antibiotics are
similar. On the other hand, after oral administration the concentrations of ampicillin
are considerably greater than phenoxymethyl penicillin.
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Table 2
MEAN BLOOD CONCENTRATIONS FOLLOWING ORAL AND INTRAMUSCULAR
ADMINISTRATION OF 100 MG/KG AMPICILLIN AND PHENOXYMETHYL
PENICILLIN TO GROUPS OF 5 RABBITS
Concentration /xg/'ml. of blood
at hr
Antibiotic 1 2 3 4 Route
Ampicillin 3-0 2-91 0-73 0-13 Intramuscular
Phenoxymethyl penicillin 4-7 2-42 0-65 0-22
Ampicillin 2-16 0-92 0-27 0-06 Oral
Phenoxymethyl penicillin 0-67 0-5 0-03 0
(ii) Dogs. The mean serum concentrations after 20 mg/kg of ampicillin and
phenoxymethyl penicillin given orally and of 5 mg/kg ampicillin and benzyl-
penicillin given intramuscularly are shown in Table 3. Following the oral admini¬
stration of phenoxymethyl penicillin, the highest blood concentration recorded
occurred 30 min after administration, whereas with ampicillin the highest concen¬
tration occurred 1 hr afterwards. Throughout the 5 hr period of the test, when
Table 3
MEAN SERUM CONCENTRATIONS IN GROUPS OF 5 DOGS AFTER ORAl
ADMINISTRATION OF 20 MG/KG AMPICILLIN AND PHENOXYMETHYL
PENICILLIN AND INTRAMUSCULAR ADMINISTRATION OF 5 MC. KG
AMPICILLIN AND BENZYLPENICILLIN
Concentration /xg/ml. at hr after dosing
Route 0-5 1-0 1-5 2-0 2-5 3-0 3-5 4-0 4-5 5-0 5-5 24
Oral 4-87 7-23 3-67 3-51 2-15 0-96 0-4 0-32 0-22 0-19 0-11 0
Oral 2'58 1-48 0-59 — 0-15 04 0 08 0-07 0-07 004 0-04 0
Intra¬
muscular 4-6 3-3 1-55 0-95 — 0-32 0-13 0 13 0-09 0 09
Intra¬








blood samples were taken regularly, the concentration of ampicillin was always
considerably higher than phenoxymethyl penicillin. After intramuscular admini¬
stration the peak serum concentrations of ampicillin and benzylpenicillin occur at
30 min. Throughout the period of the test the concentrations of ampicillin were
greater than benzylpenicillin.
(iii) Rat—intestinal absorption. The percentage of dose excreted in the bile and
urine and that remaining in the gut after the 25 hr period of experimentation are
shown in Table 4. Maximum biliary excretion occurred in the 2 to 4 hr period
after dosing and there was no excretion in the bile after 23 hr. No urine samples
were obtained during the first 2-hr period, and maximum urinary excretion occurred
within 4 hr of dosing. Over the 25 hr period approximately twice as much
ampicillin was excreted in the urine as compared with that excreted in the bile.
In only one rat (no. 3) was there any appreciable quantity of ampicillin remaining
in the small intestine after 25 hr. Similarly, the colon, caecum, rectum and faeces
of only one rat contained a significant quantity of ampicillin after 25 hr. Approxi¬
mately 7% of the dose could be accounted for in the bile, urine and faeces.
/
Table4
ABSORPTIONNDEXCRETIONFAMPICILL1NITHECONSCIOUSATAF R1NTRADU DENALDOS GT00MG/K [0*nosampleobtained]
%ofdosere¬ mainingingut after25hr
Rat no. 2 3 4' 5 Mean




1-2 0-21 0-66 0-72 0-16 0-98 0-55
2^4- 0-83 0-78 0-38 0-71 1-80 0-90
4-6 0-19 0-28 0-10 018 1-37 0-42
6-23 0-25 0-70 0-21 0-06 016 0-28
23-25




0* 0* 0* 0* 0* 0*
2-4 0-53 0* 1-32 0-97 3-76 1-65
4-6 0-04 2-39 0-35 249 0* 1-32
6-23 0-63 2-06 0-84 0-26 2-95 1-35
23-25 0* 0-04 0 0 001 001
Bloodlevels. Concentrationfig/ml.(hr)
1 0-52 0-94 1-35 3-00 0-60 1-28
3 0-36 0-52 0-56 042 0-88 0-55
5 0-21 046 0-28 0-17 0-76 0-38
24
0 0 0-11 0 0 0-02
Colon,
Smallcaecum, intes-r ctum, tinefaeces 0-01 0 2-71 0 0-06 0-56
009 2-64 0 0 0 0-55
0-5514-872-15





ANDBILEl%OFDOSEEXCRET DIURINEANDBIL ,RA IOFU INE
ANDBILETOL ODCONCENTRATIONSAF ERO ALADMINIS RATIONF100G/KGAMPlCl LINNDPHENOXYMETHYLPENICILLINTOGROUPSOF10CONSCIOUSAT Blood concentration pg/ml.Urine concentration pg/ml.Bile concentration Pg/ml.%ofd se excreted inurine%ofd se excreted inbile
Ratioofurine tobl od concentration
































































362 P. ACRED AND OTHERS
Distribution
Cerebrospinal fluid. Ampicillin penetrates into the cerebrospinal fluid with
difficulty. The concentrations in the cerebrospinal fluid after doses of 500 nig/kg
intramuscularly at 1, 2, 4 and 6 hr following administration are respectively 1.4,
0.12, 0.05 and 0.13 /xg/ml., whereas the corresponding levels in the serum are
54.0, 14.25, 4.2 and 5.8 /xg/nfl.
Elimination in the conscious rat. Table 5 shows the mean blood, urine and bile
concentrations of phenoxymethyl penicillin and ampicillin at 2-hr intervals following
the administration of 100 mg/kg orally of each antibiotic. The concentration ratio
from the blood to the urine, and from the blood to the bile, is also given. The
mean ratios show that there is little difference between the two antibiotics regarding
the blood/bile concentration, the bile concentration being approximately 300 times
that found in the blood. However, the concentration of ampicillin in the urine is
twice that of phenoxymethyl penicillin, and the mean blood to urine concentration
ratios of each antibiotic are 800 for ampicillin and 400 for phenoxymethyl penicillin.
Urinary excretion—the hen. In hens treated with ampicillin only, almost all
of the antibiotic administered is excreted in the urine during the 6-hr period follow¬
ing intramuscular administration into the left leg. Four to five times more is
excreted by the left kidney than by the right kidney. After probenecid which
blocks renal tubular filtration the mean total amount excreted by the left kidney
is reduced to about 1.6 times that excreted by the right kidney ; moreover, following
probenecid approximately 66% of the injected dose only can be accounted for
during the period of test (see Table 6).
Table 6
EXCRETION OF AMPICILLIN IN THE HEN
The mean urinary excretion from the left and right kidneys of 4 hens each of which received 100 mg
ampicillin and 100 mg ampicillin -f 100 mg probenecid. Ampicillin was administered into the














Total 0-6 77-78 16-68
0-1 18-56 12-75
1-2 10-07 6-85




Total 0-6 40-75 25-72
Tissue distribution. The amounts of ampicillin recovered from the various tissues
after oral and intramuscular administration are shown in Tables 7 and 8. The
amounts are expressed in /xg/g wet weight (column a) and as the ratio of concen¬
tration in the tissues to the concentration in the serum (column b). The values
Table7
DISTRIBUTIONOFAMP CILLINRA SAFTERORALADMIN STRATION
Sevengroupsf10ratw regivenrally1 0mg/kgam icil in.Ongroupw skill dtth fchep riod.Thm anconcentrationfamp cilli






















































































































































































































































































represent the mean of 10 rats. The amount of the antibiotic recovered expressed
as a percentage of the dose administered is shown in the tables.
After oral administration the concentration of ampicillin fell off more rapidly in
the serum than any other tissue, with the exception of the spleen. The high con¬
centrations in the livers and kidneys were probably accounted for by the presence
of bile and urine in these organs. The passage of the antibiotic along the alimentary
canal is well illustrated. The antibiotic passed very rapidly from the stomach
to the small intestine. There were only trace amounts found in the colon for the
first 2 hr of the test, but at 4 lir large quantities were recovered in the colon and
faeces. Throughout the period of the test the total quantity recovered decreased
until at 12 and 24 hr only 9.6% and 4.3% of the doses administered were recover¬
able ; the majority of these quantities were in the urine, 6.6% and 3.7% respectively.
After oral administration 43 to 65% can be recovered in the first 4 hr.
After intramuscular administration there is a rapid increase of serum level during
the first half-hour following administration ; however, this is followed by a very
rapid decrease in serum levels. Within 4 hr serum levels have been reduced from
64.4 /xg/ml. to 0.18 jag/ml. Practically the whole of the amount injected is recovered
in the urine within 1 to 2 hr after administration. The concentrations occurring in
the liver and the kidneys are also initially very high, and they decline very rapidly
but not quite at the same speed as the serum levels. The concentrations in the
spleen and lung during the first hour never reach the concentration found in the
serum, but the decline in the concentrations in these two organs is much less than
in the serum, so that at the end of 4 hr the concentrations are higher than the
serum. The amount found in the small intestine and the large intestine resulting
probably from biliary excretion does not exceed 6.5% of the dose administered.
After intramuscular injection 73 to 117% can be recovered in the first 4 hr.
Protein binding




Mean % of ampicillin and phenoxymethyl penicillin bound to bovine, horse and human serum
Mean % serum bound
Antibiotic Bovine Horse Human
Ampicillin 17-15 7-9 17-0
Phenoxymethylpenicillin 51-37 39-3.7 68-7
Chemotherapy
Ampicillin is effective against a number of experimental infections produced by
gram-negative and gram-positive organisms in mice (Table 10). Against the
penicillin-sensitive staphylococci (Staphylococcus aureus Smith) ampicillin, benzyl-
penicillin and phenethicillin, given subcutaneously, are the most active antibiotics
followed by phenoxymethyl penicillin and tetracycline ; chloramphenicol is inactive.
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Table 10
ACTIVITY OF AMPICtLLIN, PHENOXYMETHYL PENICILLIN, PHENETHICILLIN,
BENZYLPENICILLIN, TETRACYCLINE AND CHLORAMPHENICOL AGAINST GRAM-
POSITIVE AND GRAM-NEGATIVE INFECTIONS






















Antibiotic fig/'ml. CD50 mg/'kg n CD50 mg/kg n
Ampicillin 01 0-3 4 0-3 4
Phenoxymethyl
penicillin 0-02 0-3 3 0-5 1
Benzylpenicillin 0-02 5--8 1 0-3 3
Phenethicillin 0-05 0-3 2 0-1 1
Tetracycline 01 5-2 r 6-0 1
Chloramphenicol 50-0 Inactive 100 2 Inactive 100 2
Ampicillin >200 0 Inactive Inactive
Phenoxymethyl
Inactivepenicillin >200 0 Inactive
Benzylpenicillin >200-0 Inactive Inactive
Phenethicillin >200 0 Inactive Inactive
Tetracycline >200-0 Inactive Inactive
Chloramphenicol >200-0 Inactive Inactive
Ampicillin 0-1 0-1 1 0-025
Phenoxymethyl
penicillin 0-05 0-1 1 0-1 I
Benzylpenicillin 0-05 — —
Phenethicillin 0-2 0-5 1 0-1 I
Tetracycline 0-2 0-5 1 0-5 1
Chloramphenicol 2-0 3-2 1 3-2 1
Ampicillin 0-05 0-25 2 0-5 2
Phenoxymethyl
penicillin 0-05 0-6 2 0-9 2
Benzylpenicillin 0-02 — 2 0-6 2
Phenethicillin 0-05 0-4 1 0-2 1
Tetracycline 0-2 130 1 5-0 2
Chloramphenicol 2-0 >100-0 1 Inactive 100 1
Ampicillin 0-5 11-6 9 .35-4 8
Phenoxymethy!
penicillin 50-0 Inactive 400 4 Inactive 400 4
Benzylpenicillin 10-0 — Inactive 400 3
Phenethicillin 500-0 Inactive 400 2 Inactive 400 2
Tetracycline 0-5 Inactive 400 61-0 14
Chloramphenicol 1-0 165-0 280-0 2
Ampicillin 1-0 18-0 10 12-8 10
Phenoxymethyl
penicillin 200-0 Inactive 400 4 Inactive 400 4
Benzylpenicillin 10-0 Inactive 400 3 82-0 3
Phenethicillin >100-0 Inactive 400 2 Inactive 400 2
Tetracycline 2-0 62-4 5 59-2 16
Chloramphenicol 5-0 310-0 1 250-0 3
When given by the oral route ampicillin, phenoxymethyl penicillin and phenethicillin
are equally active, but the activity of benzylpenicillin is reduced to that of tetra¬
cycline ; chloramphenicol again is inactive. None of the antibiotics is active against
staphylococci resistant to benzylpenicillin.
Against streptococci, ampicillin, phenoxymethyl penicillin, phenethicillin and
tetracycline are all very active when given orally or subcutaneously, although
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ampicillin is the most active when given subcutaneously. Again, chloramphenicol
is the least active.
Against pneumococci, ampicillin is the most active, followed by phenoxymethyl
penicillin, phenethicillin and benzylpenicillin. Tetracycline is less active and chlor¬
amphenicol is only slightly active.
In the animals infected with gram-negative organisms, benzylpenicillin, phenethi¬
cillin and phenoxymethyl penicillin are inactive, while ampicillin is considerably
more active than tetracycline, which in turn is more active than chloramphenicol,
both orally and subcutaneously.
DISCUSSION
Ampicillin is the first semi-synthetic penicillin which is effective orally against
grant-negative and gram-positive organisms. Unlike other broad-spectrum anti¬
biotics, which are usually limited in their usefulness by untoward side-effects,
ampicillin is non-toxic. As with benzylpenicillin, high doses can be administered
safely by injection and by mouth to laboratory animals. In the prolonged toxicity
studies the only observable symptoms occurred in dogs, where the initial dosing
resulted in the passage of semi-liquid stools. In contrast to tetracycline and chlor¬
amphenicol, which produce severe tissue damage at the sites of injection (Hanson,
1961), ampicillin after intramuscular and intradermal administration has little
irritant effects.
In the rat after oral and intraduodenal administration, ampicillin and phenoxy¬
methyl penicillin are poorly absorbed. However, in dogs after oral administration,
ampicillin gives higher blood levels than phenoxymethyl penicillin. The levels are
also higher than those obtained after administration of much larger doses to rats.
In humans, ampicillin (Knudsen, Rolinson & Stevens, 1961) also gives good blood
levels after oral administration ; and 30% of the antibiotic can be recovered in the
urine within 6 hr. The results indicate that the rat is an unsuitable animal for
the study of oral absorption of penicillin derivatives.
After oral administration a large proportion of the antibiotic is destroyed in the
intestine. Since the antibiotic is not stable to bacterial " penicillinase " it can be
assumed that it is destroyed by the intestinal flora. There would appear to be
no destruction of the antibiotic within the body, as bile and urine chromatography
revealed only unchanged ampicillin.
After intramuscular administration almost all of the antibiotic is recovered in the
urine in 2 hr. This is in marked contrast to the oral results, where the total recovery
in the urine does not exceed 10%. The concentration of ampicillin in the bile and
urine during the first 4 hr after administration to rats is 600 and 250 times respec¬
tively the corresponding serum concentrations, these concentration ratios being
similar to those found with methicillin. However, in the experiments in which the
bile ducts were cannulated, it would appear that the stress of the operation reduces
the urinary excretion considerably, since only 23.4% of the antibiotic is recovered
in 4 hr, whereas 95% of the antibiotic is recovered in the urine in the unoperated
animals within the same time period.
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Ampicillin is rapidly cleared from the blood by the kidneys. It is removed both
by renal tubular secretion and glomerular filtration. This was demonstrated in
the hen, which possesses a renal portal system (Sperber, 1949). The venous return
from the hind limbs is shunted through the parenchyma of the renal tubules. There¬
fore, when a substance is injected into a hind limb and both renal tubular secretion
and glomerular filtration take place, the concentration of the substance excreted
is greater in the urine from the ipsilateral kidney than in the urine from the contra¬
lateral kidney. If only glomerular filtration takes place, then the concentration in
the urine excreted from both kidneys is identical. In our experiments, prior to
the block in tubular secretion by probenecid, 95% of the dose of ampicillin
administered is excreted within 6 hr following administration, and of this 78%
is excreted by the kidney nearest to the injection site, while only 16.6% is excreted
by the contralateral kidney. On the other hand, after the administration of pro¬
benecid, although the amount excreted by the contralateral kidney is increased and
that excreted by the other kidney is reduced, the kidneys still do not excrete equal
amounts, suggesting incomplete block of renal tubular secretion. Knudsen (personal
communication) has found that in humans a single dose of probenecid similarly
does not block completely renal tubular secretion of ampicillin. A second dose
is required to produce complete block.
Ampicillin is distributed throughout the body tissues, but is concentrated only
in the kidney and liver, the high values in these organs probably being attributed
to the presence of urine and bile respectively. As with other penicillins, only small
quantities penetrate the cerebrospinal fluid.
Benzylpenicillin, phenoxymethyl penicillin, phenethicillin and ampicillin all have
the same order of activity in vitro against the gram-positive organisms, and this
relationship in activity is born out in vivo. Tetracycline likewise gives a reasonable
parallelism between in vivo and in vitro activity. On the other hand, chlor¬
amphenicol has a CD50 of 3.2 mg/kg against the streptococcal infection, but is
inactive in doses of 100 mg/kg against Staphylococcus-aureus Smith and Diplococcus
pneumoniae, although in vitro the activity of chloramphenicol against the three
organisms differs by only one tube dilution.
Against the grain-negative organisms which were investigated the activity of
ampicillin in vivo corresponds to its in vitro activity, but both tetracycline and
chloramphenicol are considerably less active in vivo than ampicillin, even though
their in vitro activities are only slightly less than ampicillin.
There is no valid explanation for these differences at present. They cannot be
attributed simply to ampicillin being better absorbed, being less protein-bound or
being distributed throughout the body more effectively than either tetracycline or
chloramphenicol, since if this were so it would be expected that the difference in
the in vivo and in vitro activities of these antibiotics would be- the same against
the grain-positive as well as the gram-negative organisms. In the assessment of
the activity of chemotherapeutic agents, therefore, these results emphasize the need
to correlate all the in vitro and in vivo experimental results.
We wish to thank Dr A. C. Thackray, of the Bland Sutton Institute of Pathology, for
expert histological comment ; Dr A. A. G. Lewis, Physician to the Connaught Hospital,
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Walthamstow, under whose skilled guidance the dog studies were conducted ; Mr F. P. Doyle
and his colleagues for the preparation of the compound : and Mr K. R. L. Mansford for
the chromatography.
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A great deal has been written about the significance of
protein binding of antibiotics and it is commonly aooepted
that if the antibiotic is bound to the body proteins only the
free antibiotic is active. In other words an antibiotic which
is bound to the extent of 90^ to serum albumin will only show
activity in the serum equal to one tenth of the total concen¬
tration of antibiotic tested in the absence of serum albumin.
This conoept developed by pharmacologists in other spheres
appears to be rational and taken as a whole would seem to b6
satisfactory. However the systems which have been studied have
in general been in vitro and the conditions hardly approximate
to those found in vivo where there is a continuing changing
environment. The rate of absorption, elimination and destruction
of the drug is not accounted for in vitro; neither d© in vitro
systems take into account natural anatomical barriers or barriers
produced as a result of bacterial infection or inflammatory
lesions. Hence the effeot of an antibiotic cannot be fully pre¬
dicted by means of in vitro tests. Infections are rarely systemic
and are in general confined to specific sites. The activity of
the antibiotic in the blood while of considerable importance is
not of over-riding importance and it is perhaps of much greater
interest to determine the concentration of antibiotic at the
site of infection. The exTectiveness. of an antibiotic in vivo
can also be determined by assessing the effectiveness of an anti-
biotio against localised infections. Only a limited number of
attempts have been made to study the action of antibiotics against
localised infections. Eagle, Eleischman and Musselmann (1950) .
examined the effect of penicillin in mice which had received an
intramuscular injection of pneumococoi and streptooocoi and in
rabbits which had in'crates ticular injection. Serbia studied
the development of the staphylococcus after intramuscular injec¬
tion in mice and Selbie and 0'Grady (195k) examined tuberculous
lesions similarly produced. ~ . .
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The methods largely depend on the selection of the correot
strain of organism for the species used and unless an adequately
virulent- infection can be established the tests are difficult to
interpret and can be misleading- By selection of the appropriate
strain of mouse and staphylococcus Brown and Acred (i960) developed
the thigh lesion technique of Selbie and have screened a large
number of semi-synthetic penicillins. A comparision of activity
in vivo of penicillins having different protein binding properties
can now be made. The results obtained in mice with a number of
penicillins are shown in Table I but it must be understood that
the protein binding figures are those determined in human serum.
The actual binding in mouse serum could be less but it is not
unreasonable to assume that,the ratio of binding is the same.
The results illustrate that irrespective of variations in binding
the activities of the antibiotics are of the same order. This
suggests two alternatives a) the bound antibiotic is active and
penetrates to the site of infection b) the amount of free peni¬
cillin present in the infection is equal for each antibiotic and
that this free concentration is not the same as in the blood.
The latter explanation"is more likely but the precise reasons for
this have not been elucidated.
CE50 "tests which depend on administering a lethal infection
to a group of animals then determining the amount of antibiotic
which will protect 5C$ of the group also provide information on
the value of an antibiotic in vivo. The animals are infected
intraperitoneally and the drugs are given su'bcutaneously. To be
effective therefore they must be taken up on the blood and then
penetrate into the peritoneal fluids. Our results (Table II)
obtained with CD50 tests against staphylococci illustrates
another facet in the problem. The protoin binding figures obtained
by static dialysis technique show that the antibiotios tosted are
all fairly heavily bound and more or less within a given range.
Howevers when the binding was determined by continuous dialysis over
a period of 24 hours two groups clearly emerge; one where the anti¬
biotic is nearly all removed from the serum and the second group
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1621 98.8 87 71
1702 97.8 91.3 90
145^ 87.3 60.6 75











BROXIL 86 17.5 0.3
AB 1929 75 20 0.1
AB 1936 65 0.3
AB 1904 92 15 0.3
AB 2001 ^ 66 56 1 1.8
AB 2006 97 43 1.8





Protein binding and activity of a number of
penicillins of the "Broxil" series and their
activity against Staphylococcus aureus infec¬
tion in mice.
The antibiotics of the first group will give CD^q values of a
low order i.e. they are all very active, and those in the second
group give much less satisfactory CD50 values.
Huang, Seto, Weaver, English, McBride and Shull (1963)
comment on their studies with a-substituted penicillin amides
that in spite of low in vitro activity and mediocre serum levels
that ct-methyoxy-n-propyl penicillinamide is an extremely effective
chemotherapeutio agent;. From their observations they state that
in vitro activity and serum levels are by no means the only decisive
factors which determine chemotherapeutic efficacy of an antibiotic.
i ! i . . ' ■
The results of both Acred and Brown and Huang et al could
be criticised on the grounds that the activities in the animal
could differ because of differing degrees of protein binding bet¬
ween the serum of animal species under test and human serum.
However particularly with regard to the results of tine first investi¬
gators it is perhaps more than co-incidence that the results have
separated out in the way they have done.
Penetration of Penicillin into oxtravascular sites
In the early days of penicillin therapy there was a strong
belief that the concentration of penicillin in the blood was
insufficient to account for its antibacterial action. Jawetz (1946)
and White, Lee and Alveson (1946) showed in animal experiments that
the duration of survival depends more on the total dose of anti¬
biotic given rather than the interval between injections. To explain
the observations and to study further the fate of penicillin in the
body with a view to predicting its action many workers have attempted
to measure the active concentration of penicillin in tissues. Florey,
Chain and their associates (1941) were the first to report on the
« i*?t.jrihuii©n of penicillin in experimental animals after administration
by various routes. • They found that high concentration appeared in
the urine and that it was. also present in saliva, al'though they could
*
83
demc :: itrate none in tears or pancreatic juice. M.E. Florey (1946)
measured the amount of penicillin in human wound exudates after
intramuscular administration of 100,000 unit3 (- 66 mg). The
antibiotic was found in every case after 3 hours and in 50?o of
the cases it was detectable 12 hours afterwards while the Gcnoen-
tration in the blood fell rapidly to zero after 4 hours. At 4 hours
the blood concentration was 0.004 - 0.08 units/ml and the exudate
concentrations were 0.16 - 0.32 units/ml. This work is supported
by Weinstein, Daihos and Perrin (1951)- iney placed sterile fibrin
clots in several areas under the rabbit skin on the back. After
the intramuscular administration of various doses of penicillin the
clots'were removed and assayed. They found that in the first hour
the blood levels were more than in the clots but subsequently the
levels were higher on the clots and activity was still detectable
twelve hours afterwards. Applying the sane principle as Weinstein
et al, Werner, Knight ana McDermott (1954) implanted specially prepared
agar discs in the peritoneal cavity of rabbits. The animals were
given a large intravenous dose of the penicillin and streptomycin
and the discs were removed for assay at intervals. Blood was taken
from the cardiao vein or by cardiac puncture. High concentrations
were readily attained in the agar discs and concentrations equal to
or exceeding the serum concentration were achieved in 1-2 hours in
the case of penicillin and 1-4 hours with streptomycin. In a second
series of tests with oats a comparisicn was made with chloramphenicol
and penicillin and they found that the levels of chloramphenicol did
not achieve the same magnitude as found with penicillin, Nathanson and
Liebhold (1946) found that sulphonamides did not penetrate into fib¬
rin clots but penicillin was freely diffusible. McCune (i960) extended
the work of Werner et al and implanted agar discs in the peritoneal
cavity of rabbits. He allowed 28 days for a fibrous capsule tc be
produced round the disc then he injeoted penicillin intravenously.
At given intervals the discs were removed from the rabbit and the
penicillin concentration estimated. Within two hours of administration
concentrations of penicillin in the disc were much higher than in
the blood but on the other hand in a comparable test with streptomycin
the levels in the disc were no higher than the blood. Using implanted
cotton pellets to produce a granuloma Brown (1964) found that the
concentrations of four semi-synthetic penicillins found in the granulomas
we!re equal to the concentrations found in the blood. In order to obtain
further information on the concenia. itir>n of penicillins in
inflammatory fluids Ungar (1950) measured the amount appearing
in inflammatory fluids following intramuscular injection' of 0.5 nil
turpentine. When sufficient oedema had been produced 24 hours
later the penicillin was given intramuscularly and the fluid and
blood levels were determined at intervals afterwards. Within one
to two hours the levels in the exudates were higher than the blood
levels and persisted much longer. Brown (1964) found that fol¬
lowing the intraperitoneal injection of 0.1 ml of turpentine to
rats that the concentrations of Cloxacillin, Phenethicillin and
Penicillin V were slightly higher than the corresponding blood
levels while the concentration of Ampieillin in the inflammatory
fluid was considerably higher. A coraparision of Quinacillin and
Methicillin by Hale and Spooner (1964) where the concentrations
were determined in pus in an abscess produced by staphylococci in
rats showed that both the penicillins gave persistent levels in the
pus over those found in the blood, The experimental evidence that
penicillin persisted in tissues long after its disappearance from,
the blood, led Schacter (1948) to examine the concentration of peni¬
cillin appearing in the lymphatic system. Dogs were suitably anaes¬
thetised and the thoracic lymph duct cannulated. Penicillin v/as
injected intravenously and. intramuscularly and samples of lymph
and blood taken from the femoral vein were removed for assay' at
intervals, The tests showed that the penicillin lymph levels were
more prolonged than the blood levels and after two hours the con¬
centrations in the lymph were higher than the blood. Vervey and
Williams (1962) examined a number of penicillins with a view to
determining the penetration from plasma into lymph. They cannulated
the peripheral lymphatic ducts in dogs and after a primary dose of
the penicillin continued to administer the penicillin by slow intra¬
venous infusion. Samples of lymph and blood were taken at inter¬
vals throughout the tesr. They found that apart from Methicillin
none of the other penicillins gave as high levels in tb.9 lymph as in
the blsodo 1 In a aeries of experiments with rats, Brown (1964) and
Acred, Brown and Clarke(1964) found that thoracic lymphatic con¬
centrations were generally higher than those found in the blood after
intramuscular administration, Ampioillin and Penicillin & gave
values in the lymph which were twioe the serum concentrations.
In preliminary experiments in dogs Acred and Clarke (iSQy) have
oollected the peripheral lymph and compared the concentrations in
the lymph with the blood taken from the right and left femoral
veins after intramuscular administration into the left leg. The
results indicated that after initial levels in the blood higher
than in the lymph, the lymph concentrations oontinue' to rise
steadily, and within 2-3 hours are in excess of the blood con¬
centrations. Peak levels have so far not been obtained in the
lymph.
Apart from the work of Aored and Brown (1963); Aored, Brown.
Turner, and Wright (l96l); Acred, Brown, Turner and Wilson (1962)
no systemio investigation has been carried out with penicillins
to determine the mode of exoreticn of penicillin and to obtain
information on the amount excreted, in a given period. Aored and
Brown used the hen which has a renal portal system and injected
intramuscularly into the left leg the antibiotic under test. The
urine was oollected directly from the ureters at intervals. The
total quantity of penicillin excreted by the right and left kidneys
was recorded. The elopes of the elimination curves were all identical
apart from the experiment with Ampioillin. The excretion of Ampioillin
from the right kidney in the chicken which did not receive probenecid
was extremely low. The bulk of the antibiotic was excreted by the
left kidney which received the blood draining the injection site and
therefore contained a higher concentration of antibiotic than the
blood in the other leg. After the administration of probenecid the
slopes for the excretion of Ampioillin from the right and left kidneys
became similar and corresponded to the excretion eliminated in one
hour. Table III gives the percentage of the total dose administered,
by the right and left kidneys before and after the administration of
probenecid.
The results indicate that the amount excreted by glomerular
filtration for all the penioillins tested 'are very similar. Ampioillin
would appear to be excreted largely by this route. Taking into con¬
sideration therefore all the experimental results, it is important to
decide in which way protein binding affects the activity of antibiotic
particularly penicillin.
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Ampiciilin 16,7 77.9 25.9 40.8
Penicillin G- 14.1 38.3 25.3 28.5









Percentage of Penicillin eliminated by the right
and left kidneys of thG hen before and after the
administration of Probenecid.
■ •
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When the concentration of a penicillin is measured in "body
fluids information must he available on the degree of oindang
in these fluids. The technical difficulties of 3uch a:; exer¬
cise is considerable. Scholton (l9b3) has attempted to uetermine
the concentration of antibiotic present in tissue fluids but since
his methods depend on macerating the tissue and spinning down the
solids, it is more than likely that he is measuring largely the
concentration in the serum. Vervey and Williams (1962) assayed the
concentration in the lymph following slow intravenous infusion of
the penicillin. They measured total levels, their assay procedure
was the usual cup plate technique using Sarcina lutea as the test
organism. Specimens were diluted in buffer, 1 in 10 for lymph,
prior to assay. The total amount bound in plasma and in lymph for
a number of antibiotics was measured by ultrafiltration techniques.
Their results indicated that "although the proteins in lymph are
predominantly derived from plasma their affinity for penicillin is
decreased". They could only hazzard a guess at the reason. Table 4
presents the "free" penicillin in plasma and peripheral lymph as
a percentage of total penicillin in plasma. If these figures are
correct they indicate that a higher percentage of free penicillin
exists in the tissues than in the blood. This therefore extends
the actual usefulness of an antibiotic. In addition if Brown and
Acred's result also reflects a true state of affairs higher con¬
centrations of antibiotic can be present in the extravascular fluids
and coupled with Vervey and Williams' figures a still higher free
level of antibiotic would be present. The report Brown and Acred,
also shows that the free concentration of penicillin in the lymph is
higher than in the serum. The results were obtained by ultrafil¬
tration of rat lymph and serum.1
I ! '!
These experimental results therefore imply that blood levels
and the degree of binding in the blood are not the only factor in
assessing the value of an antibiotic in vivo. It is possible that
higher concentrations of total and 2nree penicillin can exist in the
extravascular fluids. On the surface this would appear to contradict
the simple model of reversible diffusion of the free antibiotic
across a sosi-permeable membrane leading to a build up of antibiotic







Penioillin G- 56 61
Phenethioillin 39 47
Penioillin V 36 49
.
Oxaoillin 35 32
SKF 12141 23 31
PA 253 19 30
The "free" penioillin in plasma and peripheral lymph as a
percentage of iota?., penioillin in plasma.
• I
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The concept implies that the "free" level of antibiotic through¬
out the body is constant. Both Ve~-rey and 'Williams' and Brown and
Acreds1 results suggest some alternative, and this may be provided
by the work of Malek, Herold, Hoffman and Pole.(1957)* ™hese
investigators have combined stretpomycin, neomycin and viomycin
and streptomycin with carbcxyl Sulphonic or phosphorylated high
molecular compounds and studied changes in their pharmacological
properties. They found in dogs that the preparations referred to
as Antibiolymphins appeared in the lymph in much higher conoentx-ation
than in the blood. Penicillin as such was not studied but the
mechanisms whereby the antibiotic preparations were eoncontrated
in the lymph relative to the blood, could similarly apply with peni¬
cillins. Ampicillin for example could be carried through into the
lymph in combination with a aacromoiecuie and concentrated within
the lymphatic system. Whether the product is active would have
to be determined. However if one assumes that it is, an explanation
for the enhanced activity of ximpicillin in in vivo experiments in
relation to chloramphenicol would bs forthcoming.
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' | SHE use of methicillin, 2,6-dimethoxyphenyl,
X penicillin, in the treatment of infections caused
by penicillinase-producing strains of staphylococci
is now well established in clinical practice. Its one
disadvantage is that it must be given by injection
since it is unstable in acid solution and poorly
absorbed from the gastrointestinal tract. This
article describes a new penicillin which does not
suffer from this defect, and is, moreover, active at
lower concentrations than methicillin. Clinical
investigations are being reported concurrently else¬
where1.
Chemistry
Acylation of 6-aminopenieillanic acid with reactive
derivatives of several types of sterically hindered
carboxylic acid gives penicillins which resist inactiva-
tion by penicillinase. These penicillins vary con¬
siderably in their chemical and antibacterial proper¬
ties, and a particular class which combines resistance
to both penicillinase and mineral acid with useful
activity against most Gram-positivo bacteria consists
of 3,5-disubstituted 4-isoxazolvl penicillins (1). The
preparation of two such penicillins, BRL. 14001
('Oxacillin') [I; 11 — C6H5, It' = CH3] and its
isomer, BRL. 14.54 [I; 11 — CH3, R' = C0HS], has
♦ 'Orbenin', Beecham Research Laboratories, Limited, registered .
trade mark.
t Trostaphlin', Bristol Laboratories, Inc., registered trade mark.
been described in detail2. Many other penicillins of
typo (I) have been prepared3 and examined, and one
of them, 3-o chlorophenyl-5-methyl-4-isoxazolyl peni¬
cillin [II; RRT.1621], has been selected as the com¬
pound of choice.
BRL. 1621 is available as the sodium salt mono-
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powder. It is freely soluble in cold water to give a
solution stable at 5° C for one week. A 1 per cent
solution in water has [a]™ + 163° and pH of 6-0-7-5.
The half-life in solution in 50 per cent aqueous alcohol
at pH 1-3 and 35° C as determined by a previously
described method1 is 160 min, which is approximately
equal to that of BRL.MOO and penicillin V.
Animal Studies, Toxicology and Pharmacology
Protection tests. The protective effect of BRL.\G~2l
against the penicillin-resistant Staphylococcus pyogenes
Russell (type 80) was estimated using the method of
Selbie and O'Gradv5 as modified by Brown and
Acred6. Groups of 10 mice (1S-22 g) were infected
by injecting into the muscle slioath of the thigh
0-2 ml. of a 1 /2 dilution of an overnight growth of
Staphylococcus pyogenes Russell. BRL. 1621, methi-
cillin and penicillin G were administered in doses of
200 and 50 mg/kg orally and subcutaneously, daily
for three days, the first injection being given immedi¬
ately following the infection. An infected control
group received no treatment. The maximum thigh
diameter of each mouse was measured with calipers
on the first, second, third and sixth day after infection.
The results are expressed as the percentage protection
calculated in the following manner.
mean daily thigh enlarge- mean daily thigh enlarge-
ment infected controls — ment penicillin group 100
mean daily thigh enlargement of infected controls * T~"
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Acute toxicities. The acute oral, subcutaneous
and intravenous toxicities were determined in male
mice (18-22 g), 10 mice boing used at each dose
level. The LDi0 values (g/kg) for the various routes
were respectively > 5-0, 3-0 and 1-2 g/kg.
Prolonged tests. (1) Bats. BBL. 1021 was admini¬
stered orally and subcutaneously to groups of 12
male rats over a period of 12 weeks at doses of 500
and 100 mg/kg. A control group of rats received
0-2 ml./100 g normal saline subcutanoously.
During the test, daily weights and food intake were
recorded. Weekly observations were made of packed
coll volume, white coll counts, and qualitative tests
for proteins, sugars and occult blood were carried out
on urine specimens. Spectroscopic examination of
the blood of the rats in all groups and haemoglobin
concentration was determined on the last week of the
experiment.
All rats were killed at the end of the test and post¬
mortem examinations made. Weights of the spleens,
livers, kidneys, adrenals and testes were recorded.
In addition to determination of organ weights at
autopsy, the following tissues were removed for
histological examination: salivary gland, lymph
node (mesenteric), thymus, thyroid, heart, lung,
liver, kidney, adrenal, spleen, testes, bone marrow,
stomach, duodenum, pancreas and small intestine.
The tissues at the site of injection wero also removed.
No lucmatologieal, biochemical, histological or organ
weight abnormalities were observed. Macroscopically
the only untoward effect was small areas of necrosis
noted at the site of injoction in the rats receiving
BBL. 1621 500 mg/kg subcutaneously. These tissue
reactions were only seen during the first 3 weeks
of the test after which time they disappeared.
(2) Dogs. BBL. 1021 was administered in doses of
2,000 and 500 mg/kg twice daily to groups of 3 dogs
for a period of 4 weeks. Tlio following biochemical
and hematological estimations wore made at the
beginning and end of the test: ESR (mm/h), PCV
(per cent), Hb G (per cent), reticulocytes (per cent),
MCHC (per cent), total white cell count and differen¬
tial count, blood urea (mg per cent), blood glucose
Tabic ]. Percentage protection by brl.iezi, methicillin and
































(mg per cent) scrum proteins—total, albumin,
a,-, a2-, [3- and y-globulins, alkaline phosphatase
KA units, SOFT units and presence of bilirubin. At
autopsy the following organs were weighed: brain,
heart, lungs, liver, spleen, pancreas, kidneys, thyroids,
adrenals and gonads. In addition to those, tho
histology included examination of: stomach, ileum
and colon, cervical and mesenteric lymph glands,
salivary glands, skeletal muscle and bono marrow.
Xo luematological, biochemical or histological abnor¬
malities were noted.
Local toxic effects. There were no observable tissue
reactions to intradermal and intramuscular injection
of 1 per cent solutions of the penicillins in groups
(3 per group) of guinea pigs and rats 3 days after the
injection. The only observable reactions to admini¬
stration of 10 per cent solutions were a hardening of
the skin and erythema around the sites of the intra¬
dermal injections.
.Following the subconjunctival injection in rabbits
of 0-5 ml. of a 50 per cent solution, BRL.l 021 pene¬
trates into the aqueous humor but an opacity of
tho cornea develops which persists for at least 14
days with only a slight decrease in the intensity. It
would appear, therefore, that BRL. I (121 is contra-
indicated for ophthalmological use.
General pharmacology. The effect of BILL. 1021
Table 2. Minimum Inhibitory Concentration or liTtL.1621 (Scri.-.I
dilutions in agar, incubated at 37°C. for £4 hours)
Staph, aureus (6 strains)
Strep, ft-haemolytic (5 strains)
Strep, viridans (4 strains)










Table 3. Activity or URL.1621 against fresh Clinical Isolates
of Penicillin-resistant Staphylococci compared with that of
Metiiicillin
M.I.C. (jug/ml.)
Staph, aureus strain C'440
Staph, aureus strain C465
Staph, aureus strain C417
Staph, aureus strain 0444
Staph, aureus strain C452
Staph, aureus strain 0443
Staph, aureus strain 0442
Staph, aureus strain 0427
Staph, aureus strain 0433
Staph, aureus strain 0420
Staph, aureus strain 0421
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on the blood pressure and respiration was determined
in the anaesthetized cat.
Four cats were anaesthetized with a chloralose
(1 per cent) urethane (5 per cent) mixture. Doses of
up to 100 mg/kg administered intravenously had no
effect on the blood pressure but doses in excess of
this up to 400 mg/kg had slight hypotensive effects
which usually did not exceed 10 mm mercury.
The responses to adrenaline (5-0 gg), acetylcholine
(0-2-0-5 gg), histamine (0-5-5-0 fig), were unaffected
by doses of 200 mg/kg of BRL. 1621. Repeated doses
of Bill.. 1021 at 5-rnin intervals increasing from
25, 50, 100, 200 and 400 mg/kg were given. Death
occurred when the cat had received a total of 1*0 g/kg.
BRL. ] 021 penetrates poorly into the C.S.F. After
a dose of 500 mg/kg intramuscularly in rabbits the
concentration in the C.S.F. was no greater than
2-3 [ig/ml. 1 h after administration, while the corre¬
sponding serum concentration was 370 gg/ml.
BRL. 1021 is eliminated from the body by excret ion
in high concentration both in the bile and urine of
rats. After the oral administration of 100 mg/kg
18-7 per cent is recovered in the urine after 24 h.
while after intramuscular administration 42-1 per
cent is recovered. 10-2 per cent of the orally admini¬
stered antibiotic can be accounted for in the bile.
Metabolism in animals. Paper chromatographic
examination of the urine collected over 24 h from
rats which had received 100 mg/kg BRL.\02\ intra¬
muscularly, indicated the presence, in small amounts,
of two metabolites. Further investigation of these
substances is in progress. •
Microbiology
Antibacterial activity. Minimum inhibitory con¬
centrations (M.I.C.) for bacteria were determined as
described previously7. It will be seen from Table 2
that BRL. 1621 is highly active against Staph, aureus.
Strep. p>yogenes, Strep, viridans and Strep, pneumoniae.
but against Strep, faecalis and the Gram-negative
bacilli the level of activity is very low. Penicillin-
sensitive staphylococci were usually inhibited by
0-1-0-25 gg/ml. Strep, pneumoniae. Strep, viridans
and fi-haemolytic Streptococci were usually inhibited
by 0-1 gg/rnl.
Penicillin BRL. 1021 is primarily of interest for its
activity against penicillin-resistant staphylococci.
Results in Table 3 show that BRL. 1621 is appreci¬
ably more active than methicillin in this respect.
Results for the activity of BRL. 1621 against a larger-
number of hospital strains of Staph, aureus are
shown in Table 4. The total of 382 cultures tested
6
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Table 5. Activity or JtP,L. 1621 compared with BIIL.1400 in
Tests with and without Human Serum, using 30 Strains of
Staphylococci recently isolated clinically
Serial dilution in agar M.I.C. /'g/ml. and number of
strains
5 0 2-5 1-25 0-5 0-25 0-12 0 05 0-02
and and
over below
Penicillin G 20 7 2 3 4
Bill621 8 21 6 1
BRL.1021 + 23 10 ~3
BRL.U00 13 17 3
BRL. 1400 + 3 28 5
+ denotes agar containing 40 per cent human serum
comprised 152 penicillin-sensitive (penicillin G M.I.C.
< 0-1 jig/ml.) and 230 penicillin-resistant (penicillin
G M.I.C. 0-1 jig/ml. or greater). Taking the penicillin-
sensitive strains, only one required a concentration
of BItLAG'2\ as high as 1-25 ug/ml. to inhibit growth
and approximately 95 per cent of the strains showed
M.I.C. values in the range 0-05-0-25 ug/ml. Of the
total of 230 penicillin-resistant strains only two
required a concentration as high as 1-25 ug/ml. for
inhibition and 97 per cent of the strains showed M.I.C.
values in the range 0-125 0-5 ug/ml. The largest
single gioup of strains were those with an M.I.C.
value of 0-25 gg/rnl.
Comparative results aro also included in Table 4
for URL. 1400 (oxacillin). It will be seen that
BRL. 1621 is slightly more active than BRL. 1400.
Of the total of 230 penicillin-resistant strains, only
two showed an M.I.C. as high as 1-25 tug/ml. with
BRL.IG21, whereas with BRB.1400 the corresponding
number of strains was 36 (15 per cent).
Determination of M.I.C. values in solid media and
in broth give similar results and M.I.C. values aro
not significant Ij' influenced by inoculum size.
Effect of serum on activity. Activity of RBI.. 1 021
is depressed by the presence of human serum to
an extent somewhat greater than is the case with
methicillin. Results are shown in Tablo 5 for 36
strains of staphylococci. In the absence of serum all
were inhibited by 0-5 ug/ml. BRL. 1621 or less and
most of the strains were inhibited by 0-25 jig./ml.
In the presence of human serum, however, the major¬
ity of the strains required 1-25 ug/ml. to prevent
growth. It will be seen from Table 5 that BRL. 1400
is also influenced by serum, the extent being similar
to that with BRL. 1621.
Bactericidal activity. Viable counts in broth cul¬
tures containing BRL. 1621 wore carried out in a
manner similar to that of Miles, Misra and Irwin8.
Penicillin URL. 1621 is highly bactericidal to penicillin-
resistant staphylococci at concentrations only slightly
higher than the M.I.C. values. In bactericidal tests
7
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Table 6. Stability of BRL.1621 to Stavhylococoal Penicillinase:
Compared witii BRL. 1400 and Methicillin
(1) At a concentration of 50 /ig/ml. :
ng/ml. remaining
Time (mill) Penicillin!? Methicillin BRL. 1021 BRL.1400
0 50 (50)* 50 50 50'
15 0 (35) 49 40 43
30 0 (17) 47 42 39
45 0 (6) 46 39 33
60 0 (0) 45 35 27
00 0 (0) 42 28 18
* Penicillinase at a dilution of 1/1,000.
(2) At a concentration of 2,000 t'g/ml. :
/'g/ml. remaining
Time (mill) Penicillin G Methicillin BRLA 6-1 BRL.1400
0 2,000 (2,000)» 2,000 2,000 2,000
15 0 (1,600) 1,840 1,550 1,340
30 0 (1,400) 1,720 1,350 830
60 0 (820) 1,520 800 250
* Penicillinase at a dilution of 1/200
BllL. 1621 is substantiallymore act ive thanmethicillin
and also slightly more active than BTtL.l-iOO. At a
concentration of 2-0 ug/ml. BRL.1621. a kill of
approximately 99-9 per cent is obtained in 7 h in
broth cultures of penicillin-resistant staphylococci.
Activity of BRL. 1021 by the paper disk method.
Whatman antibiotic assay disks 6 mm diameter
were used with two levels of BRL.1621, 2 pg and
5 pg per disk. Nutrient agar plates were inoculated
with the test organism to result in dense but non¬
confluent growth and the dishes were loft at room
temperature for .9 4 h with the disks in place before
incubating at 27"~J C overnight. For a range of
staphylococci of varying penicillin G sensitivity the
zone diameters with BRL. 1G2 L showed a fairly good
correlation with the M.I.C. 'values for the strains.
Using a 2 pg disk the zone diameters ranged from
19-29 mm, depending on the strain, and with a .7 pg
disk the range was 22-33 mm diameter, including the
diameter of the disk. Very heavy inoculum, and
particularly the presence of blood in the agar, results
iii smaller zone diameters.
Stability to penicillinase. A penicillinase-producing
strain of Staph, aureus was grown as describod
previously7, and the whole culture, including the oells.
was used as enzyme. The tests on penicillinase
stability of BRL. 1621, BRL. 1400 and methicillin
were carried out at two levels of substrate, 50 pg/'ml.
and 2,000 pg/ml. One volume of the enzyme Avas
added to two volumes of phosphate buffer, pll 7,
containing the penicillin.. The reaction mixture was
incubated at 37° C and assays carried out at intervals
of time. Because of the extreme instability of
penicillin G to penicillinase, a parallel test was carried
out with penicillin G in which the penicillinase was
present at a given dilution since with the penicillinase
at the concentration used for the methicillin and
8
isoxazole tests the penicillin G was destroyed almost
instantaneously. It will be seen from Table 6 that
BRL. 1621 is extremely stable to penicillinase,
although slightly less stable than methicillin, and
that BRL.1621 is slightly more stable than BRL. 1400.
It should bo noted that the penicillinase stability
of _B.Riv.lG21, and also that of BRL. 1400 and methi¬
cillin, is greatly influenced by the concentration of
the compound present in the test. With these com¬
pounds, the concentration of substrate is a limiting
factor for penicillinase activity except at very high
concentrations and the stability of these compounds
is largely due to this effect of substrate concentration
on rate of enzyme action. Consequently, the lower
the concentration of these penicillins the more stable
they become to penicillinase.
Penicillin BRL. 1621, like methicillin, is a powerful
inducor of penicillinase formation.
Emergence of resistance to BRL. 1621. By repeated
sub-culture of staphylococci in the presence of
BRL. 1621, resistant strains can bo selected out in a
step-wise manner similar to that seen with penicillin
G, mothicillin and other penicillins. Single step
mutants of high resistance to BRL. 1021 have not
been encountered in laboratory experiments with
staphylococci. On the other hand, naturally occur¬
ring staphylococci resistant to mothicillin9 are also
resistant to BRL. 1621, although since BRL. 1621
is a more active compound the M.I.G. values with
BRL. 1G21 against these resistant strains are lower
than those for methicillin. This means that although
the M.I.C. values for methicillin may bo above the
serum levels normally obtained, the same may not
be the case with BRL. 1621. For example, certain
strains showing M.I.C. values of 12-5-25 pg/ml.
with methicillin were found to bo still sensitive
to 1-25 gg/ml. BRL. 1021. In general, the highlv
rosistant strains which showed M.I.C. values of
125 [ig/ml. and over with methicillin, also showed
M.I.C. values with BRL. 1621 above the concentra¬
tions obtainable in the body but one strain showing
an M.I.C. value of 50 gg/ml. with methicillin was still
sensitive to 1-25 gg/ml. BRL. 1621.
Metabolite of BRL. 1621. After administration of
BRL. 1621, either orally or intramuscularly, in normal
human subjects a small proportion of the compound
undergoes a metabolic change in the body to give
rise to another penicillin. This metabolite is present
in the serum as well as in the urine, and in human
beings approximately 10 per cent of the penicillin
excreted is in the fonn of the metabolite. A similar
metabolite also occurs with BRL. 1400.
The metabolite of BRL. 1021 has been isolated and
found to have antibacterial activity very similar to
BELAG'21 itself. Moreover, using Sarcina Inlen and
also a penicillin-resistant staphylococcus as test
organism, BEL. 1 (521 and the metabolite both have
tho same ring-diameter concentration relationship
in the cup-platc assays.
In view of tho very close similarity in the biological
properties of tho metabolite and BEL. 1(521 itself,
and also in view of the small amount of the metabolite
formed it seems quite certain that the latter does not
in any way complicate the determinations of serum
levels or the general evaluation of BEL. 1621.
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Mr. F. P. Doyle, director of research. Brockham
Park, in tlie preparation of the manuscript. We also
thank our many colleagues who assisted in the work
discussed in this article.
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In concentrations greatly in excess of therapeutic blood levels cloxacillin has a
slight hypotensive action. As with other antibiotics, it sometimes causes diarrhoea
in rabbits but, in doses up to 200 mg/kg, it does not have a teratogenic effect on the
rabbit foetus. Cloxacillin is distributed throughout the body. High concentrations
are found only in the liver and kidney, these reflecting the high concentrations in the
bile and urine respectively. It differs from other penicillins investigated in that there
appears to be little or no renal tubular secretion as demonstrated in experiments
on the hen. Cloxacillin is excreted as the unchanged drug and as an active metabolite
in the urine and bile. After oral administration it is metabolized in the caecum
giving a penicillin which differs from the urinary metabolite and which has a
greater antibiotic action against Sarcina iutea than the parent penicillin. The activity
of the caecal metabolite against resistant and sensitive strains of Staphylococcus,
however, remains similar to that of cloxacillin. Against infections due to resistant
and sensitive Staphylococcus in animals cloxacillin is active by both the oral and
subcutaneous routes and it is more effective orally than an equal subcutaneous dose
of methicillin.
Nayler, Long, Brown, Acred, Rolinson, Batchelor, Stevens & Sutherland (1962)
have recently reported on the chemistry, toxicology, microbiology and pharmacology
of a new semi-synthetic penicillin, cloxacillin. This penicillin is stable to staphylo¬
coccal penicillinase and is active orally. Further studies on the chemotherapy and
pharmacology are described in this paper.
METHODS
In all the experimental work cloxacillin was used as its pure sodium salt monohydrate,
which is freely soluble in cold water giving a solution stable at 5° C for 1 week. Methicillin
(Celbenin) and penicillin G (Solupen) were also administered as their pure sodium salts.
The antibiotics were assayed by the cup-plate technique using Sarcina lutea as the test
organism. The zone diameters obtained for the control dilution of the antibiotics were
plotted against the log of the concentration, and from the regression lines obtained the con¬
centrations of the antibiotics in the specimens were estimated by interpolation. The appropriate
dilutions of the controls and samples were made in 0.05 M-phosphate buffer at pH 7.0,
except that in the experiments where serum concentrations were determined the controls were
prepared in serum. Before assay all specimens were stored at 4" C.
Chromatographic studies were carried out using 1 cm wide strips of Whatman No. 1 filter
paper 53 cm long with the origin at 11 cm. The solvent was a saturated solution of ether
in water buffered to pH 6.2 (Karnovsky & Johnson, 1949). 100 ml. of solvent were used
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in the troughs of each tank. All tanks were lined with Whatman No. 3 filter paper. The
chromatograms were run from 16 to 20 hr at 20° C after equilibration for at least 1 hr.
Detection of the penicillins on the chromatograms was carried out by placing the strips
on agar plates seeded with Sarcina lutea and incubating overnight at 30° C. The location
of the penicillins was seen as clear zones of inhibition of growth on the plates. Control
strips were set up using an aqueous solution of cloxacillin.
Cardiovascular and respiratory effects
The carotid arterial blood pressure of cats anaesthetized with a 1% solution of chloralose
was recorded with a mercury manometer on a smoked drum. Respiration was recorded by
a lever connected by means of a thread sewn to the skin over the xiphisternum. Compounds
in 0.9% saline were administered intravenously through a cannula in a femoral vein. The
actions of cloxacillin on the blood pressure responses to acetylcholine (4 pg), adrenaline
(10 pg) and histamine (2 and 0.5 pg) were observed. The effect on the blood pressure response
to stimulation of the uncut cervical vagus nerve (a rectangular-wave stimulus of 2 V and 5
msec duration, at a rate of 20 shocks/sec for 5 sec every 5 min) was also observed.
The electrocardiogram was recorded by an Ediswan pen recorder linked to hypodermic
needle electrodes, placed subcutaneously 2 cm on either side of the midline of the anterior
thorax. After the administration of cloxacillin, tracings for 30 sec periods were obtained
at 2 min intervals. Simultaneous records of carotid arterial blood pressure were obtained by
means of a capacitance manometer, and respiratory movements by a thermistor device (Bain-
bridge, Warren & Wiggins, 1962).
The action of cloxacillin on the superior cervical ganglion of cats was studied by applying
rectangular-wave stimuli of 5 msec duration at a rate of 20 shocks/sec for 30 sec every 10 min
to the preganglionic trunk. The voltage was adjusted to give just maximal contractions of the
nictitating membrane. A similar stimulus was applied to the postganglionic trunk 2 min
after the preganglionic stimulation. Responses were recorded by a frontal writing lever on a
smoked drum. The effect of intravenous injection of adrenaline (10 /<g) on the nictitating
membrane was also observed.
Blood concentrations of cloxacillin were determined in each of six cats which had had
successive doses of cloxacillin, samples being taken from the left femoral vein every 10 min
after the administration of the penicillin.
Pregnancy tests
Six female rabbits of mixed breed and six New Zealand white females of proved fertility
were mated. From the 8th day of pregnancy nine of the rabbits (three mixed breed and
six New Zealand) were injected intramuscularly with 250 mg/kg of cloxacillin in aqueous
solution, and three (mixed breed) were given 180 mg/kg of thalidomide orally. Treatment
continued until the 16th day of pregnancy. The animals were observed daily for abortions
during the whole course of pregnancy. The animals which came to term had their litters
normally.
Absorption of penicillins
Rabbits. 100 mg/kg of cloxacillin, methicillin and penicillin G were administered intra¬
muscularly to groups of five rabbits. Blood samples were removed from the lateral ear
vein at 0.5, 1, 2, 4 and 6 hr after administration. The samples were allowed to clot at room
temperature and the serum removed for assay.
Dogs. Cloxacillin was administered orally at a dose of 100 mg/kg. Blood samples (0.3 ml.)
for assay were taken at 0.5, 1, 2, 3, 4 and 6 hr after administration, by means of a sterile
syringe from the radial vein and placed in heparinized tubes containing 5.0 U of heparin in
0.05 ml. of saline.
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Distribution and elimination of cloxacillin
Distribution in tissues. The distribution of cloxacillin throughout the body was determined
in groups of five male rats, weighing 100 to 200 g, after oral and intramuscular administration
of 100 mg/kg. Groups of rats were killed by exsanguination at 0, 0.5, 2, 4, 6 and 24 hr after
administration of the penicillin. The urine and faeces from each group were collected and the
amounts recorded. The following organs and tissues from the rats receiving the intramuscular
dose were removed and weighed: liver, spleen, kidneys, lungs, small intestine, large intestine,
caecum, muscles from the site of injection and carcass.
After oral administration of cloxacillin the stomach also was removed. All specimens were
homogenized in a "Waring blendor" and appropriate dilutions were made with phosphate
buffer at pH 7.0 for assay.
Urinary excretion. The mode of urinary excretion in the hen was examined as described
by Acred, Brown, Turner & Wright (1961). by stitching a polyethylene funnel over each
ureteral opening to collect urine from each kidney. Cloxacillin was dissolved in 2.0 ml. of
0.9% saline and injected into the muscles of the left leg at a dose of 100 mg/kg. Probenecid,
which blocks renal tubular secretion, was administered intravenously at a dose of 100 mg.
Biliary excretion. Groups of male rats (weighing 250 to 350 g) were starved overnight.
After they had been anaesthetized with ether laparotomy was performed and the bile duct
was cannulated with polyethylene tubing (0.4 mm bore). The tubing was passed through a
small aperture in the skin at the back of the neck, and the skin and muscle incisions were
sutured. The animals were then given an intramuscular injection of 100 mg/kg of cloxacillin
and placed in metabolism cages. The polyethylene tubing was taken through the top of the
cage and led into a 10 ml. cylinder for collection of the bile. Throughout the 24 hr period
samples of the bile and urine were taken.
Cerebrospinal fluid concentrations. The cerebrospinal fluid concentrations of cloxacillin
were determined in rabbits after intramuscular administration of 500 mg/kg. 0.5, 1, 2 and
4 hr after administration of cloxacillin two rabbits were anaesthetized with urethane (1 g/kg,
intravenously) and cerebrospinal fluid samples were withdrawn from the cisterna magna by
means of a sterile syringe and needle. Blood samples were taken from the lateral ear veins
at the time of taking the cerebrospinal fluid samples. The blood samples were allowed to
clot at room temperature. The serum and cerebrospinal fluid samples were kept at 4° C
until assayed.
Investigation of metabolite
In vivo. 100 mg/kg of cloxacillin was administered orally to groups of five male albino
rats (weighing 100 to 200 g). At 2, 4 and 6 hr after administration one group was killed and
the alimentary tract was removed. The small intestine, caecum and large intestine were
separated and the contents removed by washing out with saline. The different parts of the
intestine were weighed and homogenized in the same way as in the distribution studies and the
homogenates assayed for penicillin. The contents obtained from each section of the intestine
were also assayed by the cup-plate technique using Sarcina lutea, Staphylococcus pyogenes
Oxford and Staphylococcus pyogenes Russell (the Russell Staphylococcus being resistant to
penicillin G). The results were expressed as a concentration in hg/g of tissue or /<g/ml. of
content and also expressed as a percentage of the dose administered. The extracts and the
washings were chromatographed.
In vitro. Homogenates weighing 1 g from various sections of the alimentary canal and
the contents were suspended in 3.5 ml. of Krebs solution. To the suspension 0.5 ml. of a
1 mg/ml. solution of cloxacillin was added to give a final concentration of the penicillin in
the suspension of 100 A'g/ml. The homogenates were placed in a water-bath heated to 37° C
and shaken throughout the period of the test. Samples were removed from each homogenate
at 0, 2 and 4 hr after adding the penicillin and assayed for penicillin concentration by the
usual cup-plate technique using Sarcina lutea as the test organism.




Single infection. The protective effect of cloxacillin was determined using the method of
Selbie & O'Grady (1954) as modilied by Brown & Acred (1960). Groups of ten mice were
infected by injecting into the muscle sheath of the left thigh 0.2 ml. of a 1:3 dilution of an
overnight growth of Staphylococcus pyogenes Russell, type 80. Cloxacillin and methicillin
were administered in doses of 50 and 200 mg/kg orally and subcutaneously daily for 3 days,
the first dose being given immediately after the infection. The infected control group received
no treatment. A non-infected, no treatment, control group was set up with each experiment.
The maximum thigh diameters of each mouse were measured with callipers on the 1st, 2nd
and 6th days after infection.
Double infection. A double lesion test was also carried out in which the animals were infected
with Staphylococcus pyogenes Russell in the left hind-limb, and with Staphylococcus pyogenes
2187 (penicillin G-sensitive) in the muscles of the right hind-limb. 0.2 ml. of a 1:3 dilution
of an overnight culture of each organism was injected into each mouse. Cloxacillin, methicillin
and penicillin G were administered in doses of 100 mg/kg orally and subcutaneously, the
dose schedule being the same as for the single lesion test.
Daily thigh enlargement was assessed as the difference in thigh diameters between an
infected group of animals and the thigh diameters of the non-infected, no treatment, control
group. The results were expressed as the percentage protection calculated in the following
manner:
Mean daily thigh enlargement of Mean daily thigh enlargement of
infected control penicillin group
x 100
Mean daily thigh enlargement of infected control
CD50 tests
The effects of cloxacillin, methicillin and penicillin G were also determined in mice infected
with Staphylococcus pyogenes Smith (penicillin G-sensitive). The method for determination
of the LD50's of the culture and the amount of organism given in the infectivity tests were
identical to those described by Acred, Brown, Turner & Wilson (1962). For the antibiotics a
4:1 dose ratio was used, the dose being administered in 0.2 ml. of 0.9% saline immediately
after the infection. The mice were observed for 4 days and deaths were recorded daily. The
percentage of deaths was plotted against dose on log probit paper and the dose of the com¬
pound in mg/kg giving protection to 50% of the mice (CD50) was read off from the graph.
RESULTS
Cardiovascular and respiratory effects
Intravenous doses of 25 to 400 mg/kg of cloxacillin administered to anaesthetized
cats lowered the blood pressure. With doses below 200 mg/kg the effects were tran¬
sient and recovery occurred within 5 to 10 min ; after 200 and 400 mg/kg the hypo¬
tension was more prolonged, persisting for more than 10 min. Responses to intra¬
venous administration of adrenaline, acetylcholine and histamine, and to electrical
stimulation of the uncut cervical vagus nerve, were not significantly altered by
cloxacillin. Doses up to 50 mg/kg of cloxacillin had no significant action on the
electrocardiogram, while larger doses extended the PQRS complex by 30 to
50% of the control value. Recovery to normal occurred within 8 min of administra¬
tion of the drug. No significant effects on respiratory movements were demon¬
strated.
Increasing doses of cloxacillin in the same animal caused an inhibition of up
to 67% of the responses of the nictitating membrane to pre- and postganglionic
nerve stimulation. A single dose of 200 mg/kg in a previously untreated animal
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caused a 32% reduction of the response, but within 5 min it had returned to normal.
The responses of the nictitating membrane to adrenaline were, however, unaffected.
Pregnancy tests
Nine out of twelve rabbits in the test became pregnant, six of which received
cloxacillin and three received thalidomide. All the rabbits given cloxacillin
delivered normal litters; the litter size for the individual animals being (i) 5, (ii) 14,
(iii) 8, (iv) 5, (v) 7, and (vi) 1 +. The last rabbit (vi) had a litter but, before inspec¬
tion could be made, it had partially eaten all the young except one, which appeared
normal. Examination of the remaining limbs of the young which had been killed
revealed no abnormalities. In rabbits (iv) and (v) there was evidence that two
embryos in one, and three embryos in the other, had not been maintained after
implantation. Of the rabbits which received thalidomide, one showed signs of
abortion on the 20th day; this rabbit was killed and there were five underdeveloped
foetuses of which four showed spinal deformities or limb abnormalities ; two other
foetuses had died and at these sites there was bleeding. This condition had given
the external appearance of impending abortion. In the second rabbit given thali¬
domide there was a complete abortion on the 22nd and 23rd days of pregnancy, and
in the third rabbit ten undersized foetuses were delivered normally. Four of these
showed deformities of the hind-limbs. The mother was killed and the uterus
examined. One dead foetus was found which consisted of a mass of disorganized
tissue and blood, enclosed by the amniotic membrane.
A bsorption
Blood levels after intramuscular administration of the penicillins into rabbits.
The blood levels after the intramuscular administration of 100 mg/kg of penicillin
G, methicillin and cloxacillin are given in Table 1.
Table 1
SERUM CONCENTRATIONS IN GROUPS OF FIVE RABBITS RECEIVING 100 MG/KG
OF CLOXACtLLIN, METHICILLIN AND PENICILLIN G tNTRAMUSCULARLY
Serum concentration (/jg/ml.) at time after dosing
Penicillin 1 hr 2 hr 4 hr 6 hr
Cloxacillin 100 6-6 5-0 4-5
23-5 17-0 3-6 3-0
7-2 3-9 4-1 3-1
8-8 5-0 2-5 4-1
11-5 7-4 2-1 2-6
Mean 12-2 8-0 3-5 3-5
Methicillin 12-5 3-65 0-51 0
18-0 3-65 0-3 0
14-0 4-2 0-74 0
180 5-0 0-34 0
14-0 6-2 1-3 0
Mean 15-3 4-48 0-64 0
Penicillin G 110 5-1 2-65 1-13
9-0 5-0 1-17 0-5
16-0 10-5 10 01
10-5 4-7 0-48 0
9-8 6-1 1-15 0-23
Mean 11-26 6-28 1-29 0-39
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The patterns of blood level after methicillin and penicillin G are similar, maximum
concentrations of 15.3 and 11.3 ,«g/ml. respectively being obtained 30 min after
administration. After 30 min from administration of cloxacillin a concentration of
12.2 /xg/ml. was found, but the levels of cloxacillin were more prolonged than those
of melhicillin or penicillin G, and significant concentrations (3.5 fig/ml.) were
detected 6 hr after administration.
Blood levels after oral administration of cloxacillin into dogs. The mean blood
levels after oral administration of 100 mg/kg of cloxacillin into dogs are shown in
Table 2. A maximum concentration of 4.4 yg/ml. was found 30 min after adminis¬
tration.
Table 2
WHOLE BLOOD CONCENTRATIONS OF CLOXACILLIN (ftG/ML.) IN DOGS FOLLOW¬
ING ORAL ADMINISTRATION OF 100 MG/KG
The dogs weighed from 10 to 12 kg. *No sample
Whole blood concentration (fig/ml.) at time (hr) after dosing
Dog 0-5 1-0 1-5 2-0 2-5 4-0 5-0 6-0
1 5-2 3-1 1-8 2-5 0 0 0 0
2 5-4 6-5 3-0 1-0 0 0 0 0
3 3-0 1-8 2-4 0-8 0 0 0 0
4 6-1 * 1-5 1-4 1-0 0 0 0
5 1-8 2-6 1-7 1-0 0-8 0 0 0
6 4-4 2-6 1-3 1-6 1-0 0-8 0 0
7 4-7 2-8 1-7 1-2 1-0 1-1 0-9 0
Mean 4.4 3-2 1-9 1-3 0-54 0-27 0-1 0
Distribution and elimination
Distribution in tissues. The distribution of cloxacillin after oral and intra¬
muscular administration of 100 mg/kg to groups of five male rats is given in Tables
3 and 4. Following intramuscular and oral administration there was no preferential
concentration of the penicillin in any particular organ, except in the liver and kidney,
the organs specifically concerned with the excretion of the penicillin from the body.
The high concentrations found in the sections of the alimentary canal following oral
dosing are a consequence of the route of administration. After 6 hr from intra¬
muscular administration, 42.5% of the antibiotic had been recovered in the urine
and during the following 18 hr a further 10.6% was obtained.
Following oral administration the total percentage recovered from all sites
increased to a maximum of 124% at 6 hr, falling to 63% at 24 hr. While most of
the antibiotic was recovered in the urine following intramuscular administration,
only approximately 30 to 50% of the total recovered was found in the urine after
oral administration. As the antibiotic moved along the alimentary canal from the
stomach to the large intestine the concentration of the antibiotic, instead of decreas¬
ing as would be expected due to absorption, dilution and loss, actually increased,
until at 6 hr the concentration in the large intestine (3,750 yg/ml.) was greater than
that found in the stomach at the beginning of the experiment (2,800 pg/ml.).
Urinary excretion in the hen. The mean percentage of the dose excreted by the
left kidney during the 1st hr after administration was only 5.8% greater than that
excreted from the right kidney (Table 5). Thereafter there was no difference in the
Table3
DISTRIBUTIONOFCLOXACILLININTISSUESFMA ELB ORATSAFTERRALADMINIST ATIONOF100MG/KG
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URINARY EXCRETION OF CLOXACILLIN IN THE HEN
Values are urinary excretions from the left and right kidneys of five hens each of which received
100 mg of cloxacillin. Cloxacillin was administered into the left leg muscles
Cumulated % of dose excreted at time (hr) after administration
Left kidney Right kidney
Hen I 2 3 4 5 6 1 2 3 4 5 6
A 12-4 20-8 24-6 26-2 29-1 29-4 9-1 15-2 19-2 23-6 24-2 24-2
B 9-2 12-3 15-4 17-7 19-7 21-3 17-0 22-7 25-3 26-8 28-8 29-3
C 25-6 30-9 35-3 37-5 40-9 41-7 25-2 32-0 36-8 39-6 40-9 41-9
D 29-6 34-1 38-0 41-5 43-3 44-4 17-2 27-3 30-2 33-4 35-0 36-1
E 35-8 44-6 48-4 51-5 53-6 55-4 15-1 15-3 18-4 20-0 22-1 23-7
Mean 22-5 28-5 32-3 34-8 37-3 38-4 16-7 22-5 26-0 28-7 30-2 31-0
accumulated percentage excreted from the left and right kidneys. After the intra¬
venous administration of 100 mg of probenecid, which blocks renal tubular secretion,
the. percentages of the antibiotic excreted by the right and left kidneys were almost
identical.
Biliary excretion. The concentration of cloxacillin and the percentage of the
antibiotic recovered in the bile at hourly intervals over 6 hr, in groups of eight rats
administered 100 mg/kg intramuscularly, are given in Table 6. 23% of the anti-
Table 6
THE CONCENTRATION OF CLOXACILLIN AND PERCENTAGE RECOVERED IN BILE
FOLLOWING INTRAMUSCULAR ADMINISTRATION OF 100 MG/KG
Values are means for groups of eight rats weighing between 250 and 350 g
Cloxacillin recovered at time (hr) after dosing
Cloxacillin 0-1 1-2 2-3 3-4 4-5 5-6
Concentration
(pg/ml.) 3,862 2,173 978 437 99 51
Cumulated
recovery (%) 10-4 18-1 21-1 22-6 22-8 22-9
biotic was recovered in the bile in 6 hr. From an experiment put up in parallel
using twelve rats in pairs with collection of urine, 16% of the antibiotic was
recovered.
Cerebrospinal fluid concentrations. After intramuscular administration of 500
mg/kg of cloxacillin the concentration in the cerebrospinal fluid was considerably
less than that found in the serum. The results are shown in Table 7.
Table 7
CONCENTRATION OF CLOXACILLIN IN SERUM AND CEREBROSPINAL FLUID OF
RABBITS AFTER INTRAMUSCULAR ADMINISTRATION OF 500 MG/KG
Values are means of two rabbits per time period
Concentration (/xg/ml.) at time after dosing
Fluid 1 hr 2 hr 4 hr
Cerebrospinal fluid 2-3 2-3 3-3
Serum 440 142-5 112-5
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Metabolism
In vivo. The concentrations of the antibiotic in the intestinal contents and the
intestinal walls are given in Tables 8 and 9. As the antibiotic entered the caecum
there was a very considerable increase in amount assayable against Sarcina lutea.
Table 8
CONCENTRATION OF CLOXACILLIN IN THE TISSUES OF RATS AFTER ORAL
ADMINISTRATION OF 100 MG/KG
The concentrations were determined by assaying in parallel against Sarcina lutea, Staphylococcus
pyogenes Russell (penicillin-resistant) and Staphylococcus pyogenes Oxford (penicillin-sensitive)
Concentration (ng/mt.) at time after dosing
2 hr 4 hr 6 hr
Tissue and Staph. Staph. Staph. Staph. Staph. Staph.
fluid Sarcina Oxford Russell Sarcina Oxford Russell Sarcina Oxford Russell
Small intestine, walls 88-0 76-0 135-0 18-0 0 0 24-0 0 0
Small intestine,
contents 1,600-0 1,400-0 1,950-0 245-0 165-0 225-0 110-0 30-0 74-0
Caecum, walls 65-0 3-6 0 460-0 49-0 78-0 210-0 13-0 26-0
Caecum, contents 1,005-0 160-0 56-0 7,300-0 650-0 545-0 8,400-0 350-0 365-0
Large intestine, walls 0 0 0 26-0 0 0 79-0 6-5 16-0
Large intestine,
contents 0 0 0 5,150-0 53-0 44-0 4,150-0 505-0 418-0
Urine 935-0 735-0 1,025-0 1,170-0 380-0 650-0 270-0 160-0 230-0
Table 9
TOTAL PERCENTAGE RECOVERY OF CLOXACILLIN FROM ALIMENTARY CANAL
AND URINE OF RATS GIVEN 100 MG/KG ORALLY
Assays were as in the experiments summarized in Table 8






but when assayed against the two strains of Staphylococcus there was a considerable
reduction in the relative amount recovered. In relation to the amount of metabolite
in the intestinal contents the amount in the walls of the intestine was negligible.
When the urine from the same animals was also assayed, the concentrations obtained
when assayed against the three organisms were of the same order or size.
Chromatograms of the samples showed clearly two zones of inhibition for the
samples from the caecum and large intestine, one zone corresponding with the
parent compound. The second large zone was near the origin (Fig. 1). The R F
value for this latter zone differed from that of the metabolite isolated from the urine.
In vitro. After incubation of the homogenates of various tissues and intestinal
contents with cloxacillin there was a considerable increase in the antibiotic activity
in the caecal and large intestine contents (Table 10). The initial concentration was
100 /tg/ml. but at 4 hr the concentration in the caecal contents was 360 p.glml.







increase in concentration on incubating cloxacillin with faeces. No increase in
concentration was recorded with the caecal and large intestine walls, or with any
other section of the alimentary canal.
Fig. 1. Chromatography of urine and intestinal homogenates obtained from rats 4 hr after admin¬
istration of 100 mg/kg of cloxacillin, showing the intestinal metabolite (C and E) and urine
metabolite (A). The chromatography paper strips were placed on agar plates seeded with
Sarcina lutea and incubated at 30° C. A, urine; B, aqueous control; C, caecal contents;
D, caecal wall; and E, large intestine contents.
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Table 10
STABILITY OF CLOXACILLIN IN HOMOGENATES OF RAT TISSUES
1 g of the tissue was suspended in 3.5 mi. of Krebs solution. Cloxacillin was added to give a
concentration of 100 /ig/ml. and the suspension was incubated at 37° C. At 0, 2 and 4 hr, samples
were removed for assay
Concentration (fig/ml.) at time
Tissue and fluid 0 hr 2 hr 4 hr
Pancreas 91-0 69-0 66-0
Liver 92-0 62-0 50-0
Small intestine,
contents 91-0 71-0 68-0
Small intestine,
walls 90-0 73-0 63-0
Duodenum, contents 82-0 43-0 52-0
Duodenum, walls 84-0 86-0 74-0
Control 90-0 91-0 90-0
Caecum, walls 120-0 100-0 70-0
Caecum, contents 110-0 210-0 360-0
Large intestine,
walls 115-0 90-0 70-0
Large intestine,
contents 105-0 190-0 300-0
Faeces —. 230-0 250-0
Control 96-0 91-0 72-0
Chemotherapy
Thigh lesion test
Single injection. The results of oral and subcutaneous administration of 50 and
200 mg/kg of cloxacillin and of subcutaneous injection of 50 and 200 mg/kg of
methicillin on the size of the thigh lesion in mice are given in Table 11. Cloxacillin
(200 mg/kg by either route) gave virtually complete healing. Following oral and
Table 11
PERCENTAGE PROTECTION AGAINST INFECTIONS IN MICE DUE TO PENICILLINASE-
PRODUCING STAPHYLOCOCCUS PYOGENES RUSSELL
Doses of 200 and 50 mg/kg of cloxacillin or methicillin were administered to groups of ten mice.
Cloxacillin was given orally and subcutaneously, methicillin subcutaneously only
Protection (%)















































subcutaneous administration of 50 mg/kg, the healing was reduced to 59% and 88%
respectively. Administered subcutaneously, 50 mg/kg of cloxacillin gave better
protection than 200 mg/kg of methicillin administered by the same route, while
50 mg/kg orally of cloxacillin was superior to 50 mg/kg of methicillin given sub¬
cutaneously. Methicillin was inactive orally.
Double infection. The effects of cloxacillin, methicillin and penicillin G, adminis¬
tered subcutaneously and orally to groups of mice, against infections of a penicillin-
sensitive Staphylococcus in one hind-limb and a resistant Staphylococcus in the
other hind-limb, are shown in Table 12 and Fig. 2. Cloxacillin was highly effective
against both organisms, by both routes. It was not as effective as penicillin G
against the sensitive staphylococcal infection, but was considerably more active than


























Cloxacillin Methicillin Penicillin G Control
Fig. 2. Histogram showing percentage protection of mice (ten per group) infected intramuscularly
with Staphylococcus pyogenes Russell (penicillin-resistant) in the left hind-limb and Staphylococ¬
cus pyogenes 2187 (penicillin-sensitive) in the right hind-limb. 100 mg/kg of cloxacillin,
methicillin and penicillin G were administered orally (upper histogram) and subcutaneously
(lower histogram) daily for 3 days. The controls were non-infected mice.
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Table 12
PERCENTAGE PROTECTIONAGAINST INFECTIONS IN MICE DUE TO PENICILLINASE-
PRODUCING STAPHYLOCOCCUS PYOGENES RUSSELL INJECTED INTO THE LEFT
THIGH AND PENICILLIN G-SENS1T1VE STAPHYLOCOCCUS PYOGENES 2187
INJECTED INTO THE RIGHT THIGH
Doses of 100 mg/kg of cloxacillin, methicillin and penicillin G were administered orally and sub-
cutaneously into groups of ten mice. The percentage protection was calculated as described in
Methods
Protection (%) against


























ACTIVITY OF CLOXACILLIN, METHICILLIN AND PENICILLIN G AGAINST
STAPHYLOCOCCUS PYOGENES SMITH (PENICILLIN-SENSITIVE)
Activity is expressed in terms of the dose of antibiotic calculated to protect 50%





Penicillin G 5-8 0-2
CD50 tests
The CD50 values for cloxacillin, methicillin and penicillin G against Staphylococcus
pyogenes Smith (penicillin G-sensitive) are given in Table 13. Penicillin G was the
most effective when given both orally and subcutaneously. Methicillin was only
effective by injection, but against this strain of Staphylococcus was more effective
than cloxacillin.
DISCUSSION
Cloxacillin is one of a series of isoxazol penicillins which is well absorbed orally
and is highly effective against staphylococci'resistant to penicillin G. After intra¬
venous injection it slightly lowered blood pressure due to a direct action on the
heart, and probably to an inhibition of sympathetic nerve conduction. Concentrations
in the blood at which these effects were found were in the region of 850 /rg/ml.
and were therefore very much in excess of those required to produce a therapeutic
effect (over 2.5 ,ug/ml.) and highly unlikely to be encountered clinically.
Cloxacillin, when administered to rabbits, did not induce abnormalities in the
foetus, although the mothers may have been affected due to an alteration in the
intestinal flora, all the rabbits under test showing varying degrees of diarrhoea.
The number of resorption sites which occurred in two of the rabbits was well within
the normal expected limits (Adams, 1960), and is of no significance. On the other
hand thalidomide killed a number of the foetuses with resulting abortion and in
most of the survivors there were signs of limb and other abnormalities.
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The effectiveness of cloxacillin against both penicillin-resistant and penicillin-
sensitive strains of Staphylococcus in vivo has been clearly demonstrated. Cloxacillin
when given orally was more active than the same dose of methicillin administered
by injection. Against the sensitive Staphylococcus cloxacillin was less active than
penicillin G. The effectiveness of penicillin G, when administered orally, against
the sensitive Staphylococcus was probably due to the massive dose of penicillin
administered, which would ensure that some of the antibiotic passed through the
stomach and was subsequently absorbed giving rise to concentrations in the blood
adequate to overcome the infection.
The distribution in the body and the excretion in the bile followed the same
pattern as seen with other penicillins (Acred et al„ 1961, 1962), and the high
concentrations found in the kidney and liver merely reflect the concentrations in
the urine and bile. The total amount excreted in the bile was similar to that found
with methicillin, ampicillin and penicillin G. The excretion of cloxacillin by the
hen's kidney, however, differed in that there was very little renal tubular secretion.
After oral administration of cloxacillin there was an unexpected increase in the
amount of antibiotic recovered in the caecum and large intestine, the antibiotic
activity in terms of cloxacillin being greater than the amount administered. From
these results it was evident that a metabolite was being formed which was more
active than cloxacillin against Sarcina lutea, but the increased activity was not seen
when resistant and sensitive strains of Staphylococcus were used in the cup-plate
assay. The relative activities of the metabolite of cloxacillin against the two strains
of Staphylococcus were identical and hence it can be inferred that the metabolite
was also stable to staphylococcal penicillinase.
The intestinal metabolite was not absorbed since the conversion occurred in the
large intestine and caecum where active absorption is minimal. However, the body
can also metabolize cloxacillin producing another active metabolite, which is
probably formed in the liver (Mansford, personal communication). This metabolite,
which appears in the urine and the bile of rats, is distinct from the intestinal
metabolite. Other workers (Vanderhaeghe, Van Dijck, Claesen & De Somer, 1961 ;
Rolinson & Batchelor, 1962 ; Rollo, Somers & Burley, 1962) have reported the
presence of penicillin metabolites in the urine of humans and it is possible therefore
that a number of other penicillins can be metabolized in the body. In estimating
penicillins in body tissues, therefore, it is necessary to verify, chroma tographically
as well as by bioassay that the activity measured is due to the administered penicillin
and not due to a mixture of the parent penicillin and metabolites. If a mixture
is present, spuriously high or low values can be registered since a metabolite can
show a different relative activity against the test organism compared to the parent
penicillin, as we have found with the intestinal metabolite of cloxacillin when this
is assayed against Sarcina lutea. Under these circumstances, to obtain values of
absolute concentrations it is necessary to isolate the metabolite and determine its
in vitro activity against the assay organism. In relation to therapeutic activity it is
also essential to determine the antibiotic spectrum of the metabolite since it could
be more effective against some organisms and less effective against others than the
parent penicillin.
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Most of the semi-synthetic penicillins developed from
6-amino-penicillanic acid have little or no activity
against Pseudomelia pyocyanea. a-Carboxybenzylpenicillin
(carbenicillin : BRL 2064), on the other hand, is active
against these organisms and seems to be almost com¬
pletely non-toxic to man.
by P. ACRED, D. M. BROWN, E. T. KNUDSEN,
G. N. ROLINSON and R. SUTHERLAND
Beecham Research Laboratories, Brockham Park, Betchworth,
Surrey
During the preparation in these laboratories of many
hundreds of semi-synthetic penicillins from 6-amino-
penicillanic acid, activity against Pseudomonas pyocyanea
(Pseudomonas aeruginosa) has been found only infrequently.
This article describes investigations of the properties and
pharmacology of one compound that has been selected for
clinical trial. The clinical results (to bo reported else¬
where) have shown that carbenicillin has effective anti-
Pseudomonas activity when given to human subjects by
intramuscular or intravenous injection. As with most
penicillins, carbenicillin is virtually non-toxic and has no
local irritant effects.
Chemistry
The introduction of ionized substituents into the side-
chain of benzylpenicillin (I) is known to lead in some cases
to enhanced activity against certain Gram-negative bac¬
teria., as in ampicillin (II) which contains a basic a-
substituent. We now wish to report on an analogue with




I I I I
R CO—N CHCO.,11
I : /?=H (benzylpenicillin)
II : fi=NHj (ampicillin)
III : 7?=C02H (carbenicillin)
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Carbenicillin (which will shortly be available under the
registered trademark of 'Pyopen' from Beecham Research
Laboratories) is supplied as the disodium salt and contains
5-6 per cent water. It is a white powder which dissolves
freely in cold water to give a solution with a pH between
6 and 8. Carbenicillin is only moderately stable to acid,
the half life at 21° C and p~H. 2-0 being about 140 min and
at 37° C and at pH 2-0 about 30 min.
On prolonged storage, carbenicillin may decompose to
some extent into benzylpenicillin and carbon dioxide.
The presence of benzylpenicillin can readily be detected
by paper chromatography in butanol-ethanol-water
followed by development on an agar plate seeded with
B. subtilis. Carbenicillin gives a zone of inhibition of
bacterial growth near the origin (Rf about 0-03) whereas
benzylpenicillin has an Rf of about 0-4. The technique is
sensitive because benzylpenicillin is considerably more
active than carbenicillin against Gram-positive bacteria.
Microbiology
The antibacterial spectrum of carbenicillin is shown in
Table 1. Serial dilutions of the drug were prepared in
agar in Petri dishes and the surface of the agar was inocu¬
lated using one drop of undiluted overnight broth cultures.
The minimum inhibitory concentrations were read after
incubation overnight at 37° C. In some respects the anti¬
bacterial spectrum of carbenicillin is similar to that of
.ampicillin. For example, carbenicillin shows significant
activity against penicillin-sensitive staphylococci and the
streptococci, although this is substantially lower than
that of ampicillin or penicillin G. Also, carbenicillin is not
stable to staphylococcal penicillinase and is relatively
inactive against penicillin-resistant strains of staphy¬
lococci. Against Haemophilus influenzae, Escherichia coli,
Salmonella species, Shigella species and Proteus mirabilis,
carbenicillin shows a similar level of activity to that of
ampicillin although, in general, the activity of carbeni¬
cillin is somewhat lower. Like ampicillin, carbenicillin
shows only a low level of activity against most strains of
Klebsiella aerogenes. The spectrum of carbenicillin differs
from that of ampicillin, however, with regard to Pseudo-
monas pyocyanea and certain Proteus species and carbeni¬
cillin is primarily interesting because it is active against
these organisms.
Activity against Pseudomonas pyocyanea. Compared
with the activity one is accustomed to see with most
antibiotics of clinical value, the activity of carbenicillin
against strains of Ps. pyocyanea is low. Not many anti¬
biotics are effective against Pseudomonas, however, and
in the case of those which are active there are certain
problems of toxicity. Carbenicillin, on the other hand, is
remarkably free from toxic effects and this allows a
dosage to be used which can result in inhibitory con-
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* Serial dilution in agar; inoculum, one drop of an overnight culture.
t Pcnicillinase-producing strain.
contrations being reached in the body even though these
levels are comparatively high.
The activity of carbenicillin against seventy-four
strains of Ps. pyocyanea is shown in Table 2. All the
strains were recent clinical isolates. It will be seen that a
concentration of 50 gg/ml. carbenicillin was required to
inhibit the majority of the strains. Some strains were
inhibited by 25 gg/ml. but other strains were only in¬
hibited with concentrations as high as 125 fig/ml. De¬
termination of the minimum inhibitory concentrations of
carbenicillin is made difficult by the fact that typical
strains of Ps. pyocyanea do not show a sharp end point
when the inoculum is heavy (Table 3). When a heavy
inoculum is used, that is, one comprising 10° or more cells,
confluent growth occurs on agar containing concentrations
of carbenicillin up to about 12-5 gg/ml., and at this con¬
centration of drug there is no evidence of any inhibitory
effect. At a concentration of 25 gg/ml. carbenicillin,
however, growth is extremely scanty compared with the
control and the inhibitory effect of the drug at this
concentration is very marked, although growth is by no
means completely inhibited. At concentrations of car¬
benicillin above 25 gg/ml., growth is extremely meagre,
taking the form of a very thin film which may only just be
discernible on the surface of the agar. Consequently, if
the criterion of the "minimum inhibitory concentration"
(MIC) is one of absolute inhibition of any trace of growth,
the MIC with a very heavy inoculum may well be as high
Table 2. activity or carbenictllin against Pscudomonas pyocyanea
Minimum inhibitory concentration* 5<g/ml.) and number of
strains
No. of strains 250 125 50 25 12-5 5-0
74 6 50 15 3
* Determined by serial dilution of the drug in agar: inoculum one drop
of overnight broth culture diluted 1/100.
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Table 3. EFFECT OF CARBEXICILI.IN 03 TIIE GROWTH OF A TYPICAL STRAIN
OF I's. pyocyanea
Carbenicillin (yg/ml.)
Inoculum 500 250 125 50 25 12-5 5-0 2-5
Undiluted growth barely sparse growth with confluent growth
(about 107 cells) discernible some separate
colonies
Diluted 1/100 no growth semi-confluent
(about 10s cells) growth
Serial dilutions of carbenicillin prepared in agar and the surface inoculated
by flooding with overnight broth culture
as 250 gg/ml. or more, as a result of the scanty growth
which occurs at concentrations of carbenicillin of 25 gg/ml.
and greater. When a smaller inoculum is used in the
sensitivity tests, a relatively sharp end point is obtained.
With an inoculum of about 105 cells a normal, pigmented,
semi-confluent growth is obtained on agar with concentra¬
tions of carbenicillin up to 12-5 gg/ml., but at 25 gg/ml.
and over there is usually no growth at all.
As might bo expected, this effect of inoculum size on the
MIC of carbenicillin is also seen when the tests are
carried out in liquid medium. With a heavy inoculum,
growth appears normal with formation of pigment and
pellicle up to a concentration of about 12'5 u.g/ml. carbeni¬
cillin, but at 25 (xg/ml. there is no pellicle or pigment and
growth is markedly diminished, although complete in¬
hibition of growth may only be obtained with concentra¬
tions as high as 250 gg/ml. With a smaller inoculum, a
sharp end point is obtained and with most strains of
Pseudomonas the MIC under these conditions is usually
about 50 ug/ml.
This effect of inoculum size on the MIC is outwardly
similar to that seen with penicillin G and penicillinase-
producing staphylococci. Carbenicillin, however, is itself
highly stable to the penicillinase produced by typical
strains of Ps. pyocyanea and the inoculum effect in this
case is not due to destruction of drug, nor is the effect
due to the growth of resistant mutants present in the
original inoculum. When sensitivity tests are carried out
on tho growth which occurs in the presence of high con¬
centrations of carbenicillin the result obtained is tho same
as that seen with tho original culture, that is, marked
suppression of growth at concentrations of 25 gg/ml. and
over, but with scanty growth nevertheless persisting up to
a concentration as high as 250 gg/ml. when the inoculum
is heavy.
Carbcnicillin is bactericidal and typical results with a
strain of Pseudomonas are shown in Fig. 1. For the first 7 h
a concentration of 50 gg/ml. usually results in the killing
of at least 99 per cent of the original inoculum, but some
resumption of growth takes place thereafter which may
even increase to a visible amount after 24 h. When this
growth is used as inoculum in a repeat test, the same kill
is again obtained over the first 7 h followed by a certain




Fig. 1. Bactericidal activity of carbeuicillin against Psetidomoiias
pyocyanea. ©, Control; O, 50 /fg/ml.; A, 250 jag/ml.
followed by growth is not known, but it does not seem to
be due to the selection of resistant mutants present in the
original inoculum.
Activity against E. coli and. Proteus species. Table 4
shows the activity of carbenicillin and ampieillin against
strains of E. coli and Proteus species. Against E. coli,
carbenicillin shows activity equal to that of ampicillin
when tests are carried out using dilutions of the drug in
agar. An inoculum effect is also seen with E. coli, however,
similar to that described with Pseudomonas. This effect
is more marked with some strains of E. coli than others
and it is also more pronounced when the tests are carried
out in liquid medium. Consequently the results of sensi¬
tivity tests with E. coli carried out in broth frequently
show carbonicillin to be markedly less active than ampi¬
cillin when the inoculum is large, but comparable with
ampicillin in activity when a smaller inoculum is used.
Against P. mirabilis, carbenicillin shows the same
pattern of activity as does ampicillin, that is, penicillinase-
producing strains are resistant while non-penicillinase-
producing strains are highly sensitive. Against strains of
P. morganii, rettgeri, and vulgaris carbenicillin is interesting
in that many such strains which are resistant to ampicillin
are relatively sensitive to carbenicillin. This would appear
to be duo to the greater stability of carbonicillin to the
penicillinase produced by these species of Proteus.
Table4.activityofarbenicillinndmpi liagainstE.colidPro euss cies
No.of














































*Determinedbyserialdilut onofthuginag r;inoc lumo edr pfundilutedov rnightb cu ture, tPenicillinase-producingstrains. tNon-peniciilinase-producingstr ins.
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Effect of serum on activity. Carbcnicillin is not highly
bound to serum proteins. Sensitivity tests carried out in
broth containing 95 per cent human serum show that the
activity of carbenicillin is not significantly diminished by
tho presence of serum, and determinations by an ultra¬
filtration technique show that 53 per cent of the drug is
free in human serum.
Disk sensitivity testing with carbenicillin. Using G mm
paper disks containing 100 gg carbenicillin, all strains of
Ps. pyocyanea tested in this laboratory have given zones of
inhibitions of 12-20 mm with a heavy inoculum and zones
of 18-30 mm with a dilute inoculum. With a heavy
inoculum a number of colonies can usually be seen within
the zone of inhibition, although when these colonies are
picked off and re-tested they show the same sensitivity as
the original culture and again give rise to a number of
colonies within the clear zone of inhibition.
In tho case of Gram-negative bacilli other than Pseudo-
monas, for example, E. coli and Proteus species, a 2'5 gg
disk would be suitable for sensitivity testing. Using a
heavy inoculum, inhibition zones of 20 mm or more are
usually obtained with strains which are inhibited by 5
gg/ml. carbenicillin.
Animal Studies
General pharmacology. Carbenicillin in doses up to
500 mg/kg intravenously had no marked effects on the
cardiovascular and respiratory systems and the autonomic
nervous systems of cats. At 500 mg/kg there was a slight
transient hypotensive effect which disappeared within
10-20 min.
Absorption, distribution and metabolism. Carbenicillin
is poorly absorbed orally in the rat, but after intramuscular
injection the penicillin becomes distributed throughout
the body in a similar manner to other penicillins. Rela¬
tively high concentrations of the penicillin appear in the
alimentary tract after intramuscular administration.
Chromatographic examination of intestinal contents and
tissue confirms the presence of the drug in the gut. This is
probably due to the excretion of bile containing carbcni-
cillin into tho intestine.
In order to determine the biliary excretion, the bile
ducts of rats were cannulated with 'Polythene' tubing
(0-4 mm diameter) and the animals placed in metabolism
cages, after being injected with 100 mg/kg carbenicillin
intramuscularly.' Bile specimens were obtained at intervals
of 1 h over a period of up to 0 h after dosing. A total of
15-1 per cent of the penicillin was recovered from the bile
during this period and 28-S per cent of tho antibiotic was
recovered from the urine oyer a period of 4 h.
Following intramuscular injection of carbenicillin into
rabbits at a dose of 500 mg/kg, samples of cerebrospinal
fluid were withdrawn from the cisterna magna at 0-5, 1, 2
7
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and 4 h and assayed. No antibiotic was found in the
cerebrospinal fluid, indicating a failure of carbenicillin to
penetrate the blood-brain barrier.
When given subconjunctivally, 0-5 ml. of both 10 per
cent and 25 per cent solutions of carbenicillin in xylocaine/
adrenaline solution B.P. gave concentrations up to 200
pg/ml. in tho aqueous humour. Detectable concentra¬
tions were present for a longer period after the injection
of the 25 per cent solution.
Prolonged toxicity studies in dogs. Thirty pedigree
beagle dogs were used in tho study. They were housed
singly and fed with weighed quantities of dry diet twice
daily, the food intake being calculated. Unlimited supplies
of water were provided and, in addition, one-third of a
pint of milk daily was available.
The animals were divided into five groups of three males
and throe females and were dosed as follows: group 1,
commencing at 2 g/kg/day subcutaneouslv; group 2,
500 mg/kg/day subcutaneously; group 3, 250 mg/kg/day
subcutaneously; group 4, 250 mgzkg/day intravenously;
group 5, controls dosed with saline subcutaneously.
Carbenicillin was dissolved in physiological saline so
that 1 g of carbenicillin was contained in 1-5 ml. of saline;
the solution was made up freshly each day. The dogs
were weighed once a week and the dose to be given during
the ensuing week was calculated. The intravenous in¬
jections were given into the veins of tho forelimb. The
duration of dosing was 3 months for the subcutaneous
groups and 1 month for the intravenous group.
Clinical symptoms were recorded daily, body weight
once a week, food intake twice daily and ophthalmoscopic
examination was carried out just before tho dogs were
killed. Haematological, biochemical, urinalysis and
serum glucose concentration tests were performed on all
dogs, once before dosing began and at 4, 8 and 13 weeks
after dosing had begun.
All animals which died during the experimental period
were examined after death and all the remaining animals
were killed at the end of the dosing period. The internal
organs were examined macroscopically and the brain,
pituitary, heart, lungs, liver, spleen, pancreas, thymus,
prostate/uterus, kidneys, thyroids, adrenals and gonads
were removed and weighed. Portions of these tissues,
together with sections of aorta, trachea, cervical and
mesenteric lymph nodes, salivary glands, various levels
of the alimentary tract, gall bladder, skin from injection
sites, sciatic nerve, optic nerve, eye, skeletal muscle and
bone marrow, were fixed and stained with haematoxylin
and eosin. Additional sections of the liver and kidney
were specially stained for fat.
There were no deaths from drug toxicity and only one
accidental death. There were no observable changes in
general physiology, apart from slight local swelling of
8
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tissues around the sites of intravenous injections. Severe
local swelling, pain, "cyst formation", but little ulceration,
occurred when the subcutaneous route was used for the
highest dose level. At 500 mg/kg/day, moderate dis¬
turbances resulted, whereas at 250 mg/kg/day there was
only minimal evidence of local irritation.
There was some suppression of weight gain associated
with a suppression of appetite at the highest dose level by
subcutaneous injection, the animals receiving 6- 9g/ltg/day.
Local irritation rather than the systemic absorption of
carbenicillin may have been the chief cause of this loss
of weight gain, because while at 250 mg/kg/day by intra¬
venous injection there was no weight suppression, less
weight was gained by the same dose level given by the
subcutaneous route.
A slight reduction in the serum potassium concentration
occurred after 4 weeks at the highest subcutaneous dose
level but was not seen later. In two dogs dosed for 4
weeks by intravenous injection at 250 mg/kg, there was
some reduction in the concentrating power of the kidney.
No effect on the kidney was found in a repeat tost at
500 mg/kg intravenously.
Only local tissue damage was found on macroscopic
examination at post-mortems and only local irritant
reactions at the injection sites were found on histological
examination. There was no evidence of organ damage.
Prolonged toxicity studies in rats. Doses of 250, 500
and 1,000 mg/kg carbenicillin were given subcutaneously
to groups of thirty Sprague-Dawley caesarian-derived
rats from the Charles River Breeding Laboratories,
Wilmington, Massachusetts, fifteen males and fifteen
females to each group, over a period of 13 weeks. The
rats had access to weighed quantities of autoclaved
Spillers 'Laboratory Animal' diet and to tap water. The
solutions of the drug were prepared freshly each day and
administered in a volume of 0-4 ml./lOO g. Two injection
sites were chosen for each rat, each site being used on
alternate days. Tlrroughout the course of the test a
record of food consumption and body weight change was
kept daily and the mean weekly intake per rat calculated.
Urinalysis and haematology were carried out at the
beginning of dosing and at 4, 8 and 12 weeks. At the
end of the test all the animals were killed by anaesthetiza-
tion with ether followed by exsanguination.
After the post-mortem examination, all the essential
organs were prepared for histological examination. No
histological or clinical effects attributable to the drug were
detected throughout the course of the dosing apart from
a trend in the top group towards a slight fall in the red
blood count.
Local irritancy studies. The local action of carbenicillin
was determined in the rabbit eye after subconjunctival
injection and after topical application. In the first
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series of experiments two animals each were allocated
to groups which received 0-2 ml. of a 25 per cent, 10 per
cent or 1 per cent solution of carbenicillin, respectively.
The 25 per cent solution of carbenicillin was prepared in
xylocaine/adrenaline solution B.P., in order to reduce the
painful response to the hypertonic solution. All the
animals were observed twice daily for one week after the
injections and any inflammatory responses were recorded.
At the end of tho period the rabbits wero killed and the
eyes and surrounding tissues removed for histological
examination. The 10 per cent and 1 per cent solutions
produced very littlo reaction with only a very mild
inflammatory response, and the histological examination
showed no damage. The 25 per cent solution, however,
caused inflammation with leucocytic infiltration within
3 h of the injection. Within 48 b, however, the reaction
had subsided and by the end of the tost period there was
no evidence of inflammation.
0-2 ml. of a 25 per cent solution of carbenicillin was
applied for 2 min to the eyes of rabbits after which tho
antibiotic was washed out with warm saline. The eyes
of the control animals were treated with saline in the same
period of time. The animals were treated twice a day for
3 days. They were then killed on the fourth day and the
tissues removed for histological examination. After the
first application of tho 25 per cent solution there was a
slight inflammation of the conjunctiva in one animal
which lasted 24 h, but on post-mortem examination no
damage was observed; othorwise local application caused
no ill effects.
Carbenicillin was also given by intramuscular injection.
Twelve rabbits were closely shaven across the dorsum and
two injection sites chosen in each of two sacro-spinalis
muscles of the back. One site was injected with 1 ml. of a
50 per cent concentration of carbenicillin in saline and
the other with 1 ml. of saline. 4 days later the animals
were killed and tho treated areas prepared for histological
examination. At all tho sites which received the drug
there was fibrolysis and necrosis accompanied in five
animals by oedema.
Effects on pregnant rats. Sprague-Dawley caesarian-
derived rats from t he Charles River Breeding Laboratories
Wilmington, were used. The animals were allowed to
mate, the day of mating being judged by tho appearance
of the vaginal plug. Dosing began on day 6 of pregnancy
up to and including day 15. Three groups of twenty
females were taken, group 1, the control group, being
dosed with salino, while groups 2 and 3 received respec¬
tively 100 and 500 mg/kg carbenicillin in physiological
saline, subcutanoously. The volumes of all injections
were standardized to 0-2 ml./lOO g body weight. The
animals were given free access to Spillers 'Laboratory
Animal' diet and to tap water and were closely observed
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throughout pregnancy. On day 21 the animals were
killed and the uterine contents examined for the number of
viable young, resorption sites, litter weight and foetal
abnormalities. The young were examined externally
after removal from the uterus, one-third being retained
for detection of visceral abnormalities and the remaining
two-thirds for subsequent dissection of animals followed by
clearing and staining of the skeleton by alizarin to detect
skeletal abnormalities.
No obvious signs of maternal reactions were observed
during the test, but treatment with carbenicillin was
associated with a slight retardation in body weight gain.
Conception rate, average litter weight and size were not,
however, significantly affected by the treatment and there
was no incidence of abnormalities due to the drug.
Effect on pregnant mice. Groups of twenty-two mice
were mated and treated in a similar way to the rats in the
rat pregnancy study except that the animals were killed
on the seventeenth day of pregnancy when the uterine
contents wore similarly examined.
Carbenicillin had no effect on the body weight changes
in the mouse, and conception rate, litter size and foetal
loss were unaffected at either dosage. There was also no
incidence of abnormalities and skeletal deformities due
to the drug treatment.
Peri- and post-natal development of the rat. Tests were
carried out to determine the effect of carbenicillin on
male and femalo rats before mating and through gestation
and lactation to the twenty-first day after birth. Daily
doses of 100 and 500 mg/kg of carbenicillin were adminis¬
tered subcutaneously throughout this period.
Parent animals were unaffected, as assessed by daily
observation, body weight change, conception rate,
length of the gestation period, and parturition. Litter
size, litter and mean pup weights and pup loss of rats
receiving 500 mg/kg were unaffected at birth or after 4 or
21 days. The increased pup mortality recorded at the lower
dosage, of 100 mg/kg was therefore considered to be un¬
related to the treatment. No abnormal pups were found.
We conclude that carbenicillin at dosages of 500 mg/kg
and below does not adversely affect the peri - and post-natal
development of the rat.
Absorption and Excretion in Man
The following absorption and excretion studies were
undertaken in order to determine a suitable dosage and
route of administration for a proposed clinical trial.
Assay methods. The concentration of carbenicillin in
serum and in urine was determined by the cup-plato
biological assay method. Details of the technique were as
described previously1 except that Pseudomonas pyocyanca
NCTC 10490 (Ellsworth strain, 1973) was used as the test
1 1
organism. Sarcina lutea and Staphylococcus aureus are
unsuitable as assay organisms because carbenicillin
contains a small amount of benzylpenicillin and this may
appear in the serum and urine together with the carbeni¬
cillin. Because Sarcina lutea and Staph, aureus are many
times more sensitive to benzylpenicillin than to carbeni¬
cillin the presence of traces of benzylponicillin may
invalidate the assay. Ps. pyocyanea NCTC 10490, 011.
the othor hand, is sensitive to carbenicillin but is relatively
resistant to. bonzylponicillin. The culture is unusually
sensitive to carbenicillin, showing an MIC of about
1-25 pg/ml., and it is possible to assay concentrations of
carbenicillin as low as 2-5 pg/ml. using this strain, while
benzylpenicillin at concentrations of up to 500 pg/ml.
fails to show any zone of inhibition. Standard solutions
of carbenicillin from 1-100 ug/ml. were prepared in human
serum, and where necessary the serum samples .were
diluted with human serum to give a concentration within
this range. For the assay of urine samples the standard
solutions of carbenicillin were prepared in 0-05 molar
phosphate buffer pH 7-0 and urine samples were also
diluted as required using the same buffer.
Oral administration. After a dose of 500 mg carbenicillin
in gelatine capsules to healthy adults in the fasting state,
no carbenicillin (that is, < TO gg/ml.) could be detected
in serum samples taken at 0-5, 1, 2, 4 and G h after
administration.
Carbenicillin was detected in the urine, which was
collected over the 6 h period after the administration of
the drug, but the quantity present in the urine amounted
to less than 1 per cent of the dose administered. It would
appear, therefore, that carbenicillin is not absorbed to any
extent when given by mouth.
Intramuscular administration. Carbenicillin was admini¬
stered by intramuscular injection to healthy adults in
doses of 250 mg, 500 mg and 1 g dissolved in water for
injection. The 250 mg dose was dissolved in a volume of
1 ml. and the 500 mg and 1 g doses were administered in a
volume of 2 ml. The serum concentrations obtained are
shown in Table 5.
It will bo seen that intramuscular injection resulted in a
high concentration of carbenicillin in serum with a peak
at about 1 h after injection. Thereafter the serum levels
fell relatively quickly and about 80 per cent of the dose
appeared in the urine over the first G h.
Tablo 6 shows results for the effect of probenecid on
the serum levels and the urinary excretion of carbenicillin.
Table 5. mean serum concentrations of carbenicillin after intra¬
muscular injection in adult volunteers
No. of Dose Soruin concentration Oug/ml.)
subjects (mg) 0-5 h lh 2 h 3 h 4 h 6 h
10 250 5-9 7-9 5-7 2-G
9 500 13-7 17-7 13-2 - 20
16 1000 21-6 25-3 22-1 - 10-9 3-7
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Table 0. effect of probenecid on serum levels and urinary excretion




No. of Mean serum concentration (iig/ml.) urine over
subjects 0*5 h 1 h 2 li 4 h G ii 0-G h
With probenecid* 10 25-7 39*9 48-0 27-4 19-4 48
Without probenecid 10 26-8 29-4 22-2 10-8 3-3 84
Carbenicillin dose 1-0 g by intramuscular injection.
* 1 g 1 it and 10 h before administration of carbenicillin.
Probenecid was administered to healthy adults in a dose
of 1 g 10 h, and again 1 h, before the intramuscular admini¬
stration of 1 g carbenicillin. It will be seen that pro¬
benecid produced a substantial increase in the peak levels
of carbenicillin obtained in serum and the rate of elimina¬
tion of the drug from the serum was markedly diminished.
Chromatography of human urine, obtained after intra¬
muscular administration of carbenicillin, indicated that
the drug does not undergo any substantial metabolism in
the body.
Intravenous administration. Results are shown in
Table 7 for the serum levels obtained after intravenous
injection of 1 g carbenicillin. This amount was dissolved
in 10 ml. water and administered over a period of 3 min.
Although the drug was eliminated rapidly from the blood
it will be seen that serum levels in excess of 100 gg/ml.
were obtained during the first 30min after administration
of this dose.
Table 7. serum concentration of carbenicillin after intravenous
ADMINISTRATION OF 1 g
Serum concentration (//g/ml.)
Subject 0-25 h 0-5 h lb 2 h 4 h 6 h
A 140 127 60 28 3-7 <3-0
B 140 114 55 32 4-4 <30
Carbenicillin levels in serum and in urine in relation to
antibacterial activity. As a result of the extensive elimina¬
tion of the drug by way of the kidneys, relatively high
concentrations of carbenicillin are obtained in the urine.
In the studios involving a dose of 500 mg by intramuscular
injection, the concentration in the urine collected over the
first 6 h was generally 1,000-2,000 pg/ml. This is con¬
siderably in excess of the concentration of drug required
to inhibit the growth of Ps. pyocyanea. On the other
hand, it is questionable whether intramuscular injection
of 1 g carbenicillin at intervals of 6 h, even in conjunction
with probenecid, would result in tissue concentrations
which would be inhibitory towards typical strains of
Ps. pyocyanea. The minimum inhibitory concentration
of carbenicillin for most strains of Ps. pyocyanea appears
to be 50-100 (Ag/ml., and although the drug is not highly
bound to serum protein (about 50 per cent is bound) it
would probably be desirable to achieve serum levels some-
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what in excess of 100 (xg/ml. This can readily be attained
by intravenous administration.
In addition to the activity which carbenicillin shows
against Ps. pyocyanea, the drug is active against other
pathogens, including E. coli, and also strains of Proteus
morganii, P. rettgeri and P. vulgaris which are generally
resistant to ampicillin. On the basis of the in vitro
sensitivity of these latter organisms to carbenicillin, the
serum concentrations achieved by intramuscular admini¬
stration of the drug might be adequate and the levels
attained in urine are again greatly in excess of the mini¬
mum inhibitory concentrations.
The results obtained in these studies suggested that for
clinical trials on the therapeutic effectiveness of carbeni¬
cillin in urinary tract infections, a suitable dosage might
bo 1-0 g by intramuscular injection at intervals of 6 h.
The treatment of pseudomonas septicaemia, wound
infections and tissue infection in general would require the
intravenous infusion of carbenicillin (with or without
probenecid) in order to attain inhibitory serum and tissue
concentrations.
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PHARMACOLOGY AND TOXICOLOGY OF A NEW SEHI-SYNTHETIC PENICILLIN
BRL 20&f (CARBBNICILLIN)* ACTIVE AGAINST PSKUPOMONAS AERUGINOSA
P. ACRED AKD D.M. BROWN
Beecham Research Laboratories
Brockham Park, Betchworth, Surrey, England
a-Carboxybenzyl penicillin (BRL 2064) is a new semi-synthetic
penicillin which has been shown to have interesting activity against
Pseudomonas aeruginosa (Sutherland and Rolinson, 19&7). This paper
describes some aspects of the toxicology and pharmacology.
TOXICOLOGY
BRL 20G+ is virtually non-toxic when administered subcutaneously,
intramuscularly and intravenously to rats and mice (Table I).
Species Route LDj-q mg/kg
i.m. > 10,000
Mouse s. c. > 4,000
i.v. > 10,000
Rat
s. c. > 5,000
i.v. > 5,000
TabUe I
Acute Toxicity of BRL 2064 in Rats and Mice
Prolonged administration studies were carried out in rats and
dogs over a period of 13 weeks. Subcutaneous doses of 250, 500 and
1000 mg/kg/day were administered to the rats and 250, 500 and 2000
mg/kg/day to the dogs. The high dose in dogs was increased at three
weeks to 3000 mg/kg/day and subsequently reduced because of local
reactions. A further group of dogs was dosed intravenously with
250 mg/kg/day for a period of four weeks.
Clinical symptoms were observed daily, body weight once per week,
food intake twice daily and opthalmoscopic examination was carried out
just prior to termination. Haeraatology, biochemistry, urinalysis and
S.G.' concentration tests were carried out before dosing commenced, and
4, 8 and 13 weeks after dosing had begun. Selected organs were weighed
* lyopen is the registered trade mark of
Beecham Research Laboratories for carbenicillin.
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and histological examination carried out on samples of most body
tissues.
There were no deaths due to drug toxicity during the course of
test and no clinical symptoms were seen which were indicative of
systemic toxicity. Local reactions of increasing severity with
increasing dose were seen in the dogs receiving BRL 2064
subcutaneously. The highest dose group showed localised swelling
within two days of dosing beginning. The irritation in this group
became increasingly worse and the dose was progressively reduced from
the 5th week of the test and stopped at the 9th week. The reactions
were less marked in the group receiving 500 mg/kg and there was only
slight evidence of irritation from the 9th week onwards in the group
receiving the 250 mg/kg dose. Actual ulceration of the skin was rare.
Post mortem examination revealed only local tissue reactions,
there being no macroscopic organ changes. Apart from a slight increase
in the weights of the kidneys and adrenals obtained from dogs receiving
the highest subcutaneous dose, no organ weight changes were observed.
Histologically, apart from local irritant effects characterised by
tissue necrosis, haemorrhage and marked fibroblastic reaction, there
was no evidence in any of the tissues examined of alterations in
morphology which could be attributed to the administration of BRL 2064.
Teratogenic studies were carried out in rats and mice using the
protocol recommended by the F.D.A. Doses of 500 mg/kg and 100 mg/kg
BRL 2064 administered subcutaneously were used in the study. Conception
rate, average litter size and weight were not significantly affected
and there was no evidence of abnormalities.
Peri- and post-natal development of rats was unaffected by
subcutaneous administration of doses of 50^ ^d 100 mg/kg BRL 2064.
HIARMACOLCGY
Distribution and Metabolism in Rats
The distribution of BRL 2064 following intramuscular
administration of 100 mg/kg was studied in rats. 3RL 20o4 was found
to be distributed throughout the body in a manner similar to other
penicillins. No preferential concentration of the penicillin in any
particular tissue was found apart from the organs associated with
elimination of the penicillin from the body, i.e. liver and the
kidney. Chromatographic examination of intestinal contents arid tissue
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homogenates revealed unchanged BRL 2064 in the samples, indicating
little or no metabolism of the penicillin within the body. However,
chromatographic examination of the urine from rats following intra¬
muscular administration revealed a trace of a metabolite which was
active against Sarcina lutea but had no activity against Pseudomonas.
Biliary and Urinary Excretion in Rats
Excretion of BRL 2064 in bile was examined in conscious rats
(375 ~ 475 g.) following cannulation of the bile duct. . Experiments
were also set up in which urine was collected from normal unoperated
rats. The penicillin was administered intramuscularly in a dose of
100 mg/kg.
The results obtained with BRL 2064 are shown in the accompanying
table and compared with the results we have obtained for other new
penicillins and penicillin G-.
Mean Concentration pg/ml % of dose % of dose
Penicillin at hours after dosing recovered recovered
0-2 2-4 4-6 in bile in urine
BRL 2064 1984.0 54.0 1.75 15.1 28.8
Cloxacillin 3017.0 707.0 75.0 23.0 16.0
Ampicillin 1835.0 469.0 - 9.6 31.3
Benzyl (g) 1934.0 476.0 183.0 15.0 25.0
Table II
Excretion of Penicillins in Bile and Urine of Conscious Rats following
intramuscular administration of 100 mg/kg
BRL 2064 is excreted in the bile and urine in a manner similar to
other penicillins. The high concentration found in bile, the ratio of
the concentrations in bile compared to that found in blood are in the
range 200 - 500, contrasts markedly with those found for other
antibiotics. Stewart and Harrison (1961)'using a technique similar to
that described above found for streptonycin, neonycin, paramonycin
and chloramphenicol, that the concentrations in the bile were very
much lower than those found in blood. Streptonycin gave the highest
yield in the bile, the amount excreted being only 0.08^ of the
administered dose. These results emphasise a property which
distinguishes the penicillin from most other antibiotics, namely
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their excretion in high concentrations in the bile.
Penetration into the Cerebrospinal Fluid (C.S.F) of Rabbits
Only trace concentrations of RRL 2064 were found in the C.S.F. of
rabbits at intervals up to 4 hours following intramuscular
administration of 500 mg/kg of the penicillin. Blood samples removed
at the same time as the C.S.F. samples contained high concentrations
of the penicillins. Penicillins in general do not penetrate the C.S.F.
readily and the results shown in Table III compare those found for
BRL 2064 with other penicillins.
Concentration pg/ml at
hours after dosing
Penicillin 1. 0 2. 0 0
C.S.F. Serum C.S.F. Serum C.S.F. Serum
BRL 2064 Trace 72.5 Trace 45.0 Trace 8.0
Cloxacillin 2.3 440.0 2.3 142.5 3.3 112.5
Ampicillin 1.4 54.0 0.1 14.2 0.05 4.2
Benzyl (G) 0.13 130.0 0.43 38.0 0.05 200.0
Table III
Concentrations of Penicillins in the C.S.F. and Serum of Rabbits
following intramuscular administration of doses of 500 mg/kg
Penetration into the Aqueous Humour of Rabbits
10f.' and 25/-• solutions of BRL 2064 were prepared using xylocaine
2#0^c + adrenalin injection solution 3.P. and 0.5 nil. injected
subconjunctivally into groups of rabbits 1.5 ~ 2.0 kg. At 0.5, 1 and
2 hours after dosing the rabbits were anaesthetised and the aqueous
humour withdrawn from the injected eye. Cardiac blood samples were
taken at the same times. The results, together with those found for
other penicillins, are shown in Table IV.
BRL 2064, as found with cloxacillin and ampicillin, readily
penetrates into the aqueous humour. A moderate transient inflammation
of the subconjunctival tissue was seen follo?/ing injection of the 25^
solution of BRL 2064. No adverse responses were seen following
injection of the 10^ solution.
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Concentration p&/ml at hours after injection
Penicillin
Dose









ML 2061+ 10 200.0 10.8 110.5 0 0 0
BRL 2064 25 203.0 24.1 45.5 6.0 7.9 0
Ampicillin 25 60.0 12.3 48.0 5.6 19.0 0.4
Cloxacillin 50 - - 660.0 98.0 210.0 16.0
Table IV
Penetration of Semi-synthetic Penicillins into the acueous humour of
Rabbits following subconjunctival administration
CONCLUSIONS
BRL 206l+ is a new semi-synthetic penicillin active against strains
of Pseudoraonas, which is distributed throughout the animal body in a
manner similar to other penicillins. High concentrations appear in
bile and urine, and the penicillin penetrates readily into aqueous
humour following subconjunctival administration. As with other
penicillins, BRL 2064 does not penetrate readily into the cerebro¬
spinal fluid. Carbenicillin is non-toxic and can be administered in
high doses over long periods of time to dogs and rats. Some local
irritation at the sites of subcutaneous injection were seen in animals
receiving high doses of the penicillin. No effects on foetal, peri-
and post-natal development were observed in mice, and rats, following
administration of high doses of BRL 2064.
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The concept of chemotherapy as advocated by
elirlicii received considerable impetus by fleming's
discovery of penicillin in 1929, However, the full
significance of Fleming's work was not fully appre¬
ciated until Abraham, Chain, Florey and their
colleagues in 19411' isolated natural penicillin in
sufficient quantities for clinical evaluation.
The remarkable clinical effectiveness of penicillin
stimulated a flood of research into the development
of new natural antibiotics. Many of these, however,
proved to be toxic and their side effects restricted
their application. Nevertheless, this work diverted
attention from penicillin, and research work in the
penicillin field was mainly confined to studying
possible modifications produced by the addition of
different precursors to fermentation brews.
However, the research team at Beecham Research
Laboratories in collaboration with Professor CHAIN,
commenced an investigational programme with a
view to the chemical modification of p-aminobenzyl
penicillin. During the course of this work a marked
discrepancy between the corresponding biological
assays and the chemical assays was found. The
cause of the discrepancy was investigated and this
resulted in the recognition and subsequent isolation
of 6-APA by my colleagues2) (BATC1IEL0R, DOYLE,
NAYLER and ROLINSON). We were now in a position
to prepare numerous new penicillins by semi-synthe¬
tic routes which were hitherto unaccessible by
the previous fermentation methods. It was hoped
that by a systematic study of the new compounds
it would provide in the first instance a lead to the
development of a new penicillin which would be
effective against staphylococci previously insensitive
to the natural penicillins and which would still
retain the character of non-toxicity. Our second
objective was the development of another penicillin
which would be effective against a wider range of
organisms than penicillin G, particularly in the gram
negative field.
In our approach to these studies we went on the
assumption that in vivo activity might differ from
in vitro activity. For example, a more active me¬
tabolite may be formed in the body or the activity
of the antibiotic may be potentiated in vivo by some
other mechanism. As far as was possible, therefore,
all compounds which by in vitro tests were more
stable to penicillinase than penicillin G were tested
in the animal for activity against a penicillin-resis¬
tant and penicillin-sensitive staphylococcus.
The activity of the penicillins against penicillin-
sensitive Staphylococcus aureus (Smith) was assessed
by determining the dose of penicillin needed to cure
50% (CD50) of a group of mice infected intraperi-
toneally with a large dose of the organism. Activity
against infections due to penicillin resistant Sta¬
phylococcus pyogenes (russell) was determined by
the thigh lesion method described by selbie3' and
as adapted by BROWN and ACRED4' for evaluating
antibiotics.
In the first stages of our investigation we prepared
a large number of different penicillins. Amongst
these was tri-phenylacetyl penicillin :
Fig. 1 Tri-phenylacetyl penicillin
A
This penicillin proved in vitro to be stable to
Staphylococcal penicillinase and was active against
the majority of resistant staphylococci at minimal
inhibitory concentrations of l~2/zg/ml. However,
in vivo the compound proved to be completely in¬
active. No blood levels could be obtained as it was
highly protein bound and was held firmly to the
tissue proteins at the site of injection. In addition,
after intravenous administration it proved to be toxic
and therefore of no value clinically. This work, how¬
ever, gave us a major pointer to the production
of new penicillins which would be stable to peni¬
cillinase. It would appear that the steric configura-
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tion of the side chain prevents attachment of the
enzyme and therefore prevents the disruption of the
nucleus. A number of penicillins were now prepared
which by their structural configuration would
prevent the access of the enzyme to its points of
attachment. This work led very quickly to the
synthesis of 2:6-dimethoxybenzyl penicillin which
has proved to be highly effective clinically and free
from side effects.
Fig. 2 2:6-dimethoxybenzyl penicillin






A large number of analogous compounds to methi-
cillin have also been prepared, but only a few have
been shown to possess activity of the same order
against both sensitive and resistant staphylococci.
Derivatives of 1-naphthoic acid were among the
more active of the new compounds. We therefore
assessed these compounds by the 'double lesion'.
In this procedure we injected the sensitive strain
into one hind limb and the resistant strain into the
other hind limb of a mouse. Groups of 10 animals
Fig. 3 Mean increase compared with non-infected
controls in thigh diameters of mice (10
per group) infected in the right thighs
with Staphylococcus pyogenes (Russell)-a
penicillin resistant staphylococcus, and
infected in the left thighs with Staphylo¬
coccus pyogenes 2187-a penicillin sensitive
staphylococcus. The mice were treated
daily for three days with 100 mg/kg sub'
cutaneously with each penicillin. I. C. -
infected non-treated control group.
1241 1336 Pen G IC
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were used and these were treated subcutaneously
with the antibiotic for 3 days, and the mean increase
in the thigh diameter was estimated and compared
with the non-treated and non-infected control group.
A comparison of 2-methoxynaphthyl penicillin and
2:6-dimethoxybenzyl penicillin is shown in Fig. 3.
The effectiveness of both compounds against both
the resistant and sensitive strains is demonstrated
whereas penicillin G is only effective against the
sensitive strain.
The penicillin derivatives of the following acids
had little or no activity : Quinoline-4-carboxylic
acid, Pyrimidine-5-carboxylic acid, Pyrazole-4-
carboxylic acid, Indole-2-carboxylic acid, Benzofuran
-2-carboxylic acid, Furan-3-carboxylic acid, Thio-
phene-2-carboxylic acid and Thiazole-4-carboxylic
acid.
All of the preceding penicillins, however, have
proved to be inactive orally, but a significant
advance has been made recently with the synthesis
in our laboratories of a series of isoxazolyl penici¬
llins5'. The general formula of this series is shown
in Fig. 4.








=alkyl or aryl radical
A number of these compounds have proved to be
considerably active against both resistant and sensi¬
tive staphylococci. Among the more active of the
compounds, however, the results in vivo show that
there is little to choose between any of these com¬
pounds by the oral or intramuscular routes. One of
these compounds, BRL. 1400 (5-methyl-3-phenyl-4-
jsoxazolyl penicillin), has been examined extensively
by Bristol Laboratories6' and this compound is now
in clinical use. We are continuing our examination
of the series and have found that some have given
superior blood levels in humans to BRL. 1400
(KNUDSEN, personal communication). Unfortunately
detailed toxicity studies and clinical assessment
have still to be completed, and it is too early at
this stage to elaborate further.
Broad-spectrum Penicillin
Penicillin G has a slight but significant activity
against certain gram negative organisms in vitro
but in general most of the new synthetic penicillins
do not possess activity in this respect. However,
we noted that cephalosporin N, which has an amino
group in the side chain, showed a slight enhance¬
ment in activity. We felt, therefore, that the amino
group might play a significant part in promoting
activity against gram negative organisms.
Consequently, we prepared a number of penicillins
1241 1336 P«nO iC




















with amino acid side chains and of these, zr-amino-
benzyl penicillin proved to be very active, and from
the in vitro investigations by rolinson and ste¬
vens7' it was shown to be slightly but significantly
more active than chloramphenicol. We therefore
carried out a comparison of the effect of ampicillin
with chloramphenicol, tetracycline and strepto¬
mycin8' in mice infected with both gram negative
and gram positive organisms. The results in vivo
clearly confirmed the in vitro results.
In these experimental infections, ampicillin was
shown to be excedingly effective against both types
of organisms. Clinically, particularly against the
coliform group of organisms associated with urinary
tract infections9', the experimental expectations
have been fully realised although the effects against
active typhoid have been somewhat disappointing,
but there are indications with increased and more
frequent dosing better clinical responses can be
obtained. Additional clinical tests show that ampi¬
cillin is also very effective in cases of chronic
bronchitis, particularly those associated with haemo-
philus influenzae. The particular merit, however,
of ampicillin is that it is devoid of systemic toxicity,
from subjects who are already sensitive
to penicillin it can be administered safely in large
doses. Most other oral antibiotics suffer from unto¬
ward toxic effects which can limit their usefulness.
General Pharmacology of Methicillin
and Ampicillin
With regard to toxicity both drugs are remarkably
free from acute toxic effects in the same way as
penicillin G. In doses up to 3 g/'kg both orally and
subcutaneously in rats and mice no toxic symptoms
have been seen with methicillin, but in the range
of 3~5g, occasional mild convulsions have occurred10'
(Acred, Brown, Turner and Wright). With
ampicillin no toxic effects have been observed with
doses of up to 5 g/kg11' (acred, Brown, turner,
wilson). In view of the very low order of toxicity
we have not tested larger doses. Ampicillin and
methicillin have also no long term toxic effects. In
prolonged tests in dogs where the drugs were
administered at 500 mg/kg daily for 30 days, neither
compound has given rise to any sign of toxicity.
Neither has the intramuscular injection of a 10%
solution of each antibiotic caused a significant degree
of irritation.
Absorption and Distribution
Methicillin is not absorbed orally, but by intra¬
muscular injection it gives good blood levels which
are comparable with penicillin G. On the other
hand, ampicillin is well absorbed orally and intra¬
muscularly in dogs. If administered orally it in fact
gives superior levels to penicillin V, though in
humans there is no clear advantage (knudsen,
personal communication).
Both antibiotics after intramuscular administration
are similarly distributed throughout the body. Apart
from the liver and kidney neither antibiotic is
concentrated particularly in one organ. The high
concentrations of antibiotic ' in these two organs,
however, probably reflect the concentration of the
antibiotic in the bile and urine and in no way
and apart fr represents an actual concentration in the tissue
Table 1 Activity of ampicillin, chloramphenicol, tetracycline and streptomycin against gram negative
and gram positive infections in mice. The results are expressed in terms of the dose of
antibiotic, administered either orally or subcutaneously, calculated to protect 50% of a group






p. o. S. C. p. o. S. c. p. o. S. C. p. o. GO p
Staphylococcus aureus Smith 0.3 0.3 Inactive100.0
Inactive
100.0
5.2 6.0 — —
Streptococcus pyogenes Group A 0. 1 0.025 3.2 3.2 0.5 0.5 — —
Salmonella typhimurium 18.0 12.8 310.0 250.0 62.4 59.2 — —
Klebsiella pneumoniae 11.6 35.4 165.0 280.0 Inactive400.0 61.0
— —




Fig. 6 Serum concentrations in dogs following intramus¬
cular administration of 5mg/kg. Ampicillin ( ),
Methicillin ( ) and Benzylpenicillin ( ).
5 mgs/Kg
Fig. 7 Serum concentrations in dogs following oral
administration of 20 mg/kg. Ampicillin ( )




Table 2 Mean concentration ug/g of methicillin and am¬
picillin appearing in the liver, kidney and serum
of groups of ten rats after intramuscular admini¬
stration of doses of 100mg/kg of each penicillin.
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Concentration ug/g wet weight
0.5 hrs. 1.0 hrs. : 2. 0 hrs. | 4. 0 hrs.
Liver 32.8 23.8 1 12.9 4.1
Kidney 122.1 88.8 24.1 2.9
Serum 32.5 30.2 | 5.46 i 0.18
spaces.
Neither methicillin nor ampicillin readily
penetrate into the C. S. F. but both drugs can be
given intrathecally provided the administration
is controlled. Excess concentrations of both
antibiotics can cause convulsions in the same
way as penicillin G. Both the new penicillins
can penetrate into the aqueous humour, but to
obtain the most satisfactory results the drugs
have to be given subconjunctivally. In our
experiments the penicillins were injected in
0.5 ml volumes subconjunctivally into the
right eyes of a group of 6 rabbits. A volume
of 0. 5 ml saline was injected into the left eye
and at 1, 3 and 4 hours after administration
two animals from each group were killed and
the eyes carefully dissected out. The aqueous
humour was drawn asceptically from the
anterior chamber. At the same time serum
specimens were also collected and the concen¬
tration of the antibiotic in the fluids deter¬
mined.
Elimination
In studying the excretion of an antibiotic,
almost invariably only the urine excretion is
considered. However, excretion in other secre¬
tory fluids are also to be taken into account,
particularly in the bile. We have found, for
example, that in the conscious rat 15% of
methicillin can be eliminated in the bile.
Allowing for the errors of assay when the
total amount excreted in the urine and in the
bile is calculated, nearly all of the adminis¬
tered methicillin can be accounted for. With
methicillin the absorption from the gut is
negligible and any of the antibiotic which is
returned to the gut by the bile or saliva is
completely lost to the body. On the other
■ hand, the penicillins which are absorbed orally
tend to be re-cycled and this factor alone can
account for the more prolonged blood levels
seen after the administration of orally absorbed
penicillins.
With regard to the mode of elimination, AC¬
RED et al",") have shown that both methicillin
and ampicillin are removed by the kidneys by
renal tubular secretion and glomerular filtra¬
tion in the same way as penicillin G, although
it is much more difficult to block with probe¬
necid the renal tubular secretion of ampicillin
than the other two antibiotics. A quantitative
study of the clearance rate of ampicillin has
not yet been made, but should be of considera¬
ble interest to the pharmacologists.
Protein Binding
Finally, in considering the value of an
antibiotic it is essential to appreciate the
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Table 3 Concentrations of ampicillin and methicillin appearing in the aqueous humour and serum of
groups of rabbits injected subconjunctivally in the left eye with 0. 5 ml of a 25% solution
of ampicillin or 50% solution of methicillin.
Time Concentration ,ug/ml
0.5 hrs. 1.0 hrs. 2.0 hrs. 4. 0 hrs.
Penicillin
RL 11 S L R S L R S L S
Methicillin 14.0 2.4 58.0 8.7 25.7 30.9 6.5 2.7 5.8 0.97 0.48 1.7
Ampicillin 60.0 0.7 12.3 48.0 0.8 5.6 19.0 0.3 0.4 1. 1 0.4 0. 1
L =Aqueous humour concentration /ig/ml in injected eye.
R= Aqueous humour concentration Mglml in control eye.
S =Serum concentration Ag/ml.
significance of protein binding. It is generally
assumed that protein binding leads to a decrease
in antibacterial activity. Most studies have been
carried out by static dialysis and assumptions on in
vivo activity have been based on these in vitro
results. However, the conditions in the body are
vastly different and we feel that unless some in¬
formation is available about the nature of the binding
it is wrong to extrapolate from in vitro results
activities in vivo. ACRED, BROWN, HARDY and
MANSFORD12) have studied protein binding on several
penicillins by gel filtration, static and continuous
dialysis techniques and have shown so far as the
clinically active penicillins are concerned that the
binding is very loose and that the penicillin is
readily available. We have also shown that the
concentrations of a penicillin which is bound to serum
and another penicillin which is unbound to serum
are the same or even greater in inflammatory fluids
than in the serum. We injected glycogen, a non-
chemntactic agent, intraperitonealiy into two groups
of rats, one which received 100 mg/kg ampicillin
which is not protein bound, and the other which
received 100 mg/kg of benzyl penicillin which is
bound approximately 45% to serum proteins. At
0. 5, 1, 2 and 4 hours afterwards 3 rats from each
group were killed and the peritoneal fluid removed ;
at the same time samples of serum were taken for
assay. The concentrations of the antibiotics in the
peritoneal fluid and the serum are given in Table 4.
Apart from the first half an hour after administra¬
tion when the concentration of the antibiotic in the
peritoneal fluid was less than in the serum, the
concentrations subsequently were 1 l/2 to 2 times as
great as the serum. This is contrary to what would
be expected if the penicillins were firmly bound to
the serum proteins, and clear evidence that the
penicillin-protein complex breaks down readily and
allows the free penicillin to diffuse into the tissue
spaces.
In conclusion, the discovery of new penicillins
had led to two notable advances in the field of
Table 4 Concentrations of penicillin in peritoneal
fluid and serum after intramuscular
administration of 100 mg/kg penicillin


































chemotherapy. It is now possible to deal effectively
with infections due to resistant staphylococci which
have constituted a major problem in hospitals throu¬
ghout the world. The introduction of oral penicillins
effective against these organisms is a still further
step towards. combating these infections. The
development of ampiciilin has widened the clinical
application of penicillins and much wider range of
infections can now be successfully treated.
With these two additions in synthetic penicillins,
the primary objectives of our research have been
achieved but there is still considerable scope for the
development of new penicillins. This applies parti¬
cularly in the field of allergy where hypersensitivity
to penicillins still remains a serious problem.
Bibliography
1) Abraham, E. P., Chain,E., Fletcher,c.M.,
Florey, h. w., Cardiner, A. d., Heatley,
M. G. and jenning, M. A. (1941). "Further
observations on penicillin" Lancet, Vol. 2, p.
177—188.
2) Batchelor, F. r., Doyle, F. P., Nayler, J.
H. C., and rolinson, G. N. (1959). "The
synthesis of penicillin : 6-aminopenicillanic
acid in penicillin fermentationsNature
(Lond.) Vol. 183, p. 257.
3) SELBIE, F. R., and O'Grady, F. (1954). "A
measurable tuberculous lesion in the thigh of
6 CHEMOTHERAPY NOV. 1
the mouse". Brit. J. Exp. Path., Vol. XXXV,
p. 556.
4) Brown, D. M., and Acred, P. (1960). "Che-
motherapeutic studies on a new antibiotic- 9)
BRL. 1241 ". Lancet, September 10, p. 568—
569.
5) Doyle, F. P. D., Long, A., Stove, E., and
nayler, J. H. C. (1961). "New penicillins stable 10)
towards both acid and penicillinase". Nature
(Lond.), Vol.192, p. 1183-1184.
6. Gourevitch, A., Hunt, G. A., Pursiano,
T. A., Carmack, C. C\, Moses, A. J., and n)
LEIN, J. (1961). "Microbiological evaluation
of 5-methyl-3-phenyl-4-isoxazolyl penicillin".
Antibiotics and Chemo., Vol. 11, p. 780—789.
7) ROLINSON, G. N., and STEVENS, S. (1961).
" Microbiological studies on a new broad- 12)
spectrum penicillin, Penbritin". Brit. Med.
J„ July, 22, p. 191.
8) Brown, D. M., and acred,P. (1961). "Pen¬
britin A new broad-spectrum antibiotic.
Preliminary pharmacology and chemotherapy".
Brit. Med. J., July, 22, p. 197.
brumfitt, w., percival, A. and carter,
M. J. (1962). "Treatment of urinary-tract
infections with Ampicillin. A clinical trial ".
Lancet, January, 20, p. 130.
Acred, P., Brown, D. M., Turner, D. H. and
wrigiit, D. (1961). "Pharmacology of Methi-
cillin". Brit. J. Pharmacol., Vol. 17, p. 70—
81.
Acred, P., Brown, D. M., Turner, D. H. and
wilson, M. J., (1962). "Pharmacology and
chemotherapy of Ampicillin a new broad-
spectrum penicillin". Brit. J. Pharmacol.,
Vol.18, p. 356.
Acred, P., Brown, D. m., Hardy, T. L. and
mansford, K. R. L. (1962). "A new approach
to studying the protein binding properties of;
penicillins". To be published. '
(Reprinted from Nature, Vol. 199, No. 4895, pp. 758-759,
August 24, 1963)
A NEW APPROACH TO STUDYING
THE PROTEIN-BINDING PROPERTIES
OF PENICILLINS
By P. ACRED, D. M. BROWN, T. L. HARDY and
K. R. L. MANSFORD
Beecham Research Laboratories, Ltd., Brockham Park, Betchworth
r | THE interaction ofan antibiotic with serum is generally
X bolievotl to result in a decrease in antibactorial
activity. When the natural penicillins were originally
examined, it was found that in the absence of serum,
penicillin K was more active than penicillin X, and penicil¬
lin X was more active than penicillin G, but in the presence
df serum, penicillin G was the most active. The reversal
in activity was attributed to the fact that penicillin G was
less bound to protein than penicillin K or A", and hence a
greater concentration of free penicillin was available for
antibactorial action1.
The methods used to examine protein binding of
penicillins have ro'ied largely on in vitro static dialysis,
but such methods, however, bear little relationship to the
dynamic conditions in the body. We have, therefore,
studied the jihenomenon of protein binding with the view
of determining more precisely its significance to anti¬
bacterial activity in vivo. Gel-filtration and both static
and continuous dialysis methods have been used in this
investigation.
The penicillins which were selected were penicillin G.
'Ampieillin' and 'BRL 1071' (triphenylacetylpenicillin).
Static dialysis. To 5 ml. of human serum, 5 mg of the
pencillin under examination wore added. This was placed
in a dialysis bag of Wishing' tubing 0-7.5 in. diameter and
suspended in 20 ml. normal saline and dialysed at 8° C
for 24 h. Several dilutions of rotontate and dialysate were
prepared in M/20 phosphate bufferpH 7-0, and the amount
of antibiotic was assayed by the cup-plate technique using
Sarcina lutea as the tost organism. The samples of each
antibiotic wore assayod against dilutions of known con¬
centration of the same antibiotic.
Continuous dialysis. 5 mg of each antibiotic in 5 ml.
serum were jfiaccd in Wishing' tubing as described. The
bags wore suspended in a beaker through which water
flowed continuously. Tho final concentration of tho anti¬
biotic was assayed in tho serum at 24 h and tho percentage
obtained was calculated in terms of tho concentration in
serum at zero and 24 h.
Gel-filtration. 5 mg of each antibiotic woro dissolved
Traction (5 ml.)
Fig. 1. Elution patterns from 'Scphadex' columns
in 5 ml. sorum and allowed to stand for 18 h at 10° C. 3
ml. of the sorum were applied to a column jacketed at
10° C and containing 100 ml. 'Sophadex G25' gel equili¬
brated with water, tho flow rate being 20-25 ml./h.
Fractions (5 ml.) wore collected and protein elution was
followed by optical density measurements at 280 mix on
a 'Unicam' S.P. 500. Tho fractions were assayed for
antibiotic content. Aqueous solutions containing 1 mg/
ml. of tho antibiotics woro similarly treated.
Protein fractionation. Further examination of tho
bound fraction from the 'Sephadex <725' column was
carried out using DEAE-'Sophadex A50'. After con¬
centration by ultra-filtration the bound fraction was
passed down a jacketed column kept, at 10° C and contain¬
ing 30 ml. of fully swollen DEAE-'Sophadex A50' equili¬
brated with 0-02 M phosphate buffer at p11 8-6. Stepwise
elution was then carried out with 0 02 21 phosphate
buffer followed by saline of molarities 0-07, 0-12, 0-18 and
0-3 M, the change-over point being based on the optical
donsitios of the fractions at 280 mp.
{a) Dialysis. The results obtained for the degree of
protein binding are shown in. Table 1. Bv static methods
'BRL 1071' is bound S0-90 per cent to the serum proteins;
penicillin G is much less bound, while 'Ampicillin' is only
slightly bound. When examined by continuous dialysis,
the final percentages bound wore reducedbut the reduction
in the binding of 'BRL 1071' was less than with the other
penicillins (Table 1).
(b) 'Sephadex.' Typical elution patterns from three
penicillins of different binding properties obtained on
'Sophadox' columns aro shown in Fig. 1. With the peni¬
cillin alone the antibiotic activity is confined to fractions
8-10. With serum alono the protein as determined by
optical density at 280 nig. emerged in fractions 4-G. When
the incubated penicillin serum mixture was passed down
the 'Sephadex' column the protein again emerged in
fractions 4-6, whereas tho antibiotic activity showed two
poaks, if there was significant binding. One peak was
associated with the protein and the other again emerged
in the protoin-froo fractions 8. 9 and 10. Tho degree of
protein binding was then calculated from the antibiotic
content of the appropriate fractions. Tho 'Sophadox'
method2 offers considerable advantages over dialysis
methods since tho fractionation occurs in less than 2 h, and
after a short wash with water the column is roady for
further use. Tho dilution factor of both tho bound and
unbound material is small, and this aids the sensitivity of
the method. Tho reduction in time needed for the separa¬
tion of bound and unbound compound is also an advan¬
tage when dealing with labile materials.
'Sophadox (725' grade has a lower limit for complete
exclusion of molecular weights of 3,500-4.500 and is tho
preferred grade for protein binding studies. With tho
'(750' and 'Gib' grades of different degreos of cross-linkage,
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(c) Protein fractionation. Tho bound fraction from tho
'Sophadex G2o' column, on further examination 011
DEAE-'Sophadox A50', gave tho bulk of the antibiotic
activity in tho 0-18 M salino fractions, whereas aqueous
penicillin, solutions gave a peak of antibiotic activity in
tho 0 07 31 salino fractionswith some tailing into tho 0-12 M
saline fractions. Starch-gel and cellulose acetate electro¬
phoresis was then carried out on tho protein fractions.
Tho material eluted with 0-02 M phosphate was found to
consist of pure y-globulin. Tho other fractions were all
multi-component, but the 0-02 M, 0-07 31 and 0-12 31'
fractions contained no albumin and were made up of
mixtures of a- and (3-globulins. Tho material elutod with
0-18 31 salino consisted almost entirely of albumin whereas
tho material eluted with 0 03 31 salino contained some
material of the same mobility as albumin together with a
high clectrophoretic 'pro'-albumin content. It is evident
from this method that tho bound penicillin is associated
with tho albumin fraction of tho serum protein.
Discussion
From tho results of the three methods described, it is
ovident, that penicillins can differ in the degree and naturo
of their binding to serum protoins. Static dialysis shows
that 'Ampicillin' is slightly bound, penicillin G is moder-
atoly bound while 'BEL 1071' is considerably bound.
Tho nature of tho binding of ''BEL 1071' and penicillin
G is evident from the results under tho different conditions
of continuous dialysis and gel-filtration. Tho binding of
penicillin G is shown to be of a very loose nature and the
binding of 'BEL 1071' to bo very firm. Such differences
in binding can affect activity in vivo. If a compound is
firmly bound to the serum proteins tho concentration of
free penicillin is reduced and hence its intrinsic activity
is reduced. The in vivo activity, however, may not bo
significantly influenced if the binding is of such a loose
character that the penicillin is readily available for anti¬
bacterial activity. This is the case with penicillin G which
is bound to the extent of 40 per cent to serum protein
yet its activity is apparently uninfluenced by the presence
of serum in the some way as a compound, for example.
'Ampicillin' which is only slightly bound. On tho other
hand, ''BEL 1071' is very firmly bound and its activity is
much reduced in the presence of serum in vitro and in
vivo. Therefore, before conclusions on in vivo activity
can be drawn from in vitro results, information should bo
availablo on both tho actual degree and nature of tho
binding to serum proteins.
1 Tompsctt, It,, Shultz, S., and MoDennott, W., ,/. Bad., 53. 581 (1047).
2 Hardy, T. L., and Hansford, IC. It. L., Liochcm. J., 83, 341' (1902).
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Biotransformation of Hetacillin to Ampicillin in Man. Brown, D. M.,
Hannan, D. P., and Langley, P. F. (1969). Toxicol. Appl. Pharmacol. 15,
136-142. A high voltage electrophoresis technique has been used to assay
directly a mixture of two penicillins, ampicillin and hetacillin, in the
plasma of humans after oral administration of hetacillin. Results show
that ampicillin accounts for over 90% of the total biological activity at
the peak plasma concentration, and it may be concluded that the clinical
effectiveness of hetacillin is due to its conversion to ampicillin.
Hetacillin has essentially the same antibacterial spectrum of activity as ampicillin
(Bunn et al., 1965; Sutherland and Robinson, 1967), and it has been suggested that
since hetacillin can readily be broken down to ampicillin in vitro, the activity of heta¬
cillin in vivo also depends on the formation of ampicillin (Sutherland and Robinson,
1967).
Owing to the rapid hydrolysis of hetacillin to ampicillin (Fig. 1), it is impossible to
obtain an estimate of the composition of mixtures of these antibiotics by the usual
cup-plate assay method. We have therefore used a high voltage electrophoresis tech¬
nique to separate and assay the antibiotics in the plasma following intramuscular
administration to man.
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Fig. 1. Hydrolysis of hetacillin.
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METHODS
High voltage agar gel electrophoresis. The blood samples were assayed by high
voltage agar gel electrophoresis as described by Lightbown and de Rossi (1965). A
film of Noble agar,1 approximately 2 mm thick, was prepared on a glass plate by
pouring a 1 % w/v solution, of Noble agar in Tris-maleicacid buffer pH 5.6, into amold.
The plate was then placed on an aluminum block cooled to —15° and aqueous Tris-
rnaleic acid buffer solution was placed in the electrode compartments, which were
connected to the agar gel by gauze wicks. The samples were placed on the agar film
with microcap disposable pipettes,2 and a voltage of 1.5 kV was applied for 45 min in
order to obtain separation of hetaeillin and ampicillin.
On completion of electrophoresis, the agar film was overlaid with nutrient agar
seeded with Sarcina lutea, and the plates were incubated overnight at 30°. The loca¬
tions of the penicillins were seen as clear zones of inhibition on the plate.
Conversion ofhetacillin to ampicillin on incubation in agar gel. Two microliter samples
of hetacillin and ampicillin solutions, 0.25 mg/ml and 0.125 mg/ml, respectively, were
subjected to electrophoresis on an agar film for 60 min; the agar film was then overlaid
with nutrient agar seeded with Sarcina lutea.
A second plate was run under identical conditions to the first, but on completion of
electrophoresis was not overlaid with seeded agar. Both plates were then incubated at
30° for 16 hours. After incubation, the second plate (test) was again subjected to
electrophoresis under identical conditions to the first run and was then overlaid with
seeded agar and incubated as previously.
Conversion ofhetacillin to ampicillin in plasma. The effect of temperature on the rate
of hydrolysis of a 5 pg/ml solution of hetacillin in fresh human plasma was studied.
Hetacillin solutions, and control solutions containing 5 /ug/'ml ampicillin in plasma,
were incubated at 37°, 20°, and 4° for 15, 60, 120, and 240 min and 24 hours. At each of
these time intervals 10-^1 samples ofhetacillin and ampicillin incubates were subjected
to electrophoresis, together with freshly prepared standard ampicillin solutions pre¬
pared from sodium ampicillin (potency 840 /rg/mg) at concentrations of 5, 3, and 1.5
jug/ml plasma.
The zone diameters obtained from the standard solutions for each electrophoreto-
gram were plotted against the logarithm of the concentration and, from the regression
line obtained, the concentrations of the antibiotic in the test samples were estimated by
interpolation.
Human plasma levels ofhetacillin. Five volunteers in the nonfasting state were given
an intramuscular dose of 500 mg of potassium hetacillin in 2 ml of sterile water, and
blood samples were taken from the median cubital vein 10, 20, 40, 60, 80, and 160 min
after dosing. The samples were placed in heparinized centrifuge tubes which had been
precooled in ice, and they were then centrifuged at 1000 g for 5 min at 4°. The speci¬
mens were stored at this temperature until they were examined by the electrophoretic
and cup-plate assay techniques.
Standard ampicillin solutions in plasma were prepared at concentrations of 2.5,
1.25, 0.63, 0.31, and 0.16 p.g/ml. Forty-micro!iter samples of both the test plasma
1 Difco Laboratories, Detroit, Michigan.
2 Shandon Scientific Company Limited, 65 Pound Lane, Willesden, London, N.W.10.
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samples and ampicillin standards were assayed by the electrophoretic technique. Total
penicillin levels were also determined by the cup-plate assay method, using Sarcina
hitea as the test organism.
These experiments were performed in duplicate on the same group of volunteers, a
period of 3 weeks separating the first experiment from the second.
RESULTS
Hetacillin is rapidly hydrolyzed in aqueous solution. This is shown following the










Fig. 2. Conversion of hetacillin to ampicillin after incubation in agar gel. "Control" indicates
results obtained when samples were subjected to electrophoresis for 60 min and immediately overlaid
with nutrient agar seeded with Sarcina Intea. "Test" indicates results obtained when samples similar
to controls were subjected to a second electrophoresis after incubation at 30 for 16 hours but before
being overlaid with seeded agar.
ampicillin is clearly demonstrated (Fig. 2, Control). The results of subjecting a heta¬
cillin solution to high voltage electrophoresis, incubation of the plate for 16 hours
followed by further high voltage electrophoresis are shown in Fig. 2 (Test). All the
hetacillin has been converted to ampicillin. A comparison of equimolar solutions of
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TIME OF INCUBATION. [iN MINUTES.]
Fig. 3. Effect of temperature on in vitro hydrolysis of hetacillin in human plasma.
hetacillin and ampicillinby cup-plate assay demonstrated that both compounds gave
rise to zones of the same diameter. Tn view of this and the fact that hetacillin is
converted entirely to ampicillin during incubation on an agar gel plate, it is considered
justifiable to assay hetacillin samples against ampicillin standards.
Conversion of Hetacillin to Ampicillin in Plasma
The hydrolysis of hetacillin in plasma at three different temperatures is shown in
Fig. 3. Our results show that 50% hydrolysis of hetacillin occurs after approximately
25 min at 37°, 90 min at 20°, and more than 4 hours at 4°.
Plasma Levels in Man
The individual results for total antibiotic activity of hetacillin and ampicillin in the
plasma following intramuscular administration of 500 mg of hetacillin are given in
Tables 1 and 2.
The differences between cup-plate assay levels and total electrophoresis assay levels
were first tested for significance at each time point, by the paired / test. Each time point
was considered, where appropriate, for the two groups of 5 subjects and an overall
group of 10 subjects. For the groups of 5, only one showed significance at the 5% level
(160 min, group 2) and of the groups of 10, two showed significance at the 5% level
(80 min and 160 min), i.e., no more than expected. It should be noted that the signifi¬
cant results were all associated with positive values and the higher blood levels. Never¬
theless, no overall trend of the differences can be proved on the basis of these results.
It is therefore assumed that the electrophoresis technique does not show any bias.
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Having established the absence of bias, the ampicillin levels were calculated as a
percentage of the total level found in the electrophoresis technique, and paired t tests
for the two tests were carried out for each time point. Significance at the 5 % level was
found in only one instance (40 min). The mean percentage ampicillin levels are given
in Table 3.
TABLE 1
Cup-Plate Assay: Levels of Total Penicillin Activity in Human Plasma after
Intramuscular Administration of 500 mg Potassium Hetacillin
Concentration (/^g/ml)
Subject 10 min 20 min 40 min 60 min 80 min 160 min
First experiment
A 1.65 2.7 4.3 5.3 4.7 2.6
B 0.27 0.79 2.1 2.6 1.7 2.8
C 0.80 1.8 3.3 5.3 3.6 4.0
D 0.25 0.58 3.2 4.4 2.7 2.8
E 0.62 1.5 3.8 4.8 3.25 2.9
Mean 0.72 1.47 3.34 4.48 3.19 3.02
Mean total by 0.64 1.91 3.46 4.82 3.04 3.03
electrophoresis
Second experiment
A 2.5 2.9 4.3 7.8 6.8 6.4
B 1.0 1.3 1.8 2.4 2.7 4.6
C 1.8 2.2 4.0 6.8 8.3 7.2
D 1.9 2.2 3.5 4.6 5.0 7.0
E 2.0 2.7 4.1 6.0 8.5 8.0
Mean 1.84 2.26 3.54 5.52 6.26 6.64
Mean total by 1.60 2.14 3.55 —- 5.98 5.76
electrophoresis
DISCUSSION
Sutherland and Robinson (1967) and Bunn et al. (1965) have reported on total levels
ofantibiotic activity following intramuscular administration of hetacillin, and although
their results differ slightly both agree that the peak serum concentration occurs 2 hours
after injection. In our studies the peak antibiotic level occurs somewhat earlier.
Sutherland and Robinson (t967) also reported that most of the antibiotic activity
present in the blood was largely due to ampicillin, but no quantitative figures for this
conversion were quoted. By using the high voltage electrophoresis technique to
separate ampicillin and hetacillin in the plasma, we have assayed the respective
concentrations of the antibiotics and have found that at the peak blood concentration of
antibiotic, ampicillin could account for over 90%, and even 10 min after injection the
conversion was as high as 68%. Therefore, it can be concluded that the clinical effec¬
tiveness of hetacillin is due to ampicillin.
TABLE2
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TABLE 3
Parameters for the Mean Percentage AmpicillinLevel.
Based on 10 Results (5 Results in the Case of 60_Min)
Time
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TISSUE DISTRIBUTION OF PENICILLINS
D. M. Brown
Beecham Research Laboratories, Brentford, Middlesex.
While it is of obvious importance to determine
the antibacterial activity of a penicillin in the
blood it is perhaps of greater importance to
know what concentrations are present in the
extravascular fluids. In view of the current
interest in protein binding and its influence on
activity it is also of importance to determine
in what way binding influences distribution
throughout the body.
Usually methods for estimating tissue levels
of antibiotics have consisted mainly of grind¬
ing the tissue or organ in a homogeniser with
the appropriate buffer, spinning down the
debris and estimating the penicillins in the
supernatant. The total amount of penicillin
present is calculated and then expressed as
the amount per gram of tissue, wet or dry
weight. However these figures give very little
information about the actual tissue levels.
Depending on the vascularity of the organs
they may reflect largely the blood levels.
Alternatively, they may give quite erroneous
results due to specific concentration within the
organ, for example, the high levels found in
the liver and kidney merely reflect the high
concentration in the bile and urine. It
is highly improbable that there is specific¬
ally high concentration of the antibiotics
in the intracellular space of the liver
a"d kidney. Hence it is very difficult
to get a true figure for the amount of
penicillin in tissues. We therefore estimated
the concentration of penicillin in inflammatory
fluids and lymph which can be obtained in
adequate quantities for assay purposes. In
addition we determined the penicillin concentra¬
tion in granuloma tissue. For the studies,
four penicillins were selected—phenethicillin,
phenoxymethylpenicillin, cloxacillin and ampi-
cillin.
In order that all the results should pertain
to the one species the serum protein binding
was determined for each using rat serum by
the ultrafiltration technique. The assay pro¬
cedure was the cup plate technique using
Sarcina lutea as the test organism, the usual
precautions necessary for assaying in the
presence of protein being observed. (Table I).
Table I.






Since it is generally agreed that penicillin
combines reversibly only with the albumin
fraction of tissue protein, it was also of interest
to see if differences in the albumin content of
the body fluids could influence the penetration
from serum. We therefore estimated the total
amount of protein by the micro-biuret method
in the autoanalyser and the albumin/globulin
ratios were determined by electrophoresis. The
results are given in Table II.
Table II
Sample Total Protein Albumin/
gms. % Globulin Ratio
Rat Lymph. 3.2 1.33:1
Rat Peritoneal Fluid. 6.8 1.27:1

































Fig. 1.—Concentrations of Penicillins /ig./ml. in Blood and Inflammatory Peritoneal Fluid
of Rats following the Intramuscular Administration of 100 mg./kg. of the Penicillins.
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To estimate the concentration of penicillin
in inflammatory fluids groups of ten rats of
average weight 150 gms., ten per group, were
injected intraperitoneally with 0.1 ml. turpen¬
tine. Immediately afterwards the penicillin
being investigated was injected intramuscularly
into the left hind limb at a dose of 100 mg./kg.
At 1, 2, 4 and 6 hours afterwards the rats
were killed and the peritoneal fluid withdrawn,
a blood sample was also removed, and assayed.
The fluid was diluted with M/20 phosphate
buffer pH 7.2 for assay. The results are shown
in Figure 1.
The serum and inflammatory fluid con¬
centrations are similar with phenethicillin where¬
as the inflammatory fluid concentrations are
slightly higher than the blood levels with
phenoxymethylpenicillin and cloxacillin. How¬
ever ampicillin gives much higher levels in
the inflammatory fluid than the blood.
Irrespective of the degree of protein binding
one would expect equal concentrations of anti¬
biotics on either side of the capillary wall
provided one assumes that the capillaries func¬
tion as semi-permeable membranes and the
concentrations of protein in the serum and
intraperitoneal fluids are the same. Since the
total concentration of ampicillin is much
greater in the inflammatory fluid than the
serum, simple equilibrium conditions do not
appear to exist, and the concentrations found
would riot appear to be entirely dependant
on the degree of protein binding.
Further evidence that the degree of binding
to serum does not appear to influence penetra¬
tion into extravascular tissues was obtained
by studying the penetration of penicillins into
granuloma tissue. A cotton pellet was inserted
into the subcutaneous tissues in the axillary
region of rats and 4-5 days afterwards when
the granuloma around the pellet had formed,
injections of 100 mg./kg. of the penicillin were
given intramuscularly. The rats were killed
at 4, 1, 2, 4 and 6 hours afterwards. The
granuloma was removed, homogenised with
M/20 phosphate buffer pH 7.2 and the penicillin
assayed in the homogenate. A blood sample
was taken at each time period. Figure 2 shows
that in general the concentration per gram
granuloma is less than the blood concentration
but there is a considerable amount of fibrous
tissue present into which the penicillin cannot
penetrate. Flowever the amounts of phenoxy¬
methylpenicillin, phenethicillin and cloxacillin
present were similar in relation to the blood
levels but ampicillin which is the least protein
bound of the four penicillins penetrates much
less readily.
Finally we estimated the concentration of
penicillin in lymph. Werwey and Williams
(1962) have shown that lymphatic levels during
continuous intravenous infusion are in general
less than the corresponding serum levels, but
their method of administration is not one which
is normally employed clinically. We therefore
decided to study lymphatic levels following
intramuscular administration. Groups of five
rats were anaesthetised with pentobarbitone
and the thoracic lymph duct cannulated. The
penicillins were injected intramuscularly into
the left hind limb. Samples of lymph and
blood, which was taken from the tail vein,
were removed for assay at 1, 2 and 4 hours.
The levels obtained are given in Figure 3.
With phenoxymethylpenicillin, phenethicillin
and cloxacillin the levels in the lymph are
somewhat higher than those in blood while
the levels of ampicillin in lymph are much
greater than the corresponding blood levels.
It could be argued that since ampicillin is only
slightly protein bound that it diffuses more
rapidly from the site of injection than the other
penicillins which are more heavily bound. It
is then taken up in the lymph in much greater
concentration. Our experiments with inflam¬
matory fluids and granuloma tissue would
appear to show however that the combination
of penicillin and protein does not influence the
passage of the penicillin from one site to
another.
The albumin content of the peritoneal fluid
is slightly higher than serum while the content
of the lymph is much less even though the
albumin/globulin ratio is increased. It would
seem therefore that the higher total levels in
lymph and peritoneal fluid than blood are not
a consequence of an increased amount of
albumin in the tissues.
These results also suggest that the body is
not divided into a number of compartments
separated by semi-permeable membranes but
rather the division between each compartment
allows particular molecules to pass through
selectively. In other words it is possible to
obtain different concentrations in different
tissues irrespective of the albumin content on
either side of the dividing membrane.
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Fig. 2.—Concentrations of Penicillins in Granuloma Tissue /ig./gm. and Blood ^g./ml.
following Intramuscular Administration of 100 mg./kg. of the Penicillins to Rats.
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Fig. 3.—Concentrations of Penicillins /ig./ml. in Blood and Lymph following Intramuscular
Administration of 100 mg./kg. of the Penicillins to Rats.
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When comparing the properties of different
penicillins with a view to predicting their
therapeutic efficacy it is not only necessary
to know the concentration of penicillin in the
blood and the degree of binding to the serum
albumin, it is also necessary to know the levels
in the extravascular fluids and the degree of
binding to the albumin in these fluids.
REFERENCE
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microbial Agents and Chemotherapy, p. 476.
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The distribution of antibacterial agents
between plasma and lymph in the dog
P. ACRED, D. M. BROWN, B. F. CLARK* and LINDA MIZEN
Beecham Research Laboratories, Brockham Park, Betchworth, Surrey
Summary
1. Plasma, peripheral and thoracic lymph concentrations of penicillin V,
phenethicillin, carbenicillin, ampicillin, cloxacillin, penicillin G, chloram¬
phenicol and sulphadiazine were determined at various time intervals up to
6 h following intramuscular administration of 50 mg/kg to dogs.
2. Peak plasma concentrations of the penicillins occurred within half an hour
after administration with the peak lymphatic concentrations occurring 1-5 to
3 h afterwards. For the remaining period of the test the concentration in the
lymph exceeded the corresponding concentration in the plasma. Sulphadiazine
gave concentrations in thoracic lymph equal to the plasma concentration, but the
peripheral lymph concentrations were lower while the concentrations of chlor¬
amphenicol in both peripheral and thoracic lymph were always lower than the
plasma concentrations.
. 3. After the peak concentrations were reached, the concentration curves for
penicillins in lymph followed the same pattern as found in plasma, the penicillin
concentrations declining exponentially. Sulphadiazine produced more persis¬
tent levels both in lymph and in plasma while the concentrations of chloram¬
phenicol were still rising 6 h after administration.
4. The free concentrations of penicillin in lymph were equal to the free con¬
centrations in plasma, whereas the concentrations of free sulphadiazine and
chloramphenicol in lymph were less than those in the plasma.
Introduction
Since bacterial infections are normally localized and confined to specific sites
within the body, it is perhaps of greater importance to know the concentrations of
antibiotic at these sites rather than the corresponding blood levels. In audition,
since it is generally agreed that the protein bound fraction of the antibiotic is
inactive the concentration of the free antibiotic in the extravascular fluids should
also be known. There have been only a limited number of studies carried out to
determine free antibiotic levels in infected tissues because it is technically difficult
to get sufficient fluid from such a site to carry out the assays. According to Yoffey
& Courtice (1956) there are only minor differences in the composition of peripheral
lymph and interstitial fluid from which it is derived. We have therefore carried out
experiments to determine the relationship between plasma and peripheral lymph
* Present address: Imperial Cancer Research Fund, Lincoln's Inn Fields, London, W.C.2.
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concentrations of some antibacterial agents and have noted the effect of serum
protein binding on the distribution in blood and extravascular tissues.
Methods
Drugs
The following chemotherapeutic agents were used: cloxacillin (Orbenin, Beecham
Research Laboratories) was used as the sodium salt, phenethicillin (Broxil,
Beecham Research Laboratories) as the potassium salt, phenoxymethylpenicillin
(Penicillin V, Eli Lilly & Co. Ltd.) as the potassium salt, ampicillin (Penbritin,
Beecham Research Laboratories) as the sodium salt, benzylpenicillin (Crystapen,
Glaxo Laboratories Ltd.) as the sodium salt, carbenicillin as the sodium salt
(Pyopen, Beecham Research Laboratories), chloramphenicol (Chloromycetin,
Parke Davis & Co.) and sulphadiazine (May & Baker Ltd.).
Solutions of the penicillins were prepared in normal saline. Chloramphenicol
solutions were prepared by dissolving the compound in absolute ethanol and
making up to volume with normal saline. The resulting solution contained 10%
ethanol. The solution of the sulphonamide was prepared by dissolving the agent
in 1 n NaOH, neutralizing with 1 n HC1 and making up to volume with normal
saline.
Doses
Groups of two or three greyhounds (20-30 kg body weight) were used. The
compounds were administered intramuscularly into the left hind leg muscle at a
dose of 50 mg/kg.
Samples of blood and lymph for assay were taken at 0-5, 1, 2, 3, 4, 5 and 6 h
following administration. All samples were stored at 4° C until assayed.
Sways'
Penicillins and chloramphenicol were determined in the samples by the hole-plate
technique ; Sarcina lutea was used as the test organism. The plates were incubated
overnight at 29° C. In the assays in which the samples were used undiluted, the
solutions for the standard curve were prepared in the same fluid as the test specimen,
blood or lymph. When specimens required dilution they were assayed against the
standard prepared in saline. The zone diameter (mm) of each standard solution
was plotted against the logarithm of the concentration (ixg/ml) and from the
regression line obtained the concentration of the antibiotic in the sample was esti¬
mated by interpolation. Concentrations appearing in plasma were calculated
assuming a packed cell volume of 40%. Studies previously carried out had indica¬
ted that none of the compounds used in these experiments penetrated red cells or
were bound to cells.
The free and total sulphonamide content of the sample was determined using
the colorimetric method of Bratton & Marshall (1939).
Protein content
The total protein content (g/100 ml) of lymph and serum was determined by the
biuret method. The albumin/globulin ratio was determined by the cellulose acetate
electrophoresis technique. 10 /J quantities of the samples were spotted onto the
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cellulose strips and a constant current of 0-6 mA/cm width was applied for 3 h.
The buffer used was 0 06 m barbitone, pH 8-6. The strips were stained with
Ponceau " S " (0-2% in 3% trichloracetic acid) and were scanned by transmitted light
using a Cliromoscan densitometer.
UltrafHtralion
The amount of binding of the compounds to proteins was determined by ultra¬
filtration. Samples of lymph and serum were obtained from a number of dogs
and pooled. The pooled samples, stored at 4° C, were kept for a maximum period
of 2-3 days before use. The pH of the samples was checked before each experiment
and where necessary adjusted to pH 7-2-7-4 by bubbling CO, through the specimen.
Concentrations of the chemotherapeutic agents of 40 /.ig/ml were prepared in both
serum and lymph, and 2-0 ml samples were placed into 8/32 inch Visking tubing
which was suspended in a tube 3 inches x 1 inch. The pressure in the tube was
reduced to 15 mmHg (1 mmHg=1-333 mbar) and the system was sealed to prevent
evaporation of the filtrate. The filtrate volume was never allowed to exceed 10%
of the original solution for filtration. Control experiments were carried out with
aqueous solutions to confirm that free passage of the compounds through the mem¬
brane occurred in the absence of protein. All experiments were carried out at
room temperature (20°-24° C) over a maximum period of 90 min. The filtrate
was assayed and the binding of the compounds to serum and lymph was calculated
using the following formula :
Initial concentration /.ig,/ml—filtrate concentration ^g/mlxl00
,/obinding Initial concentration ,ug/ml
Collection of lymph
The method used for the collection of peripheral lymph was similar to that de¬
scribed by Smith, Dunton, Protas, Blocker, Cooley & Lewis (1959) and Verwey &
Williams (1962a, b).
The dogs were anaesthetized intravenously with pentobarbitone sodium (veterin¬
ary Nembutal) 30 mg/kg. The right hind paw lymphatics and the thoracic duct
were cannulated as follows:
(a) Peripheral lymph. The skin on the dorsal surface of the paw was shaved and
an area 5 x 2-5 cm carefully removed from a region extending forward from the base
of the metatarsals. To render the lymphatics clearly visible 0-1 ml of Evans Blue
dye (0-1%) was injected into the subcutaneous spaces between the metatarsals.
About 1 cm of one of the larger paw lymphatic vessels was dissected free and
cannulated with a No. 12 hypodermic needle (23 gauge) from which the mount had
been removed. It was carefully secured and a length of polythene tubing (Portex
polythene No. 46, 0 8 mm external diameter) was then attached. The lymph was
collected in tubes containing 20 i.u. of heparin. Collection from the peripheral
lymph vessel on the side of the animal opposite the injection site was carried out
since the concentration of the antibacterials in the lymph on the injected side could
be influenced by drainage from the site of injection. Volumes of peripheral lymph
up to 1 ml/h were collected.
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([b) Thoracic lymph. A median longitudinal incision through the skin of the
ventral surface of the shaved neck of the dog was made, the trachea and left carotid
artery exposed, and a respiratory cannula inserted. At the junction of the sub¬
clavian, jugular and common jugular veins the anastomosis of the lymphatic system
with the venous system was located. At the anastomosis, lymphatic vesels from the
head and left foreleg meet together with the thoracic lymph duct, which ascends
from the thoracic region and is identified as a flattened thin walled translucent
vessel. The duct was carefully freed from the surrounding tissues and cannulated
with a polythene cannula 1-7 mm external diameter. Lymph which flowed freely
along the duct was collected in tubes containing heparin (0 05 ml, 1,000 i.u./ml). A
mean thoracic lymph flow of 23-6 ml/h was produced.
Results
Protein concentration
The total protein content of serum, thoracic and peripheral lymph in g/100 nil
and the albumin globulin ratios are given in Table 1. The electrophoretic studies
showed that all the plasma proteins were present in the lymph, but at lower con¬
centrations. The lymph values are in good agreement with reported results (Field,
Leigh, Heim & Drinker, 1934—1935 ; Glenn, Gresson, Bauer, Goldstein, Hoffman
& Healey, 1949 ; Nix, Mann, Bollman, Grindlay & Flock, 1951 ; Courtice & Morris,
1955 ; Verwey & Williams, 1962a, b).
Protein binding
The degree of binding of the antibacterial agents to serum and lymph proteins is
shown in Table 2.
The binding to the serum protein decreased in the following order: phenethicillin,
cloxacillin, penicillin V,- chloramphenicol, penicillin G, sulphadiazine, carbenicillin
and ampicillin. The amount of drug bound to protein in the serum, thoracic and
peripheral lymph depended on the protein content of these fluids. The decrease























table 2. Percentage ofdrug bound to protein in serum, thoracic and peripheral lymph, as determined
by ultrafiltration
Thoracic Peripheral
Compound Serum lymph lymph
Phenethicillin 65-5 58-0 11-1
Cloxacillin 64-5 59-2 36-9
Penicillin V 63-9 55-7 6-3
Penicillin G 33-4 341 21-6
Carbenicillin 4-7 0 0
Ampicillin 3-5 0 0
Chloramphenicol 361 36-8 21-0
Sulphadiazine 21-7 230 6-4
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in the binding in the peripheral lymph is therefore due to the lower protein content.
The results obtained for the penicillins are in good agreement with those reported
by Verwey & Williams (1962b). The percentage protein binding of sulphadiazine
to dog serum is in close agreement with that reported by Anton (1960).
Concentration of antibacterial agents in plasma, peripheral and
thoracic lymph
The total concentrations of the antibacterial agents appearing in the three body
fluids following intramuscular dosing are shown in Table 3. The free (unbound)
concentrations (Table 4) were calculated by deducting from the total concentration
the fraction bound as estimated by the ultrafiltration experiments.
Since two to three animals were used for each estimation, only the mean anti¬
bacterial concentrations have been quoted. The majority of individual values were
within 20% of the mean, but a few values varied by as much as 50%. Within
these limits the penicillins gave similar concentration patterns in the plasma,
thoracic and peripheral lymph, the peak plasma concentration occurring 0-5-2 h
after dosing, and the peak lymphatic concentration occurring 1-3 h after dosing.
Following the peak values the total thoracic and lymphatic concentrations for the
penicillins and sulphadiazine were of the same order as the plasma. The total
plasma concentration for chloramphenicol, however, was greater than the lymphatic
concentration and did not follow the same pattern as that of the penicillins. The
concentration with this antibiotic was still increasing 6 h after the time of
administration.
The concentration of free penicillin in the lymph was generally in excess of the
plasma following the peak plasma concentration. The free levels of sulphadiazine
in thoracic lymph were of the same order as those found in plasma, but the free
concentrations in peripheral lymph were less. The free concentrations of chlor¬
amphenicol in peripheral and thoracic lymph were less than the plasma
concentration.
Discussion
Estimates of the amount of drug passing from the blood into the tissues have in
many previous studies been made by determining drug concentrations in macerated
organs. The results obtained by this method can be misleading, however, owing to
the presence of blood in the tissue, and therefore the apparent concentration of anti¬
biotic in the tissue can vary with the vascularity of the particular tissue. Extra-
vascular tissue fluids are, however, difficult to obtain in sufficient quantities for assay,
but Yoffey & Cortice (1956) consider that peripheral lymph, which can be obtained
in adequate quantities uncontaminated by blood, is very similar to extravascular
fluids. Schachter (1948) was the first to determine the concentration of penicillin G
in the lymphatic system of dogs following intramuscular and intravenous administra¬
tion. He found that penicillin persisted in the thoracic lymph longer than in the
blood, but that the peak concentration following intramuscular dosing was less than
in blood. A more recent study was made by Verwey & Williams (1962a, b), who
determined the concentrations of a number of penicillins in peripheral lymph during
constant intravenous infusion in dogs. These authors found that the amounts of
the penicillins free in lymph were very similar to the amounts free in plasma and
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table 3. Mean total concentration (jig/ml) of antibacterials appearing in plasma, thoracic and peri¬







Compound Concentration (fig/ml) at hours after administration
0-5 10 20 3 0 4-0 5-0 6-0
Cloxacillin 16-7 11-7 7-8 60 4-5 4-0 3-3
Phenethicillin 8-0 13-2 140 110 8-8 6-7 6-2
Penicillin V 8-7 7-0 7-2 6'5 4-3 3-2 2-7
Penicillin G 58-7 65-8 39-2 22-5 15-7 10-5 5-0
Carbenicillin 70-25 430 18-5 7-2 5-5 3-25 0
Ampicillin 14-7 15-8 12-5 9-2 5-2 4-0 3-5
Chloramphenicol 10-7 10-0 11-8 15-3 14-3 14-2 20-0
Sulphadiazine 19-2 16-7 16-6 20-0 16-7 14-7 —
Cloxacillin 0-7 3-6 6-3 4-7 2-5 2-8 1-7
Phenethicillin 1-9 5-0 8-2 8-0 4-7 4-1 3-8
Penicillin V 0-9 2-7 3-7 4-5 3-4 2-4 1-8
Penicillin G 8-9 33-0 37-5 22-5 16-7 11-0 4-2
Carbenicillin 4-5 25-5 32-5 14-7 6-9 5-8 —
Ampicillin 4-4 9-7 10-6 8-9 8-7 5-6 —
Chloramphenicol 2-3 6-5 6-7 6-5 7-6 11-8 14-0
Sulphadiazine 20 3 0 8-0 140 130 10-0 4-0
Cloxacillin 4-8 11-1 9-3 6-8 7-2 3-2 2-5
Phenethicillin 0-6 5-4 11-5 13-8 11-9 7-9 7-1
Penicillin V 1-2 7-8 100 6-6 5-0 3-3 1-8
Penicillin G 23-5 46-5 31-5 27-0 18-6 11-2 6-9
Carbenicillin 15-5 680 500 21-75 6-3 4-6 4-3
Ampicillin 5-3 17-2 19-3 12-9 9-2 6-8 6-7
Chloramphenicol 2-5 60 7-7 8-9 9-3 8-7 13-0
Sulphadiazine 5-5 16-5 21-5 16-5 19-0 21-3 18-8
table 4. Calculated free concentrations (pg/ml) of antibacterials in dog plasma, peripheral and
thoracic lymph






0-5 1-0 2-0 3-0 4-0 . 5-0 6-0
Cloxacillin 5-9 4-2 2-8 2-1 1-6 1-4 1-2
Phenethicillin 1-3 4-6 4-8 3-8 3-0 2-3 2-1
Penicillin V 3-1 '2-5 2-6 2-4 1-6 1-2 0-97
Penicillin G 39-1 43-8 28-2 15-0 10-5 7-0 3-4
Carbenicillin 66-9 40-9 17-6 6-8 5-2 3-1 0
Ampicillin 14-2 15-2 12-1 8-9 5-0 3-9 3-4
Chloramphenicol 6-8 6-4 7-55 9-8 9-15 9-1 12-8
Sulphadiazine 15-0 13-1 13-0 15-7 13-1 11-5 —
Cloxacillin 0-4 2-3 4-0 3-0 1-6 1-8 1-1
Phenethicillin 1-7 4-4 7-3 7-1 4-2 3-6 3-4
Penicillin V 0-8 2-5 3-5 4-2 3-2 2-2 1-7
Penicillin G 7-0 25-9- 29-4 17-6 13-1 8-6 3-3
Carbenicillin 4-5 25-5 32-5 14-7 6-9 5-8 —
Ampicillin 4-4 9-7 10-6 8-9 8-7 5-6 —
Chloramphenicol 1-8 5-1 5-3 5-1 6-0 9-3 11-1
Sulphadiazine 1-9 2-8 7-5 13-1 12-2 9-4 3-7
Cloxacillin 2-0 4-5 3-8 2-8 2-9 1-3 1-0
Phenethicillin 0-25 2-3 4-8 5-8 5-0 3-3 3-0
Penicillin V 0-5 3-4 4-4 2-9 2-2 1-5 0-8
Penicillin G 15-5 30-6 20-8 17-8 12-3 7-4 4-55
Carbcnicillin 15-5 68-0 50-0 21-75 6-3 4-6 4-3
Ampicillin 5-3 17-2 19-3 12-9 9-2 6-8 6-7
Chloramphenicol 1-6 3-8 4-8 5-6 5-9 5-5 8-2
Sulphadiazine 4-2 12-7 16-55 12-7 14-6 16-4 14-5
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they concluded that " the concentration of free penicillin in plasma may be a prac¬
tical and conservative estimate of the free penicillin concentration in interstitial
fluid Chisholm, Calnan & Waterworth (1968) determined the concentrations of
nitrofurantoin, gentamicin and carbenicillin in plasma, thoracic and renal lymph of
dogs. The thoracic lymph concentrations of carbenicillin were found to be in
equilibrium with those in plasma 0-5-2 h after intramuscular administration of 20
mg/kg of the penicillin. Peak plasma concentrations were approximately twice the
peak thoracic lymph concentrations. In some initial experiments with " tissue cage
fluid " these authors found that carbenicillin was still present in the fluid even after
the penicillin could not be detected in the plasma. In a preliminary communication
(Brown, 1964) we reported on the concentrations of penicillin V, phenethicillin,
cloxacillin and ampicillin appearing in the thoracic lymph and whole blood of rats
following intramuscular administration of 100 mg/kg. The lymph concentrations
were found to be higher than the whole blood concentrations ; however, recalcula¬
tion to give the plasma concentrations, allowing for the packed cell volume of the
blood, showed the concentrations in the thoracic lymph to be lower than those in
plasma apart from ampicillin, for which the thoracic lymph and plasma concentra¬
tions were approximately equal. The results of our experiments in which single
intramuscular injections of the antibacterial were administered to dogs are in good
agreement with those of Chisholm et al. (1968) and Verwey & Williams (1962a, b)
and indicate that penicillins, even those which are highly bound to plasma proteins,
penetrate well into extravascular spaces. This observation is supported by other
workers (Abraham, Chain, Fletcher, Florey, Gardner, Heatley & Jennings, 1941 ;
Brown, 1964 ; Florey, Turton & Duthie, 1946 ; Jawetz, 1946 ; McCune, 1960 ;
Nathanson & Liebhold, 1946 ; Ungar, 1950 ; Weinstein, Daikos & Perrin, 1951 ;
Werner, Knight, McDermott, Adams & Dubois, 1954 ; White, Lee & Alverson,
1946).
Our experiments therefore indicate that penicillins penetrate readily from plasma
to extravascular fluids as represented by peripheral lymph, thereby achieving good
antibacterial concentrations of the free active penicillins in the tissues. The extent
of binding does not appear to influence the transfer from plasma to interstitial fluid
and equilibrium between free concentration in plasma and free concentration in
peripheral lymph is achieved. The two non-penicillin antibacterials, sulphadiazine
and chloramphenicol, do not pass so readily from plasma to extravascular fluids,
possibly indicating a less readily dissociable protein/antibacterial combination.
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EXCRETION OF PENICILLINS INTO URINE AND BILE
The elimination of these compounds by excretion into
urine and bile is an important factor to be considered in evaluating
their therapeutic use. Consequently, the urinary and biliary
excretion patterns of several 6-aminopenicillanic derivatives
have been investigated and preliminary studies of seme of the
factors which influence the excretion patterns have also been
carried out.
Materials and Methods
In all experiments, the penicillins were administered as
their sodium salts, all doses being given in terms of the pure
compound. The antibiotics were assayed by the cup plate technique
using sarcina lutea as the test organism. The zone diameters
obtained for the control dilutions of antibiotics were plotted
against the logarithm of the concentration; and from the regression
line obtained, the concentrations of the antibiotics in the
specimens were estimated by interpolation. The appropriate
dilutions of the controls and samples were made in phosphate
buffer pH 7.0 (M/20) except in experiments where blood concentrations
were determined, in which case, controls were prepared in blood.
Urinary Excretion in Rats
100 mg/kg doses of the penicillins were administered either
subcutaneously or orally to groups of 6 male albino rats deprived of
food overnight of weight range 300-400 g. Urine formation was
promoted by oral administration of 2 mis warm tap water for each
100 g weight of rat.
The animals were housed in pairs in metabolism cages
supported over glass urine-collecting funnels and allowed drinking
water ad lib. Urine was collected in sterile tubes cooled in iced
water.
Anaesthesia
In some experiments conscious animals were compared with
anaesthetised rats which had received intraperitoneal injections




Urine was collected from rats injected intramuscularly
with 100 mg/kg ampicillin and subjected to various forms of stress:
(i) Cannulation of bile duct and restraint in close fitting
wire cages,
(ii) cannulation without restraint, and
(iii) isolation in metabolism cages.
Biliary Excretion in Rats
Groups of 6 rats deprived of food overnight (v/t. 300-400 g.)
were anaesthetised with ether. After laparotomy, the bile duct was
cannulated with polythene tubing (0.4 mm internal diameter). On
recovery from anaesthesia, 100 mg/kg doses of penicillin were
administered orally or intramuscularly. The bile was collected at
intervals in sterile tubes cooled in iced water.
Influence of Anaesthesia and Weight in Blood Concentrations
Two groups of 6 male rats deprived of food overnight
(wt. 300-400 g) were injected intraperitoneally with 60 mg/kg
pentabarbitone in 0.5 ml normal saline. Each animal then received
100 mg/kg methicillin intramuscularly. 0.1 ml blood samples were
taken from the tail vein at intervals up to 6 hours and mixed with
0.1 ml normal saline containing 100 units heparin.
Sixteen conscious rats of weight range 210-360 g received
100 mg/kg methicillin intramuscularly. Blood samples were taken at
intervals up to 6 hours.
RESULTS
Urinary Excretion in Rats
Oral Administration - Table 1. 20-25/S of cloxacillin
and Penicillin V were recovered in the urine within 24 hours. Only
4% of ampicillin was recovered within this period.
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Effect of Anaesthesia:
The influence of anaesthesia on urinary excretion is
demonstrated, by the effect of pentabarbitone sodium on the excretion
of intramuscular methicillin. (Table 2). Over 6 hours the mean %
recovery for conscious rats was 51«S^> and from anaesthetised rats,
69.4%. The difference was not statistically significant. During
the first hour of the experiment, no urine was voided by the
anaesthetised animals.
Effect of Stress:
The recovery of ampicillin in the urine of rats under
stress is shown in Table 3. Close restraint and cannulation caused
a reduction in the amount of ampicillin recovered. Isolation in
metabolism cages reduced the urinary recovery to a lesser extent.
Paired animals gave the greatest output of penicillin.
Biliary Excretion in Rats
The percentage recovery of penicillins in the bile
following oral administration is shown in Table 4.
Influence of Anaesthesia and V/eight on Blood Concentrations
Pentabarbitone anaesthesia depressed the blood concentrations
of methicillin reached after intramuscular administration of 100 mg/kg
(Figure l). Peak concentrations which occurred during the first
hour after injection, were reduced by about 40^. Subsequently the
concentration in the blood of the anaesthetised rats fell at a
slower rate than in the conscious animals.
Peak blood concentration of methicillin varied with the
weight of the rat injected. Large rats of about 300 g gave peaks
which were approximately double -that of animals at the lower end




Oral absorption of penicillins in the rat is poor.
About 30% of Penicillin V and cloxacillin is recovered in the
urine (20%) and bile (10%) while only about 4% of ampicillin is
recovered in the urine and 4% in the bile. The bile would
therefore appear to be an important route of elimination in the
rat.
Anaesthesia depresses the blood concentration but the
overall quantity of antibiotic excreted in the urine is
unaffected in spite of an initial lag period where little or no
urine is formed as a result of the anaesthetic.
Other factors influencing blood concentration are:-
(i) weight, where "the heavier the animal results in
higher blood concentrations,
(ii) stress, where the influence of an operative procedure
or a psychological stress in having the animals alone
results in significantly lower blood concentrations.
TABLE 1
Excretion of Penicillins into Rat Urine
100 mg/kg doses of penicillins administered orally to rats.
Urine collected over the following 24 hours. Results express
as mean % of dose recovered from urine of 12 animals.
Penicillin % of dose recovered





Recovery of Methicillin in Urine of Conscious and
Pentabarbitone Anaesthetised Rats
Mean % recovery of methicillin in urine of groups of 10 rats
over 6 hours after intramuscular administration of 100 mg/kg
CONSCIOUS
Mean Rat








304 7.7 11.3 10.3 17.0 5.6 51.9
ANAESTHETISED 305 - - 18.8 45.0 5.6 69.4
TABLE 3
Percentage recovery of 100 mg/kg intramuscular
ampicillin in urine of rats subjected to stressing
experimental conditions








Free and bile duct
cannulated
12 single A4.3
Free 12 single 64.0
Free 12 paired 86.0
TABLE 4
Mean percentage recovery of penicillins in bile over 6
hours following oral administration of 100 mg/kg to
groups of 6 rats
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25. Teratogenicity of Diphenylhydantoin in Swiss-Webster and AjJax Mice. J. E. Gibson and
B. A. Bicker, Department of Pharmacology, College of Medicine, University of Iowa,
Iowa City, Iowa.
Diphenylhydantoin increases incidence of cleft palate in A/Jax mice, which are genetically
prone to that malformation. The purpose of this study is to evaluate diphcnylhydantoin-
induced teratology including cleft palate in a nonprone mouse strain. Diphcnyihydantoin,
50 mg/kg, sc, was administered to primigravid Swiss-Webster and A/Jax mice during early
(days 7, S, 9) and late (11.12,13) cmbryogencsis. Litters were delivered by cesarean section on
gestational day IS, weighed, examined, and measured. Resorption rales were not altered in
either strain treated during early cmbryogencsis. A/Jax, but not Swiss-Webster, mice treated
during late cmbryogencsis had a significant (P < 0.05) increase in resorptions in treated
w A/Jax control mice. Diphenylhydantoin resulted in reduced fetal weight in both strains
when given during late cmbryogencsis. Fetal long-bone-length, measured in alizarin red-stained
preparations was shortened only in latc-trcatcd Swiss-Webster mice. The incidence of cleft
palate, corrected for cleft palate occurring with cleft lip, was significantly elevated in late, but
not early, treated progeny of both strains: Swiss-Webster (7/46) and A/Jax (8/26) vs 0/37 and
1/24 for the respective controls. Cleft palate with cleft lip occurred only in A/Jax mice; the
rate was not different from vehicle-treated controls. No other soft tissue malformations were
found in either strain following Bourn's fixation and freehand cross-section examination. In
summary, diphenylhydantoin produced micromelia and cleft palate in Swiss-Webster mice,
which arc not genetically prone to cleft palate.
¥
26. 'Effect of Antibiotics upon Pregnancy in the Rabbit. D. M. Brown, K. H. Harper, A. K.
Palmer, and S. A. Trsrt, Beecham Research Laboratories, Betchworth, Surrey, England,1
and Huntingdon Research Centre, Huntingdon, England.
Previous communications to this Society [Gray and Lewis, Toxicol. Appl. Pharmacol. 8,
342 (1266); Madissco <7 ah. ibid. 10. 379 (i 967)] dealt with the lethal and abortifneient actions
of amniotics in pregnant rabbits. Studies in our laboratories have confirmed and extended
these observations with a. number of antibiotics.
Tetracycline and penicillins in general proved the most toxic, therefore meaningful terato¬
genicity data could not be achieved with conventional tests. Chloramphenicol, polymyxin B,
colomycin. and cycloserine, on the other hand, were well tolerated.
Because of I he probable role of the gut flora in determining the effect of antibiotics it was
suggested that the suckling rabbit, known to have an incomplete flora, might be conditioned
to a particular antibiotic by gradually increasing the dosage, thus providing '"antibiotic
tolerant" adults for teratogenic studies.
To test this hypothesis, groups uf weanling New Zealand White rabbits were treated with
Pen G, Pen V, cloxacillin, dicloxacillin, mcthiciiiin. or tetracycline at an initial daily dosage
of 10 mg/kg increasing weekly by 10 mg/kg until a dosage of 100 mg/kg was reached; this
was maintained through mating and gestation.
Although some animals died before the dose reached 100 mg/kg, survivors were able to
support pregnancy; there was no increased incidence of abortion and no evidence of a tera-
togenic action. There was some evidence of embryonic death related to maternal condition.
It is felt therefore that abortifacient and cmbryotoxic response to penicillins and tetracycline
relates to the deterioration in maternal condition rather than to direct action on lite embryo.
27. Development ofMouse Populations for Use in Toxicology. £. D. Palmes and J. DelPup,
Institute of Environmental Medicine, New York University Medical Center, New York,
New York.
An attempt was made to develop mouse populations which could be used as test objects in
toxicity studies, ft was possible to breed and maintain four populations of 400 mice each living
at a population density of about 1 mouse per 4 square inches. Females are removed from
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(received may 13, 1957)
A series of esters of l-alkyl-2-hydroxyalkylpyrrolidine and their quaternary derivatives have
been shown to possess significant anti-acetylcboline activity. The benzilic acid esters were the
most active, followed by xanthene-9-carboxylic acid, fluorene-9-carboxylic acid and diphenylacetic
acid esters in that order. The quaternary derivatives were more active than their corresponding
tertiary compounds both in vivo and in vitro. The most active compound of the series tested
in vivo was (1 -methylpyrrolid-2-vl)methyl benzilate methiodide and was as potent as atropine.
There was a progressive decrease in anti-acetylcholine activity and a proportional increase in
local anaesthetic activity as the number of carbon atoms was increased from 1 to 3 in the pyrrolidyl
side-chain of the tertiary salts of the benzilic acid ester series. Likewise increasing the size of the
group on the nitrogen atom led to a decrease in anti-acetylcholine activity and an increase in
local anaesthetic activity. Quaternization of the tertiary salts resulted in a loss of local anaesthetic
activity. Most of the compounds tested possessed some antihistamine properties, while papa-
verine-Like activity was confined to the tertiary salts only. No significant neuromuscular blocking
activity was evident.
There have been numerous attempts to modify
the structure of atropine with a view to minimiz¬
ing its undesirable side effects, and many simple
esters have been prepared which have shown anti-
acetylcholine activity. This paper describes the
pharmacology of the esters of pyrrolidyl alcohols
synthesized by Doyle, Mehta, and Sach (unpub¬
lished observations). Of these compounds only the
benzilic and diphenylacetic acid esters of 1-methyl-
2-hydroxymethylpyrrolidine have previously been
reported (Blicke and Lu, 1955).
Methods
Tests in Vitro
Anti-acetylcholine Action. — Segments, approxi¬
mately 2 cm. long, were removed from the lower
ileum of young guinea-pigs weighing not more than
250 g. and suspended in oxygenated Tyrode solution
at 37° in a 5 ml. bath. Acetylcholine (ACh), which
was allowed to act for 30 sec., was added at 2 min.
intervals until constant responses were obtained. The
doses of atropine and test compound were added 30
sec. before ACh and were adjusted so that the ACh
response was reduced to approximately 30% and 70%
of the original. Between the successive doses of anta¬
gonist the ACh response was allowed to return to
normal. A 16-point assay was then performed using
a Latin square design (Fisher and Yates, 1953) and
the results analysed by the procedure of Schild (1942).
Segments 2 to 3 cm. long, cut from the mid-portion
of the jejunum of young rabbits weighing approxi¬
mately 1.5 kg., were suspended in Tyrode solution at
37°. An identical statistical procedure to that used for
the guinea-pig ileum anti-ACh assay was employed.
A 4 min. cycle was used. The antagonist was added
60 sec. before the ACh. Fresh rabbit jejunum often
gave irregular responses to ACh for the first 1 or
2 hr. ; regular responses were obtained more rapidly,
without loss in sensitivity or accuracy, w.;,h gut which
had been stored for 18 hr. at 7°.
Antihistamine Action.—Preparations of guinea-pig
ileum were made as for the anti-acetylcholine test.
Histamine was added at 90 sec. intervals until the
responses were regular. The antagonist was then
added to the bath 30 sec. before the histamine and
the depression in responses compared with that ob¬
tained by a standard antihistamine drug. If the acti¬
vity of the unknown exceeded that of the standard, a
16-point Latin square design assay was performed.
Papaverine-like Activity.-—A strip of rabbit je¬
junum 2 to 3 cm. long was suspended in Tyrode solu-
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tion at 37° in a 5 ml. bath. Spasm was induced with
barium chloride (250 /<g./ml.) and the spasmolytic
added 2 min. later, while the barium chloride was still
present. The compound was allowed to act for a
further 2 min. and then washed out. The degree of
relaxation of the barium spasm produced by the com¬
pound under test was compared with that produced by
papaverine HC1. Two further washings were per¬
formed at 5 min. intervals during the 15 min. cycle
employed.
Curare-like Activity.— The rat phrenic nerve:
diaphragm preparation, as described by Biilbring
(1946), was used.
Langeitdorff Heart.—The heart from a guinea-pig
weighing approximately 400 g. was removed under
ether anaesthesia and connected by an aortic cannula
to a perfusion system. Oxygenated Locke solution
containing NaHCCE 0.5 g./l. was allowed to flow
through a warming coil to the heart. The perfusion
pressure was maintained between 60 and 70 cm. water.
Drugs were injected in 0.05 to 0.1 ml. Locke solution
close to the heart. The amplitude and frequency
were recorded and the rate of coronary outflow was
measured by a Gaddum drop recorder.
Tests in Vivo
Acute Toxicity.—Acute intravenous toxicities were
estimated in male albino mice (18 to 22 g.); 10 mice
were used with each dose and the results were analysed
according to the method described by Finney (1952).
A nti-acetylcholinc A ction on Cat Blood Pressure.—
The method of Kiihl (1925) was used. Cats were
anaesthetized with ether followed by chloralose-
urethane mixture (40 mg./'kg. chloralose, 160 mg./kg.
urethane intravenously). Blood pressure recordings
were made from the carotid artery and injections were
made through a polythene cannula inserted into the
femoral vein. "The compounds were dissolved in
saline.
A dose of ACh (0.5 to 1.0 ,«g.), which gave a just
submaximal depression in blood pressure, was admini¬
stered intravenously at 2 min. intervals until a regular
depression of the blood pressure was obtained. The
% depression of the ACh response caused by a small
intravenous dose of spasmolytic given 1 min. pre¬
viously was measured and matched with that caused
by a dose of atropine (0.2 to 5.0 ,"-g.). Small doses
were employed so that recovery was rapid and several
compounds could be assayed on each animal. Each
drug was tested on several animals and the results
averaged.
Intestinal Motility.—Decerebrate cats were used. A
midline stab incision was made in the abdomen. The
intestine was drawn out through the incision and glass
cannulae were inserted into the duodenum and je¬
junum or ileum. The cannulae were bent at right
angles so that when in position the longer arm was
vertical. A ligature was tied round the intestine 5 to
10 cm. from the cannula and the loop was filled with
liquid paraffin to give an internal pressure of about
10 cm. water. The cannula was connected to an air
tambour and the intestine replaced in the abdominal
cavity. Handling of the intestine was reduced to a
minimum. After 2 to 3 hr., when the effects of the
anaesthetic had worn off, kymographic recordings of
intestinal movements were made. Compounds were
injected intravenously in saline through a cannula
inserted in the femoral vein.
Anti-acetylcholine Activity on Guinea-p'g Colon.-—
Guinea-pigs were anaesthetized with urethane (2 g./kg.
subcutaneously), and a cannula was tied into the colon.
Carbachol (1 to 2 ,«g./guinea-pig) was injected intra¬
venously, at 3 to 5 min. intervals, through a cannula
in the jugular vein until the intestine responded regu¬
larly by contraction. A single dose of compound was
administered intravenously and two further injections
of carbachol were made. If there was no response
to these, the drug was considered to be active at the
dose given. From 2 to 6 animals were used at each
dose level. The activity was expressed in terms of
minimal effective dose.
Mydriatic Activity.--Assays for mydriatic activity
were carried out on the mouse according to the
method of Pulewka as used by Ing, Dawes, and Wajda
(1945). The pupil diameter was measured in arbitrary
units with the aid of a micrometer scale set in the
eyepiece of a dissecting microscope (x 10). Com¬
pounds were given subcutaneously or orally to groups
of 5 mice (18 to 22 g.). The pupil diameter was
measured at 5 min. intervals over a period of 30 min.
Atropine was used as a standard. The results were
assessed at the time of maximum activity, which was
usually 20 min. after administration.
Local Anaesthetic Activity.—The intradermal weal
method described by Biilbring and Wajda (1945) and
modified by Somers and Edge (1947) was used to deter¬
mine local anaesthetic activity. Guinea-pigs weighing
400 to 450 g. were employed.
A modification of the corneal reflex method de¬
scribed by Chance and Lobstein (1944) was also used.
Three dose levels of both test and standard compound
were employed and 2 guinea-pigs were used for each
dose. The solutions of the compounds were made
in phosphate buffer at pH 7.3. The standard (pro¬
caine HC1) solution was applied to one eye and the
test solution to the other. The cornea wax then
touched lightly with a thin bristle 6 times every 2 min.
for 20 min., and the number of times that the animal
failed to blink was noted. After a 4 hr. period, the
same animals were used again in a crossover test. The
results, expressed as % response, were plotted against
log concentration and analysed according to the
method described by Burn, Finnev. and Goodwin
(1950).
Salivary Flow.—The effect of compounds on sali¬
vary flow was estimated by the method employed by
Issekutz (1917), as modified by Brown and Quinton
(1957).
Gastric Secretion.—The method used was essentially
that of Shay, Komarov, and Fels (1945). Six male
albino rats weighing 100 to 200 g. were starved for
18 to 24 hr. in cages with wide-mesh wire bottoms to
1
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prevent coprophagy. The duodenum was then ligated
under ether anaesthesia and 4 mi. of warm saiine was
given intraperitoneally. Three rats were given 5 mg./
kg. of the test compound subcutaneously, while the
remaining three were given 1.0 ml. saline. The
animals were returned to their cages and killed 6 hr.
later. The oesophagus was ligated and the stomach
was removed and cleared of adhering mesentery, dried
with blotting paper, and the contents drained through
a slit into the centrifuge tube. The gastric contents
were centrifuged for 10 min. at approximately 4,000
rev./min. and the total volume and the volume of
solid contents measured. 1 ml. of the supernatant was
titrated with n/100 NaOH for free and total acid.
Topfer's reagent being used as indicator.
Neuromuscular Blocking Action.—The decerebrate
cat gastrocnemi us-sciatic nerve preparation was used.
Stimuli of 2 to 3 V., frequency 7/min., were applied
to the sciatic nerve. Compounds at 1 /20th and 1 /10th
of their respective intravenous LD50 values were
administered in saline at 10 min. intervals through a
cannula in the femoral vein.
Results
Anti-aceiylcholine Activity on Isolated Guinea-
pig Ileum and Rabbit Jejunum.—The result
of the anti-ACh activity of each compound on the
isolated guinea-pig ileum (Table I) represents the
weighted mean of at least four separate assays.
The standard error of the combined mean values
was calculated, giving on average a standard
error of the order of 5% (P=0.05). At least two
anti-ACh assays were also performed on the rabbit
jejunum, and, as a rule, the relative potencies were
less, generally by a factor of about 25%, than
Table I
intravenous toxicities, anti-acetylcholine and spasmolytic activities of a series of "tertiary
and quaternary salts of pyrrolidyl alcohols esterified with various acids. acid radical
r, derived from diphenylacetic acid (group a); benzilic acid (group b); xanthene-9-carboxylic
acid (group c); fluorene-9-carboxyl1c acid (group d)
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those obtained on the guinea-pig ileum. The most
active compound tested on isolated guinea-pig
ileum was /3-(l-methylpyrrolid-2-yl)elhyl benzilate
methiodide (BRL 481). On the other hand
(l-methylpyrrolid-2-yl)methyl benzilate (BRL 485)
was the most active compound of the series on the
rabbit jejunum. On this tissue, however, methan-
theline was the most active of all the compounds
tested. The quaternary derivatives were more
active than their corresponding tertiary salts.
Antihistamine, Papaverine-like, and Curare-like
Actions in Vitro.—Most of the compounds showed
some detectable antihistamine action, compounds
BRL 485 and BRL 529 having activities equal to
that of anlazoline sulphate. Most of the tertiary
salts exhibited a papaverine-like action against
barium-chloride-induced spasms of the rabbit
jejunum equal to that of papaverine HC1. Com¬
pound BRL 529 was the most potent, being twice
as active as papaverine. Quaternization destroyed
or greatly reduced this property. Potencies less
than 0.05 of papaverine HC1 were taken as nil.
No significant curare-like action could be
detected in any of the compounds.
Isolated Mammalian Heart.—Atropine in single
doses up to 100 p.g. usually had no effect on the
amplitude, or was slightly stimulant; it had no
effect on the rate or coronary (low of the perfused
heart. In doses over 20 pg. the tertiary amine
esters of benzilic acid appeared to have negative
inotropic and chronotropic actions, which were
particularly marked with BRL 416. A dose of 50
/i.g. of this compound usually produced a pro¬
nounced decrease in all cardiac functions leading
to complete ventricular arrest. The secondary
base BRL 539 and the ethyl-compound BRL 433
were equally depressant, whereas the short- and
long-chain homoiogues BRL 485 and BRL 490
showed less activity in this respect. The quatern¬
ary amines had generally no action or a slight
positive inotropic effect with high doses.
Toxicities.—The acute intravenous toxicities of
the compounds are given in Table I. In general
there was an increase in toxicity with increase in
length of the side chain attached to the pyrrolidine
nucleus and with the size of the group attached to
the nitrogen atom. Quaternization of the tertiary
compounds invariably led to greater toxicity,
although the tertiary salts showed signs of possess¬
ing central stimulant properties absent from the
quaternary derivatives.
BRL 485 and BRL 416 were (he least toxic of
the tertiary salts, while BRL 499 and BRL 425,
their methyl quaternary analogues, were approxi¬
mately one and a half times as toxic, but were the
least toxic of the quaternary salts. On the other
hand, atropine methonitrate was much more toxic
than atropine.
Anti-acetylcholine Effect on Blood Pressure.—
The results obtained are given in Table I. Com¬
pound BRL 499 was the most active of the com¬
pounds tested in the BRL series and was equal to
propantheline in this respect. Compounds BRL
526 and BRL 481 had also considerable activity.
The recovery from most of the compounds fol¬
lowed much the same pattern as after atropine.
Gastro-intestinal Motility.—There was no appa¬
rent relationship between the effect of drugs on the
gastro-intestinal motility of (he cat and their
action in antagonizing acetylcholine on the blood
pressure of the cat. An inhibitory response of the
intestine was usually obtained from the first
injection of the drug, but the response to a second
injection was variable. In many experiments a
second response was frequently not obtained and
the gut became completely refractory to anli-ACh
drugs. This made the interpretation of results and
a direct comparison of activities difficult. We also
found that the charcoal meal test in mice gave no
clear guide to intestinal inhibition by anli-ACh
drugs.
Anti-acetylcholine Action on Guinea-pig Colon.
—In view of the wide variability obtained with the
preceding method and the uncertainty of correct
interpretation, it was decided to use carbachol as
an intestinal stimulant, and to note the depressant
effect of compounds on this response. Difficulties
were again experienced in that the intestines of
some animals were found to be completely resist¬
ant to carbachol, even though profuse salivation
occurred in response to the injections. Further¬
more, a response to carbachol tended to appear
and disappear spontaneously during the course of
the experiment. For this reason the experiments
were designed to be of short duration, and all
animals which failed to respond to an initial dose
Table ii
MINIMUM EFFECTIVE INTRAVENOUS DOSE REQUIRED





























of carbachol were discarded. The results obtained
with the more active compounds of the benzilic
acid series (group B) are given in Table II. A
typical response to carbachol and its inhibition by
an anti-ACh drug (BRL 499) is seen in Fig. 1.
This compound proved to be the most active
synthetic compound tested.
Table 111
COMPARISON OF LOCAL ANAESTHETIC ACTIVITY OF
TERTIARY SALTS WITH PROCAINE HCI
The effect of increasing the. number of carbon atoms in side chain,
the size of group on the nitrogen atom, and of altering the acidic
radical is recorded. Sec Table I for explanation of n, R3, and R4
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BRL 485 1 CTL, H 205 0-2 to 0-5
BRL 416 2 ch3 H 16-5 2-9
BRL 490 3 CH, H 29-3 4-9
BRL 433 2 c2h5 H 26-6 8-6
BRL 447 2 CM, ch3 28-6
BRL 529 2 C3H, H 36-5 7-4
BRL 539 2 h H 0-2 to 0-5
BRL 373 2 ch3 H 13-8
Fig. 1.—Recording of the response of the guinea-pig colon following
1 //g. carbachol administered intravenously at the dots and the
inhibition produced by compound BRL 499 (16 /'g. kg.) given
at the arrow. Time, I min.
Mydriasis.—All the benzilic acid esters were
tested for their mydriatic action. By the sub¬
cutaneous route compounds BRL 481, BRL 526
and BRL 499 were all of the same order of acti¬
vity as atropine. Oxyphenonium and propanthe¬
line were somewhat less active and all the other
members of the BRL series were much less active.
Given orally, only the tertiary salts showed
regular absorption and gave repeatable results, but
none was as active as atropine. The ratio of
potencies of BRL 485 and BRL 416 to atropine
between the subcutaneous and oral routes was,
however, of the same order. The quaternary salts
were absorbed erratically and required a dose of
the order of 100 times the subcutaneous dose to
show an effect. Even with such a dose, no signi¬
ficant absorption occurred in a considerable % of
animals.
Local Anaesthetic Activity.—Selected com¬
pounds were tested for local anaesthetic activity,
which was found in tertiary salts but not in
quaternary salts. The results are given in Table
III.
Salivary Flow.—The regression for inhibition of
salivation by atropine against log dose was linear
in two sets of 8 rabbits. Dose-response curves
were also found for compounds BRL 416 and BRL
425 on the first set of rabbits and for compound
BRL 499, oxyphenonium, propantheline and
atropine methonitrate on the second set of rabbits.
Since none of the curves obtained showed
significant deviation from parallelism or linear
regression, it was decided to estimate activity at
one dose level and to assume that the dose-
response line passing through the point obtained
would run parallel to the standard atropine curve.
The dose which gave a 50% depression in
response (ED50) was found by interpolating on
the line so obtained. The relative potencies arc
given in Table I.
Gastric Secretion.—A quantitative assay was
impractical owing to the large variation in the
amount of acid secreted in untreated rats. The
activities have, therefore, been measured in terms
of an " all cr none " response. All the compounds
tested produced a significant reduction (F=0.05)
in the volume of gastric secretion, except com¬
pounds BRL 485, BRL 447. BRL 454, BRL 4S1,
and BRL 417.
Cat Gastrocnemius-sciatic Preparation.—None
of the compounds had any significant action on
the response of the gastrocnemius muscle to
sciatic nerve stimulation.
Discussion
All the compounds of the BRL series showed
anti-ACh activity both in vitro and in vivo. On
the basis of the in vitro comparative assays, the
benzilic acid esters were the most active, followed
by xanthene-9-carboxylic acid, fiuorene-9-car-
boxylic acid and diphenylacetic acid esters, in that
order.
Detailed study of the benzilic acid esters showed
that maximum activity on the guinea-pig ileum
occurred when the carbon side-chain attached to
the pyrrolidine nucleus contained two carbon
atoms. When the side-chain was kept constant, an
increase in the size of the group on the nitrogen
atom resulted in a proportional decrease in
in vitro anti-ACh activity.
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There was little difference between the tertiary
compounds containing one or two carbon atoms
in the side-chain in their antagonism of the vaso¬
depressor action of ACh, although the shorter
chain compound appeared to be more active as a
mydriatic and the two carbon chain compound
more active as an anti-salivatory agent. The
three carbon chain compound was, however,
much less active as an anti-ACh agent. The
short chain compound tended to be somewhat
stimulatory and produced variable results against
carbachol stimulation of the guinea-pig colon.
The precise activity could not be measured, but
appeared to be much less than that shown by the
two carbon chain compound. The three carbon
compound had little activity.
A feature of the tertiary derivatives was their
local anaesthetic activity, the quaternary com¬
pounds being completely inactive in this respect.
As the anti-ACh action decreased, the local anaes¬
thetic activity increased in proportion to the
number of carbon atoms in the side-chain or
attached to the nitrogen. Relative to procaine
hydrochloride the compounds were much more
active on the corneal reflex test than by the intra¬
dermal weal test, indicating that they penetrate
mucous membranes. On the corneal reflex /?-(1 -
ethylpyrrolid-2-y!)ethvl benzilate (BRL 433), how¬
ever, appeared to be more active than /3-(l-n-
propylpyrrolid-2-y!)ethyl benzilate (BRL 529),
which has a larger group on the nitrogen. This
discrepancy is probably due to the error of the
assay, which, by the nature of the test, was large.
All the tertiary salts were active orally. This
was well shown by the oral mydriatic test. In
mice, absorption from the alimentary tract was
poor and erratic with all quaternary derivatives.
Tests in human volunteers, however, indicated that
BRL 499 was regularly absorbed at a dose of 5
mg. after oral administration.
The quaternary compounds having the same
groups on the nitrogen atom showed maximum
anti-ACh activity in vino and in vivo when the
side-chain contained only one carbon atom.
(l-methyl-2-pyrrolid-2-yl)methyl benzilate meth-
iodide (BRL 499) was the most active of all the
compounds tested in vivo, and in every test was
as potent as atropine. When the side-chain of the
quaternary compounds was kept constant and
the alkyl groups on the nitrogen atom increased
in size, maximum in vitro activity occurred with
the methyl-ethyl-derivatives (BRL 481 and BRL
526). In the two carbon chain series the corre¬
sponding methyl-propyl-compound (BRL 521) was
comparatively much less active and had the same
order of activity as the diethyl-compound (BRL
494). In vivo, the relative potencies of this series
on salivary flow and mydriasis were greater than
those for their action against ACh on the cat
blood pressure and against carbachol-induced
stimulation of the guinea-pig colon. In this latter
test, however, activity was maximal with the
dimethyl-compound (BRL 425).
The substitution of a methyl group in the 5-
position in the pyrrolidine ring greatly reduced
anti-ACh activity, but did not appear to influence
local anaesthetic activity. Anti-ACh activity
appears to depend, therefore, on the overall size of
the group or groups on the nitrogen atom, on the-
length of the side-chain, and on the absence of
other substituents in the pyrrolidine nucleus.
The authors wish to thank Dr. D. O. Holland for
his interest and helpful discussions and Miss J.
Sutcliffe and Mr. R. Burton for their assistance.
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Experimental conditions affecting tests of atropine-like agents for antagonism of pilocarpine-
induced salivation in rabbits have been examined. A simple method of assay of such agents is
described. It gave results of fair accuracy and reproducibility, permitted a full statistical analysis,
and provided an estimate of the error.
The effect of drugs on salivary flow has been
examined in experimental animals by several tech¬
niques. Cushny (1920) used dogs with salivary
fistulae, and Biilbring and Dawes (1945) measured
the flow of saliva from the submaxillary gland of
anaesthetized cats by cannulation of Wharton's
duct. Issekutz (1917), who collected the saliva
which dripped from the mouths of rabbits under
urethane, reported that 1.5 to 2.0 mg. atropine
stopped pilocarpine-induced salivation. This last
method, which requires little technical skill, has
been adapted by many workers, but there has been
little detailed analysis of the optimal conditions.
Furthermore, statistical evaluation of the results
has rarely been attempted and the accuracy of the
methods is therefore virtually unknown. Brown
and Werner (1949), indeed, found such variability
between responses of different rabbits that they
regarded any quantitative assay as impracticable.
This paper describes conditions that affect the
responses and the accuracy of the assay and out¬
lines a simple method which gives results whose
accuracy can be readily and fully assessed.
Analysis of Factors Influencing Salivary
Flow
Use of Urethane.—Unlike several workers who
used unanaesthetized animals (e.g., Fromherz,
1933 ; Lands, Nash, and Hooper, 1946; Chen,
1954), we could not regularly obtain a suitable
amount of saliva from rabbits which had received
no urethane. However, a large oral dose of
urethane 1 g./kg. or more was undesirable, for the
narcotic action lasted some 6 to 10 hr., and the
animals lost their cough and swallowing reflexes
completely (Brown and Werner, 1949 ; Brown,
Thompson, Klahm, and Werner, 1950 ; Hoekstra,
Tisch, Rakieten, and Dickison, 1954; Tripod,
1949). The dose of urethane is therefore critical.
The variation in the amount of saliva collected
in 30 min. with the dose of urethane was deter¬
mined after various doses of pilocarpine, for one
set of eight rabbits (Fig. 1). The drugs were given
in random order, over 4-) weeks, each animal
receiving every possible combination. At all three
doses of pilocarpine, the slopes of the urethane
dose-response lines were very steep. Indeed, the
urethane dose appeared to control the response
more effectively than did the pilocarpine. The
urethane probably did not affect the actual rate of
salivation, but only increased the efficiency of
collection.
An oral dose of 0.5 to 0.625 g./kg. of urelhane
was effectively sedative to the rabbits without pro¬
ducing loss of consciousness, and a good collec¬
tion of saliva was possible. Collection was more
efficient from rabbits given 1.0 g./kg. urethane,
but, owing to the risk of harmful effects to the
animals, 0.5 to 0.625 g./kg. was preferred.
The urethane was administered orally in 25 ml.
saline to ensure adequate hydration and a good
reserve of body water upon which to draw during
and after the profuse salivation.
No other anaesthetic was tried in these investiga¬
tions.
Dose of Pilocarpine.—Doses of pilocarpine
used by previous workers in this field have ranged
from 0.25 mg./kg. (Fromherz, 1933) to 100 mg./
kg. subcutaneously (Graham and Lazarus, 1940).
The relation between the dose of pilocarpine
nitrate and the salivary response was investigated
over the range of 1.25 to 5.0 mg./kg., at three
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Fig. 1.—Combined dose-salivary response curves for various doses
of urethane and pilocarpine, in a set of 8 rabbits. Pilo¬
carpine (log dose on top abscissa) after various doses of urethane
(g./kg., in squares). |—l—l— l—i Urethane (bottom abscissa)
preceding various doses of pilocarpine (mg./kg., in circles).
different doses of urethane (Fig. 1). The pilocar¬
pine nitrate was injected subcutaneously 30 to 45
min. after the oral dose of urethane. The rabbits
were then placed in their stocks and the saliva
which dripped from their mouths was collected.
In the absence of urethane, an increase in the
dose of pilocarpine from 1.25 to 5.0 mg./kg. had
little effect on the small amount of saliva obtained.
On the other hand, with 0.5 g./kg. and 1 g./kg.
of urethane, the response to even 1.25 mg./kg.
pilocarpine was considerably more than that to 5
mg./kg. after no urethane. When 0.5 g./kg. of
urethane was given, there was little difference
between the amounts of saliva secreted after the
injection of 2.5 mg. and 5 mg./kg. pilocarpine.
However, the higher dose was used throughout the
investigations, since, after it, salivation was of
convenient duration (90 min.) and of suitable
intensity—not too readily antagonized by drugs,
yet susceptible enough to give a sensitive assay.
Choice of Animals.—Rabbits of 1.5 kg. and
over were used. Differences in sex and weight did
not appear to influence the response to the drugs.
The rabbits showed enormous variability in their
sensitivity to atropine. In about half of them the
salivary response to pilocarpine was not affected
significantly by doses of atropine up to 80 pg./kg.,
given subcutaneously 15 min. before the pilo¬
carpine. On the other hand the remainder showed
about a 50% decrease in flow after 5 to 10 p.g./kg.,
and almost a 100% decrease after 25 pg./kg. This
insensitivity to atropine was presumably due to the
presence in the blood of an enzyme—atropinester-
ase (Glick, 1940)—capable of hydrolysing atro¬
pine. Serum from several resistant rabbits was
able to destroy atropine in vitro.
Although both Glick and Glaubach (1941) and
Amnion and Savelsberg (1949) have reported
widely ranging figures for the effective atropin-
esterase activity of the blood of those rabbits
possessing it, we found that rabbits showed either
a large (>50%) reduction in salivary flow after
25 jxg./kg. atropine, or else an insignificant re¬
duction (<20%) after double or treble that dose.
Consequently, once a consistent salivary response
to the pilocarpine alone had been obtained in a
rabbit, a single test with 25 /xg./kg. atropine given
15 min. before the pilocarpine was sufficient for
the assessment of atropine resistance. All the
animals showing less than a 50% inhibition of
salivation by this dose were rejected.
Interval Between Administration of Atropine
and of Pilocarpine.—-In order to find the optimal
time interval between the injection of atropine, or
similar drugs, and of pilocarpine, a random design
assay was performed on one set of eight rabbits,
in which the antagonism of salivary flow was
measured for four different atropine-like drugs
given 0, 5, 15, 35, and, on two occasions, 70 min.
before the injection of pilocarpine. The drugs
used were atropine sulphate, atropine methyl
nitrate, benactyzine (/Tdiethylaminoethyl benzilate
HC1) and oxyphenonium (phenylcvclohexyi gly-
collic acid ester of /J-diethylaminoethanol metho-
bromide). The animals received 0.5 to 0.625 g. /
kg. uretbanc orally and 5 mg./kg. pilocarpine
nitrate subcutaneously.
The mean percentage inhibitions of salivation
are given in Table I and the time-response curves
are plotted in Fig. 2.
Atropine appeared to exhibit maximal activity
when administered about 15 min. before the pilo¬
carpine ; its effect after 35 min. was less than
after 5 or 15 min. Atropine methyl nitrate had a
more prolonged action which reached a maximum
when it was given about 35 min. before pilo-
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Table I
THE EFFECT OF VARYING THE INTERVAL BETWEEN THE
INJECTIONS OF AN ATROPINE-LIKE DRUG AND OF













Mean % Inhibition of Salivation
at Different Times (min.) Between






















S.E. of each mean, 7-2.
* Response significantly different from that at 15 min. (P<0 05).
carpine. Even 70 min. after administration,
atropine methyl nitrate still showed a greater
effect than after 0 to 15 min. Oxyphenonium, the
other quaternary compound, gave identical results.
With benactyzine, however, maximal activity was
obtained when the drug was given at the same time
as pilocarpine.
It thus appears that the times at which different
atropine-like drugs exert maximal activity after
subcutaneous injection vary considerably. In the
assay method described subsequently, the time
between administration of the atropine-like drug
and the pilocarpine was 15 min., in order to stan¬
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Fig. 2.—The effect of varying the time of injection of the atropine-
like drug on the observed potency. Abscissa, time (min.) between
injections of the drug and of pilocarpine (5 mg./kg.). Ordinate,
mean percentage inhibition of salivary flow, for 8 rabbits. All
drugs injected subcutaneously. © © Atropine sulphate
5 fxg.fkg. x—l—I— |—x Atropine methyl nitrate 2 //g.'kg.
© © Benactyzine HC1 750 /tg. 'kg. O O Oxypheno¬
nium bromide 5 //g./kg.
these conditions may not be maximal, particularly
with compounds containing a quaternary nitrogen
atom, and the relative potencies in terms of
atropine might thus be smaller than could other¬
wise be obtained.
Analysis of Results
Regular gradation of response with dose was
shown in atropine-sensitive rabbits—that is, a
regular decrease of salivary flow was obtained
with increasing doses of atropine. The response
of each animal was expressed as the percentage
depression of the total volume of saliva collected
after a dose of atropine or similar agent, compared
with the mean of the volumes obtained from the
same animal in two control experiments. The
results obtained from each of eight animals in a
set were averaged. In practice, control experi¬
ments were performed only once in every six to
twelve experiments, the responses in all those tests
falling between any two controls being expressed
with reference to the mean of these two control
values. The average standard deviation of such
a mean control value, calculated from figures for
each of eight rabbits tested over nine months, was
10.9 ml. Collection of saliva was maintained for
90 min. after the rabbits had received pilocarpine
and had been placed in their stocks. By the end
of this time, the flow had ceased in all except a
few control observations where it had fallen to a
rate of below 0.2 ml./min.
Eight animals for each experiment gave results
of adequate accuracy. A set of animals could be
used twice weekly, with only very occasional rests,
for at least 15 months without any ill-effects or
tolerance.
A large number of drugs could therefore be
compared for their activity in antagonizing piio-
carpine-induced salivation, on the same set of
eight rabbits.
The time course of the salivation obtained from
a set of eight rabbits in control experiments and
in tests with various doses of atropine is given in
Fig. 3. Where no atropine was given, the saliva¬
tion response to pilocarpine appeared to fall away
exponentially with time. If moderate to strong
doses of atropine were given 15 min. before the
pilocarpine, however, the time-log response lines
appeared to curve. This might indicate that
atropine was less readily eliminated or removed
from the receptors than pilocarpine.
The dose-response relation for atropine was
investigated several times, on two different sets of
rabbits. Good approximations to a linear log



























Fig. 3..—Time-salivary flow curves for a set of 8 rabbits, after 5mg./kg.
pilocarpine nitrate, preceded by various doses of atropine. Dose
of atropine in /rg., kg. is given alongside the appropriate line.
Abscissa, time (min.) after injection of pilocarpine. Ordinate,
mean log volume (ml.) of saliva for each rabbit, measured for
15 min. periods.
90% maximal response range, and regression
lines were fitted by the method of least squares
(Fig. 4). The variance due to deviation from
linearity was never statistically significant (i.e.,
P<0.05). Results were analysed by the standard
analysis of variance method ; one set of results is
given in Table II. Although atropine sulphate was
used, the doses were always calculated in terms of
the base.
Table 111 gives data front five different assays,
four on one set of rabbits and one on another.
There is a close similarity of the results in Set B.
The difference in the estimates of ED50 for
atropine between the two sets of rabbits is largely
an indication of differences encountered in the sen¬
sitivity of individual rabbits to atropine—even
those apparently entirely lacking atropinesterase.
The differences in response of these two sets of
rabbits emphasize the need to compare anti-
acetylcholine agents in the same group of rabbits.
Many different compounds were so tested and
0.4 0.8 I.2 1.6
Log dose fiig./kg.)
Fig. 4.—Log dose-response lines for 4 assays of atropine on two
different sets of 8 rabbits. Regression lines calculated by
method of least squares. © 9 Assay 5/55 on set A rabbits,
x x Assay 8/55, O — • — O Assay 2 56, O—1—l— O
Assay 2/56 on set B rabbits.
Table II
DOSE-INHIBITION OF SALIVATION DATA FOR ATROPINE
ON ONE SET OF 8 RABBITS
Rabbit
Total
i Decrease in Salivary Flow 15 min.
after Atropine s.c.
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Table III .
results of various assays of atropine for
inhibition of salivation
Rabbits: Set A Set B
Assay No. 1 1 2 3* 4*
Date of Assay 5/55 8,55 2/56 2/56 4 56
No. of dose-levels used. . 6 4 3 2 2
Slope (6) . . 65-7 611 680 81-3 60-3
S.E.6 11-5 9-7 7-1 17 9 12-4
ED50 G/g./'kg.) .. 7-5 3-6 3-4 4-2 51
Limits of error (P=0-05) 5-8- 2-9- 2-8- 3-5- 4-2-
of ED50 9-9 4-8 4-2 4-9 6-1
A 0-40 0 31 0-20 0-30 0-22
* Part of a randomized design assay incorporating two other
compounds.
their potency referred constantly to that of the
standard (atropine), whose effective potency
appeared to stay reasonably constant for at least
nine months.
Results jor Other Atropinc-like Agents
In addition to atropine, several other anti-
acetylcholine agents were tested by this method
for their antagonism of induced salivation.
Atropine methyl nitrate, oxyphenonium, and prop¬
antheline were tested on rabbits of Set B at about
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Log dose (fig./kg.)
1.0 1.2
Fig. 5.—Log dose-response lines for: ©-
III); several doses were used in each assay. For
all these compounds, doses were calculated in
terms of the salt. The calculated regression lines
are shown in Fig. 5, and the analysis of the results
given in Table IV. The variance due to linear
regression was highly significant (P<0.01) and
that due to deviation from linear regression not
significant (P>0.2).
Table IV














No. of dose-levels tested 3 4t 5 3
Slope (6) 680 55-3 63-7 74-3
S.E.b 71 15-2 9-4 10-2
ED50 (//g./kg.) 3-4 2-2 3-9 3-2
Limits of error of ED50 2-8- 1-4- 3-2- 2-6-
(P=0-05) 4-2 3-6 4-8 40
Approx. relative potency* . . 10 1-5 0 9 11
A 0-20 0-41 0-25 0-21
# ED50 Atropine
^ED50 Compound
f Only 3 used in the analysis, the fourth giving a response over
90% of maximal.
The relative potencies of the three compounds
in terms of atropine are expressed as the ratios of
their ED50s (Table IV). There was little differ¬
ence in the activity of these four agents, although
atropine methyl nitrate appeared slightly more
potent than the tertiary base.
(2 + 2) Assay
The assessment of the relative potency of one
drug in terms of another from dose-response data
obtained at different times must, however,
inevitably be liable to more error than that
derived from tests carried out under identical
conditions for both drugs. An assay method
incorporating randomized doses was therefore
adopted, in which, at any one time, the four pairs
in a.set of eight rabbits received different doses.
Two doses of each compound giving respectively
about a 35% and 70% response were administered
Table V
comparison of activities of atropine-i.ike drugs
with that of atropine
© Atropinesulphate.
O—I—I—O Atropinemethyl nitrate, x x Oxyphenon¬
ium. O — • — O Propantheline. All results obtained on same
set of 8 rabbits.
Log
Rela¬ Limits of
A tive S.E. Rel. Error of




Combined 6 = 65-6 0-30
Atropine x atropine MeNO, 0-357 0-104 2-28 1-40-3-70
x homatropine HBr -2-039 0-109 0-0091 0-0055-
0-0152
Assay 2:
Combined 6 = 59-8 0-22
Atropine x tricyclamol CI -0-211 0-086 0-62 0-41-0-93
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0.2 0.4 0.6 2.6 2.8 3.0 3.0.8 1.0 2.2 2.4
Log dose (Mg./kg.)
Fig. 6.—Log dose-response lines obtained for atropine sulphate, atropine methyl nitrate
and homatropine HBr in a 2 + 2 + 2 assay on a set of 8 rabbits. Values for M (log














0.2 0.4 0.6 0.8 1.0
Log dose (pg./kg.)
1.4 1.6
Fig. 7.—Log dose-response lines obtained for atropine sulphate and
tricyclamol CI in a 2 -J- 2 assay on a set of 8 rabbits. Log relative
potency (M) i its limits of error (P — 0.95) are given, with atro¬
pine taken as standard.
subcutaneously. The ratio of
the two doses was the same for
all compounds in an assay. In
the first assay, three compounds
were tested—atropine sulphate,
atropine methyl nitrate, and
homatropine HBr. The doses
were given in random order over
six experiments. The assay
results were compared with the
mean result of two control ex¬
periments performed just before
and just after the assay. In a
second assay, tricyclamol chlor¬
ide was tested against atropine
in a similar manner. Analysis
of results followed the same lines
as before, with adaptations of
the Schild (1942) and Holton
(194S) methods of evaluating
2 + 2 assays.
The dose-response lines ob¬
tained in these assays can be
seen in Figs. 6 and 7, and
the relevant data tabulated in
Table V. Variance due to regression was always
highly significant (P<0.01), whereas that due to
deviation from parallelism was not (P>0.2).
The relative potencies of atropine methyl
nitrate, homatropine HBr, and tricyclamol in terms
of atropine were 2.28, 0.0091, and 0.62 respec¬
tively ; the difference in activity between the test
compound and atropine was statistically significant
with all the drugs.
Discussion
Rabbits fully sensitive to atropine are essential
for a reliable assay, since the dose of atropine
producing 50% inhibition of salivation in about
half the animals tested was more than ten times
that necessary in the other half. Serum from the
former rabbits destroyed atropine in vino,
whereas serum from the atropine-sensitive rabbits
did not. Other atropine-like drugs are also sus¬
ceptible to destruction in the serum of certain
rabbits; homatropine, for example, is almost as
readily attacked as atropine (Ammon and
Savelsberg, 1949). On the other hand, Trasentin
(Glick, 1942) and Trasentin 6H and Lachesine
(Blaschko, Chou, and Wajda, 1947) have been
reported to be unaffected by atropinesterase, and
it would be possible, therefore, to compare these
compounds on atropine-resistant rabbits. Other
more recently synthesized atropine-like compounds
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do not appear to have been investigated for their
susceptibility to destruction by atropinesterase.
The incidence and transmission of atropine
resistance in rabbits have been investigated by
Sawin and Glick (1943) and others ; it seems to
be at least partly controlled by hereditary factors.
Consequently, it would be expected that for any
one strain the atropine-resistance factor would be
present to a fairly consistent degree, but that there
would be a variation between different strains.
About 90% of our "English" rabbits, bred
locally, were atropine-sensitive, whereas roughly a
similar percentage of various blue " Beveren " and
black rabbits obtained from another dealer were
resistant. According to Sawin and Glick, there
may be a relation between the presence of
atropincsterase in the blood and the extent of black
pigment in the rabbit's coat.
Several authors testing anti-acetylcholine agents
for salivary blockade in rabbits have reported a
wide variability in sensitivity to atropine, but none
has related this to the presence of an enzymic
mechanism for destroying atropine. Brown and
Werner (1949), for instance, reported that 0.075 to
0.3 mg./kg. atropine intramuscularly "markedly
inhibited salivary secretion in some animals, but
had little effect in others." They therefore used a
quantal response, and reported that the minimal
dose of atropine which would reduce the salivary
flow to below 20 ml. in 2 hr. in five out of six
rabbits tested was 600 /tg./kg. At least some of
the animals used by these workers probably pos¬
sessed atropinesterase in their blood.
Cahen and Tvede (1952), in a quantal assay of
salivary blockade in rabbits, showed that the per¬
centage (probit) of rabbits with at least a 50%
inhibition of pilocarpine-induced salivation was
linearly related to the log dose of atropine. The
ED50 for atropine by this method was 62 /ig./kg.,
whereas assessment by graded response in the
same 40 animals gave an ED50 of 110 /tg./kg.
Such a difference between ED50 values might be
expected if it is assumed that certain of these 40
rabbits (but less than half of the total) possessed
atropinesterase. Thus, a dose of atropine just
sufficient to cause a 50% inhibition of salivation
in the sensitive animals—giving an ED50 in quan¬
tal response—would produce a mean inhibition of
considerably less than 50% on the graded response
scale, when the almost negligible responses of the
atropine-resistant animals are taken into account.
Cahen and Tvede eventually regarded the rabbit
as an unsuitable test animal " because of the vari¬
ability of the individual responses and its unusual
tolerance to atropine." We have found, however,
that rabbits without atropinesterase are very sen¬
sitive to atropine. In the rabbit the dose of
atropine causing a 50% reduction in pilocarpine-
induced salivation (3-7 /ig./kg. s.c.) is consider¬
ably less than that needed in the mouse for a 50%
maximal increase in pupil size (100 /xg./kg. s.c.)
and similar to that causing a 50% inhibition of
the hypotensive response to a just-maximal dose of
acetylcholine in the cat (1 /ig./kg. i.v.) (Brown,
Quinton, Acred, Bainbridge, and Turner—unpub¬
lished observation). Lands et al. (1946) also quote
a low dose (1 /ig./kg. i.v.) for a 70% inhibition of
pilocarpine-induced salivation in rabbits.
Certain workers have administered atropine
intravenously (Lands et al., 1946 ; Tripod, 1949 ;
Chen, 1954; Luduena and Lands, 1954). Atropin¬
esterase may not have time seriously to affect the
action of atropine given in this way, particularly
when, as in the technique of Luduena and Lands,
the salivary flow is measured for two periods
of only 10 min. each, immediately before and
after the injection of atropine. This point was
therefore investigated in two sets of eight rabbits.
In the first set, composed entirely of atropine-
sensitive animals, the mean salivary response in the
10 min. after an intravenous injection of 10 /ig./
kg. atropine was 6.0 ±2.0% (S.E.) expressed as a
percentage of the amount of saliva obtained in
the preceding 10 min. In the other set of animals,
all of which possessed atropinesterase in their
blood, the corresponding figures were 63.6 +
12.3% (S.E.). Pilocarpine nitrate (1 mg./kg.) was
given to both groups 15 min. before the atropine.
The difference between the mean salivary re¬
sponses for the two groups is highly significant.
It appears therefore that even with intravenous
administration of atropine it is still necessary to
use atropine-sensitive rabbits, since the atropin¬
esterase affects the activity of a low dose of
atropine even within 10 min. of intravenous injec¬
tion.
In order to minimize variation between different
rabbits, drugs were compared in the same animals.
By the use cf a (2 + 2) or (2 + 2+ 2) design whereby
each of a set of eight rabbits received each of
two dose-levels of the drugs tested, the relative
potency in terms of a standard has been obtained
with its limits of error (P= 0.95). The values for
A (the standard deviation of a single log dose)
ranged from 0.20 to 0.40. We found the relative
potencies of atropine methyl nitrate and hom-
atropine in terms of atropine to be 2.3 and
0.009 respectively. Tssekutz 11917) reported that
atropine methyl nitrate was 3 to 4 times, and
homatropine about one fifth, as potent as atropine,
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whereas according to Luduena and Lands (1954)
the methyl nitrate was eight times as potent as
atropine on intravenous administration. It is pos¬
sible that slowness of absorption of the quaternary
compound after subcutaneous injection may partly
account for the lower potency obtained by us.
We have not found any reports on the activity
of tricyclamol, oxyphenonium, and propantheline
in antagonizing pilocarpine-induced salivation in
rabbits, although Drill (1954) quotes from some
unpublished data supplied by Clark and co-workers
that " the intrinsic anti-salivary activity (of oxy¬
phenonium) assayed in rabbits is 1.85 times greater
than that of atropine." We have found the rela¬
tive potency of tricyclamol to be 0.62. The
approximate relative potencies for oxyphenonium
and propantheline, derived by comparing ED50
values from responses in the same rabbits but not
at the same times, were 0.9 and 1.1 respectively.
We wish to thank the Directors of Beecham
Research Laboratories Ltd. and of C. L. Bencard
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GANGLION-BLOCKING PROPERTIES OF ATROPINE-LIKE
DRUGS
BY
J. G. BAINBRIDGE AND D. M. BROWN
From the Beecliam Research Laboratories, Ltd., Brockham Park, Betcliworth, Surrey
(RECEIVED OCTOBER 28, 1959)
The ganglion-blocking properties of atropine, atropine methyl nitrate, oxyphenonium, poldine,
methantheline and propantheline have been examined and compared with those of hexamethonium,
mecamylamine, pentolinium and tetraethylammonium. The ganglion-blocking activity was assessed
by stimulating the preganglionic nerve to the superior cervical ganglion and recording directly the
percentage depression in the postganglionic action potentials. In this way any ambiguity due to the
peripheral actions of the drugs was removed. As a group the atropine-like compounds are not
markedly less potent than the ganglion-blocking agents, but their action is relatively transient.
This work suggests that the ganglion-blocking action of atropine-like substances plays no part in
their therapeutic effects.
Atropine-like drugs are frequently used in
clinical practice for their peripheral anti-acetyl-
choline effects. The actions of atropine-like drugs
at peripheral sites have been fully investigated, but
their actions at autonomic ganglia have been
examined in less detail [Marrazzi (1939), Dutta
(1949), Konzett and Rothlin (1949), Ambache
(1949), Cahen and Tvede (1952), and Paton
(1954)]. We therefore thought it important to
find out whether these drugs produce significant
ganglion-block in doses which antagonize the
peripheral actions of acetylcholine.
The measurement of ganglion-blocking action
has usually been carried out on the cat nictitating
membrane preparation, but there are several
objections to this, particularly for atropine-like
drugs which have a considerable peripheral
action. For example, Cervoni, West, and Fink
(1956) found that atropine directly depressed the
smooth muscle of the nictitating membrane. This
was confirmed by Thompson (1958) using the
isolated nictitating membrane preparation. Even
direct perfusion of the ganglion with the drug
does not eliminate this error, since up to 50% may
not reach the ganglion, being diverted possibly by
arterio-venous anastomoses to peripheral sites
(Paton, 1954).
In this investigation we have avoided complica¬
tions due to peripheral actions of the drugs by
measuring directly the postganglionic nerve
potentials evoked by stimulating the preganglionic
nerve to the superior cervical ganglion. We have
studied the ganglion-blocking activity of several
atropine-like drugs and some true ganglion-
blocking agents.
Methods
Stimulation and recording of postganglionic action
potentials were similar to the method described by
Eccles (1935).
Anaesthesia was induced in cats with ether,
followed by intravenous chloralose/urethane solution
(1% and 5% respectively) at approximately 5 ml./kg.
The cervical sympathetic . nerve and the post¬
ganglionic nerve from the superior cervical ganglion
were dissected out. Care was taken to leave the
blood supply to the ganglion intact. The cat was
then transferred to a metal screening cage, stimulating
and recording electrodes were placed in position and
the exposed tissues were covered with liquid
paraffin.
•A rectangular pulse of approximately 0.1 msec,
duration, 2 to 10 V. and 2 pulses/sec. frequency was
applied to the preganglionic nerve. The recording
electrodes on the postganglionic nerve led to a
condenser-coupled amplifier and oscilloscope with
recording camera.
Drugs were given intravenously into the femoral
vein. The - action potentials were photographed
immediately before and at 1 min. after the injection,
the effect of the compounds being maximal at this
time. The action of the drug was expressed as the
percentage reduction of the spike amplitude as
measured from the photographic record.
Four to eight observations were made with each
drug. The response was plotted against the dose on
a log scale and a regression line was fitted by eye to
the points obtained. The ED50 was read directly
from the graph.
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The duration of action of the atropine-like drugs
was determined by injecting a dose equal to the
ED50 and photographing the action potential before
administration and at 1, 2, 4, and 8 min. after
administration. The action potentials following
hexamethonium were measured at 5 min. intervals
until recovery. The percentage depression of spike
amplitude was plotted against time, and from the
graph the time taken from maximum depression to
half recovery was estimated. Two experiments were
carried out with each drug.
The following salts of the various drugs were
used: pentolinium tartrate, hexamethonium bromide,
mecamylamine hydrochloride, atropine sulphate,
tetraethylammonium bromide, methantheline
bromide, propantheline bromide, oxyphenonium
bromide, and poldine methosulphate (Nacton).
The doses given below are expressed in terms of
these salts.
Results
Fig. 1 illustrates the action potentials before
and after the administration of 0.2 mg./kg. of
hexamethonium and 4 mg./kg. of atropine. This
dose of atropine reduced the spike potential by
approximately 80%, and hexamethonium by about
35%.
Fig. 2 shows the dose-response lines obtained
for most of the drugs investigated. The slopes of
the lines would appear to be all of the same order.
The doses of atropine-like drugs and ganglion-
blocking agents giving a 50% reduction in spike
amplitude, as determined from the dose-response
lines, are given in Table I.
It will be noted that the atropine-like drugs, as
a group, are somewhat less potent than the true
ganglion-blocking agents, but the difference is
not marked. In the case of atropine methyl
nitrate this drug is even more potent than
Table I
RELATIVE GANGLION-BLOCKING POTENCY











Atropine methyl nitrate 0-14 2-22
Propantheline 0-70 0-545
Methantheline 0-70 0-510
Tetraethylammonium . . 0-80 0-226
Atropine 2-4 0-249
Oxyphenonium 2-4 0-154
Poldine (Nacton) 3-8 0-097
mecamylamine and hexamethonium. Flowever,
the two groups of drugs differ considerably in
their duration of action. The atropine-like drugs
have a short effect of approximately 2 to 6 min.,
while the duration of action of the true ganglion-
blocking drugs administered at the ED50 level is
upwards of 30 min.
A comparison of the duration of action of
atropine-like-... drugs with hexamethonium was
made and the results are given in Table II. As
the time of complete recovery was rather variable,
and as the initial slope of the recovery curve was
more constant, the " mean half recovery time " as
defined above was worked out.
50 uV L
10 msec.
0.2 mg./kg. hexamethonium bromide




and after the intra¬
venous injection of
0.2 mg./kg. of hexa¬
methonium. Bottom
records: before and
after 4 . mg./kg. of
atropine.
ATROP1NE-LIKE DRUGS
Dose (mg./kg. log scale)
Fig. 2.—Dose response lines
obtained for the ganglion-
blocking activity of a
number of atropine-like
drugs (atropine (a) ;
atropine methyl nitrate
(b); oxyphenonium (c) ;
poldine (d) ; methanthe-
line (e); propantheline
(/)) and true ganglion-
blocking agents (hexa-
m e t h o n i u m (g) ;
pentolinium (/;) ).
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Table 11
TIME TAKEN FOR THE POSTGANGLIONIC
ACTION POTENTIAL TO RECOVER BY 50%
AFTER THE ADMINISTRATION OF THE
ED50 OF SOME ATROPINE-L1KE DRUGS
AND HEXAMETHONIUM
Discussion











have been shown by a
transmission through
ganglion.
Fig. 3a shows the
ganglion-blocking, and
choline activity of the





Fig. 3b shows the relationship between the toxic
and ganglion-blocking doses for the true ganglion-
blocking drugs. The toxic dose is the intravenous
LD50 for mice, and the figure for anti-acetyl-
choline activity is the dose required to obtain
50% inhibition of the vasodepressor response to
intravenous acetylcholine in the cat ("Acred,
Atkins, Bainbridge, Brown, Quinton, and Turner,
1957). The ganglion-blocking dose is the ED50


























Fig. 3.—Diagram showing (a) relationship between toxicity, ganglionic and peripheral activities of atropine-like
compounds (1, atropine methyl nitrate; 2, atropine; 3, propantheline; 4, poldine; 5, oxyphenonium; 6, meth-
antheline) ; and (/>) toxic and ganglionic activity of ganglion-blocking agents (7, hexamethonium;




In the case of the ganglion-blocking agents the
ratio between toxic and ganglion-blocking doses is
large, ranging from 400 for pentolinium to 90 for
mecamylamine and tetraethylammonium, whereas
in the atropine-like group the ratio varies from 6
for propantheline to 60 for atropine methyl
nitrate. ED50 values for the ganglion-blocking
activity for the two groups actually overlap,
atropine methyl nitrate being remarkably potent
whereas tetraethylammonium is less potent than
methantheline and propantheline. The ratio
between ganglionic and peripheral ED50 values in
the atropine-like group is of the order of 1,000,
and so it is most improbable that ganglion-
block contributes to their therapeutic actions.
No simple relation exists between ganglionic
and peripheral potencies in the atropine group.
Quaternization of the nitrogen in atropine leads
to an increase of toxicity and peripheral anti-
acetylcholine activity and to a proportionately
much greater ganglion-blocking potency. The
presence of a quaternary nitrogen atom is, how¬
ever, not essential to a high ganglion-blocking
potency (for example, mecamylamine and
pempidinc).
The effect of anti-acetylcholine drugs at
ganglia could be due to depolarization or
competition with acetylcholine. Paton and
Perry (1953) have shown that acetylcholine,
nicotine, and tetramethylammonium block
■ ganglia by depolarization, all causing an initial
stimulation of the ganglion cells. Other known
ganglion-blocking agents neither depolarize nor
cause an initial stimulation and are assumed to
act competitively. We have no evidence that the
atropine-like drugs cause an initial stimulation of
the superior cervical ganglion, although we did
produce an initial stimulation of the intestine
in vivo after intravenous administration (Acred
et al., 1957). It is possible that this is a nicotine¬
like effect. On the other hand, Konzett and
Rothlin (1949), perfusing the superior cervical
ganglion and recording from the nictitating
membrane, overcame the block produced by
atropine with higher concentrations of acetyl¬
choline, suggesting a competitive mode of action.
The ganglion-blocking action of atropine can
be attributed partly to its local anaesthetic activity
(Paton, 1954). Flowever, most of the compounds
we have investigated are quaternary esters and
have no local anaesthetic properties (Acred et al.,
1957 ; Barlow, 1955). Further, while atropine has
about half the local anaesthetic potency of
procaine the latter has a much smaller ganglion-
blocking action than atropine both by intravenous
and close intra-arterial injection to the ganglion
(see also Dutta, 1949). Hence the available
evidence as to mode of action suggests a
competitive block such as probably occurs at
peripheral sites, although other modes of action
are possible (Paton, 1954).
Although the ganglionic action of atropine
could hardly become manifest in clinical use it
could explain the observation that in anaesthetized
cats intravenous doses greater than 1 mg./kg.
often cause a transient fall of blood pressure.
We can conclude that the ganglion-blocking
action of atropme4ike drugs does not add signifi¬
cantly to their peripheral actions. In the first
instance, the dose required to produce a ganglion-
block is so great that the degree of side-effects
alone would prohibit their use. In the second
instance, the duration of block is so short that
in no way could it be said to influence
the therapeutic action. Finally, the precise
mechanism of the block has not as yet been
elucidated.
The authors wish to thank Miss A. Trenchard for
technical assistance.
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Acred, Atkins, Bainbridge, Brown, Quinton and Turner (i) have
shown that esters of i-alkyl-2-hydroxyalkylpyrroIidine and their qua¬
ternary derivatives possess considerable atropine-like activity. None
of the compounds examined, however, had an activity which signi¬
ficantly exceeded that of atropine sulphate either in potency or duration.
The pharmacological properties of a new derivative, (i-methyl-2-
pyrrolid-2-yl) methyl phenylcyclohexyl glvcollate methobromide (BRL.
556) are described in this paper. The compound has a strikingly long
duration of action in vivo.
Methods
Tests in Vitro
Anti-acetylcholine action, (a) Segments, approximately 2 cm long,
were removed from the lower ileum of young guinea pigs weighing not
more than 250 g and suspended in oxygenated Tyrode solution at 370
in a 5 ml bath. Acetylcholine (ACh), which was allowed to act for 30 sec,
was added at 2 min intervals until constant responses were obtained.
Doses of atropine sulphate and test compound were added 30 sec
before the ACh and were adjusted so that the ACh response was reduced
to approximately 30 % and 70 % of the original. Between the successive
doses of antagonist the ACh response was allowed to return to normal.
A 16-point assay was then performed using a Latin square design (10)
and the results analysed by the procedure of Schild (15).
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(b) A further estimate of anti-ACh activity was obtained on the isolated
guinea pig ileum preparation by determination of the pA., value as
described by Schild (16). When the responses to a submaximal dose
of ACh became constant the normal Tyrode solution was replaced
by Tyrode containing a known concentration of antagonist. At the same
time the dose of ACh was doubled. A 2 min cycle with a contact time
of 30 sec was used for the ACh. Dosing continued for 14 min. Three
concentrations of antagonists were used and for each test a fresh piece
of gut was employed.
Antihistamine action. Preparations of guinea pig ileum were made
as for the anti-ACh test. Histamine was added at 90 sec intervals until
the responses were regular. The antagonist was then added to the bath
30 sec before the histamine and the depression in response compared
with that obtained by a standard antihistamine drug (antazoline sulphate).
Curare-like activity. The rate phrenic nerve-diaphragm preparation,
as described by Bulbrjng (7), was used.
Tests in Vivo
Acute toxicity. Acute oral, subcutaneous and intravenous toxicities
were determined in mice of either sex, weighing 17-23 g. For the intra¬
venous toxicity doses were given into the tail vein in 5 sec. The dose
volume used throughout was 1 ml/100 g. Ten mice were used at each
of three dose levels and the number of deaths within 30 min recorded
for the intravenous toxicity, and at 24 hr for the subcutaneous and
oral toxicities. The results were analysed by the method of Finney (9).
Anti-acetylcholine activity on cat blood pressure. Cats were anaesthe¬
tised with ether followed by intravenous chloralose/'urethane (0.7 %.
w/v chloralose, 2.8 % w/v urethane, approximately 8 ml/kg). A tracheal
cannula was inserted and blood pressure recordings made from the
carotid artery which was cannulated and connected to a mercury mano¬
meter. Injections were made via a polythene cannula inserted in the
saphenous vein. A submaximal dose of ACh (1-5 p-g) was given intra¬
venously at 2 min intervals until a regular depression of blood pressure
had been obtained. Atropine sulphate and BRL. 556 were given intra¬
venously at 1 min precontact to ACh and low and high doses selected,
such that approximately 20 % and 80 % inhibition of the depressor
response was produced. After each dose of antagonist, further doses
of ACh were given until a normal or constant response was obtained.
A2 X 2 Latin square design assay (10) of BRL. 556 against atropine
d. m. brown, d. e. hall and d. h. turner 554
sulphate was carried out. The results were subjected to standard sta¬
tistical procedure (15).
Ganglionic block. The action of BRL. 556 on autonomic ganglia
was examined in the superior cervical ganglia of the cat by the method
described by Bainbridge and Brown (3).
Mydriatic activity and duration of action.
(a) Mice. An estimation of mydriatic activity was carried out in
the mouse according to the method of Pulewka, as used by Ing, Dawes
and Wajda (12). Three doses of each compound were given subcu-
taneously using a dose ratio of 1 : 2. Ten mice, 16 to 24 g, were allocated
to each dose and the pupil diameter was measured in arbitrary units
with the aid of a micrometer scale set in the eyepiece of a dissecting
microscope. The pupil diameter was measured at 10 min intervals over
a period of 140 min after dosing. Atropine sulphate was used as a stan¬
dard. The relative activity of BRL. 556 was estimated at 20 min after
dosing and the results were analysed according to the procedure described
by Bliss and Marks (4).
(b) Rats. Rats of either sex, weighing 100 to 200 g, were used.
After measurement of the initial pupil diameter BRL. 556 and atropine
sulphate were given at a dose level of 20 mg/kg subcutaneously to each
of 3 rats. The pupil diameter was measured at various intervals after
administration.
Salivary flow.
(«) The effect of BRL. 556 on salivary flow; was estimated by the
method described by Brown and Quinton (5).
(b) A further estimate of the effect of BRL. 556 was obtained in
the cat by the technique described by Bulbring and Dawes (8).
Cats were anaesthetised with ether followed by intravenous chloralose/
urethane mixture (8 ml/kg : 0.7 % chloralose, 2.8 % urethane). Whar-
tons duct was cannulated with polythene tubing (Allen and Hanbury
No. 1). The cannula was connected to a water displacement bottle,
which in turn was connected to a drop tube. The number of drops was
recorded by a Thorpe impulse counter. Continuous intravenous infusion
of carbachol/'adrenaline solution was made into the saphenous vein by
a Palmer constant rate infusion apparatus. Infusion solutions were made
up in normal saline containing 4 % w/v ascorbic acid. Satisfactory
rates of salivary flow were obtained with initial doses of 4 to 8 pg/min
carbachol and 2 to 4 pg/min adrenaline, but as the preparation became
less sensitive the final doses after about 2 hr were 10 to 2op,g/min
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carbachol and 5 to ioyag/min adrenaline. A 2 X 2 Latin square design
assay (10) of atropine sulphate against BRL. 556 was carried out. The
drugs were given intravenously. The results were subjected to standard
statistical procedure (15).
Gastric secretion. The activity of BRL. 556 in relation to atropine
sulphate was assessed by measuring the inhibition in volume of gastric
secretion in the 2 and 6 hr. Shay rat preparation by the method described
by Brown and Turner (6). In addition the mydriatic effect of the
compounds was estimated during the course of the assay, the response
being scored as follows :
75-100 % dilatation — 4
50-75 % dilatation — 3
25-50 % dilatation — 2
5-25 % dilatation — 1
Pancreatic secretion. A test for inhibitory action on pancreatic secre¬
tion was carried out on the lines of the starch tolerance test used by
Althausen and Uyeyama (2). Rabbits, 2 to 3 kg (male or non-pregnant
females) were used. The rabbits were fasted for 24 hr during which
period water was allowed ad lib, and were rested quietly for at least
half an hour before commencement of an experiment. An initial blood
sample was taken from the marginal ear vein (fasting level) and then
at intervals of one hour up to 5 hr after the administration, by stomach
tube, of starch, glucose or water (control). The starch meal, per animal,
consisted of 5 g soluble starch in 20 ml distilled water containing 1.0 ml
N/10 HC1. The starch was partially hydrolysed by boiling for 10 min
after which the meal was allowed to cool to 40° C, the temperature at
which it was administered. 20 ml 50 % w/v glucose in distilled water
was used as the glucose meal. The administration of the starch and
glucose was followed by 10 ml of distilled water. The control consisted
of 30 ml distilled water. BRL. 556 was administered intravenously 1 hr
before giving the starch, glucose or water. Blood sugar determinations
were carried out by the method of Hagi-dorn and Jensen (i i) and plasma
amylase estimated by the method of King and Wootton (13).
Absorption from the gastro-intestinal tract. The absorption of BRL.
556 and atropine sulphate was assessed in the Shay rat by estimating
the pupil dilatation produced at i |, z\, 4 and 6 hr after dosing. Four
rats were used at each dose level and 4 control rats which received
normal saline were set up at the same time. Pupil dilatation was scored
by the method used in the gastric secretion experiments. The drugs
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were dissolved in normal saline and the dose volume used throughout
was 1 ml/100 g.
(a) Intragastric dosing. Doses were administered immediately the
rats regained consciousness after pyloric ligation.
(b) Intra-intestinal dosing. After ligating the pylorus a loop of nylon
thread was placed around the duodenum about 2 cm below the pylorus.
With the aid of a fine cautery a small aperture was made into the duo¬
denum between the pylorus and the loop. A cannula consisting of about
3 cm polythene tubing attached to a hypodermic needle was passed
down the duodenum and the thread tied round it. The dose was then
administered, the cannula slowly withdrawn and the thread tied simul¬
taneously.
Results
Anti-acetylcholine, antihistamine and curare-like activity in vitro.
BRL. 556 was found to possess no significant antihistamine or curare¬
like activity. When anti-ACh activity was assessed at a precontact period
of 30 sec BRL. 556 was found to have anti-activity of 0.77 times that
of atropine sulphate. pA2 determinations for anti-ACh activity at a
14 min contact period gave values of 9.0 and 8.6 for BRL. 556 and
atropine sulphate respectively, representing an activity for BRL. 556
of 2.5 times atropine sulphate.
Acute Toxicity. The following LDS0 (with 5 % fiducial limits) values
for BRL. 556 were obtained in mice : intravenous 18.0 (16.8 to 19.2)
mg/kg, subcutaneous 303.0 (289.1 to 317.0) mg/kg, and oral 1039.9
(626.7 t0 1722.0) mg/kg.
Anti-acetylcholine activity on cat blood pressure. It was found that
there was a decrease in sensitivity to acetylcholine and increase in
sensitivity to the antagonists as the experiment proceeded, but constant
responses to both were obtained after about 3 hr of dosing. Two com¬
plete assays were carried out and a mean relative potency of BRL. 556
of 0.4 times atropine sulphate was obtained. Recovery from doses of
BRL. 556 was slower than from atropine sulphate.
Ganglionic block. At a dose level of 1.5 mg/kg intravenously BRL. 556
produced a 50 % reduction in post-ganglionic potential following stimu-r
lation of the pre-ganglionic nerve to the superior cervical ganglion.
BRL. 556 was found to have 0.2 times the activity of hexamethonium
bromide but it's duration of action was only 9.5 min compared to 31 min
for hexamethonium at an equi-effective dose.
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Mydriatic activity and duration of action.
(a) Mice. The mean pupil diameter of mice receiving atropine
sulphate and BRL. 556 at various time intervals after subcutaneous
administration with 0.05, 0.10 and 0.20 mg/kg are shown in Fig. 1.
At all dose levels maximum dilatation occurred after 20 min. After
140 min the pupil diameter of mice which had received atropine sulphate
had returned to normal, but with mice which had received BRL. 556
there was still pronounced dilatation even with the lower dose of 0.05













Mydriatic activity of subcutaneously administered BRL. 556 (broken line) and atropine
sulphate (continuous line) in groups of 10 mice.
(b) Rats. The pupil diameter at various time intervals after the sub¬
cutaneous administration of 20 mg/kg BRL. 556 and atropine sulphate
were recorded until they had returned to the approximate pretreatment
levels. Following atropine sulphate the pupil diameters had returned
to normal within 27 hr, while following BRL. 556 they did not return
to normal till 190 hr (8 days) after dosing (Fig. 2).
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Salivary flow. The relative potency of BRL. =556 to atropine sulphate
was determined in the rabbit at 15 min after administration of the drugs,
and it was found that BRL. 556 was 3.0 times (5 % limits of error of
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Fig. 2
Mydriatic activity in groups of 3 rats receiving 20 mg/kg subcutaneously of either
BRL. 556 (black columns) or atropine sulphate (blank columns).
In the cat, however, where the activity was assessed immediately
following the administration of the drug, it was found that the relative
potency of BRL. 556 in terms of atropine sulphate was 1.5 (5 % limits
of error of 1.2 to 2.0 mg/kg).
Gastric secretion. The results of the effect of BRL. 556 and. atropine
sulphate are shown in Fig. 3.
For the 2 hr Shay rat BRL. 556 was found to be 7.2 times as active
as atropine sulphate (5 % limits of error of 5.0 to 10.6 mg/kg). The
pupils of the rats in this experiment were considerably dilated with
atropine sulphate at the high dose, although there was only slight dila¬
tation at the low dose. On the other hand, the rats receiving BRL. 556
showed negligible dilatation of the pupil at the high dose and no de¬
tectable dilatation at the low dose. In the 6 hr Shay rat the relative po¬
tency of BRL. 556 to atropine sulphate was 37.6 (limits of error of 12.4
to 114.0 mg/kg). During the course of the experiments at the 6 hr period
the high dose of BRL. 556 showed comparable dilatation of the pupil
to atropine sulphate, but at the low dose the dilatation was much less
with BRL. 556 although by the end of the forth hour of the test the











































Dose response lines for BRL. 556 (broken line) and atropine sulphate (continuous line)
in the 2 and 6 hr pyloric ligated rat. Columns represent the mean pupil diameter for













glucose starch 2 5 5 0 7 5 ioo 2000 glucose
starch ancj BRL 556 (/xg) and BRL 556
Fig. 4 (2000 /xg)
Effect of pretreatment with BRL 556 on the elevation of blood sugar produced by
orally administered starch. Each column represents the mean of four observations with
the standard error of the mean.
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effect of atropine sulphate had worn off and the pupil dilatation was not
greater than that seen with BRL. 556.
Pancreatic secretion. The effect of BRL. 556 on the blood sugar
picture of rabbits following a starch meal is illustrated in Fig. 4.
BRL. 556 within the dose range of 2.5 to 7.5 pg/kg intravenously
caused a reduction in blood sugar which was proportional to the dose,
but with dose of 7.5 /xg/kg and greater a complete block of the response
to the starch meal was not obtained. BRL. 556, 2 mg/kg intravenously,
had no effect on the blood sugar level following administration of glucose.
The serum amylase of plasma of control rabbits, and rabbits receiving
2 mg/kg BRL. 556 intravenously did not differ significantly. Levels
ranged between 400 to 500 Somagyi units/100 ml plasma in both
groups.
Absorption from the gastro-intestinal tract. Pupil dilatation after
intra-intestinal and intra-gastric administration of 1.0, 5.0 and 10.0 mg/kg
BRL. 556 and atropine sulphate is shown in Fig. 5. Intestinal absorption
of atropine sulphate occurred at a dose level of 1.0 mg/kg. However,
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Fig. 5
Absorption of BRL. 556 (black columns) and atropine sulphate (blank columns) from
the intestine and stomach of the pyloric ligated rat. Each column represents the mean
of four observations.
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10 mg/kg. With BRL. 556 there was a greater absorption from the sto¬
mach than the intestine following a dose of 5 mg/kg but when the dose
was increased to 10 mg/kg there was more absorbed from the intestine.
Discussion
BRL. 556 is a potent anti-ACh compound but it's relative potency
to atropine sulphate both in vitro and in vivo is dependent on the method
of assessment. On the isolated guinea pig ileum with a pre-contact
time of 30 sec, the anti-ACh activity of BRL. 556 was 0.77 times that
of atropine sulphate, whereas in the determination of the pA2 value,
where the pre-contact time was 14 min, BRL. 556 had a relative potency
of 2.5.
In in vivo experiments where the activity of the drug is assessed within
periods up to 20 min of administration, i.e. the inhibition of the vaso¬
depressor response to ACh, the inhibition of salivation as measured by
cannulation of the Wharton's duct and the mydriatic response in mice,
the activity of BRL. 556 was of the same order as atropine sulphate.
However, in the Shay rat test when the assessment of activity was
carried out at 2 and 6 hr after administration of the compounds, the
relative activity of BRL. 556 to atropine sulphate rose from 7.2 to 37.5
respectively.
In addition to its effect on gastric secretion, BRL. 556 had a pronoun¬
ced action on salivation and pancreatic secretion. With regard to the
latter, there was complete block of the vagal component in doses above
7.5 fig/kg intravenously leaving the basal secretion unaffected.
Biochemical studies (Mansford, personal communication) have shown
that 28 % of the injected dose of BRL. 556 is excreted within 24 hr.
of administration, and that the close analogue poldine methosulphate
([i-methyl-2-pyrrolid-2-yl] methyl benzilate methosulphate) is excreted
at the same rate. Poldine methosulphate has a similar duration of action
to atropine sulphate (6) and therefore the enhanced duration of action
in vivo may be accounted for by a firmer binding to the cholinergic
receptor site and is not due to a difference in rate of elimination.
According to observations made by Sciianker (14) only weak bases
which are dissociated in acid solutions are absorbed by the stomach
and in the intestine, weaker bases are preferentially absorbed to stronger
bases. As regards intestinal absorption we have found that our results
agree with these observations. However, in the stomach we have found
that the stronger base, BRL. 556 is absorbed more readily than the
weaker base, atropine sulphate.
21G
d. m. brown, d. e. hall and d. h. turner 562
From previous studies we have noted that the phenyl-cyclohexyl
glycollic acid moiety is responsible for the duration of action. For
example, oxyphenonium [diethyl(2-hydroxyethyl) methyl ammonium
bromide a-phenylhexyl glycollate] is 7.6 times as active as atropine
sulphate in the 6 hr Shay rat. As far as is known no other acid moiety
has been shown to be responsible for such prolonged activity.
Summary
BRL. 556 (i-methyl-2-pyrrolid-2-yl) methyl phenylcyclohexyl gly¬
collate, has been found to be a potent atropine-like compound with a
long duration of action.
In the pyloric ligated (Shay) rat, relative potencies, in terms of atropine
sulphate (= 1.0), of 7.2 and 37.5 were obtained in the 2 and 6 hr pre¬
paration respectively. Other in vivo tests such as the inhibition of vaso¬
depressor response to acetylcholine, the inhibition of salivation, and the
mydriatic response, have shown the activity of BRL. 556 to be of the
same order of activity as atropine sulphate. In vitro anti-acetvlcholine
activity as assessed at 30 sec contact and 14 min contact (pA2 deter¬
mination) have given relative potencies of 0.7 and 2.3 respectively.
The differences in the relative potency obtained by the various methods
is discussed.
BRL. 556 has no curare-like or antihistamine properties.
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BRL 1288—A NEW ANTI-PARKINSON
DRUG
By
D. M. BROWN, B. O. HUGHES
and
M. D. MEHTA
(Reprinted from Nature, Vol. .223, No. 5204, pp. 416 417,
July 26, 1969)
(.Reprinted from Nature, Vol. 223, No. 5204, pp. 416-417,
July 26, 1969)
BR.L 1288—a New Anti-Parkinson Drug
The symptomatic treatment of Parkinson's disease
usually involves anti-acetylcholine drugs which may block
muscarinic receptor sites on neurones in the reticular
formation. Unfortunately, all of the drugs in common
use have pronounced peripheral anti-acetylcholine actions
which result in unpleasant side effects, such as dryness of
the mouth and mydriasis.
Doyle et al.1 have described the pharmacology and
chemistry of a series of basic esters and have prepared
glycollic acid esters derived from the open chain alcohols by
transesterification of methyl a,a-diphenyl-glvcollate with






(X= alkylene group containing two or three carbon
atoms)
R, and R2 = alkyl groups containing one to six carbons
While examining this series of compounds for anti-
Parkinson activity, we found that the compound 2(ethyl-"
n-propylamino)ethyl a,a-diphenyl-glycollate hydrochlor¬
ide2 (BRL 1288) had maximum activity in the CXS and
minimal peripheral anti-acetylcholine activity. In mice
a dose less than one fifth of that which caused mydriasis
reduced tremor. Any other anti-Parkinson drug would
not inhibit tremor until doses, at least six times greater
than those required to produce mydriasis, were given.
A modification of the method described by Everett,
Blockus and Shepperd3 was used to assess anti-Parkinson
activity. These authors found that tremorine (1:4
dipyrrolidine but-2-yne) produces a generalized tremor and
akinesia in mice, and that these effects can be antagonized
by drugs having anti-Parkinson activity. Subsequently,
it was shown4 that the metabolite of tremorine, oxo-













tremoriiie, was the active treinorogenic agent when given
orally or subcutaneously.
We induced tremors in mice by the intraperitoneal
injection of oxotremorine (2 mg/kg), and an observer, who
was unaware of the treatment programme, assessed them
subjectively on a scale of 0, 1 or 2 according to the degree
of tremor.
Maximum tremor occurs approximately 10 min after
oxotremorine injection and therefore the injection of
BRL 12SS and of t he reference drug, benzhexol, was timed
so that the peak anti-tremor activity would coincide with
the time of maximum tremor. BRL 1288 and benzhexol
were given orally 40 min or subcutaneously 20 min before
this peak. Ten female mice (SAS/ICI strain) weighing
18-22 g were allotted to each group. A control group,
which received only oxotrcmoriiie, was included. Reduc¬
tions in tremor in the test groups were expressed as a
percentage of the control group and the results plotted on
log probit paper. The ED50 values (mg/kg) were read from
this graph (see Table 1).
To assess peripheral anti-acetylcholine activity in vivo
the compounds were injected subcutaneously to mice kept
under subdued lighting. Pupil diameters were measured
on an arbitrary scale using a binocular dissecting micro¬
scope with a. focal light source directed on the eye. Meas¬
urements were taken before and at suitable intervals
after drug administration. The potency of BRL 1288
relative to benzhexol was 0-036, and Fig. 1 shows the
time course of the mydriatic activity.
Further pharmacological studies have shown that the
compound possesses anti-convulsant activity against
maximal electroshock seizures in mice. An EDS0 of
10-6 mg/kg was obtained 0-5 h after subcutaneous admini¬
stration of BRL 1288 compared with an ED50 of 17-0
mg/kg for sodium phenobarbitone. Sedation occurs with
largo doses, but no other significant effects have been
detected.
Rats absorb almost all the "0 BRL 128d given orally
and no unchanged BRL 1288 can be detected in urine or
faeces. Approximately 2o per cent of the radioactivity
was excreted in the urine; the remainder, as a result of
biliary excretion, went in the faeces. After giving un¬
labeled BRL 1288, benzilic acid, propylaminoethanol,
ethylaminoethanol and ethylpropylaminoethanol have
been identified by chromatography in urine. Humans
excrete similar metabolites in the urine. Whole body
400
0 L0 40 60 80 100
Time (min)
Fig. 1. Time course of mydriatic activity of BEL 1288 (O -- O, 20
mg/kg; x— x, 10 mg/kg) and benzhexol (A--A, 0-8 mg.'kg;
Q ©, 0-4 mg/kg) in mice subcutaneously.
autoradiography of mice has shown that radioactivity is
present in the brain, and preliminary chromatographic
examination ofmouse brain homogenates has revealed the
presence of unchanged BRL 12S8.
Initial toxicity studies have been carried out in the
rat. and dog. Toxic symptoms appear in rats injected
subcutaneously with daily doses in excess of 150 mg/kg
and there is evidence of hepatotoxicity. In the dog slight
convulsions were observed after daily oral doses of 50
mg/kg, and lower doses were sedative.
Preliminary clinical studies with Parkinson patients
at St Thomas's Hospital made in collaboration with Dr
Marsden of the MRC Medical Unit,. Department of Medi¬
cine and Neurology, St Thomas's Hospital, have shown
that BRL 12SS is of considerable value in the symptomatic
treatment of Parkinson's disease; peripheral anti-acetyl-
eholine side effects were absent at effective clinical doses
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Abstract - Metabolism studies in rats with C-labelled
Benapryzine hydrochloride showed that the drug was well
absorbed from the gut after an oral dose and that the bile was
the most important route of excretion. No unchanged drug was
detected in the urine, faeces or bile and the major route of
metabolism was found to be hydrolysis to benzilic acid and
ethylpropylaminoethanol. Some N-dealkylation occurred and
propylamineethanol and ethylaminoethanol were excreted in the
urine. Benzilic acid and ethylpropjiaminoethanol were found in
the urine of Parkinsonian patients receiving the unlabelled drug.
Whole body autoradiography of mice showed that radioactivity was
widely distributed within ten minutes of an oral dose of
14
'C Benapryzine hydrochloride. The radioactivity in the C.1I.S.
was found by T.L.C. to be due to unchanged Benapryzine and the
presence of Benapryzine in the C.U.S., as.shown by the autoradio¬
graphy, coincided with the time course of central antiacetylcholine
activity of the drug in similar mice. The degree of penetration of
Benapryzine into rat brain was studied and evidence was obtained that
the unchanged drug penetrated into brain cells. The results were
consistent with pharmacological evidence that Benapryzine hydro¬
chloride is a centrally acting antiacetylcholine drug.
INTRODUCTION
Of a series of basic esters of benzilic acid tested
in these laboratories, Benapryzine hydrochloride 2(ethyl-n-propyl-
amino)-ethyl-a,o-diphenylglycollate hydrochloride ^ (BRL 1288)
was found to have significant central antiacetylcholine activity
(2)associated with minimal peripheral activity and it was, there¬
fore, chosen for further pharmacological, toxicological and clinical
studies with a view to assessing its potential as an anti-Parkinson
drug. The present work on the metabolism and distribution of the







Benapryzine hydrochloride labelled with C on the






It was synthesized by the reaction of benzilic acid
(carboxylase) with 2-chloroethyl ethylpropylanine in isopropyl
alcohol. The labelled benzilic acid was prepared by carbonation
14 t 14 ^
with C-carbon dioxide (derived from C-bariuia carbonate; of the
disodio adduct of benzophenone.
14
The specific activity of the C-Benapryzine hydrochloride
was 62.7 jiCi/mg. It was found to be radiochemically pure when checked
by T.L.C. and autoradiography.
Some of the experiments to determine the route of elimi¬
nation from the body were performed using "^C-Benapryzine hydrochloride
synthesized from benzaldehyde (carbonyl-^C) via benzoin. The drug
produced by this route was labelled on the carboxyl carbon and on the
a carbon of the a,a diphenylglycollic acid moiety, and had a specific
activity of 0.44 pCi/mg.
Animal Studios
Sprague-Dawley rats (Charles River, France) weighing
between 150 and 350 g and CF/lP mice (Carworth Europe, Huntingdon,
England) weighing 20 g were used.
14
C Benapryzine hydrochloride was administered either
t>y gastric intubation or by subcutaneous injection in isotonic saline.
For the excretion and metabolism studies, rats were housed
singly in glass metabolism cages designed to effect the separation of
urine and faeces, ^he samples were collected in tubes cooled to -73° .
14
2-aminoethanol was used to trap any expired C-carbon dioxide.
For the study of biliary excretion, bile ducts were
(3)
cannulated according to the method of Harrison, White and Steward
and the rats were kept in close-fitting restraining cages.
In the studies on the distribution of radioactivity, nine
mice were dosed orally with ^C-Benapryzine hydrochloride (50 mg/kg.
1 pCi/g). At 5, 10, 20, 40 minutes and 1, 2, 4, 8, 16 and 24 hours
after dosing, one of the mice was anaesthetized with ether and killed
by immersion in solid carbon dioxide-ethanol. The distribution of
radioactivity was investigated by a whole-body autoradiographic
(4)
technique similar to that used by Ullberg . 1 mm sections were
cut on a base-sledge microtome in a cold room at -10° and were then-
exposed at -78° to Kodak Royal Blue X-ray film which was held in wooden
cassettes. Control sections from animals which had received no radio¬
activity were exposed at the same time.
The penetration of radioactivity into rat brain was studied
(5)
by the method of Nair and Roth *
227
Determination of Radioactivity
Measurements of radioactivity were performed on a
Packard Tri-Carb Liquid Scintillation Spectrometer (Model 5314)
or a Packard Auto Gamma Spectrometer,
The faeces were freeze dried and then weighed
portions were oxidized by the method of Dobbs
Urine was diluted to a convenient volume, then 0,5 ml
portions were added to 10 ml of Omnifluor (N.E.H. Corp, 4 g
dissolved in 1000 ml toluene) and 6 ml of 2-ethoxyethanol. 0,1 ml
portions of bile were counted in a similar way.
Blood (0,1 ml) was dissolved in 1T.C.3. (Amersham/Searle)
(7)
and bleached with benzoyl peroxide in toluene before the
addition of 10 ml of Omnifluor scintillator.
Weighed samples of brain were counted as for blood except
that no bleaching was inquired,
131
Samples of brain or blood containing I -were mixed
thoroughly with 4 ml of water in plastic tubes before being counted
on the Packard Auto Gamma Spectrometer.
228
Analytical Methods
The radioactive compounds present in whole urine and
bile, and faecal or brain honogenates were separated by T.L.C.
and located by autoradiography. The biological materials were
then acidified to pH 2 with concentrated hydrochloric acid or
made alkaline to pH 10 with solid sodium carbonate and extracted
with chloroform. The extracts were examined by T.L.C. and.auto¬
radiography.
In some experiments, urine or bile samples were mixed
with acetate buffer at pK 5.2 and incubated with ^-glucuronidase
(Sigma) at 37° for 24 hours to hydrolyse any glucuronides present.
Use was made of colour spray-reagents mainly to detect non¬
radioactive metabolites. Amines were detected with ninhydrin,
(8)
glucuronides with naphthoresorcinol and benzilic acid and
(9)
benzilates with concentrated sulphuric acid . Where appropriate,
control materials from undosed animals were examined.
T.L.C. was carried out on Silica Gel Q prepared according
to Stahl (E. Merck, Darmstadt). The solvent systems used are shown
in Table 2. Spots on the T.L.C. plates were identified chromatographi¬
cally by using, as reference compounds, the potential metabolites, which
were available as pure compounds.
-7-
Human Urine
24-hour urine samples were obtained from patients with
Parkinson's disease who were receiving unlabelled Benapryzine
hydrochloride (25 mg t.d.s.). Control urines were obtained from






The results of the experiments on rats, summarized in
Table 1, show that the excretion pattern was similar irrespective
of the route of administration. Over 75/S of the radioactivity-
administered was excreted within 24 hours and the remainder was
accounted for within 72 hours.
The table also shows the result of an experiment in
14 14
which C-labelled bile obtained after dosing a rat with C~
Benapryzine hydrochloride was readministered orally to other rats.
An average of 7,"5% of the radioactivity was excreted in the urine,
demonstrating that some reabsorption occurs.
No radioactivity was detected in the expired air in any
experiment.
TABLS1




































































No unchanged Benapryzine could be detected in urine or
extracts of urine. The major radioactive metabolite was identified
14
as benzilic acid. It had the same Rf value as authentic C-benzilic
acid in each of the solvents used (Table 2) and ran as a single spot
when combined with benzilic acid. It gave the same red colour as
benzilic acid when aprayed with concenti'ated sulphuric acid and
heated at 100°C for a few minutes, ^he benzilic acid excreted in
the urine accounted for 40/fe of the total urinary radioactivity.
Other radioactive metabolites appeared to be identical
to spots detected with the .naphthoresorcinol spray for glucuronides.
Incubation of urine with (3-glucuronidase increased the amount of
radioactivity extractable into chloroform at pH 2 from 40.5^ to
61.6% and the radioactive zones which corresponded to glucuronides were
no longer detectable.
Three non-radioactive metabolites were detected with
ninhydrin and were identified as ethylpropylaminoethanol, propyl-
aminoethanol and ethylaminoethanol by T.L.C., using authentic chemicals
as reference compounds.
Human Urine:
Benzilic acid was identified by T.L.C. in a chloroform
extract of acidified human urine and ethylpropylaminoethanol with
traces of propylaminoethanol and ethylaminoethanol were identified in
a chloroform extract of urine which had been made alkaline. No
unchanged Benapryzine was detected.
Rat Faeces:
233
No unchanged Benapryzine was detected in aqueous
homogenates of faeces or in chloroform extracts made after the
homogenates had been adjusted to pH 10. Benzilic acid was identified
in chloroform extracts of acidified homogenates.
Rat Bile:
14
C- benzilic acid was found to be present in the bile,
together with a number of unidentified radioactive metabolites. As
in the case of rat urine, evidence was obtained by f.L.C. that some
of the metabolites were present as glucuronides. Incubation of the
bile with (3-glucuronidase increased the amount of radioactivity
extractable into chloroform under acidic conditions from an average
of 3.6/o to an average of 30.670. Again, no unchanged Benapryzine was
detected.














Benapryzine 0.56 0.95 0.95
^C-Benzilic acid 0.80 0.33 0.80
Ethylpropylaraino-
0.56ethanol 0.31 0.51
Propylaninoethanol 0.37 0.22 0.51
Ethylaminoethanol 0.32 0.13 0.12
Distribution Studies in Mice
235
The whole-body autoradiography obtained after dosing
14
mice orally with C-Benapryzine hydrochloride showed that the
drug was rapidly absorbed and was widely distributed throughout
the body within ten minutes of dosing. The drug or its radioactive
metabolites had penetrated into the C.N.S. by this time and high
concentrations of radioactivity were found in the stomach, intestine,
liver, kidney, urine and Harder's gland. At forty minutes, the
generally high level of radioactivity was beginning to decrease
and, eventually, by four hours radioactivity was localized mainly
in the liver, gall bladder, intestine and urine. Radioactivity was
practically absent from the C.N.S. by two hours. At twenty-four hours,
very little radioactivity remained and was localized in the liver and
intestine.
In the accompanying photographs of the whole-body auto-
radiographs, a higher intensity of black indicates a higher concentration
of radioactivity.
, , 236Fig.l Distribution of radioactivity in mice, 10 mins (,A;
1 hour (b), and 4 hours (c) after oral administration
14
of C-Benapryzine hydrochloride
1 = Brain 2 = Liver 3 = Stomach 4 = Kidney
5 = Intestine 6 = Harder's gland 7 = Salivary gland
8 = Urine 9 = Spinal cord 10 = Gall bladder
c. o /
Fig.l Distribution of radioactivity in mice, 10 mins (a)
1 hour (b), and 4 hours (c) after oral administration
of "^C-Benapryzine hydrochloride
1 - Brain 2 - Liver 5 ~ Stomach 4 ~ Kidncjr
5 " Intestine 6 - Harder1s gland 7 = Salivary gland
8 = Urine 9 = Spinal cord 10 » Gall hi adrifts
Brain •penetration studies
Extracts of mouse brain made at 10, 20, and 30 minutes
14
after oral or sub-cutaneous dosing with C-Benapryzine hydrochloride
were examined by T.L.C. and autoradiography and were found to contain
unchanged drug. After oral dosing, three unidentified' metabolites
were also present.
The results of an experiment to determine the degree of
penetration of radioactivity into rat brain are given in Table 3. The
relative concentrations of radioactivity in each of the regions of
brain studied were higher after intravenous administration of
14 14 35
C~B,enapryzine hydrochloride than after C-urea, S-sulphate or
131
I~serun albumen.
The radioactivity in rat brain, 30 minutes after an
14
intravenous dose of C-Benapryzine was found by T.L.C. and auto¬
radiography to be due to unchanged drug.
































































The principal route of excretion of radioactivity after
administration of "^C-Benapryzine hydrochloride to rats is via the
bile. The amount of radioactivity recovered in the bile in 12 hours
after oral administration is about the same as the amount excreted in
24 hours in the faeces of intact animals, indicating that the drug is
well absorbed from the gut after an oral dose.
Benapryzine hydrochloride is extensively metabolized by rats
and the excretion of unchanged drug was not detected. The major route
of metabolism is hydrolysis of the ester bond to give benzilic acid and
ethylpropylaminoethanol. Evidence was obtained that some acidic
metabolites are excreted in the urine and bile as glucuronide conjugates.
Some dealkylation of the drug also occurs giving rise to ethylaminoethanol
and propylaminoethanol. It is not clear whether the intact ester undergoes
dealkylation before hydrolysis* or whether it is first hydrolysed to give
ethylpropvlaminoethanol which is subsequently dealkylated. Benactyzine ,
which differs from Benapryzine only by the presence of an ethyl group in
place of the n-propyl group, can be dealkylated before being hydrolysed.
Edelson and Douglas have shown in rats following intraperitoneal
injection of Benactyzine that one of the metabolites excreted in the urine
is the N-de-alkylated product, ethylaminoethyl henzilate. However, neither
of the N-dealkylated products of Benapryzine was detected in the urine
after oral dosing, the limit of detection being about 1,o of the dose.
Prom the preliminary studies carried out, Benapryzine hydro¬
chloride is metabolized in man in the same way as in rats, the principal
urinary metabolites being identical in both species.
241
The v?hole body autoradiography of mice showed that* in
this species^like rat, the bile is an important route of excretion
of radioactivity, for the gall-bladder contained prominent concen¬
trations of radioactivity for up to 8 hours after dosing. The
*
persistence of radioactivity in the liver and intestine at 24 hours
after dosing is probably due to enterohepatic circulation of pharma¬
cologically inactive metabolites.
Benapryzine is believed to act on central cholinergic
mechanisms since it inhibits the tremors induced by oxotremorine in
mice • The duration of pharmacological activity found in this
test v coincides with the duration of radioactivity in the central
nervous system as demonstrated by autoradiography. The radioactivity
in the central nervous system was shown to be due to unchanged
^"C-Benapryzine, therefore it is probable that the unchanged drug is
responsible for the central pharmacological activity.
(5)
Using the technique described by Nair and Roth , evidence
was obtained that Benapryzine penetrates into the brain cells of rats.
The relative brain to blood concentrations of Benapryzine in each of
the regions of brain studied, were found to be higher than those of
"^"C-urea which was vised as an example of a compound capable of pene¬
trating into cells. The drug was not found to be concentrated in any
specific region of the brain.
The results presented in this paper support the pharmacological
evidence that Benapryzine hydrochloride is active in Parkinson's
disease through its action in the central nervous system.
V T) A TTn i ^
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ASSAY OF ATROPINE-LIKE DRUGS FOR INHIBITION OF
GASTRIC SECRETION
IN THE PYLORIC LIGATED (SHAY) RAT
by
D. M. BROWN and D. H. TURNER
(Received for publication 8-1 o-1962 ).
The Shay rat (Shay, Komarov, Fels, Meranze, Gruenstein, and
Siplet, 1945) can be used to estimate the effect of atropine-like drugs
on the gastro-intestinal tract. Some of the methods depend on the
prevention of rumenal ulceration which occurs within 24 hours following
pyloric ligation (Barrett, Rutledge, Plummer and Yonkman, 1953;
Cahen and Tvede, . 1951; Kowalewski, Mackenzie, Shnitka and
Bain, 1954; Munchow, 1954). Other workers (Gyermek and Nador,
1957; vanProosdij-Hartzema, janssen and de Jongh, 1955; Shea, 1956;
Visscher, Seay, Tazelaar, Veldkamp and Vander-Brook, 1954) have
used the inhibition of the volume of gastric juice secreted by the 2-8
hour preparations as an index of activity of the drugs. No quantitative
assessment of the amount of acid secreted has been made in any of these
studies, change in acidity usually being expressed simply as an altera¬
tion in pH. Since none of the methods used has given a precise estimate
of potency in relation to a standard drug the present study was therefore
carried out to evolve a more reliable assay procedure.
Method
Albino rats weighing 100-200 g, of either sex were starved for 24
hours in cages with wide mesh bottoms in order to prevent coprophagy.
Four or 5 rats were maintained in each cage. Water was allowed ad lib.
49° d. m. brown and d. h. turner
The rats were anaesthetized with ether and after laparotomy the
duodenum was ligated with nylon thread about 0.5 cm below the
pyloric sphincter. The abdominal muscle layers were sutured and the
skin closed with Michel clips. 4.0 ml. of warm 0.9 % saline were given
intraperitoneal^. The drugs were dissolved in 0.9 % saline and 0.1
ml./ioo g body weight was administered subcutaneously. After 2 or 6
hours, according to the conditions of the test, the rats were again anaes¬
thetized and the abdomen opened. The oesophagus was ligated just
below the diaphragm, the stomach removed, and the animal killed.
After removal of the adhering mesentery from the stomach its contents
were drained into a centrifuge tube through a slit in the greater curvature.
After centrifuging for 10-15 min., 2,000 r.p.m., the total volume of
the juice was measured, due allowance being made for the solid content.
The free acidity was estimated by taking 1.0 ml. of the supernatant and
titrating with 0.01 N.NaOH, 6 drops of Topfers reagent being used
as indicator. If the volume of juice recovered from one rat in a group
was less than 1.0 ml. all the samples from that group were pooled.
At various intervals after pyloric ligation the degree of pupil dilatation
was also estimated and scored as follows:
75 — 100 %maximum dilatation 4
5° — 75 % dilatation 3
25 ■— 50 % dilatation 2
5 — 25 % dilatation 1
Drugs used were atropine sulphate, atropine methvlnitrate, poldine
methylsulphate (Nacton), and oxyphenonium bromide (Antrenyl).
Results
Effect of Sex and Weight
The effect of sex and weight of the rats on the volume and acidity
of the juice secreted was ascertained from all the 2 and 6 hour untreated
control rats. The animals were divided into groups of increasing weight
range, and the volume of the juice and free acidity measured. The results
are given in Table I and an analysis of variance showed that in the
various weight ranges examined there was no significant difference in
the volume of juice nor in the concentration of free acid secreted.
There was also no significant differences in the response between the
sexes.
Correlation between volume of secretion and free acid concentration
To assay atropine-like drugs it is necessary to establish that the
TableI
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Table II
Dose response line for atropine sulphate in the 6 hour pyloric ligated rat
DOSE OF ItroiMNE S U L P HATE
6.25 mg/kg 1.25 mg/kg 0.25 mg/kg 0.05 mg/kg Control
X 3> X y X y x 3' X
0.8 0 2.0 68 3-6 37 4-7 67 4-9 99
2.3 60 t-5 55 4.2 78 2.8 79 5-3 107
0.7 0 3-6 5° 2-7 121 2.8 53 6.8 62
i-7 5° 3-6 54 5-8 100 4-4 74 3-5 79
0.9 0 '•7 64 1.4 48 3-8 88 7.6 101
i-4 45 1.1 39 4° 64 4-i 60 7-i 74
2.1 47 1.1 39 5-i 78 4.0 00CO 6.6 72
1 I-7 49 2.8 59 4.8 38 7-t 70 7-3 70
1.0 17 1-4 46 4-4 60 2.3 110 9.2 80
1.2 28 2.8 7i 2.9 43 7-5 75 5-i 67
3-7 7i 3-7 73 5-2 44 6-5 61 5-9 75
t-3 13 3-t 33 3-5 69 6.9 71 12.4 64
°-3 97 1.8 5° 1.9 76 4.2 100 9.0 81
1.6 55 3-3 4i 3-3 44 4.0 90 3-3 51
0.8 97 i-9 101 6.2 99 2.2 33 3-8 85
t-7 4i 4-7 56 5-2 52 i-7 0 7.6 77
0.4 30 4-7 77 3-3 67 3-5 56 6.4 54
0.4 3° 2.4 45 2.7 43 6-3 89 9.0 7°
0.4 3° 4.6 . 66 i-7 89 3-5 57 6.7 53
°-3 43 2.6 54 3-8 49 4.6 69 3-2 56
Total 24.7 oco 54-4 1,141 75-7 1,299 86.9 t,34° 130.7 1.477
Mean 1.2 40 2.7 57 coCO 65
'


























Within Rats 76 129.40 60.02 411.58 356-9I 75 4.76
For test of sigr
1 1
lificance of adjusted means 6l.l6 3 20.39
x — Volume of gastric juice (ml). y —
20.39
F = = 4.28 — (P > 0.05 < 0.01)
4.76
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relationship between log dose and the reduction in volume and acidity
of the gastric juice is linear. Four doses of atropine sulphate, 0.05, 0.25,
1.25 and 6.25 mg/kg were administered to groups of 4 rats which were
set up simultaneously with a control group. The procedure was repeated
on successive days until a total of 20 rats had been employed at each
dose level.
The values for volume and free acid concentration of gastric juice
are given in Table II. The relationship between free acid concentration
and volume of gastric juice was examined by co-variance analysis,
(Snedecor, 1946), and it was shown that a significant correlation (F =
4.28) between the 2 variables existed. In all determinations of the effect
of drugs on gastric secretion we therefore measured only the volume
of juice secreted by each animal. This was then converted to a percen¬
tage of the mean volume of juice secreted by the control group for each
day of the test.
Assays
A number of 2 X 2 assays were performed with, known anti-acetyl-
choline drugs. Atropine sulphate was used as the standard. A high dose
and low dose of the compound was selected so that the high dose would
give an inhibition in the volume of juice secreted of about 70 to 80 %
and the low dose about 20 % of the control volume. A dose ratio of
1:12 for all compounds tested was found to be satisfactory. Five rats
were used at each dose level for each day of the test together with a
control group, untreated, of 5 rats. The test was repeated every day
for 4 days so that 20 rats were used for each dose. The percentage
inhibition of the volume of juice was calculated as previously and the
results of the 4 tests were pooled. The results were analysed by the
method of Schild (1942) and the relative potency with 5 % limits of
error calculated.
In order to obtain some measure of the duration of action the pupil
diameters were scored at 2, 3, 4 and 6 hours after dosing in the 6 hour
test, and at 2 hours only in the 2 hour test.
The assay results are given in Table III and the relative effects on
gastric secretion and mydriatic effects are shown in Fig. 1. In none of
the assays was there a significant deviation from parallelism (P > 0.1)
and the variance due to regression was always highly significant (P <
0.001). In relation to atropine sulphate, atropine methylnitrate and
oxyphenonium were respectively 1.7 and 5.2 times more active in the
6 hour than in the 2 hour Shay rat. On the other hand, poldine methyl-
sulphate has the same activity in both the 6 and 2 hour preparation.
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The mydriatic response due to atropine methylnitrate and poldine
methylsulphate in both the 2 and 6 hour preparations parallels the
activity of atropine sulphate but the effect of oxyphenonium is more
prolonged than that of atropine sulphate. This effect is more noticeable
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HIGH DOSES LOW DOSES
Fig. 1
Assays of atropine-like drugs in the 2 and 6 hour pyloric ligated rat. Continuous
dose response lines — atropine sulphate and broken line — drugs. Mydriatic activity,
mean score for pupil diameter of twenty rats, black columns — atropine sulphate, blank
columns — drug.
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Table III
Relative potencies of atropine-like drugs in terms of atropine sulphate as evaluated by the





Relative Potency with 5 % limits of error
(P = 0.95). Atropine sulphate =1.0
6 hour A 2 hour A
Atropine Methyl Nitrate 7.9 (4.0-15.4) 0.50 4.7 (2.0-10.9) 0.69
Oxyphenonium 7-3 (3-4-I5-5) 0.56 1.4 (0.7-2.6) 0.60
Poldine 0.6 (0.2-1.2) 0.63 0.6 (0.4-1.1) o-55
Discussion
In the 4 hour pyloric ligated rat, Shay, Sun and Gruenstein (1954),
found that although there was no significant difference between males
and females, there was an increase in the rate of secretion and acid
output with increase in weight. In the present study with 2 and 6 hour
pyloric ligated rat it was found that over the weight range used (100-
200 g) neither sex nor weight had any significant effect on the volume
of secretion. In the assays therefore, no adjustment for weight was made
in expressing the volume of secretion.
A 24 hour period of starvation was considered adequate, as in the
majority of cases the volume of solid present in samples of gastric
juice after pyloric ligation was 0.2 ml. or less. Such a period of starvation
did not appear to have any detrimental effect on the general condition
of the animals. Other workers (Cahen and Tvede, 1951) have used up
to 72 hours as the period of starvation, but according to Madden,
Ramsburg and Hundley, (1951) a 72 hour starvation can influence
the rate of secretion and causes a lowering of resistance of the mucosa
with consequent haemorrhagic erosions and buffering of gastric juice.
In our experiments there was considerable variation in the volume
of juice secreted in the untreated control rats. The mean volume secreted
by a group of 219 rats was 7.1 ± 2.2 ml. (S.D.) in 6 hours and 2.6 ± 1.2
ml. (S.D.) in a groups of 83 rats in the 2 hours. In view of this we there¬
fore decided to use a minimum of 20 rats at each dose level for studying
the inhibitory effect of atropine-like drugs on gastric secretion.
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For assay purposes it is necesary to set up a control group simultane¬
ously with the groups under test. The activity at a dose level is then
expressed as a percentage inhibition of juice secreted by the control
group instead of simply measuring the depression in volume secreted
between the groups without reference to the control. The former proce¬
dure takes into account solely the effect of the drug on the secretion
which can be inhibited by atropine-like drugs and is not complicated
by any basal secretion which can vary to an unknown degree.
Rats used in the 6 hour assays gave mydriatic responses indicating
that the drugs differed in their duration of action. Under the circum¬
stances, therefore, the relative effect of the drug may vary according
to the time at which the animals are killed. This was confirmed in the
2 hour preparation. Atropine methylnitrate and oxyphenonium in
the 6 hour preparation were 7.9 and 7.3 times as active as atropine
sulphate respectively, while in the 2 hour preparation the activities were
4.7 and 1.4 respectively. On the other hand, poldine methylsulphate
had the same relative activity at both time intervals, indicating that its
duration of action was similar to atropine sulphate. In quoting the
relative activities of atropine-like drugs in vivo the time at which the
final reading is made should always be stated. In addition, the in vitro
anti-acetylcholine activity of the drugs should also be given in order to
indicate the absolute activity of the compound; this absolute value
being indeterminable in the Shay rat preparation.
The assay procedure as described gives reproducible results and
relative activities can be quoted together with fiducial limits. The index
of precision (A) does not indicate a high degree of accuracy but in all
the assays carried out it is consistent.
Summary
An assay procedure using the inhibition of volume of gastric juice
in the 2 and 6 hour pyloric ligated rat is described. Relative potencies
of oxyphenonium, poldine methylsulphate and atropine methylnitrate
in terms of atropine sulphate are given for both 2 and 6 hour prepara¬
tions. The importance of the duration of action of the drug under test
in comparison with that of the standard is emphasized.
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Introductory Papers
PRACTICAL ASPECTS OF STRAIN VARIATION IN RELATION
TO PHARMACOLOGICAL TESTING
By D. M. Brown and B. O. Hughes
Department of Pharmacology and Chemotherapy, Beecham Research Laboratories,
Brockham Park, Betchworth, Surrey
The control of variation in animal experimentation particularly in the
field of bioassay and pharmacological screening is perhaps one of the
principal problems confronting the industrial pharmacologist. The
application of statistical procedures and design to problems of toxicity
and bioassay by Trevan (1927) and Gaddum (1933) pointed the way to
refinements in experimental method thereby improving the accuracy of
the tests. Further advances in bioassay procedure resulted from the
classical research of Fisher who used statistical methods to determine
precisely the variation due to different factors within the experiment and
then by appropriate design, considering each factor, limited the variation
to a minimum. With a view to reducing variation still further a number
of industrial laboratories concentrated on the production of inbred lines
in the hope that more constant and uniform responses would be obtained.
This largely became established practice although little experimental
evidence was brought forward to support the belief. Mather (1946)
subsequently observed that Fj hybrids gave more uniform responses and
were generally more vigorous than either of the parent inbred strains.
These observations were largely overlooked until McLaren and Michie
(1954) and Biggers and Claringbold (1954) independently re-discovered
this phenomenon. Biggers, McLaren and Michie (1961) feel in general
that the Fj hybrid is the most satisfactory laboratory animal. Chai
(1960) has put forward an opposing viewpoint stating that "For the
assay of a given substance, the choice of assay animal—either inbred or
an Fx hybrid—cannot be made in advance; it has to be based on existing
data or determined experimentally". Brown (1961a, b) has lent addi¬
tional experimental evidence to support this.
Environmental conditions, however, also play a vital part in biological
assay. Chance has carried out extensive investigations into the effects of
altering the environmental conditions. These investigations have been
admirably summarised by Russell and Burch (1959).
Finally in this respect mention must be made of the work of the Labor¬
atory Animals Centre under the direction of Dr. Lane-Petter and of the
Animal Technicians Association who have done so much to improve the
general quality and health of the laboratory animals. Without a healthy
robust animal all experimental work involving animals, whether pharma¬
cological or bacteriological, can be rendered virtually worthless.
Differences in the physiological response of various strains of mice have
been clearly recognised. Elizabeth Russell (1955) in an excellent review
of the "Significance of Physiological Pattern of Animal Strains in
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Biological Research", has drawn attention to the considerable differences
that occur between mice to disease susceptibility, nature of disease pro¬
duced by a given pathogen, survival time of infected individuals; capacity
for antibody production, cold tolerance, reaction to specific toxins;
sensitivity to and content of various hormones and reaction to endocrine
extirpation; differences in normal blood-cell levels, life-expectancy and
pathological pattern. The pharmacologist has been perhaps rather
slower to give consideration to strain variation and it is the purpose of
this paper to draw attention to the considerable variations which may
exist and to indicate how, by correct selection of strain the quality of
pharmacological assays may be improved.
Siegmund, Cadmus and Lu (1957) have developed a screening technique
for mild analgesic drugs which has gained considerable acceptance
among industrial pharmacologists. In this test phenylquinone is injected
intraperitoneally to mice and a typical response is produced which can be
inhibited by analgesic drugs. Phenylquinone produces a characteristi¬
cally biphasic response in a number of strains of mice—intermittent con¬
traction of the abdomen, rubbing the abdomen on the floor of the cage
and stretching of the hind limbs. Unless an adequate degree of this
writhing response is produced, the test gives erratic and non-reproducible
results (Hendershot and Forsaith, 1959). Similarly in our own laboratory
we were unable to get satisfactory responses and we therefore decided to
examine as many strains as possible in order to select the one which gave
best writhing response. We obtained eight strains through the courtesy
of Dr. Lane-Petter of the Laboratory Animals Centre, Carshalton, and
three other strains from commercial sources all of which were examined
for their writhing response.
Methods
Random samples of 6 male mice, 5 to 7 .weeks old, from each strain
were injected intraperitoneally with 2 mg./kg. phenylquinone and the
individual reaction of each mouse was recorded for a period of 30 min.,
noting the cumulative number of writhes at 2 min. intervals. Two mice
from each strainwere tested on each of 3 days, the strains being randomised
throughout the test days. From these results the frequency of writhing
during each 2 min. period was computed. The phenylquinone was
injected as an 0-2 mg./ml. solution in 5 per cent ethanol and was main¬
tained at 37°, the solution being just below saturation at this temperature.
In all tests the technician was unaware of the strain being used. In
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Results
The frequency ofwrithing in eleven strains ofmice is illustrated in Fig. 1,
and the total number of writhes per mouse in a 30 min. period following
administration of the phenylquinone is shown in Table I. The mice can
be divided into three groups: those which show a large number of writhes
C57L(i)
10 20 30 10 20 ^00 10 20 30 0
Time (min.) after 2 mg/kg. phenylquinone i.p.
Fig. 1. Frequency of writhing of II strains of mice.
CBA, C57Br/cd, CE and ALB3; those which are intermediate in responses'
C57BL/6, C57L, C3H and ALB1, and those which give poor responses
A2G, ALB2 and DBA/2. The characteristics of the writhes also differ
between those groups. In the strain which give a large number of
writhes, the syndrome is quite distinct but in the others the phases are less
clearly seen, and in the poorly responding animals a writhe may only be
detected as a slight contraction of the abdomen or stretch of the limbs.
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TABLE I
Number of writhes pf.r mouse in 30 min. for eight inbred and three commercial
mouse strains following intraperitoneal administration of 2 mg./kg.
phenylquinone
Weight Writhes per mouse
Experiment Strain (g-) No. 1 No. 2 No. 3 No. 4 No. 5 No. 6 Mean
CBA 14-17 38 60 16 90 41 38 47
C57BL/6 12-15 3 16 49 19 8 22 19
w C57L 21-25 22 21 32 20 1 30 21
C57Br/cd 15-18 47 17 53 65 49 75 51
A2G 15-18 8 16 9 9 0 10 9
CE 14-19 36 39 0 49 75 34 39
CE* 13-15 43 40 34 25 33 35
CBA 21-24 24 54 34 28 65 39 4!
(ii) DBA/2 8-14 7 1 20 36 43 14 20
CSH 20-23 12 27 55 20 10 21 24
ALB1 20-23 40 62 5 25 13 32 29
ALB2 17-19 17 12 7 18 16 19 15
ALB3 15-19 39 18 33 77 43 24 39
* Litter mates.
Individual variation in the number of writhes within groups is also
high even in mice which respond well but this does not detract from
using the phenylquinone test to give a graded response with analgesic
drugs. Records of the writhing frequencies of batches of five mice from
one strain (ALB3) show that 15 mice will give a mean number of
writhes of 129 ± ll'O S.E.M. For a more accurate test the use of litter
mates would obviously reduce this error still further (Table II) but this
would generally be impracticable in a screening programme.
TABLE II
Mean number of writhes and a comparison of the coefficients of variability
at 20 min. and 30 min. in response to intraperitoneal administration of 2 mg./kg.
phenylquinone, in different mouse strains
20 min. 30 min.
Mean no. Coefficient Mean no. Coefficient
Experiment Strain of writhes of variation of writhes of variation
CBA 390 51 47-2 53
C57BL/6 16 3 85 19 5 83
(i) C57L 18 7 58 210 55
C57Br/cd 42-7 42 510 39
A2G 7-3 54 8-7 59
CE 31-7 62 38-8 63
CE* 28-8 22 350 20
CBA 31-8 38 40-7 39
(ii) DBA/2 15-8 79 20-2 81
CSH 19-3 65 24-2 68
ALB1 24-3 73 29-5 69
ALB2 12-8 34 14-8 31
ALB3 33-3 51 390 54
* Litter mates.
The phase of most frequent writhing is complete in 20 min. although
the mice continue to writhe for some time afterwards but at a much
reduced rate. No significant difference was found between the estimates
of the variability of the number of writhes in 20 min. and 30 min. periods,
therefore it is unnecessary to count for more than 20 min.
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In order to verify that mice obtained from one source would still retain
their writhing characteristics even when reared in a different laboratory,
breeding pairs of CBA and C57BL/6 were obtained from the Laboratory
Animals Centre. The first strain gave a good writhing response and the
second an intermediate response. We raised sufficient numbers to repeat
the tests, the results of which are shown in Fig. 2. The curves of the
second test overlap precisely the initial curves obtained with both strains.
mice); x — x April, 1961 (6 mice); ©—© November, 1961 (30 mice).
Finally having shown that a mouse strain writhes consistently and then
having selected a strain which gives an adequate degree of writhing, it is
also necessary to confirm that the animals continue to give the same
response to the analgesic drugs (Fig. 3). The dose response line obtained
Log dose (mg./kg.)
Fig. 3. Single day analgesic assays of aspirin, 15 mice/dose. Q -Q 9.12.1960;
O-- O 6.12.1961; X -- x 11.12.1961.
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on 9/12/60 for the mean writhing response to graded doses of aspirin for
the 20 min. period following phenylquinone was compared with the line
obtained exactly a year later (6/12/61) using the same strain of mouse.
The two lines were found to be in very close alignment. A further dose
response line prepared 5 days after the last test (11/12/61) gave a slope
which was also virtually identical to the other two. The ED50 values for
each test were respectively 58, 54 and 60 mg./kg. Mice which responded
poorly to the phenylquinone failed to give a linear response to aspirin.
Discussion
By consideration of the genetical, physiological and environmental
background of the strain of animal used in assay and screening procedures
the quality of a test can be considerably improved with a corresponding
reduction in error variance. The sensitivity and accuracy of tests can
be enhanced further by the selection of the strain of animal which gives
the best pharmacological response. It is not uncommon that many
pharmacological testing procedures are acceptable to one laboratory and
not to another. The reason for these discrepancies can largely be found
in the strains of animal used in the different laboratories. The results
with phenylquinone writhing response indicate that there is a large
variation between mouse strains, probably much larger than hitherto
suspected, and that some strains give such poor responses that it is
impossible to get a quantitative response to mild analgesic drags. The
expediency of using a selected strain which gives a high degree ofwrithing
in the phenylquinone test is demonstrated by the consistency in the dose
response lines obtained with aspirin and in the comparatively low doses
of mild analgesic drugs required to achieve,a pronounced and consistent
reduction in the frequency of writhing. Additional support to this is
provided by Dr. P. F. D'Arcy who tells us that, by using a similar strain
ofmouse and employing identical assay procedure, he has obtained ED50
values, mean 52 mg./kg. for aspirin. These figures which were obtained
independently agree remarkably with our own.
Whilst it is not generally practicable to screen a wide selection of strains
before performing every pharmacological test, this would be advantageous
when establishing a particular long term programme for the screen or
assay of a particular series of drugs. In any pharmacology laboratory,
it would be useful to have available two to three strains of mouse of
widely differing characteristics (possibly one or two home strains supple¬
mented by commerical stocks), so that should any test appear not to be
satisfactory, although other workers have found it to be so, the test could
be performed in different strains. Certainly we would advocate that
coloured mice be more widely used in pharmacology as well as albino
mice instead of the present almost exclusive use of the latter.
With some species, the choice of strain is naturally more limited than
with the mouse and it would not be practicable, let alone economical, to
screen a variety of strains. Nevertheless, strain variation should be borne
in mind as of practical importance to an experiment rather than simply
theoretical, particularly when wide discrepancies of results appear between
404
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work performed in different laboratories. It should not, however, become
the scapegoat for all unsatisfactory results.
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Phenacetin has been implicated in kidney damage in man (Spuhler & Zollinger,
1953); however, the number of cases of kidney damage from phenacetin consumption
reported from Switzerland, Germany and Scandinavia is greater than that reported from
Australia and the United States, though the average consumption of phenacetin per head
is similar in all these countries (Ross, 1962). The reported incidence of " analgesic
nephritis " is also low in Great Britain, where the consumption of phenacetin is not less
than in the other countries (Prescott, 1965).
In preparations examined by Horisberger, Grandjean & Lanz (1958) and Grimlund
(1965) the drugs most frequently administered with phenacetin were phenazone and
amidopyrine or a close analogue. We felt that any of these drugs could be responsible
for the renal effects and we have therefore carried out a preliminary investigation in rats
comparing the toxicity of phenacetin, phenazone and amidopyrine. with particular
reference to effects on the kidney.
METHODS
Phenacetin, phenazone and amidopyrine were administered orally on 7 days a week as a
suspension in 1.25% w/v methyl cellulose in water to young, mature Sprague-Dawley strain male
rats (Charles Rivers, U.S.A.), initial weight range, 200-220 g, according to the dosage schedule in
Table 1.
Urine cytology and routine urine analysis
Not less than four animals from each group were given an oral water load equivalent to 3%
of their body weight. Immediately following this any urine in the bladder was expressed by
suprapubic pressure. The cells and particulate material in a measured aliquot of the urine collected
during the following 2-hr period were then concentrated fivefold by centrifuging for 5 min at
2,000 r.p.m., with removal of the appropriate quantity of the supernatant fluid. A portion of the
cell concentrate was then stained with a peroxidase stain (Prescott & Brodie, 1964), before quantitative
assessment in a Fuchs-Rosenthal counting chamber. At this stage the numbers of squamous cells,
peroxidase-positive cells, erythrocytes, and cells of probable renal origin, were recorded. After
centrifuging, some of the deposit was transferred to albuminized slides, fixed in alcohol, and stained
with EA 50 polychrome Papanicolaou stain (Ortho Pharmaceuticals Limited). The provisional
morphological classification made in the counting chamber wet preparation was verified using
these films.
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The remainder of the urine was examined for protein and sugar using Uaemocombistix (Ames
Division of Miles Laboratories Limited). The amount of protein required to produce an arbitrary
series of colour changes on the chemically treated strip was assesesed previously by assaying a scries
of standards on the Autoanalyser, using both the biuret and a turbidometric method. Thus, a ±
reaction is approximately equivalent to a urinary protein of less than 20 mg/100 ml., a + of 20-40
mg/100 ml., a + + of 40-60 mg/100 ml., and a -F + + of not less than 60 mg/100 ml.
Finally, urinary glutamic oxalacetic transaminase was determined on the supernatant fraction by
the Sigma Reagent Company's modification of the Reitman/Frankel procedure.
Urine 6-hr concentration test
The 6-hr concentration test used was that of Balaz, Hatch, Zawidska & Grice (1963). Drinking-
water was removed from the cage, any urine was expelled from the bladders, and exactly 6 hr later
urine was again expelled if possible. The animals were then placed in a metabolism cage equipped
with a urine-faeces separator, and the specific gravity of the urine voided in the next hour was
determined by micropyknometry. If no urine was obtained during this period the experiment was
repeated later.
Serum chemistry
Blood samples were removed by cardiac puncture with the animals under light ether anaesthesia,
and serum urea nitrogen and serum creatinine were determined with the Autoanalyser.
Terminal studies
At the end of the dosing period the animals were killed by bleeding under ether anaesthesia.
The kidneys were weighed to the nearest milligram, fixed in 10% buffered formal saline and later
prepared for histopathological evaluation.
RESULTS
Sixteen animals received phenacetin, sixteen received phenazone and twelve amido-
pyrine on 7 days a week according to the dose schedule laid out in Table 1. Sixteen
control animals received vehicle alone.
Table 1
DAILY DOSE SCHEDULE OF ANALGESICS ADMINISTERED TO RATS












Urine analyses were carried out frequently, on not less than four animals of each group
throughout the test. On day 51 of Test I and day 35 of Test II all surviving animals had
their serum urea nitrogen and creatinine determined.
The doses of the drugs administered were near the acute lethal level, so that during the
test three of the phenazone, six of the phenacetin, and six of the aminopyrine-dosed
animals died. Terminal studies were carried out on the remainder of the animals.
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Cellular exfoliation
Figure 1 shows that the rate of cellular exfoliation was considerably raised in the
phenazone-dosed animals compared with the controls and to animals given the other
two drugs. This elevation in numbers of renal tubular cells was evident even on the
second day of dosing and persisted throughout the test period. On six of the nine
occasions when the urine was examined, the elevation in urinary cell count was significant
[P<0.05] in the phenazone-treated animals compared with those receiving methyl
cellulose alone. At no time was an elevation of renal cells demonstrable in the urine of
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Fig. 1. Total renal tubular cells X 103 excreted in a 2-hr period in the urine of not less than four
rats treated orally with phenazone, phenacetin and amidopyrine according to the schedule in
Table 1. The urine was obtained following an oral water load equivalent to 3% of their body
weight.
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Routine urine analysis
There was no obvious elevation of the urinary glutamic oxalacetic transaminase at any
of the sampling dates, nor could the enzyme levels be correlated with cell count in the
phenacetin and amidopyrine groups, but there was a marginal elevation in the phenazone
group on several occasions. From the arbitrary score it was evident that there was also
a significant increase in the incidence of albuminuria in this group, as is shown in Table 2.
There was no evidence of any increased incidence of glycosuria.
Table 2
INCIDENCE OF ALBUMINURIA IN RATS DOSED WITH PHENACETIN, PHENAZONE AND
AMIDOPYRINE
A score of ± is equivalent to less than 20 nig/100 ml., + 20-40 mg,/100 ml., + + 40-60 mg/100 ml. and




















4 out of 1 +
36 animals 2+ +
Controls
4 out of 3-
40 animals 1 -
Six-hour urine concentration test
The results of the concentration test given in Table 3 show that with all three compounds
there was a statistically significant depression of urinary specific gravity, the greatest effect
occurring with phenazone and amidopyrine.
Table 3
6-HR URINE CONCENTRATION TESTS IN RATS
The specific gravity estimated by micro pycknometer at week 8 for the phenacetin- and phenazone-dosed



























Body weight and clinical condition
The terminal mean weights of the surviving animals are shown in Table 4. At the
end of the 51 days in Test I with phenacetin and phenazone, and 38 days in Test II
with amidopyrine, body weights of all the remaining test animals were depressed com¬
pared with the controls. The depression in body weight, which was significant in all
instances, was more pronounced with amidopyrine than with the other two compounds.
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Table 4
MEAN TERMINAL BODY WEIGHTS IN GRAMS OF RATS DOSED WITH PHENACETIN AND
PHENAZONE (51 DAYS) AND AM1DOPYR1NE (38 DAYS)
Numbers of animals are given in parentheses
Test I
Phenacetin Phenazone Controls
Mean 376 (10) 361 (13) 428 (16)
t 2-70 4-23
P <0 05 <0-001
Test II
Amidopyrine Controls
Mean 321 (6) 437 (12)
I 6-15
P <0-001
Apart from the effect of body weight none of the animals showed any external signs,
but serum urea nitrogen and serum creatinine levels were elevated in two out of six of
the amidopyrine and one out of thirteen of the phenazone-dosed animals at the end of
the test.
Organ weights
The mean gross kidney weight (Table 5) rose considerably in the amidopyrine-dosed
animals. Table 5 shows the mean value compared with that for the other two analgesics
and the controls.
Table 5
MEAN GROSS KIDNEY WEIGHTS IN GRAMS FROM SURVIVING RATS AT THE END OF THE
TEST PERIODS. BOTH KIDNEYS WERE WEIGHED
Numbers of kidneys examined are given in parentheses
Test I
Phenacetin . Phenazone Controls









The most striking histological finding in paraffin sections of kidneys was in animals
given amidopyrine. There was a sharply localized necrosis of the papillary tip in five
out of six of these animals. This lesion was associated with a varying degree of tubular
atrophy and dilatation, which in some cases occurred with an infiltration of cells of
the chronic inflammatory type (Fig. 2). There was some congestion of the capillaries
throughout the medulla, and occasional casts in the collecting tubules were also present
in some animals.
In contrast, however, no papillary necrosis was seen in any of the phenacetin- or
phenazone-treated animals. In one phenazone-treated animal there was much congestion
throughout the entire tissue, with the occasional focus of cellular infiltration—again of
the chronic inflammatory type—in the interstitial spaces.
Otherwise the kidneys from all other animals were normal.
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Fig. 2. Photomicrograph (X125) of a haematoxylin and eosin stained paraffin section of the renal
papilla of a rat treated orally with amidopyrine according to the dose schedule in Table 1. This
shows a sharply localized necrosis in the papillary tip.
DISCUSSION
Most analgesics are commonly taken in the form of mixtures. The composition of
these mixtures varies from country to country, but in broad terms in Europe the principal
components are phenacetin and phenazone, or a near analogue such as amidopyrine,
whereas in the United Kingdom and North America the analgesic constituents are usually
aspirin and phenacetin. Phenazone and amidopyrine are not used to any extent in the
Anglo-Saxon countries because of their recognized toxicity, particularly that of amido¬
pyrine with its propensity to cause agranulocytosis.
In assessing the possible toxic effect of these mixtures it is virtually impossible to
determine from human studies which compound is the one responsible and in the
circumstances only animal studies carried out on the individual components can provide
a satisfactory guide. Most studies in animals, however, have been inconclusive. A
two-year study by Woodard, Post, Cockrell & Cronin (1965) in dogs with large doses of
phenacetin failed to indicate any renal abnormality. In rats and rabbits, before a
nephrotoxic action could be demonstrated it was necessary to infect the kidney with
either E. coli (Miescher, Schnyder & Krech, 1958) or Staphylococci (Studer, Zbinden &
Fust, 1958). On the other hand Abrahams, Rubenstein & Levin (1963) claim to have
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induced papillary damage in rats to which tablets of phenacetin and also aspirin,
phenacetin and caffeine were administered for 15 months. They, however, used Wistar
rats, which have a high incidence of natural renal malformation, which could complicate
the picture (Sellars, Rosenfeld & Friedman, 1960).
Animal experimentation, therefore, has so far provided little information about the
effect of phenacetin on the kidneys and the circumstantial evidence points to the possibility
of another agent being the cause.
Fazekas, Fazekas & Bertok (1960) studied experimentally in rabbits and cats the effect
of high doses of amidopyrine, and have clearly demonstrated an effect on kidney function.
Initially they found an oliguria, followed by a persistent polyuria, the animals ultimately
dying in uraemia. Histological studies by the same authors showed that amidopyrine
caused extensive necrotic changes in the kidney, particularly to the glomeruli and the
vasa recti. The histological picture in these species, shown by Fazekas, Fazekas &
Bertok (1962), does not, however, correspond to the classical picture of human pyelo¬
nephritis or interstitial nephritis as described by Thiel, Spuhler & Uehlinger (1964), but
their results show unequivocally that amidopyrine causes serious damage to the kidney.
On the other hand, the results of our experiments in rats have not only confirmed the
nephrotoxic action of amidopyrine, but have also demonstrated that amidopyrine pro¬
duces papillary necrosis similar to the chronic papillary necrosis in man (Knudsen,
personal communication).
There are differences in the levels of exfoliation of renal tubular cells in the urine
between the two groups of control animals, but phenazone caused a statistically significant
elevation of cellular exfoliation in the urine over the control values, whereas amidopyrine,
which caused extensive necrosis of the renal papillae, did not. Prcscott (1956) demon¬
strated in man that mild analgesic drugs will cause an increase in the number of cells
in the urine, aspirin having by far the greatest effect, whereas the effect of phenacetin was
very much less, being only slightly greater than the control values. Taken in conjunction
with Prescott's observations, our results indicate that the elevation of cells excreted
in the urine need not necessarily suggest that the drug will cause actual renal damage.
Nevertheless, phenazone and phenacetin have an effect on kidney function in rats as
shown by a reduction in urinary concentrating ability, phenazone having a greater action
in this respect than phenacelin. Kincaid-Smith (1967) has studied the pathogenesis of
the renal lesion associated with the abuse of analgesics and has formed the view that
renal papillary necrosis is the primary lesion. In view of the fact that amidopyrine
and related drugs are used extensively in Europe, and from our own animal studies
showing that amidopyrine will cause renal papillary necrosis, it would be of interest
to carry out a retrospective epidemiological survey of the use of analgesic preparations
to determine whether the incidence of nephritis associated with analgesic abuse is related
to phenacetin or to the pyrazalone group of drugs.
SUMMARY
1. Phenacetin, phenazone and amidopyrine were given to rats in large doses by
mouth over a period of 5 to 8 weeks and the effects of these drugs on kidney function
were studied.
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2. Phenazone causes a persistent celluria with evidence of slight kidney damage,
whereas amidopyrine causes papillary necrosis but little if any celluria ; phenacetin causes
neither.
3. The ability of the kidney to excrete a concentrated urine is adversely affected
particularly by amidopyrine, to a lesser degree by phenazone, and to a very small extent
by phenacetin.
4. It is possible that cases of "analgesic nephritis," reported from Europe, may be
caused by the presence of amidopyrine and perhaps phenazone in most of the analgesic
preparations used.
Our thanks are due to Dr. A. Knudsen, consultant histopathologist to the West Middlesex
Hospital, and Dr. L. E. Mawdesley-Thomas, of Huntingdon Research Centre, for their interpretations
of the histological specimens and to Professor C. A. Keele for helpful criticism.
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A number of polymethylene bis-tertiary sulphonium quaternary
ammonium salts have been examined for their ganglionic blocking
activity on the superior cervical ganglion of the cat. The effect of
substituting different alkyl groups on the sulphur and nitrogen atoms
and varying the length of the polymethylene chain has been investigated.
Maximum activity was found in the tetramethylene di-ethyi sul¬
phonium tri-etnyl ammonium salt, which was about three times as
active as hexamethonium. With tri-, penta- and hexamethylene
salts maximum activity occurs when there are a total of 13 to 15
carbon atoms in the molecule. It is concluded that the substitution
of sulphur for nitrogen in the bis-quaternary ammonium salts does
not necessarily lead to a reduction in relative potency. The importance
of the groupings on the "onium" centres in producing ganglionic block
is stressed.
The effect of substituting sulphur for nitrogen in polymethylene bis-
quaternary ammonium salts has been investigated by several workers.
Walker1 has shown that replacing one nitrogen with sulphur in deca-
methonium led to a decrease in neuromuscular blocking activity. Muir
and Lewis2 confirmed this and demonstrated that the type of neuro¬
muscular block produced by analogous sulphur-nitrogen compounds is
unaffected. Barlow and Vane3 synthesised a number of bis-alkyl tertiary
sulphonium analogues of hexamethonium which proved to have less
ganglionic blocking activity than their corresponding bis-quaternary
ammonium salts. Wien1 reported the replacement of nitrogen by sulphur
in hexamethonium and its homologues to reduce activity. From these
investigations it would appear that the replacement of nitrogen by sulphur
in polymethylene bis-alkylammonium salts causes a decrease in relative
activity.
We have investigated the ganglionic blocking activity of a series of
straight chain polymethylene tertiary sulphonium quaternary ammonium
salts synthesised by Doyle and Stove5. Among the compounds tested a
number have been shown to possess ganglionic blocking activity in excess
of hexamethonium.
Methods
The ganglionic blocking activity of compounds was assessed on the cat
nictitating membrane preparation. The method was slightly modified
from that described by Barlow and Vane3. Cats were anaesthetised with
ether followed by intravenous chloralose-urethane mixture (0-7 per cent
chloralose, 2-8 per cent urethane, 8-0 ml./kg.). A square wave stimulus
of 1-0 millisecond duration and frequency of 14 shocks per second was
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applied for 15 seconds every 3 minutes to the preganglionic fibres of the
superior cervical ganglion. The voltage was adjusted to give just maximal
contraction of the membrane. The nictitating membrane completely
relaxed after each period of stimulation. The compounds were
administered intravenously, into the femoral vein, 30 seconds before
stimulation. The dose of hexamcthonium bromide to give approxi¬
mately 50 per cent inhibition of contraction (0-5 to 1-0 mg./kg.) was
No. of methylene groups
Fig. 1. Relationship between sympathetic ganglion blocking activity and chain
length in a series of polymethylene bis-tertiary sulphonium quaternary ammonium
salts.
General formula: R,R,S+(CH2)„N+R3R4R5
ri r2 r3 r3 rs
©—© ch3 ch3 ch3 ch3 ci13
0—0 ch3 c2h5 ch3 ch3 qhs
x—X ch3 qh5 ch3 qhs qh6
a. qh5 c2h5 qh5 c2h5 c2h6
determined. Three doses of hexamethonium were then bracketed with
two doses of the test compound and from the log-dose response lines
obtained the relative potency of the compound was calculated.
The acute intravenous toxicities were determined in male mice weighing
18 to 22 g. and expressed as the LD50 in mg./kg.
Results
Figure 1 illustrates the alteration in ganglionic blocking activity as a
result of increasing the length of the polymethylene chain and substituting
successively ethyl groups for methyl groups on the sulphur and nitrogen
atoms. Compounds with methyl groups only on the sulphur and nitrogen
have demonstrable ganglionic blocking activity, but this is always less
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than hexamethonium. The pcntamethylene, hexamethylene and hepta-
methylene compounds are equipotent, and have a relative ganglionic
blocking activity of about 0-4 times hexamethonium. The tetramethylene
and octamethylene compounds are inactive. When an ethyl group is
substituted for a methyl group on both the sulphur and nitrogen atoms the
relative activity within the series increases; the tetramethylene derivative
has an activity of 0-4 times hexamethonium, while maximum activity
occurs with the pentamethylene derivative which has a potency of 0-85
10 II 12 13 14 15
Total no. of carbon atoms in cation
Fio. 2. Relationship between sympathetic ganglion blocking activity and total
number of carbon atoms in the cation of a series of trimethylene bis-tertiary
sulphonium quaternary ammonium salts.
General formula: R1R2S+(CH,)3N+R,R1R5
Code




645 qh6 Qh6 c2h5 QHs






688 ch3 c3h7n ch3
times hexamethonium. As the chain length is increased activity falls
away rapidly and no significant ganglionic blocking activity is detectable
in the octamethylene salt.
When a further methyl group is replaced by an ethyl group on the
nitrogen atom, maximum activity occurs with the hexamethylene com¬
pound—the ethylmethylsulphonium di-ethylmethylammonium salt. This
compound was slightly more active than hexamethonium. The higher
members of this series, however, have not been investigated and therefore
a complete picture of the variation in activity within the series has not been
obtained.
Replacement of all the methyl groups by ethyl groups markedly alters
the activity. There is a sharp increase in activity between the compounds
having 3 or 4 carbon atoms in the chain. While the former is only 0-5
times as active as hexamethoniuni the latter is 3-3 times as active. The
pentamethylene derivative is less active than the tetramethylene derivative,
but is still twice as active as hexamethonium. The hexamethylene
derivative has a relative potency of only 0-6.
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TABLE I
Sympathetic ganglion blocking activity and intravenous toxicities of a
series of r^s.s+fch^in+rjrjrs salts
Code
number






bromide = 10Ri r, r, | r. r.
BRL 443 ch, ch, ch, ch, ch, 194 <002
534 ch, c,h, ch, ch, ch, 170 0-2
519 ch, c,h, ch, ch, c,h, 119 0-4
524 ch, ch, ch, c,h, c,h, 103 0-4
644 csh6 c,h, ch, ch, c.h, 99 0-9
525 ch, c,h, ch, c,h, c,h, 54 0-9
653 ch, c,h, c,h, c,h, c.h, 25 1-3
611 c,h, c,h, c,h, c,h, c,h, 45 3-3
530 ch, ch, ch, c,h,n c,h,n 75 0-6
683 ch, ch, ch, c,h;i c,h,i 26 1-8
678 ch, c,h, ch, c,h,l c.h,/ 26 2-5
654 ch, c,h,/ ch, c,h,/ c,h;i 20 0-4
531 ch, C3H7W ch, C,H,n C,H7/i 40 0-2
652 ch, csh, c,h, C,H,n CsH?/i 50 1-4
667 c.h, c,h7/i c,h, c,h, C3h:/T 31 0-4
589 ch, ch, CH, C,H,n C4h9.'j 41 0-5
8 10 12 14 16 18
Total No. of carbon atoms in cation
Fig. 3. Relationship between sympathetic ganglion blocking activity and total
number of carbon atoms in the cation of a series of tetramethylene bis-tertiary sul-
phonium quaternary ammonium salts.
Numbers refer to structures shown in Table I.
98 T
71
TERTIARY SULPHONIUM QUATERNARY AMMONIUM SALTS
The effect on the ganglionic blocking activity of substituting in turn
methyl groups by larger groups in the tri-, tetra-, penta- and hexamethylene
series was investigated further. The variation in activity of the com¬
pounds in the trimethylene series is illustrated in Figure 2. Maximum
ganglionic blocking activity occurs when only ethyl groups are present on
the sulphur and nitrogen atoms. When there are more than a total of




















Total No. of carbon atoms in cation
16
Fig. 4. Relationship between sympathetic ganglion blocking activity and total
number of carbon atoms in the cation of a series of pentamethylcne bis-tertiary sul-
phonium quaternary ammonium salts.
General formula: R1R2S+(ch2)sN+R3R4R5
Code
No. ri r2 Rb r4 r5
444 ch3 ch3 ch3 ch3 ch3
623 ch, c2h5 ch3 cfi3 qhs
606 ch3 ch3 ch3 c2h5 QH5
607 c1i3 qh5 ch3 c2h5 QH5
624 QH5 qh5 c,h5 c2h5 c2h5
685 ci-i3 ch3 ch3 c3h7/i c3h,n
682 ch3 QH5 QHj c3h,« c3h,«
In the tetramethylene series a different picture evolves. The variations
in the groupings and their relative ganglionic blocking activities obtained
are given in Table I and are illustrated graphically in Figure 3. Maximum
activity in this series again occurs when only ethyl groups are present on
the sulphur and nitrogen atoms, but in this instance the compound is
about 3 times as active as hexamethonium. Larger or smaller groups than
ethyl on the sulphur and nitrogen atoms leads to diminished activity.
There is also an interesting relationship between the compounds possessing
n-propyl and isopropyl groups. A comparison between the dimethyl
sulphonium di-isopropyl methyl ammonium salt (B.R.L. 683) and the
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corresponding «-propyl isomer (B.R.L. 530) and a comparison between
the methyl isopropyl sulphonium methyl di-isopropyl ammonium salt
(B.R.L. 654) and the /;-propyl isomer (B.R.L. 531) shows that the n-
propyl compound is in both instances much less active than the corre¬
sponding isopropyl isomer.
The compounds prepared with the pentamethylene chain form a rather
incomplete picture. The activities are expressed graphically in Figure 4.
Maximum activity again occurs when only ethyl groups are present on the
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Total No. of carbon atoms in cation
Fig. 5. Relationship between sympathetic ganglion blocking activity
and the total number of carbon atoms in the cation of a series of hexa-
methylene bis-tertiary sulphonium quaternary ammonium salts.
General formula: R1R2S+(CH2)6N+R3R4R5.
Code
No. r. r- r* r« r5
347 ch3 ch» ch, ch3 ch3
518 ch3 qh5 ch3 ch3 ch3
451 ch3
qh5
qhs ch3 ch3 QHs
701 qh5 ch3 chs QHs
523 ch3 QHs ch3
QHs
QHs QHs
612 QHs QHs QHs QHs
ammonium derivative is of the same order of activity. Compounds with
larger groups than ethyl on the sulphur were not prepared, and hence it
has been impossible to determine at which stage maximum activity does
occur.
The ganglionic blocking activity in the hexamethylene series ;s illustrated
in Figure 5. Maximum activity occurs with the diethyl sulphonium
dimethylethyl ammonium salt, and the ethylmethyl sulphonium di-
ethylmethyl ammonium salt. Both these compounds are slightly more
active than hexamethonium. The diethyl sulphonium triethyl ammon¬
ium salt is about 0-6 times as active as hexamethonium. Compounds
possessing larger groups on the sulphur and nitrogen were prepared, but
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Discussion
To achieve the maximum ganglionic blocking activity 4 carbon atoms
are required in the carbon chain separating the sulphur and nitrogen atoms
and the presence of only ethyl groups on the nitrogen and sulphur atoms
is necessary. Barlow and Vane3 similarly found that maximum activity
in the hexamethylene bis-alkyl sulphonium series occurred when only
ethyl groups were attached to the sulphur atoms. In the compounds
with 3 carbon atoms in the chain the activity is not marked, but when the
chain length is increased to 5 carbon atoms compounds With activity of
twice that of hexamethonium have been obtained. Increasing the length
of the chain to 6 carbon atoms likewise results in compounds with slightly
greater activity than hexamethonium, but activity in this series follows a
somewhat different pattern than seen in the preceding series. Relative
activity would appear to follow more closely the change in activity seen
with the bis-nitrogen compounds when the methyl groups are substituted
in turn by ethyl groups as shown by Wien, Mason, Edge and Langston6.
These workers found that the penta- and hexamethylene bis-dimethyl-
ethyl quaternary ammonium salts were the most active of the compounds
tested, and of the 4 carbon chain compounds the bis-diethylmethyl
ammonium salt was the most active. In the sulphur-nitrogen series the
most active hexamethylene derivatives are the diethyl sulphonium di-
methylethyl ammonium salt and the ethylmethylsulphonium diethyl-
methyl ammonium salts. Both are equiactive.
Wien and his colleagues also showed that the salt of hexamethylene
bis-triethylammonium was practically devoid of ganglionic blocking
action, but had a significant neuromuscular paralysing action. No such
alteration in effect has been demonstrated in the sulphur-nitrogen series
even with the substitution of larger groups. The shorter chain sulphur-
nitrogen compounds would seem to be remarkably free from neuro¬
muscular blocking action.
The modifications to structure of mono-quaternary and bis-quaternary
ammonium salts which have shown ganglionic blocking activity has been
investigated by several workers. Burn and Dale7 found that substitution
of the methyl groups by ethyl groups in tetramethylammonium abolished
nicotinic stimulatory action on the blood pressure while maintaining the
nicotine paralysing action. Subsequently Paton and Zaimis8 demon¬
strated in a series of polymethylene bis-trimethylammonium salts the
importance of the distance between the two onium centres. They showed
that maximum activity occurred when the polymethylene chain contained
5 or 6 carbon atoms, the hexamethylene derivative being 20 times as active
as tetraethylammonium. Wien and others6 extended this work and
investigated the effect of substitution of methyl by ethyl on the nitrogen
atoms. They showed that optimal activity depended on both chain length
and the nature of the substituents on the nitrogen atoms. The results of
the present investigation emphasise the importance of the groupings on
the onium centres and also stresses the fact that 5 to 6 carbon atoms separ¬
ating the onium centres are not necessary for optimal activity. Never¬
theless, depending on the type of onium centre present, an optimum
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number of carbon atoms would appear to be necessary. In tertiary
sulphonium quaternary ammonium compounds optimal activity occurs
when there are only 4 carbon atoms in the polymethylene chain. How¬
ever, to ensure an adequate fit on a receptor site, and so inducing ganglionic
block, both the total length and general shape of the molecule appear to
be of importance. That the volumes and effective radii of the groupings
on the onium centre play a part in determining activity is evident from the
difference in activity in the isomeric compounds containing «-propyl and
/^opropyl groups. The end groupings probably regulate the approach of
the molecule to the receptor site and maximum ganglionic blocking activity
is attained when there is correct electrolytic balance between drug and
receptor site.
Acknowledgements. Our thanks are due to Mr. F. P. Doyle and Mr.
E. R. Stove for synthesising the compounds.
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Effect of Anti-inflammatory Agents on
Capillary Permeability and CEdema
Formation
Following the injection of a noxious substance such
as formalin into the subcutaneous tissues of an animal an
inflammatory response ensues. If the injection is made
into the feet (usually of rats), the degree of inflammation
can be assessed by measuring the amount of swelling
produced. The inflammatory response can also be
measured by assessing the penetration of an intravenously
administered dye into the affected area. The dye is bound
to the plasma protein - and therefore the amount of
coloration produced gives an indication of the leakage
of plasma.protein through the capillary walls. Parratt
and West1 and Xorthover and Subramanian2 have
concluded from their experimental work that cedema
formation and protein leakage are closely linked. On the
other hand Gozsy and Kato3 and Wilhelm1 have indicated
that processes are independent. In examining the action
of anti-inflammatory drugs we have confirmed the -views
of the latter workers and have found that blireing and
swelling can be affected independently.
The action of the drug on the blueing of mouse ears is
assessed by giving intravenously a 0-5 per cent solution of
'Pontamine' sky blue in normal saline at a dose of 0-12
ml./10 g body-weight. The left ears of these mice are
treated with xylol (2 drops to each surface of the ear
applied with a syringe and needle) and in 15 min they
become bright blue in the majority of mice. The reactors
are picked out and randomly divided into groups (mini¬
mum number of 10 per group). Drugs at various dose-
levels are given orally and 1 h later the right ear is
treated with xylol. We have shown that in untreated
control animals the blueing is unaffected between one
ear and another under similar conditions. After 15 min
the test is read as follows: if the blue of the left ear is
more intense than the right ear a positive score is recorded.
The percentage of positives is plotted against the dose
on log paper and the FD50,value estimated graphically.
In the case of hydrocortisone, since the optimal time of
testing would be expected to occur 4-6 h after oral
administration, the test has to be modified as follows:
30 mice were taken and lo were treated with hydrocorti¬
sone crallv and the other 15 used as non-treated controls;
after 4-6 h both groups of mice were treated with intra¬
venous dye, then with xylol on the ears. After 15 min the
ears were scored 0. 1, 2 and 3 according to the degree of
blueness. Treated scores were compared with control
scores by Student's t test.
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(polybrene (s.c.)) 6-2 55
Hydrocortisone incfTective 2-5
We also assessed the anti-inflammatory potency of tlio
drugs by their effect on the increase in weight due to
oedema of mouse ears when xylol is applied. Groups of
10 mice are treated orally with the drugs to be tested.
A control group is also used. One hour later the right ears
are treated with xylol as in the blueing test and after 30
min the mice are killed with chloroform and the ears cut
off and woighed. The mean excess weight of the right ear
is compared in control and treated groups, the effect of the
drug being expressed as a percentage reduction of cedema
formation, which is plotted against dose on log probit
paper and the EDi0 estimated. In the case of hydrocorti¬
sone, xylol was applied 4 h after treatment (this being
the maximum time of effect).
The results obtained are summarized in Table 1. Hydro¬
cortisone has little effect on the blueing reaction and is
highly effective against the cedema formation. On the
other hand, phenylbutazone and polybrene (hexadime-
thrine bromide) are relatively ineffective against cedema
but active in preventing blueing. Aspirin and chlor¬
promazino have a dual action.
Armstrong and Stewart5 liave suggested that polybrene
acts as an inhibitor of kinin fonnation in vitro, and since
polybrene effectively inhibits the blueing reaction it
would appear to have a similar action in vivo. Our experi¬
ments therefore are compatible with the view that kinins
are liberated in the inflammatory response, but also show-
that oedema formation and protein transfer are two
separate aspects of this response, kinin formation being
associated with the latter aspect.
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